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ANGLIA RUSKIN UNIVERSITY 
ABSTRACT 
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EMMA KAMINSKIY 
 
Decisions concerning psychiatric medication are complex and often involve a protracted 
process of trial and error. The serious and enduring nature of side effects associated with 
psychiatric medication demands that medical and experiential expertise is shared in a way 
that is supportive of the longer term recovery journey.  Historically poor concordance 
rates point to a lack of trust and difficulties in sharing decisions constructively.  This Ph.D 
explores views and experiences of shared decision making for psychiatric medication 
management amongst mental health service users and practitioners. 
 
The study was conducted in a community mental health service, in the UK. A participatory 
methodology was employed, within a social constructionist paradigm. Service users and a 
carer were involved in all phases of the research process. Thirty qualitative interviews 
were undertaken with different stakeholders: psychiatrists, community psychiatric 
nurses, and service users. A thematic analysis was employed.  In addition, an applied 
conversation analysis was undertaken on four recorded outpatient medication related 
meetings.  
 
Enablers of and barriers to shared decision making were found at three levels of analysis: 
the interaction, the relationship, and the system.  Many divergent discourses were 
apparent across these levels, both within and between the different stakeholder groups. A 
typology of involvement is proposed and discussed, from fractured passivity through to 
active self- management. The barriers to collaborative practice identified in these findings, 
and the structural factors at work in the mental health system in particular, were seen to 
explain the gap between policy ideals and current practice. Strong therapeutic 
relationships were found to be a vital enabler, comprising of: a formation of trust, 
practitioners knowing and believing in service users’ potential, and ‘walking the journey 
together’.   
 
Shared decision making in this study is found to be a dynamic process over time, involving 
two (or more) participants in a complex interplay.  The thesis emphasizes the interaction 
between structure and agency in shared decision making in psychiatric medication 
management and highlights how power is enacted in the context of shared decisions in a 
community setting.   
 
Original theoretical, methodological and practical contributions to knowledge are 
presented and discussed. 
 
 
Key words: shared decision making, psychiatric medication management, recovery, 
mental health, participatory methodology 
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"He who does not know one thing knows another."  
Kenyan Proverb 
 
 
“We don't accomplish anything in this world alone... and 
whatever happens is the result of the whole tapestry of 
one's life and all the weavings of individual threads form 
one to another that creates something”. 
 Sandra Day O'Connor, Supreme Court Justice 
 
 
 
“Knowledge, if it does not determine action, is dead to us. 
Knowledge has three degrees-opinion, science, 
illumination. The means or instrument of the first is sense; 
of the second, dialectic; of the third, intuition”. 
Plotinus 204 or 205 C.E., Egyptian Philosopher 
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Introduction 
 
In this section, I briefly describe the context and rationale for the research in relation to 
current policy and practice in psychiatric medication management. I will then present the 
wider community roots that have shaped the scope, aims and ethos of this study, reflecting 
on my own position and outsider status at the onset of the study.  The introduction 
concludes with an overview of the layout of the thesis and chapter content. 
0.1. Empirical rationale and brief description of the study 
This thesis explores the views and experiences of both service users and practitioners, 
building a comprehensive understanding of the everyday realities of shared decision 
making for psychiatric medication management, in a community based mental health 
team.  
 
Psychotropic medication is the key component of many mental health treatment plans 
(Healy, 2009). Medication can be an important tool for an individual’s personal recovery, 
but decisions pertaining to medication are complex and involve a process of trial and 
error, where potential benefits are weighed up against the adverse impacts  medication 
may have for a person’s functioning,  quality of life and identity  (Deegan, 2005;2007; 
Kartalova‐O'Doherty  and Tedstone-Doherty, 2010).  Service users may grow in expertise 
and refine medication strategies over time finding the right balance between what they do 
to be well and what they take to be well (MacDonald -Wilson et al, 2013, p. 263). However, 
often people who are prescribed psychiatric medication do not take it systematically and 
do not share this information with their doctor. Strategies such as only taking medication 
at certain times or non adherence may, for some, act as a positive attempt at self 
management (Britten et al, 2010; Pound et al, 2005; Roe et al, 2009).  Yet previous 
research suggests that often service users do not inform or consult practitioners in the 
serious decision to come off psychiatric medication (Read, 2005). This highlights lack of 
trust between mental health service users and their clinicians, and difficulties in sharing 
knowledge, both scientific and experiential.  
 
It is proposed that shared decision making offers opportunities for service user knowledge 
and experience of taking and using psychiatric medication to move to the fore, thereby 
enabling greater empowerment, enhanced control, and a partnership with practitioners in 
their personalised treatment plan (Deegan and Drake, 2006; Drake, Deegan and Rapp, 
2010; Baker et al, 2013).  Here the service provider and prescribers' role is to assist in the 
3 
 
 
process of individual led recovery, with a corresponding move away from clinically 
defined care (Shepherd, Boardman and Slade, 2008).   
 
The model of shared decision making has been growing in support and is now ingrained 
into policy and professional discourse, sitting within the larger move towards recovery 
based practice in mental health. This, along with person centred care is now considered to 
be a core component of the UK mental health system (NIMHE, 2005; DH, 
2009;2012a;2011a).  
 
However, transactional models of SDM and research exploring its utility have originated in 
other fields of medicine. Far less research has been undertaken in mental health that 
explores service user involvement in decision making concerning psychiatric medication. 
This PhD thesis adds to existing knowledge by exploring both service users’ and 
practitioners’ views and experiences of shared decision making for psychiatric medication 
management, allowing for a contextualised and grounded conceptualisation to emerge.   
0.2. Local historical context 
The roots of this research lie in the wider local community within which the research has 
taken place.  Following MIND’s well publicised report which looked into the experiences of 
people trying to come off psychiatric drugs (Read, 2005), a group of passionate and 
concerned people came together locally, to discuss their own experiences and views about 
psychiatric medication management practice.  This group consisted of mental health 
service users, mental health service providers, carers, and researchers1. The group met on 
a regular basis and grew in membership and recognition.  Demand was such that in 2007 a 
conference was organised locally, attended by over 100 delegates. While discussion and 
debate remained the focus, tangible outputs from this event centred on the need to build 
more understanding about people’s experiences and views of sharing decisions about 
psychiatric medication, with the aim of promoting increased awareness, reflection and 
change.  This PhD was originally conceived as supporting the action research project on 
shared decision making in psychiatric medication (later funded by the RfPB scheme of the 
NIHR2 in 2011). Thus, this study has been subsequently shaped by and I hope ultimately 
contributes to this wider community initiative, to bring about positive change in people’s 
day to day experiences of medication management practice. 
                                                             
1
 Professor Shulamit Ramon, PhD supervisor, was a member of this group 
2
 Research for Patient Benefit program, National Institute for Health Research 
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I first met the supervisory team for this project as part of a panel interview for the PhD 
studentship in December 2009. I was excited at the prospect of being involved, yet 
conscious of my own naivety and lack of personal experiential understanding about 
mental ill health or indeed mental health services.  I was also aware that I did not have a 
particular psychiatric or nursing background, or in participatory research, which hindered 
my confidence.  However I felt my ‘outsider’ status would be helpful in remaining focused 
on emergent findings, as opposed to a priori knowledge, and be sensitive and grounded to 
the life world of the participants as oppose to being heavily influenced by a set of pre 
existing conceptions. Since the onset of the research, the focus has remained on 
acknowledging differing perspectives and experiences and embracing complexity. Power 
was an important theme throughout, in both the undertaking of the research, and for the 
conceptual framework of the study. I reflected on power differentials between; myself as 
academic researcher and both service user participants and co researchers; and also in the 
dynamics between the advisory group members.  My academic training in research 
methodology (for Psychology) prior to the PhD provided me with some comfort in the 
early phases of the research planning process, but subsequently much of my academic 
objectivism  was challenged as I embraced the values and participatory ethos of the study. 
This remains for me the most important aspect of this project personally and the 
knowledge that research is, in of itself, a way of engaging with the social nature of reality, 
and can promote change and reflection. 
 
There were two overarching research questions for this thesis: 
What are key stakeholder views about shared decision making for psychiatric 
medication management? 
How are decisions about psychiatric medication made in practice?  
 
Within these overarching research questions, some key research themes were identified: 
- What are the enablers of and barriers to SDM for psychiatric medication management? 
- Current medication management practice in a community-based mental health service 
- Similarities and differences in how SDM is conceptualised between stakeholder groups 
- Acknowledgement of a need for change, making recommendations for practice based 
on the findings. 
 
A social constructionist paradigm and participatory ethos underpinned the research. Co 
researchers’ contributions throughout the study are reflected in the written thesis 
presented. The study describes how different stakeholder groups viewed meaningful 
involvement and builds on key stakeholders’ valuable experience and in depth 
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understanding of sharing decisions in practice. There were two phases to the data 
collection process: an in depth research interview and recorded meetings. Findings 
emerged at three levels of analysis (the interaction; the relationship; the system) and 
these support a broader conceptualisation of SDM. Theoretical and practical implications 
are discussed and methodological contributions are considered. 
0.3 The thesis layout and chapter outline 
 
Not including this introductory section, the thesis consists of 10 chapters.  
 
Chapter One describes the context of the study. The contemporary historical and policy 
context for mental health services in the UK is introduced.  The role of psychiatric 
medication in community based mental health services is critiqued, alongside a 
presentation of key trends and changes in the provision of mental health services.  The 
model of personal recovery is highlighted as a key policy for shared decision making in 
psychiatric medication management practice.  The concept of personal recovery, its 
historical roots and influence on contemporary mental health service delivery, are 
considered. 
 
Chapter Two - the literature review - begins with an overview of dominant models of 
decision making in healthcare. This is followed by a discussion and critique of the model of 
shared decision making and an examination of broader constructs of collaboration and 
involvement.  The second part of this chapter explores the research that has examined 
decision making preferences and practice in mental health. This section explores how 
applicable  are models, such as shared decision making,  to making decisions about 
psychiatric medication. Barriers to achieving meaningful involvement in mental health are 
also considered. Gaps in the current literature are highlighted, and the research questions 
are described, highlighting the study’s original contribution to knowledge. 
 
In Chapter Three, the theoretical construct of power is considered and influential theories 
are evaluated, focussing on their applicability to the context of psychiatric medication 
management. The chapter concludes with a presentation of the conceptual framework for 
the thesis. 
 
Chapter Four considers the philosophical assumptions, values, methodological choices and 
research design of the study. Tensions that arise, as well the potentially illuminating 
aspects of the chosen methodology, are highlighted. I draw particular attention to the 
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participatory ethos of the research, exploring how this enhances the knowledge produced.  
Key decisions made in the data collection methods and analytical approaches are 
described, alongside consideration of   ethical issues and strategies for validating findings.  
 
Chapters Five, Six, and Seven present findings from the research interviews conducted 
with service users; community psychiatric nurses; and psychiatrists respectively. Findings 
are presented at three levels analysis: the interaction, the relationship and the system. A 
summary of the commonalities and areas of differences both within and between the 
stakeholder groups are provided.  
 
Chapter Eight presents findings from phase two of the data collection process: the 
recorded meetings. This chapter supplements themes presented in Chapters Five, Six, and 
Seven and contributes additional understanding of how decision making is being shared in 
the encounters. Relevant interview data from phase one, additional contextual 
information, and the dynamics of the recorded meetings are incorporated within the 
presentation of findings. Links to phase one findings are discussed and the diversity 
between meetings explored.  
 
Chapter Nine draws together the findings presented in Chapters Five through to Eight, 
linking findings to the existing literature, models of shared decision making, and the 
theoretical construct of power. A broader conceptualisation of shared decision making for 
psychiatric medication management is supported, emphasising the dynamic and 
protracted nature of the process.  Three levels of analysis: the interaction, the relationship, 
and the system, are used to structure the discussion.  Divergent discourses are discussed 
at each level of analysis. At the interaction level, a typology of involvement is offered, 
comprising: Fractured passivity; Tactful manipulation; Shared; and Active Self-
Management. 
 
Chapter Ten concludes the thesis with a discussion of the implications of the findings for 
mental health policy and practice. Theoretical and methodological contributions to 
knowledge are presented. I consider the limitations of the study and make 
recommendations for further research. 
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Chapter One. The research context.  
 
 
 
 
 
 
 
 
 
 
1.1 Contemporary UK mental health service provision.  
 
1.1.1. Historical and Policy context since the 1980s. 
 
How mental health services are delivered today is fundamentally different to that of a few 
decades ago. Today, one of the cornerstones of modern psychiatric practice is the 'multi-
disciplinary team', with social workers, occupational therapists, counsellors, clinical 
psychologists, and community psychiatric nurses, among others working as generic 
mental health professionals in the delivery of care.  The professionalisation of different 
practitioner groups in community based mental health teams has been an important trend 
during this time frame (Shorter, 2006). Whether this has led to fundamental impact on the 
cultural practice of mental health delivery service, nonetheless, remains questionable3. 
Regardless, the community mental health approach is associated with a number of 
improvements in service delivery (Thornicroft and Tansella, 2004). Under the labour 
government, mental health services saw the introduction of the National Service 
Framework(NSF) (DH, 1999) and a more functionalised approach, moving away from 
generic community mental health teams4 (Glasby, 2012). 
 
But, more broadly, since the 1980s there has been transformational change, away from 
psychiatric hospitals and institutional based care, towards care in the community.   The 
use of psychiatric medication for therapeutic purposes has also been increasing over this 
period. For example, the percentage of depressed outpatients treated with 
                                                             
 
4
 With for example the introduction of assertive outreach teams and early intervention services. 
Chapter outline 
This chapter highlights the timeliness and relevance of the study by exploring the 
contemporary historical and policy context for psychiatric medication management 
practice. The role of psychiatric medication in community based mental health 
services is highlighted, alongside a presentation of key trends and changes in the 
provision of mental health services.  The model of personal recovery is described and 
evaluated as a key policy for shared decision making in psychiatric medication 
management practice. 
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psychopharmacology has risen from 44.6 % in 1987 to 79.4% in 1997 (Olfson et al, 2002). 
To what extent the growth in psychopharmacology has driven closure of psychiatric 
hospitals is contested (see Ramon, 1992; Pilgrim et al, 2011 for fuller discussion). 
Nevertheless, it has been suggested that psychopharmacology has encouraged health care 
reforms. For example, advent of the depot antipsychotic in the 1960s enabled increased 
compliance and consequently enabled greater community care (Shorter, 2006). 
 
 Alongside the move away from institutionalised care there has also been a broader shift in 
how need is conceptualised, with increased emphasis on human rights and social inclusion 
over this time frame. The social model of disability has had a significant impact on culture 
and societal attitudes towards social inclusion, representing a cornerstone for user 
movements in this time period.  In short, the social model of disability has changed the 
focus from impairments of the individual and policy emphasis on charity and medical care, 
to an appreciation of society’s failure to accommodate diverse needs and policies focussed 
on rights, equality and citizenship.  
 
Associated shifts and, in particular, the mental health ‘survivor’ movement5 have meant 
that psychological and social interventions have gained momentum alongside increased 
attempts at social change and stigma reduction6. Stigma is now well reported as a huge 
challenge for people with mental health problems leading to discrimination, social 
marginalisation and isolation. As Secker (2011) comments the existence of the stigma 
creates a climate in which the abilities to contribute to society of this group of people are 
largely ignored, as highlighted, for example, by high unemployment  (ibid, p. 497). 
Significant investment from the Department of Health (DH) in 2009's Time to Change 
campaign indicates that stigma reduction is a key priority in UK policy. Initial evaluation is 
promising and positive impact of the campaign on public attitudes and stigma is emerging 
(Hendenson and Thornicroft, 2009; 2013). However, recent changes to unemployment 
and disability benefits under the coalition government could have a further negative 
impact in this regard (Glasby, 2012).  
 
 The promotion of social inclusion also links to an increased emphasis on empowerment 
(Secker, 2011). Initiatives such as support for the use of advance directives (where a 
person specifies their treatment preferences in case they become unwell) have emerged in 
recent years, promoting the broader agenda of personalisation. However, this is not to 
                                                             
 
6
 Also see S. 2.2 
9 
 
 
suggest that such initiatives in mental healthcare are widespread or ingrained into 
modern mental health care culture. In fact, the uptake of initiatives such as advance 
directive planning is surprisingly low, with collective resistance from practitioner bodies 
reported (Morris - Thompson et al, 2013). 
 
Related to this, neoliberal ideals of individualisation, increased choice and marketisation 
are increasing in their prominence in mental health policy in the UK (Ramon, 2008).  The 
dominant rhetoric of choice and patient centred care, alongside the ratification of the 
Health and Social Care Act 2012, is an important contextual feature of contemporary 
mental health services. How these changes will impact on the experience of choice by 
service users, nevertheless remains uncertain and under investigated (Naylor, 2012).  
Mental health policy has received increased attention within the broader policy reforms 
underway in health and social care. Wellbeing and mental health are at the top of the list of 
public health priorities in the newly organised health and wellbeing directorate of Public 
Health England (PHE, 2013). This is reinforced by recent policy that has placed increased 
priority on creating parity between mental and physical health (DH, 2011a). 
 
While the impact of the wider reforms on mental health services remain uncertain the 
trend in the delivery of services towards continued and increased emphasis on the 
marketisation and the liberalisation of financial arrangements in the NHS is apparent.  The 
current coalition government are focussing priorities towards a greater access to 
information, including for example greater use of ‘patient reported outcome measures’. A 
key strategy is to create greater choice of providers, with new organisations overseeing 
the local accountability of services. Commissioners are starting to pay for services, using 
mental health care clusters to operationalise the process. But many unanswered questions 
remain and implementation is still in its infancy7.  
 
The term shared decision making is ingrained within the policy rhetoric, following the 
white paper Choice and Equity and subsequent consultation document ‘Liberating the NHS: 
No decision about me, without me (DH, 2010;2012a). In response to this consultation, there 
has been growing concern that too much emphasis has been placed on provider choice 
and too little emphasis has been placed on the dialogue between service user and clinician 
(Coulter and Collins, 2011; RC Psych, 2012). According to the Royal College of 
Psychiatrist's response to the DH (2012) consultation: 
                                                             
7
 A care cluster identifies the needs of the service user, takes into account diagnosis and makes 
recommendations for care 
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Service users place the highest value on quality of service, rather than on choice of 
service. Research in psychotherapy consistently shows that allowing  people to 
choose the type of therapy they want is positively related to outcome. However, we 
are not aware of any similar evidence around the choice of provider.  The document  
[DH,2012] concentrates too much on the choice of provider and pays very  little 
attention to the vital dialogue between clinician and patient. 
        (ibid, pp. 5 - 6) 
 
Although it is proposed that broadening the range of choice is still less well developed in 
mental health than other health policy contexts (Beresford, 2002; Beresford and Carr, 
2012), it has nevertheless been argued that this shift has offered positive developments to 
mental health service delivery, alongside the emergence of contemporary challenges. For 
example, the increased provision of user led services is arguably a related outcome of such 
trends (Ramon, 2008). In addition, the associated trend of increased user involvement in 
the development of mental health policies, training and research, staff selection, advocacy, 
alongside the emergence of consumer directed services, such as personalised health 
budgets (DH, 2009;2012b), to allow people to choose  and purchase some of the services 
they need, may increase service user  control and change the way service users interact 
with services (RC Psych, 2013). However, paradoxically, recent reports have highlighted a 
continued increase in more coercive forms of practice (Health and Social Care Information 
Centre, 2012).  For example, in the year 2012 – 2013 there was a 12% increase in 
detentions under the Mental Health Act (Care Quality Commission, 2014).  Indeed, it has 
been suggested that the growth in neo liberalism has conversely resulted in a 
contradictory trend towards increased regulation and governmental control, 
preoccupation with risk avoidance and a reduction in the autonomy or competitiveness of 
the voluntary sector in service provision (Ramon, 2008).  There are also well voiced 
concerns that features of broader health and social care policy towards personalisation 
and choice do not necessarily complement the focus on social inclusion mentioned above 
(Glasby, 2012; Secker, 2011; Coulter and Collins, 2012).   
 
Finally, the wider tough economic climate is an important broader contextual feature 
within which contemporary mental health services operate, likely to impact on the 
implementation of the new forms of service delivery, mentioned above (Glasby, 2012).  
While the direct impact of the broader economic climate on mental health services is still 
uncertain, the trend towards cost cutting in health and social care and the widespread 
welfare reforms underway, alongside the growth in demand on services provides 
additional and significant strain on the system. For example a report recently released 
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found there was a relationship between welfare reforms in Scotland and increased 
demand on mental health services, via the routes of both increased stigmatisation 
associated with claiming benefits and increased anxieties associated with; high levels of 
unemployment; rising poverty; and increasing levels of job insecurity and part time 
working (McCartney et al, 2013). 
 
The broad and complex contextual features of mental health service provision in the UK 
have been briefly presented. The next section will discuss the dominant models of 
classification and treatment for mental health services and critique the role psychotropic 
medication performs in contemporary services. This is followed by an examination of the 
recovery model as a key policy for contemporary mental health services more generally, 
and for shared decision making for psychiatric medication management more specifically.  
1.2. Diagnosis and treatment 
 
The current International Classification of Diseases (ICD 10) defines mental illness as: the 
existence of a clinically recognisable set of symptoms or behaviours associated in most cases 
with distress and with interference with personal functions. 
 
Within mental health policy the bio psycho social model is dominant in the UK.   While not 
always viewed as complementary, models such as the 'stress vulnerability model' (Zubin 
and Spring, 1977) have received widespread support, exploring factors which increase an 
individual's vulnerability as well as highlighting maintaining factors for mental ill health. 
Mental health treatments offered in the UK today, also fall under these three broad 
categories. That is biological treatments, including psychopharmacology, but also other 
physical treatments, such as Electroconvulsive therapy; Psychological treatments such as 
CBT and psychotherapy; and psychosocial interventions such as family interventions and 
case management (Knapp, McDaid et al, 2008). The IAPT program (Improving Access to 
Psychological Therapies) has improved provision of psychological therapies, mainly CBT, 
for people diagnosed with depression and anxiety disorders. A second phase was launched 
in 2011 to also include 'severe mental illness' (DH, 2011b).  
 
Other recent therapies not usually available through the IAPT program, such as the Soteria 
therapeutic community approach (Mosher, 1999) and the 'open dialogue' approach have 
also been growing in support and evidence in recent years (Seikkula et al, 2011). For 
example, it has been found that with a minimal use of medication or no use at all, but 
within a context of an open dialogue between multidisciplinary professionals, service 
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users and family members, positive outcomes are observed (Seikkula et al, 2011).  Social 
support networks and groups such as the hearing voices network, which emphasise 
sharing experiences of mental illness and establishing new meanings and developing 
alternative approaches of being in control, have also received growing interest in recent 
years (Romme, 2009).  
 
Nevertheless it remains the case that biological therapies and in particular prescription of 
psychotropic medication remains the dominant approach. In fact most people who receive 
psychiatric services in the UK are prescribed one sort of psychiatric drug, and often 
several (Moncrieff, 2009; Healy, 2009). Conversely implementation of the 'non medical' 
therapies remains patchy and inconsistent. There appears a disconnection between what 
the 'lay person' expects from mental health services and the service provision available. 
For example, whilst psychotherapy and psychology is valued by most, there is little 
appreciation in the general public that psychiatrists are medical doctors by training, many 
without specific training in psychotherapy (Stevenson, 2000; Sartorius et al, 2010).   
Relations between mental health professionals and service users often revolve around 
medication (Moncrieff, 2009).  
 
Trend data supports this in that during the 20 years from 1980 to 2000 there was about a 
30% increase in prescriptions for the four main classes of drugs used for psychiatric 
conditions - hypnotics and anxiolytics, anti-psychotics, antidepressants. Expenditure on 
psychiatric drugs remained constant, at about 8% of NHS drug expenditure in 2000 (Rose, 
2003). However, this Figure does not consider the differing trends for different classes of 
psychiatric drugs over this period.  Certain medications, namely sleeping pills and minor 
tranquillisers, whose use received cause for concern, decreased over this period, whereas 
there was a large increase in other classes of psychiatric medication, for example, an 
incredible rise of 200% in anti-depressant prescription (Rose, 2003).   
 
In summary, mental illness and its antecedents is a contested and multifaceted area, yet 
the dominant approach in services remains the prescription of psychotropic medication. 
Linked to this, psychiatric diagnosis also remains the cornerstone of how mental health 
services are delivered. However psychiatric diagnoses are not validated like other medical 
conditions and there is a long history of debate and controversy surrounding their use 
(Pilgrim, 2007). The fifth edition of the American Psychiatric Association's Diagnostic and 
Statistical Manual of Mental Disorders, known as DSM - 5, was published on May 18th, 
2013 in the face of widespread criticism. For example, the British Psychological Society’s 
earlier consultation response stated that diagnoses were problematic and unhelpful: 
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[diagnoses] as clearly based largely on social norms, with symptoms that rely on 
subjective judgements, not value free, but rather reflecting current normative social 
expectation.... We believe that a description of a person's real problems would suffice. 
Moncrieff and others have shown that diagnostic labels are less useful than a 
description of a person's problems for predicting treatment response, so again 
diagnoses seem positively unhelpful compared to the alternatives  
      (British Psychological Society, 2011, p. 2) 
 
However criticism also emerges from within the biological psychiatry perspective. For 
example, the National Institute of Mental Health (NIMH) criticises the approach in their 
blog, as lacking validity, making the analogy with other areas of medicine. 
 
In the rest of medicine, this would be equivalent to creating diagnostic symptoms 
based on the nature of chest pain or the quality of fever....over the last half a century  
we have understood that symptoms alone rarely indicate the best choice of 
treatment. 
         (Insel, 2013) 
 
In addition wide spread criticisms have been voiced on the concerning trend towards 
medicalising normal responses or emotional states, with such discourse now receiving 
widespread media attention (Jacob et al, 2013; DCP, 2013; The Guardian, 2013; The 
Economist, 2013). Others have focussed criticism on their utilisation [being] sometimes 
used too loosely by clinicians, and too rigidly by regulators, insurers, lawyers and at times 
researchers, who afford it reference and deference disproportionate to its over acknowledged 
limitations (Berk, 2013, p. 128). 
 
1.3. Contemporary concerns surrounding psychiatric medication 
 
Sitting within the broader context of the increased use of psychopharmacology in mental 
health services, it is noted that there has been a decrease in investment into new, more 
targeted or less toxic psychiatric drugs (Healy, 2009; Moncrieff 2009; Fibiger, 2013). As 
previously mentioned it is widely accepted in clinical practice that diagnoses such as 
'schizophrenia' are heterogeneous. Alongside this still little is known about biological or 
genetic mechanisms of psychiatric illness. According to Fibiger (2013, p. 650) 'given that 
there cannot be a coherent biology for syndromes as heterogeneous as schizophrenia, it is not 
surprising that the field has failed to validate distinct molecular targets for the purpose of  
developing mechanistically novel therapeutics'. The RDoC project represents a growth in 
the endeavours to link future disease classifications on the basis of neuroscience which 
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aim to encourage newer targeted medication therapies being developed, but this is still in 
its early stages (Cuthbert and Insel, 2010). Indeed  other academic research is being 
published which is suggestive of the opposite perspective - that  genetic and biological 
indicators are non-specific to symptom clusters and instead environmental factors are 
more likely to be relevant to describe this heterogeneity (Owen, 2012). Thus, at present, 
still not much is known about how to move forward in the development of more useful 
and less toxic psycho tropic medications, thereby remaining a blunt tool, with some 
proposing that any beneficial effects are attributable only to the sedative and 
tranquillising properties of such medication (Healy, 2009). 
 
Over the last couple of decades there has also been an increased appreciation of mental 
illness in society and the burden that mental illness plays (Murray et al, 2013). According 
to the WHO, by the year 2020, if the current trends continue the burden of depression will 
be the second leading cause of disability adjusted life years lost (DALY) measure (Murray 
et al, 2013). The links between the trend of increasing prescription of certain psychiatric 
medications alongside the increasing social awareness of mental illness are uncertain.  It is 
suggested by critics that there is a strong co production in knowledge between the 
medication and the roots of the disorder, via the marketing strategies of large 
pharmaceuticals and other bodies with vested interests (Moncrieff 2006, Rose, 2003; 
Pilgrim et al, 2011).  For example Watters (2010) uses the example of depression in Japan 
to explore how psychiatric awareness and prescription rates are linked. According to the 
author depression was not recognised in psychiatric terms in Japan prior to the new 
millennium, with reference instead to descriptions of personality types, similar to the term 
'melancholic'. However, an international consensus group was created to promote the 
psychiatric term of depression, alongside the marketing campaign of a large 
pharmaceutical company. Subsequently anti depressant use has dramatically increased 
since 2000. Rose (2003) eloquently emphasises this possible link, making is clear that the 
dominance of psychiatric medication has also impacted how both professionals and the lay 
person speak and understand mental illness: So the debate cannot be only one of efficacy, as 
if illness, treatment and cure were independent of one another (ibid. p.58) 
 
Having said this, a body of criticism of psychiatric medication has been growing over the 
last 15 years also. Criticism of the role of the pharmaceutical industry in general, in 
prescribing behaviours and marketing has become increasingly popular. For example, the 
recent book by Ben Goldacre (2010) entitled 'Bad Pharma - How drug companies mislead 
doctors and harm patients' was one of the year's most popular non fiction books, receiving 
wide spread acclaim. 
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Within psychiatric medication management, there have been a significant number of legal 
cases which have brought anti depressant use into question, with large pay outs being 
settled by the pharmaceutical industry (see Rose, 2003).  With anti psychotic use, there 
has been growing appreciation of the long term and serious nature of side effects. For 
example, recent research purporting the life expectancy for people diagnosed with 
psychosis to be 15 - 20 years less than for the general population, as a result of long term 
anti psychotic medication use, has been widely publicised (Healy et al, 2012; Whitaker, 
2004; Thornicroft, 2011; Colton and Manderschied, 2006).  
 
 This was highlighted in the recent damning report by The Schizophrenia Commission 
which raised the serious concerns of physical wellbeing for those prescribed anti 
psychotic medication as one of the key areas for improvement in mental health service 
today (The Schizophrenia Commission, 2012).   As such, there is a growing doubt by 
service users over the 'cost - benefit' ratio for psychiatric medication. While some service 
users find medication helpful, and are ready to put up with its adverse effects because of 
the beneficial impact, irreversible side effects, such as memory loss, or involuntary hand 
and leg movements, damage to liver and kidney functioning,  are becoming more well 
known (Moritz et al, 2009; Healy, 2009). Of particular concern is multiple prescribing, or 
what is known as poly pharmacy. For example up to a third of users are being prescribed a 
total dose of anti psychotic medication above that deemed acceptable by the British 
National Formulary (Harrington et al, 2002; Healthcare Commission, 2007; Howes et al, 
2012). This is compounded by the trend that prescription of new medication and 
increased doses of psychiatric medication are often given during periods of crisis, yet are 
less frequently reduced once the crisis is resolved.  Policy guidelines have been issued in 
an attempt to counteract the issue (DH, 2013; NICE, 2009).  Yet, poly pharmacy remains a 
concern in the field (Ito 2005). 
 
A separate but related trend to consider for the context of psychiatric medication 
management is what has traditionally been viewed as compliance rates to medication 
regimes. Poor compliance historically has received much attention within the psychiatric 
literature, with reviews concluding that adherence rates for psychiatric medication 
regimes are far below those in physical medicine (Cramer and Rosenheck, 1998). Research 
suggests a lack of trust in the encounter. For example, in an examination of medication 
management practice, Read (2005) concludes that service users do not chose to involve or 
inform practitioners in the serious decision to come off psychiatric drugs and other 
research has been published which shows that many people chose to stop taking 
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psychiatric medication as a positive attempt to regain control (Britten, 2010; Roe et al, 
2009). 
 
Of final note here, there has been increasing acknowledgement of the detrimental impact 
psychiatric medication has in relation to stigma.  The adverse effects of psychiatric 
medication may further magnify the otherness of the person experiencing mental ill 
health. The altered physical appearance as well as the difficulties in functioning, either a 
consequence of taking or aggravated by psychiatric medication, contribute to the external 
and internalised stigma of people with mental illness (Link et al, 2001; Pescodolino et al, 
2007; Schultz et al, 2003; Corrigan, 2007).  
 
1.4. Section summary 
 
In summary, psychiatric medication continues to remain the key treatment modality in 
mental health treatment programs although psychological and psycho social interventions 
are increasing in support and availability. There nevertheless remains a dominance of the 
medical model of understanding mental illness. There is a growing body of evidence which 
raises doubt over the efficacy of psychiatric medication and also some highly worrying 
findings concerning long term side effects and quality of life, which seriously undermine 
the potential benefit for medication use. These are now relatively well known in the 
literature and there is increasing awareness in society.  Recent historical shifts alongside 
the changing policy context of mental health services, and in particular the focus on  
personalisation, marketisation, medicalisation, alongside social inclusion,  and personal 
recovery in mainstream discourse,  paint a picture of a highly complex mental health 
system, where choice, collaboration, debate and discussion for medication management 
practice would appear at the forefront, but also where there remains existing power 
structures and many stakeholders with potentially conflicting aims. The next section 
further explores the model of personal recovery for UK mental health services, exploring 
the roots of the recovery movement, discussing its definition and describing contemporary 
projects underway in the UK to implement recovery ideals into UK mental health practice. 
 
1.5. Recovery oriented services 
 
Shared decision making has proposed to be a central tool for recovery oriented services 
(Deegan and Drake, 2006). This section discusses the origins and meanings of the concept 
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of personal recovery, exploring the policy context and recent initiatives towards 
promoting recovery oriented practice in mental health services. 
1.5.1. The concept of personal recovery 
 
 A number of authors have highlighted the distinction between ‘clinical' forms of recovery 
(associated with achieving a pre illness state, reduction in symptomology and 
preoccupations with cure to a condition) and the model of ‘personal’ recovery  (Repper 
and Perkins, 2003; Davidson et al 2008c; Secker et al 2002; Slade, 2008; 2010). In the 
context of modern mental health UK policy, the term recovery is associated with the latter 
meaning:  one which instils hope for the future and is a way of overcoming losses 
associated with being mentally ill. It emphasises the process or journey of recovery as 
something which is not static but moving and changing over time, being led by the service 
user in a re-evaluation of identity (Repper and Perkins, 2003). It has also been referred to 
as a ‘consumer’ model of recovery, to reflect its historical roots (see S. 1.6) and to highlight 
its ‘individually defined and experienced nature’ (Slade, 2010, p.2).  
 
By far, the most often quoted definition of recovery is that offered by Anthony in 1993: 
...a deeply personal, unique process of changing one's attitudes, values, feelings, goals, 
skills and roles. It is a way of living in a satisfying, hopeful way and contributing to 
life even with limitations caused by illness. Recovery involves the development of new 
meaning and purpose in one's life as one grows beyond the catastrophic effects of 
mental illness. 
          (ibid, p. 527) 
 
This quote emphasises the developmental journey that the model of recovery imparts. 
Others emphasise the importance of both living with and living beyond the adverse impact 
of a diagnosis, to lead a fulfilling life with hope (Davidson, 2003). Thus, the concept of a 
journey, of growth, optimism and hope is central to narratives of personal recovery. There 
is acknowledgement that people have to come to terms with the ordeal that the 
occurrence of mental health symptoms can have on their lives and incorporate these 
experiences into a new sense of personal identity, with belief and hope for the future and 
regaining a sense of control over one's life (Shepherd, Boardman and Slade, 2008).  Leamy 
et al (2011) undertook a systematic literature review and identified more than 5000 
articles. This extensive synthesis found that the recovery process  comprised of: 
Connectedness (relationships, peer support and support groups, being part of the 
community); Hope and Optimism for the future (belief, motivation to change, hope 
inspiring relationships, positive thinking and dreams and aspirations); Identity 
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(dimensions, rebuilding, overcoming stigma); Meaning in life (spirituality, social roles and 
goals) and; Empowerment (control, personal responsibility and strengths), giving the 
acronym CHIME. Importantly this robust conceptual map highlights the importance of 
spirituality and social inclusion as important processes for recovery. The themes were 
similar across heterogeneous studies, including studies which explored perspectives of 
people of a BME origin, thereby offering a comprehensive framework from which 
organisational, social and psychological interventions can be targeted (see S. 1.7 below).  
The recovery concept has also often been represented in terms of stages. For example, the 
validated STORI model shown in Table 1 below describe five stages, each requiring 
struggle and active participation  (Andresen, Caputi, and Oades, 2006). 
   
Stage 1 Moratorium 
Denial, confusion, hopelessness, identity confusion and self protective withdrawal 
Stage 2 Awareness 
The person has a first glimmer of hope of a better life, and that recovery is possible. This 
can be an internal event, or it can be sparked by a clinician, or significant other. It involves 
an awareness of a possible self other than that of 'sick person.  A self that is capable of 
recovery 
Stage 3 Preparation  
The person resolves to start working on recovering. This stage involves taking stock of the 
intact self, and of one's values, strengths and weaknesses. It involves learning about 
mental illness and services available, recovery skills, becoming involved in groups, and 
connecting with peers. 
Stage 4 Rebuilding 
In this stage the hard work of recovery takes place. The person works to forge a positive 
identity. This involves setting and working towards personally valued goals, and may 
involve reassessing old goals and values. This stage involves taking responsibility for 
managing the illness and taking control of one's life. It involves taking risks, suffering 
setbacks and coming back to try again.  
Stage 5 Growth 
The final stage of recovery could be considered the outcome of the recovery process. The 
person may not be free of symptoms completely, but knows how to manage the illness and 
to stay well. Resilient in the face of setbacks, has faith in his or her own ability to pull 
through and maintains a positive outlook. The person looks forward to the future and a 
positive sense of self. 
Table 1. The stages of recovery model (STORI). Andresen, Caputi and Oades, 2006. 
Whilst such models are useful, they have been criticised as being too linear, where instead 
a far more individual, overlapping and dynamic representation is warranted, allowing for 
the ups and downs of the typical recovery journey to be represented (Deegan, 1988). 
 
For mental health services, recovery represents a transformation towards a new way of 
working, with service users moving towards the centre of the recovery process and where 
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decisions are based less on professionally defined goals and more on listening to and acting 
on the service user's wishes (Slade and Hayward, 2007, p. 81). Therefore recovery also 
represents the service user having expertise and knowledge, in addition to the ideas of 
regaining control over ones lives and future. As such, shared decision making is a 
fundamental tool for recovery oriented medication management practice (Deegan and 
Drake, 2006; Drake, Deegan and Rapp, 2010; Baker et al, 2013). 
 
1.6. Historical roots and theoretical links 
 
The historical roots and theoretical links with the recovery model are diverse and 
numerous. For mental health service users, the recovery model represents an 
international movement over the last 30 years, which has demanded that the voice of the 
service user be heard within main stream psychiatry.   Over this time, a growing body of 
personal accounts of mental illness, as well as what is deemed as important and 
meaningful for personal recovery has emerged, with eminent authors such as Patricia 
Deegan and Judi Chamberlin in the US and Jan Wallcraft in the UK acting as figure heads 
for change (Chamberlin 1978; Deegan, 1988;1996; Wallcraft, 2002). According to 
Davidson there has been a war within psychiatry over this period and the recovery 
movement has the overarching aim to afford people with serious mental illnesses the rights, 
opportunities and resources needed to lead meaningful and productive lives (Davidson, 
2010, p. 3). This trend links to wider changes in the disability user movements and the 
emergence of the social model of disability (see S. 1.1.1 above). The social model of 
disability has been hugely effective at emphasising a commitment to people’s civil and 
human rights and social inclusion. However some authors have also noted key distinctions 
between the survivor movement and the social model of disability. For some, the 
importance of highlighting mental illness and distress in terms of personal experiences 
and perceptions differs from the social model of disability’s acknowledgement of 
impairment (Beresford and Wallcraft, 1997).   
 
 Instead it is commonly acknowledged that recovery represents a civil rights movement 
stemming from the critical psychiatry movement, being strongly influenced by modern 
historical figures in psychiatry, such as Goffman and his work on 'total institutions' which 
highlighted the failings of psychiatric systems where the value of the individual was 
minimal (Goffman, 1961) and others such as Szasz (Thomas Szasz, 1920 - 2012) who 
criticised the moral and scientific underpinnings of psychiatry. As such, recovery is 
proposed by some as an anti thesis to the construction of power and authority in 
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traditional psychiatry (Stevenson, 2000). The recovery movement has been particularly 
useful in the highlighting problems associated with both, a dominance of deficit reduction 
models of psychiatry, as well as the fallacy of a system which focuses on abnormalising 
behaviours and creating difference to human emotions and behaviour (Stevenson, 2000; 
Rose 1986). For some there are proposed links between this movement and the ideals 
seen previously in history of psychiatric care towards 'moral or humane treatment' (e.g. 
Adolf Meyer, 1866 – 1950, see Davidson, 2010 for further review) and for others recovery 
represents a move back towards humanistic or even psychoanalytical approaches in 
psychiatry where respectful relationships and client focused therapies are valued (Carl 
Rogers, 1902 - 1987 - see Rogers, Kirschenbaum and Henderson, 1989). 
 
It has also been suggested that there are strong links with the growing appreciation of 
positive psychology and a re- emphasis on personal strengths and wellbeing (Rapp and 
Goscha, 2012; Slade, 2010). Indeed if we look at the definition of positive psychology 
bestowed by Seligman and Csikszentmihalyi  (2000) the conceptual similarity is striking, 
especially with its emphasis on hope and optimism for the future: 
 
The field of positive psychology at the subjective level is about valued subjective 
experiences well-being, contentment and satisfaction (in the past)  hope and 
optimism (for the future) and flow and happiness (in the present)  
      (Seligman and Csikszentmihalyi, 2000, p. 5) 
 
However, it is also important to emphasise the links of the recovery model to the broader 
change in westernised societies towards neo liberalism and increased consumerisation of 
public services (see S. 1.1.). Ideals of patient centred care and personalisation may have at 
least encouraged the adoption of the recovery concept in modern mental health policy 
(DH, 2011a). A criticism of note here is that recovery in these terms risks forgetting the 
social elements of recovery (O Hagan, 2003). For example, Beresford (2002) suggests that 
these two divergent roots to the recovery model of mental health (neo liberalism and 
grass roots user movement) have resulted in different branches of the recovery model 
today - one being a consumerist model of recovery, being consultative and perhaps 
tokenistic in approach and the other representing a more democratic form of recovery, 
based more on civil rights and participatory ideologies.  In addition, Campbell and Rose 
(2011) suggest that the radical beginnings of this latter recovery movement have waned.  
It has been proposed that recovery rhetoric may now have been adopted by established 
institutions of power and consequently is being used by people in authority to justify 
decisions (Pilgrim, 2005; Carey, 2009; Glover, 2012).   
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According to Pilgrim (2005):  
 
...there is a tension between democratic impulses of the service user movement on the 
one hand and on the other, the agenda  of the health care providers to co opt the 
service user voice in a corporate tokenistic effort to achieve a stated policy outcome .  
        (Pilgrim, 2005, pp. 17-26) 
 
Criticism of the recovery model has also been received on other fronts. Most notably, there 
has been criticism that the definitions of recovery remain difficult to measure, being 
possibly too broad (McCranie, 2011). Ramon (2007) also points out that language in the 
Australian mental health policy literature echoed optimism and hope long before the 
recovery term was established in 2003, suggesting that the adoption of the term 'recovery' 
is not a prerequisite for positive change in the system.  
 
Finally, it has been noted that while receiving widespread support in modern mental 
health policy, it still does not feature as a topic within the more 'traditional' peer reviewed 
literature in the professions. For example, in the fields of clinical psychiatry, recovery is 
still often referred to in clinical terms in psychiatric academic journals such as American 
Journal of Psychiatry, Journal of Clinical Psychiatry and for Clinical Psychology journals, 
such as The Annual Review of Psychology and Psychological Medicine. However there are 
some notable exceptions here, including many articles on personal recovery featuring in 
mainstream academic journals such as the British Journal of Psychiatry, Schizophrenia 
Bulletin, Psychiatric Services and the Psychiatric Rehabilitation Journal amongst others  
(McCranie, 2011).  
 
In summary, challenges to embedding the recovery model remain, with agreement 
amongst many that these challenges continue to centre around the need to place equal 
value on both service user and professional knowledge and expertise in the mental health 
encounter:  
 
The challenge coming from the service user movement, or at least significant 
elements of it, is twofold: First accept our understandings of our own experiences as 
equally valid as professional understandings. Second, acknowledge that our ability 
and expertise in self help and mutual support is commensurate to that of professional 
expertise. In short that service users are not merely consumers of mental health care 
and treatment but are primarily'experts by experience.  
       (Campbell and Rose, 2011, p.  460) 
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In other words, the binding concept for recovery is grounded in the simple yet profound 
realisation that people who are diagnosed with mental illness are human beings (Deegan, 
1993, p. 8) and hence have strengths as well as weaknesses and a future that does not 
need to mean continuation of a life as a chronic patient. This needs to remain at the 
forefront of policy and practice in mental health services.  
 
1.7. Recovery in mental health policy and practice 
 
As part of the transformational change underway within wider health and social care 
reforms (see above), the recovery model remains part of the key strategy for mental 
health policy (DH, 2011a), with an increased focus on wellbeing, awareness and 
personalisation. The increased focus within the national outcomes framework on non 
clinical outcomes, including psycho social indicators and service user’s experiences has 
the aim of promoting cultural change (Naylor, 2012). Thus the concept of recovery has 
remained a priority in UK mental health policy: 
'If adopted successfully and comprehensively, the concept of recovery could 
transform mental health services and unlock the potential of thousands of people 
experiencing mental distress' 
    (Future Vision Coalition, 2010; cited in Shepherd et al, p.2)
  
Indeed, the concept of recovery was already adopted by the National Institute for Mental 
Health in England (NIMHE) prior to the new millennium and has now been widely 
incorporated throughout overseeing professional bodies, including the Royal College for 
Psychiatrists, the British Psychological Society, Mental Health Nursing and Social Care 
Institute of Excellence (e.g. SCIE, 2007; DoH, 2006). Recovery rhetoric is now ingrained 
into professional discourse in mental health services.  
 
More recently, well funded national projects have been piloted to embed recovery 
principles into practice. In particular, the Implementing Recovery through Organisation 
Change, project (ImROC) and the RE FOCUS projects are worth particular note: 
 
The REFOCUS study is National Institute for Health Research (NIHR) funded research 
project.  It applies an RCT design to explore the success of a pro recovery intervention for 
mental health professionals, in community mental health teams in London and 
Gloucestershire.  A 12 month training and coaching program was co-produced and 
facilitated by service users with the aim to enhance skills of professionals to be able to 
better support people on individual recovery journeys. Evaluation data is yet to be 
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published but the intervention aims to target two domains; promoting values of 
personally defined recovery and pro recovery working relationships.  A particular focus 
has been on exploring service users strengths and future goal planning as part of care 
programs is seen to embed the principles of the CHIME framework8 into mental health 
service provision (Leamy et al, 2011; Slade, 2013). This study has not focussed on social 
inclusion as part of the intervention/evaluation program.   
 
The ImROC program was initiated in 2009 and 
piloted intervention projects are underway 
nationally across 44 sites, with the aim of 
changing attitudes and behaviours of 
practitioners and the culture of organisations to 
be more supportive of recovery for people 
receiving services (Shepherd, 2013). Ten 
organisational challenges were identified as 
shown in Figure 1 (Shepherd, Boardman and 
Burns, 2010, p.2).  This extensive program 
currently boasts the creation of 14 Recovery 
Colleges with co produced learning sets attended 
by thousands of people (practitioners and service 
users), briefing reports and guidance for services.  
The project has also assisted with the creation of 
150 Peer Support Worker posts  and 25 ‘Peer 
Educators’ and a stated aim of the project is to 
increase the number of peer support workers to 
50 % of the workforce.  Locally, in Cambridge and 
Peterborough Foundation Trust (CPFT), ImROC 
has helped in the recruitment and training of 60 
peers with lived experience in mental health 
problems and the majority have now been 
appointed to paid positions within the trust. One of the stated aims of this program is to 
encourage diversity and recognise the importance of lived experience in delivery of mental 
health services (http://www.cpft.nhs.uk/patients/peer-support.htm). 
 
                                                             
8
 See S.1.5.1. above 
Figure 1. 10 Organisational Challenges for 
ImROC. From Shepherd, Boardman and Burns, 
2010, p.2 
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Whilst evaluation is ongoing and research exploring peer support workers is limited (Pitt 
et al, 2013; Trachtenberg et al, 2013), mental health services may benefit from 
introduction of peer workers by combating institutional stigma and creating new 
understanding and respect for different forms of expertise, assisting with overcoming 
inherent discrepancies in power and bringing experiential knowledge more to the fore of 
appreciation in the culture of mental health services (Shepherd, 2013; Repper, 2013).  
 
Initiatives are also taking shape in other areas of the UK. In Devon the 'recovery oriented 
prescribing project' is promoting key competencies and skills for a recovery oriented 
approach in medication management practice (Baker, 2013). 
 
Finally, the SHiMMe (Shared Involvement in Medication Management) project, led by 
Professor Shula Ramon is of note here. A three year NIHR funded project took place within 
the local mental health NHS trust implementing a piloted intervention program involving a 
training program for shared decision making to both practitioners and service users and a 
rigorous evaluation. The key aim for this project is to increase service users' ownership 
and control within medication management practice and to measure the therapeutic 
outcomes associated with the intervention.  
 
However, while these projects represent examples of best practice in the UK, recovery 
oriented practice remains inconsistent in terms of implementing agreed principles of this 
approach (Shera and Ramon, 2013).  In addition, as can be seen above, while these 
interventions are undertaking important work in the areas of improving working 
relationships and training and raising awareness, other aspects of recovery principles are 
yet to be fully tackled - i.e. social inclusion, wider community involvement and overcoming 
stigma.9 
 
There is also caution about how the rhetoric of recovery is actually being absorbed within 
the wider mental health system, with fears the term recovery is instead being used as a 
tool to reinforce old ideals of compliance to service outcomes. For example, Turner, 
Crowson and Wallcraft (2002) present concerns from service users, that professionals 
may use recovery rhetoric to justify service outcomes. The authors found that service 
users were actually worried about not being compliant with their recovery plans as this 
may subsequently impact on their social welfare provision. As such there has been 
                                                             
9
 Although a notable exception is the Time to Change campaign – see S. 1.1.1 above 
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growing critique surrounding what the recovery movement has achieved in terms of 
addressing structural inequalities.  
 
Many mental health services, despite their articulation around a recovery 
orientation, still see that their core business remains to assess mental status, alleviate 
symptoms of distress, medicate, risk manage, monitor, review, plan, document, 
manage, care, refer where necessary and rehabilitate into the community. In this 
position, services have still seated themselves at the head of table as experts and 
managers of people's lives. 
        (Glover, 2012, pp. 30-31.) 
 
As the above quote illustrates, there is concern that the discourse of partnership and 
collaboration can mask power imbalances and differing agendas, making no real impact on 
the clinical authority of the mental health worker or levels of service user empowerment.  
Nevertheless the growing awareness of recovery principles in practice, the ongoing 
interventions underway, alongside the centrality of recovery in mental health policy 
represent an important and positive contextual feature for appreciation in this thesis. 
Namely in exploring views of shared decision making in the context of a community based 
mental health team and investigating how psychiatric medication management practice 
occurs in practice. 
 
1.8. Conclusion 
 
This chapter has explained the broader context within which shared decision making for 
psychiatric management exists.  The recent transformational shift in culture and policy, 
and the complexity present in the mental health system, is evident from the brief review 
presented here. As such the contemporary policy context highlights the relevance of this 
study. Of particular note is the growing awareness of serious concerns surrounding long 
term psychotropic medication use and the worrying trends towards increased diagnosis 
and prescription in the treatment of mental ill health.  As such, research exploring SDM in 
this context is particularly timely. The final section explored in depth the historical roots 
and conceptual links of the recovery model. Shared decision making is proposed to be a 
key tool for achieving change towards recovery oriented practice in UK mental health 
service provision. 
 
The subsequent chapter presents a review of the relevant literature. This begins with an 
overview of dominant models of decision making in healthcare. This is followed by a 
discussion and critique of the model of shared decision making.  Research into SDM in the 
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mental health context is then evaluated. Gaps in the current literature are highlighted, and 
the research questions are described, highlighting the study’s original contribution to 
knowledge.  
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Chapter Two. The Literature Review 
 
 
 
PART A: Healthcare Decision Making: Existing Models and 
Frameworks. 
 
2.1. Introduction 
In order to explore decision making processes for psychiatric medication management, it 
is first necessary to understand dominant and influential models of decision making in 
healthcare, more generally. There is a need to explore how these models may relate to the 
context of psychiatric medication management and how the wider decision making 
literature can help inform the conceptual framework for this thesis. 
 
The first part of this section will briefly examine the dominant approaches in decision 
making theory. A critique will then follow of the main models of service user (see note re: 
terminology) involvement in doctor patient decision making, focusing predominantly on 
the influential Shared Decision Making (SDM) model. The section concludes with an 
exploration of the broader concepts of involvement and collaboration. These broader 
conceptualisations are seen as especially useful for exploring some of the important 
contextual elements relevant to this thesis and psychiatric medication management 
specifically. It is necessary to highlight from the outset of this review, that there is no 
Chapter outline 
The chapter begins with an overview of dominant models of decision making in 
healthcare. This is followed by a discussion and critique of the model of shared 
decision making and an examination of broader constructs of collaboration and 
involvement to assist understanding about how decisions are made in mental health 
medication management. 
The second part of this chapter explores the research that has examined decision 
making preferences and practice in mental health. This section explores how 
applicable models such as shared decision making are to making decisions about 
psychiatric medication as well as exploring barriers to achieving patient involvement 
in mental health. Gaps in the current literature are highlighted and areas where further 
research is needed are presented. 
The chapter concludes by exploring how this thesis adds to the current research in the 
area, with a description of the research questions this thesis explores. 
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overriding consensus on the scope and precise definitions of many of the models 
presented. Indeed the nature of a model is such that its aim is to simplify and make 
abstract a complex and multi dimensional reality that it tries to represent. In the 
evaluation of any model, therefore, it is acknowledged that the complexity and 
experiential reality of the construct it represents, is largely lost.  I nevertheless view this as 
a useful classification system to explore current understanding of ‘good practice’ or what 
is deemed ‘ideal’. A greater knowledge of these models and their specific limitations will 
therefore help inform the construction of new knowledge to the topic. 
  
2.2 Decision Making Models in Health Care 
 
Theoretical perspectives in decision making emerge from a wide variety of disciplines, 
dominating fields such as Psychology and Economics since the utility theories of the 1950s 
(see Goldstein and Hogarth (1997) for an in depth review). 
Clinical decision making has been most influenced by the following theories: 
 Expected utility theories which see decision making as related to its utility (or value) 
and its achievability (or tradeoffs). So in the context of clinical decision making, such 
theories help weigh up the pros and cons (such as side effects in choosing between 
multiple treatment options) to inform a rational explicit decision.  
 Information processing theories (Newell et al, 1958), which explore factors which limit 
or affect rationality (such as cognitive load or the amount of information that can be 
provided for processing at one time)and  
 Social judgement theory (Juslin and Montgomery, 1999) which explores the ‘lens’ of 
decision making and how to affect attitude change. 
These models are all based on an individual perspective, with an autonomous subject 
being at the centre of the decision making process.  
 
However, the key concepts, models and measures of patient decision making developed in 
psychology and economics do not necessarily translate to decision making in the context 
of  chronic, long standing illnesses within diverse populations, and do not incorporate an 
understanding of the wider mental health system. These models are cognitive and de 
contextualised and generalising findings from controlled laboratory studies to complex 
real world examples is not necessarily appropriate or useful. In addition, factors such as; 
patient lifestyle; cultural influences; control of access to information are not taken into 
account.  The significance of these models to informing predominant decision making 
interventions in the field should nevertheless be acknowledged. For example, 
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incorporating ideas such as the preference concept into decision making interventions and 
understanding how communication during the service user practitioner interaction 
influences the decision making process and the quality of the interaction (Wills and 
Holmes Rovner, 2006).  However, in the context of building theory about decision making 
for psychiatric medication management, a schema that, at least, includes decision making as 
relational, contextual and distributed is essential  (Murtagh, 2009, p.82). 
 
Models that have explored the doctor - patient relationship and communication in relation 
to decision making, is also not a new area of study.  The 1950s saw a new trend in 
important research focusing on the doctor patient relationship and interest has remained 
since this time (Wirtz et al, 2006). In recent years, however, and in conjunction with major 
policy shifts in healthcare provision (see chapter one) there has been increased interest in 
the literature exploring patient participation in healthcare settings. For example, there has 
been a fivefold increase in the number of studies exploring shared decision making 
between 1996 and 2003 (Makoul and Clayman, 2006).  
 
At present, there are four broad categories of patient-doctor decision making models 
(Wirtz et al, 2006; Charles, Gafni and Whelan, 1997; 1999; Emanuel and Emanuel, 1992). 
These are represented in Figure 2. Generally, these models fall within a spectrum which 
varies with respect to the level of patient participation or autonomy in the decision 
making process and the role of the practitioner. Each model therefore is based on a set of 
assumptions regarding the roles of the patient and the doctor. Specifically, the models 
make assumptions about the extent to which the patient and doctor have responsibility, 
involvement in decisions and choice over the treatment option.  
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Figure 2: Models of patient - doctor decision making 
 
In the traditional paternalistic model the doctor makes the decision, after evaluation of the 
diagnosis, the treatment options and risks and benefits for these outcomes. This model 
assumes that the doctor has the duty to act in the best interest of the service user and that 
the patient is not able to make the decision due to their lack of capability or lack of 
relevant knowledge. It has been suggested that paternalism is derived from the biomedical 
paradigm of health related decision making, prioritising scientific evidence and 
professional expertise.  Here, less emphasis is placed on the patient’s values, lived 
experience or life goals (Russell et al, cited in Sandman, 2011). It is also associated, with 
the compliance paradigm, where the patient is subservient, following somebody else's 
ideas. Non compliance in this model then would be deemed problematic (Sandman et al, 
2011).  At the other end of the spectrum the informed decision making model assumes 
that the service user has ultimate accountability and responsibility for the decision made. 
Here, the professional acts as an adviser to the process, ensuring the decision made is 
informed and the service user has all relevant information.  
 
In the middle of the spectrum on levels of participation, the interpretative model, like 
paternalism, is also based on the assumption that the doctor has the duty to reach the 
decision, but focuses on taking additional information such as the patient’s preferences 
and values into account. Within the shared decision making model, the focus for patient 
autonomy is more flexible and less black and white than both paternalism and 
interpretative decision making on the one hand, and informed decision making on the 
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other. Here, communication and shared deliberation are sought in the decision making 
process and the involvement of the service user and sharing of preference and values are 
essential to the end shared decision.  It is associated with the shift towards the concept of 
'adherence' or 'concordance',  emphasising the active role of the patient alongside placing 
value on the expertise brought by a service user to the health care encounter (Sandman, 
2012; Marland, 2005; Coulter and Collins, 2011) . 
 
2.3 Shared Decision Making – a more detailed examination. 
 
For many,.. shared decision making is a philosophy as well as a way of doing things. 
Central to it is the belief that patients have a vital role in the decision making 
process; that their values and self-determination need to be considered equally 
alongside scientific knowledge. 
         (Da Silva, 2012, p. i) 
 
Shared decision making (SDM) has become a term that has received widespread attention 
both in UK health policies and research literature exploring healthcare decision making 
(Coulter and Collins, 2011; DH, 2012a; 2010).  As discussed in the previous chapter, but 
considering the health context more widely, shared decision making has been influenced 
by such factors as: 
 changing societal attitudes  surrounding patients’ rights, 
 cultural changes in attitudes towards healthcare services 
 growth in the advocacy of community support and patient groups 
 and increasing litigiousness                                 
  (Higgs et al, 2008). 
 
In the UK, recent health care policy and legislation, alongside the rhetoric of increased 
choice, there have been increased obligations to increase involvement of patients in 
decisions about treatment and care and shared decision making has been used as a central 
tool of such changes (DH, 2012a; 2010). These shifts have been reflected in good practice 
guidelines for psychiatric medication management (National Prescribing Centre, 
2007;2008; NIMHE, 2005; NICE, 2009a; 2009b; Harris Baker and Gray, 2009; Healthcare 
Commission, 2007; The Schizophrenia Commission, 2012).  
 
SDM is not only valued as an ethical ideal, but also because it is thought to be related to 
positive health outcomes. There is, for example, evidence that SDM results in greater 
patient satisfaction and collaboration (Cox et al 2003; Swansson et al 2007) and is 
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particularly beneficial for long term decision making (Joosten et al, 2008). For decisions 
made about psychiatric medication, SDM is seen to offer a particular opportunity, given 
their complexity, and the trial and error nature of the process (see S. 2.6). This is coupled 
with the increased public concerns surrounding both the adverse effects of psychiatric 
medication, and the particular issues of poly pharmacy and high dosage prescribing 
present in psychiatric medication management practice in the UK (Morrison et al, 2012; 
Whittaker, 2004;2005; Healy et al., 2012). However, whilst research interest has increased 
in this field in recent years there remains a lack of consensus on a precise working 
definition for shared decision making (Barry et al, 2011; Edwards and Elwyn, 2009; 
Makoul and Clayman, 2006).   
 
As shown in Figure 2, in terms of levels of service user involvement and responsibility in 
decision making, SDM has been proposed to occupy the middle ground between 
paternalism and informed choice. It has been proposed that there is a considerable 
overlap between SDM and terminology such as concordance, evidence based patient 
choice, enhanced autonomy and mutual participation (see Makoul and Clayman, 2009; 
Wirtz et al, 2006) and these concepts have been proposed to sit within the wider shared 
decision making model (Coulter and Collins, 2011). 
 
Shared decision making was first defined in 1982 in a report exploring informed consent 
written for the US Presidents Commission for the Study of Ethical Problems in Medicine 
and Biomedical and Behavioural Research: 
 
It will usually consist of discussions between professional and patients that bring the 
knowledge, concerns and perspective of each to the process of seeking agreement on 
a course of treatment. Simply put, this means that the physician or other health 
professional invites the patient to participate in a dialogue in which the professional 
seeks to help the patient understand the medical situation and available course of 
action, and the patient conveys his or her concerns or wishes. This does not involve a 
mechanical recitation of abstruse medical information, but should include 
disclosures that give the patient an understanding of his or her consideration and an 
appreciation of its consequences.... Shared decision making required that a 
practitioner seek not only to understand each patient’s needs and develop reasonable 
alternatives to meet those needs, but also to present the alternative in a way that 
enables patients to choose one they prefer. To participate in this process, patients 
must engage in a dialogue with the practitioner and make their views on well being 
clear.   
(ibid, p. 38 and 44) 
 
The emphasis within this definition is on SDM being very much a process based on the 
values of mutual respect and partnership. Other theorists have further elaborated on this 
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initial concept of SDM. A popular definition commonly cited in the literature is that of 
Charles, Gafni and Whelan (1997;1999). Here four characteristics of shared decision 
making are proposed: 
 
(1) that at least two participants—physician and patient be involved; 
(2) that both parties share information;  
(3) that both parties take steps to build a consensus about the preferred treatment; and  
(4) that an agreement is reached on the treatment to implement.   
 
According to Charles, Gafni and Whelan (1997;1999) the defining characteristic of shared 
decision making is its interactional nature. Within this, there is the prerequisite that there 
are legitimate treatment choices. In addition, each person has to be both willing and 
actively engage in the process of exchanging information and sharing preferences. 
However, some disagreement exists as to whether this process in itself is enough in order 
to view the interaction as SDM. There is a lack of support for the model's premise that 
shared consensus has to be reached in order for it to be seen as SDM. According to the 
authors, if consensus on the decision does not occur, even if the process itself is 
collaborative, it cannot be considered SDM. Another limitation of this definition is that it 
does little to explain the process of acting as equal partners in reality, as it does not 
acknowledge or offer solutions to the inherent power imbalance in the relationship 
between the doctor and the service user.  
 
An alternative integrated model, proposed by Makoul and Clayman (2006) has been a 
useful guide for exploring some of these concepts within the SDM literature further. Here, 
a systematic review of 418 articles was undertaken and a full analysis of the conceptual 
framework for SDM conducted. The subsequent integrated model of SDM proposed by 
these authors comprises of ‘essential’ and ‘ideal’ elements. The essential elements10 
considered necessary for SDM to be deemed as taking place comprise of the need to: 
 Define and explain problem 
 Present options 
 Discuss Pros / Cons 
 Patient values / preferences 
 Discuss patient ability / self efficacy** 
 Doctor knowledge/recommendations 
 Check/Clarify understanding 
                                                             
10
 Note, written only for practitioners 
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 Make or explicitly defer decision 
 Arrange follow up 
 
** concept added by Makoul and Clayman (2006, p.305) 
 
Interestingly the authors refer to the concept of self efficacy as a requirement for SDM. 
This term is proposed by the authors as an alternative way of explaining the need to 
discuss patient preferences and values, but specifically refers to the importance of 
understanding the patients’ outcome and efficacy expectations, as laid out in Bandura’s 
social cognitive theory, which have previously been linked to various behavioural 
outcomes (Bandura 1997). According to Makoul and Clayman (2006) then, the need to 
discuss the patient’s beliefs about how capable they see themselves in being able to 
succeed and carry out the actions under discussion is an essential component to the SDM 
process. 
 
The authors also acknowledge that the physician will often take the leadership role in the 
process, with medical knowledge in addition to the asymmetry in the provider – patient 
relationship resulting in the balance being always or nearly always tipped in favour of the 
practitioner (ibid, p.307). On this point, it is interesting to mention that this model, whilst 
noting the importance of ‘patient values and preferences’, does not see the patient's 
experiential understanding or knowledge as essential to the process (even though ‘doctor 
knowledge’ is present in the essential elements). In fact, the authors instead suggest that 
SDM does not require that practitioners need to relinquish control or decision making 
authority. For example, they comment that SDM can occur even if patients ask physicians 
to take decision making responsibility, provided that the essential elements are present. 
Also of note is the fact that the concept of mutual agreement is, in this model, marked as an 
ideal and not a required component of SDM (as oppose to that of Charles, Gafni and 
Whelan, 1997;1999). 
 
Overall, the concept of shared decision making is a relatively fluid term, being not fully 
agreed upon within the literature. The hallmark but often implicit feature that appears 
through the models, is that both the patient and the practitioner have an equally valuable 
contribution to the decision making process. The term a “meeting between experts” may 
be especially pertinent here then. 
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2.4. Critical considerations 
As eluded to above, the main defining characteristics of shared decision making is its 
interactional nature and the value it places on an equality of different types of knowledge. 
This is both its main strength and weakness. Important barriers between theory and 
practice currently exist, and the true complexity of how decisions are made or what 
structural and individual constraints need to be overcome in order to move towards the 
idea of a “meeting between experts” is not fully encapsulated by the model.  
 
There is a lack of detailed understanding of what is meant by the sharing of the decision 
and the process that this involves in practice. Terms such as ‘negotiation’ or ‘mutual 
discussion’ are often used but do not elaborate on the deliberation that occurs during the 
encounters and how to balance the differing requirements of the healthcare consultation. 
  
The model is based on important ‘unspoken assumptions’ which are not explicitly 
addressed or elaborated upon in these models.  For example, Wirtz et al (2006) makes the 
point that, in addition to patient autonomy or involvement, there needs to be an 
acknowledgement of an additional assumption: ‘the accountability of professionals’. At the 
heart of these models is the differing scope of doctor and patient power and 
responsibilities (see theory chapter for further discussion). This in turn links to the 
differing levels of accountability for these key stakeholders and other external influences, 
e.g. the wider culture, institutional practice, the societal expectations. Here Wirtz et al 
(2006) argue that unless these wider influences made explicit, SDM models will continue 
only to act “as lip service to the decision making process” (ibid; p. 122). Therefore, to 
increase understanding of decision making further it is proposed that the differing and 
often conflicting demands from system, policy and professional influences need to be 
made more open in the decision making process (Wirtz, 2006).   
 
More generally however, the model needs to make more explicit what barriers exist (and 
therefore may need to be overcome) in order to uphold respect and recognition for the 
value of different forms of knowledge in the decision making process.  Linking in with 
Wirtz’s point above, at the forefront of these is the inherent power imbalance present 
between patient and doctor in the healthcare encounter and therefore this needs to be 
made more explicit by the SDM model. Prevalent paternalistic cultural norms such as the 
“doctor knows best” and patients “do as they are told” mean that power relations will 
continue to shape the experience and outcome of the healthcare encounter (Murtagh, 
2009).  This, in addition to a consideration of cultural components of the contemporary 
U.K. mental health system and its broader historical context, impact on how power may be 
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shared in reality (see chapters one and three, for further discussion). More broadly, there 
is recognition that structural constraints such as class and education, in addition to 
people's previous experiences, may all impact on the mutuality and preferences towards 
levels of participation in an encounter (Elwyn, 2009). In addition, levels of involvement 
may fluctuate over time and change according to the seriousness of their condition (O’ 
Grady, 2010). 
 
In such a complex process, it is easy to see how engagement may, at times, be difficult and 
why such models are not being taken up in practice. For example, it has been found that 
even when doctors explicitly support patient’s right to autonomous choice, this is often 
not reflected in their actual practice (Agledahl, 2010; Karnieli Miller, 2009). More 
fundamentally however, it has been suggested that unless the process of patient 
involvement and the process of communicating with the medical practitioner is seen as 
part of the therapeutic process, as opposed to an additional support to care, then such a 
complex and demanding process will not be embarked upon (Wirtz et al, 2006). In other 
words, whilst SDM is an ideal concept within medical ethics, unless the values it 
represents are embraced throughout care, then the value of this model may be relatively 
arbitrary.  
 
2.4.1 Summary 
 
In summary, different models of decision making exist in the literature. Both the informed 
and shared models of treatment decision making were developed largely in reaction to the 
paternalistic models, reflecting broader change towards ‘patient led’ care. Shared decision 
making is seen as the ethical ideal standard for health care practice, focussing on the 
exchange of expertise and information and joint weighing up pros and cons of a decision. 
Its value remains the acknowledgement of the different forms of knowledge in the 
encounter and enabling experiential knowledge to move more towards the fore (Charles, 
Gafni and Whelan, 1999; Whitley and Woltmann, 2010).  
 
However, the most substantial criticism of the SDM models for healthcare consultations 
generally is that it does not encompass ideas that decisions are made over time in a 
complex interplay between multiple stakeholders. The rationale for SDM as a model may 
be a valid one in medical decisions where there is choice from several treatments options 
(Montori et al, 2006). But for people who may have been marginalised by society, deprived 
of agency and self-efficacy by previous encounters with the mental health system (see 
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context chapter ) additional support may be needed to bring service user perspectives and 
preferences to the fore (Whitley and Woltmann, 2010).  The tendency for models to avoid 
the full context and reality of the situation presents the additional danger of enlarging the 
gap between medical ethics and theory on the one hand and practice on the other 
(Matthias et al, 2013; Agledahl, 2010; Karneli Miller, 2009).  
 
In conclusion while being influential and seductive in nature, the models discussed in this 
section are essentially ‘transactional’ in nature, focusing only on a narrow range of 
requirements, actions and behaviours (Trede and Higgs, 2008).  The models fall short in 
considering how various structural factors, interests and motivations influence the 
decision making and how thoughts, feelings and longer term relationships may facilitate 
or hinder outcomes.  According to Trede and Higgs (2008), with whom I agree, models of 
patient involvement need to incorporate a  more critical and complex contextual 
understanding of decision making in health care generally (and for medication 
management in mental health, more specifically). In order to do this, it may instead be 
useful to focus on the answers to the following questions: 
 
Who defines the problem? What options are being considered? How are service users’ 
values and views incorporated into the discussion?  What knowledge counts?  
 
It is only through the critical appreciation and reflection by practitioners of these issues 
(as opposed to a list of requirements as proposed by SDM theorists), that transformative 
change towards a democratic collaboration between practitioner and patient may occur. 
 
2.5. Moving towards a broader conceptualisation of involvement  
 
Before the research exploring service user involvement in psychiatric medication 
management is discussed, broader conceptualisations of collaboration and patient 
involvement are considered. 
 
2.5.1 Collaboration 
 
Collaboration may be seen as distinct from SDM in that it refers to working together in the 
pursuit of shared goals, where the participants have a level of equality and where the there 
is a less clearer division of labour (Dillenbourg, 1999, p. 8). As such, collaboration describes 
a more general approach or style of working whereas SDM focuses specifically on the 
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pursuit of reaching a decision. Unlike shared decision making which focuses on an event in 
time, collaborative decision making is a process of engagement with action plans under 
regular review. The model focuses more broadly on problems that emerge from both 
medical and non-medical issues. That is to say, the resolution of these problems may 
address the medical issue but within the context of broader health or life goals (O’ Grady, 
2010).  
 
Although distinct, shared and collaborative decision making do not necessarily compete 
but may be seen as complementary approaches contributing to the emergence of well-
balanced partnerships between patients and health professionals. Gray (1989) defines 
collaboration as “a process through which parties who see different aspects of a problem [or 
issue] can constructively explore their differences and search for solutions that go beyond 
their own limited vision of what is possible” (ibid, p.5). 
 
According to O’Grady (2010), the increased focus on non medical perspectives may be 
especially relevant for patients with complex chronic conditions or people taking multiple 
medications and experiencing a wide variety of symptoms. As such, collaborative decision 
making and increased focus on health related goals is highly relevant to the context of 
psychiatric medication management (see chapter one). However the question 
nevertheless remains, how to achieve this state of partnership working detailed within 
collaborative approaches to decision making? 
 
This question is addressed further by Trede’s doctoral research that explored the 
importance of reflection for practitioners moving towards collaborative decision making 
(Tredes and Higgs, 2008). According to the model of ‘critical collaboration’ proposed by 
the authors, the first essential  requirement for collaborative decision making is the need 
for a critical self awareness of what is motivating professional bias, professional authority 
and role thereby illuminating the various interests and interpretations underpinning 
practice.  
 
Within this framework, the practitioners sought to share knowledge and power with 
patients, placing value on the patients input to the decision making process. According to 
Trede and Higgs (2008):  
..making intentions and arguments for decisions transparent is key for truly 
collaborative decisions... In addition, collaborative decision making requires critique 
(including self critique) and moderation of interests, values and expectations of all 
parties involved in the decision making process, and safe, democratizing and caring 
environments to foster open transparent collaboration where patients feel they are 
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listened to and taken seriously’                 
        (ibid, p.46). 
 
Overall, factors that were found to be related to participation in collaborative decision 
making included: appreciating patients perspectives; becoming self aware of personal 
bias;  providing opportunities for patients to participate; being willing to reconsider 
treatment choices; exploring options with patients; establishing reciprocal relationships; 
being open; teaching and learning from each other and  recognising clearly the values of 
informed decision making. 
 
Comparing these items then to the SDM model, many are overlapping and complementary 
items (for example, exploring options with patients, providing opportunities for patients 
to participate and appreciating patients' perspectives etc.). Where this model of critical 
collaborative decision making however differs (or at least elaborates on previous models), 
is the emphasis on the importance on critical self reflection in the process of collaboration 
and the need to make explicit the power imbalance and professional bias for scientific 
based knowledge. This self reflection assists the move towards a more equitable 
relationship with patients, where different types of knowledge and understanding are 
incorporated into the decision making process.  The emphasis on decision making as a 
process over time is also recognised in this model. This critical approach to exploring 
collaboration is thus able to overcome some of the concerns about what degree of 
collaboration is appropriate, in which situation, and for which patient, by making the 
degree of collaboration for a particular situation more explicit. 
 
Collaboration is a useful concept for exploring decision making mental health medication 
management. Although the term is somewhat overused in practice with many differing 
meanings, it is a useful concept in that it is more readily able to explore decision making as 
a process over time as part of the wider practitioner patient therapeutic relationship. 
Trede and Higgs (2008) explore how skills such as critical self reflection may be key for 
understanding how collaboration may be implemented in practice, allowing for bias 
inherent in the healthcare system to be made more explicit and for dialogue for decision 
making to be more open and honest. 
 
2.5.2. Patient Involvement 
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Entwistle and Watt (2006) provide another broader model of patient involvement, 
inviting more complexity and sophistication in conceptual understanding.  As shown in 
Figure 3, the authors focus on exploring patient involvement from the perspective of not 
only what people do or say in any given decision encounter, but also by incorporating 
people’s views and feelings about their roles, efforts and contributions relating to the 
decision making and their relationship with the practitioner.  
 
 
Figure 3. Aspects of involvement (Entwistle and Watt, 2006, p.273)  
 
This model is interesting; firstly, as it broadens the understanding of what service users 
being involved in decision making includes; but secondly, because it visually represents 
the service user and clinician as equally contributing to the process. The model, by 
focusing on feelings and views about roles and contributions in the process also allows 
reflective processes such as being in control and having an influence to move to the 
forefront of understanding. This focus on individual views and feelings of involvement in 
decision also appears to reflect how mental health service users and practitioners 
encapsulate and describe being involved (Woltman and Whitley, 2010; Davidson, Miller 
and Flanagan, 2008; Shepherd, Boardman and Slade, 2008). Moreau et al (2012), in a 
recent focus group study of patient’s experiences also found SDM to comprise of 
emotional, aesthetic and social and value oriented components. Here, patients were more 
concerned with the affective aspects of the decision rather than the informational or 
technical components. 
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Entwistle and Watt (2006) suggest that most research in this area has either explored the 
communication of the decision making encounter, or focused on how to encourage 
patients’ efforts and contributions to the process. Instead this model supports the 
emerging literature which places increasing emphasis on recognising the importance of 
the ‘clinicians efforts and contributions to decision making’. For example exploring the 
importance of clinicians’ attempts to understand the problem in light of their professional 
knowledge and the patient’s perspective, and their efforts to ascertain and respond to the 
patient’s needs and preferences. As such, this conceptual model helps assist the process of 
understanding what components are necessary for the resultant ‘meeting of experts’, thus 
moving beyond the narrow conceptualisation of SDM focussed on requirements related to 
practitioner communication and service user behavioural contributions. 
 
2.5.3. Summary 
 
Decisions concerning psychiatric medication often involve many different participants and 
often occur over long periods, in a lengthy process of trial and error. Broader 
conceptualisations of collaboration and patient involvement may be particularly useful to 
consider in the context of psychiatric medication management, exploring how partnership 
may be forged and how the ideal of a 'meeting of experts' may be achieved in practice. 
However the policy context, the growing recognition of the importance of shared decision 
making in professional discourse, and the emphasis it places on valuing experiential 
knowledge in psychiatric medication management practice, results in this being a central 
concept for this thesis to explore.  
 
Part B – Research into Shared Decision Making in mental health 
services 
 
2.6. Opportunity for SDM 
 
“SDM reflects the values and processes of client centred care, evidence based 
medicine and the recovery movement” 
        (Adams and Drake, 2006, p. 1) 
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SDM in psychiatric medication management represents part of a larger change in the 
mental health system. As discussed in the previous chapter, in addition to the wider 
changes towards 'patient centred care', SDM is also a central tool for models of personal 
recovery and recovery based practice in mental health11 (Schauer et al, 2007). Indeed, 
Deegan and colleagues suggest that: “SDM is congruent with the foundational tenets of the 
consumer –survivor movement” (Deegan, Drake, Rapp 2010, p. 7). Accordingly then, SDM 
for medication related decisions is one tool in a larger system which focuses on giving the 
mental health service user choice, enhanced control, placing increased priority on 
partnership with practitioners as part of a personalised approach (Shepherd, Boardman 
and Slade, 2008).  Here the service providers and prescribers' role is to assist in the 
process of individual led recovery and the corresponding change in the service users’ re 
evaluation of identity (Shepherd, Boardman and Slade, 2008).  However as discussed in 
the previous section, whether prescribed shared decision making models are the most 
appropriate constructs for such principles is more questionable, with other concepts, such 
as collaboration, perhaps better fitting with the ideals of the personal and ongoing journey 
of recovery. 
 
Nevertheless concepts such as shared decision making and collaborative decision making 
have become popular terms within mental health policy. However they have originated 
from other areas of medicine.  Compared to other fields of health care, less is known about 
SDM in mental health service contexts. The studies that have been conducted show that 
mental health service users are keen to participate in decision making and desire greater 
involvement (Hamann, 2005; Loh et al, 2007a; Say, Murtagh and Thomson, 2006; Adams, 
Drake and Wolford, 2006). Positive impact of SDM has been shown for improved 
treatment adherence, satisfaction, knowledge, involvement in decision making, reduced 
drug use and a trend for reduced hospitalisation (Hamann et al, 2007; Clever et al, 2006; 
Loh et al 2007b; Joosten et al, 2008; 2009). Other reviews show that when people are 
given greater choice in decisions, positive outcomes are observed (Davidson et al, 2012a). 
However, research is limited. This was highlighted by the recent Cochrane review, which 
only identified two studies for inclusion12 in their review of shared decision making 
interventions within mental health services (Duncan, Best and Hagan, 2010).  
 
Despite the apparent opportunity for SDM in mental health, some ethical concerns have 
been raised about the decisional capacity and capability of patients in mental health to 
                                                             
11
 See Chapter One for further discussion 
12
 Studies which did not adopt a randomised control trial design were not included 
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effectively participate (e.g. Appelbaum et al, 2006). Practitioners have expressed 
scepticism about ability to participate due to cognitive deficits. However, involuntary 
mental health treatment is contrary to the value placed on service user autonomy and 
experiential knowledge, within SDM concepts. In addition, these views are incompatible 
with evidence that shows service users are capable of participating in most decision 
making situations (Loh et al, 2007a).  
 
It is this background which means that it is necessary to further explore the value of SDM 
for mental health and more specifically medication management in mental health, 
providing a more comprehensive picture of what aspects of involvement are important 
and what barriers currently exist to implement SDM in practice. In short, a fuller 
contextual understanding is necessary to build a richer and more relevant understanding 
of SDM for psychiatric medication management. 
 
Whilst the context chapter explores some of the defining features of medication 
management in mental health in more depth, for the purposes of this chapter, the below 
bullet points assist in understanding some of the complexities of the decision making 
process in psychiatric medication management: 
 
 Medication continues to remain the key treatment modality in mental health treatment 
programs (Healy, 2009). 
 Historical dominance of medical model of understanding mental illness (although see 
point 8 below) (Shorter, 1997; Davidson, Rakfeldt and Strauss,2010) 
 Historically poor compliance rates for psychiatric medication (above 50%) (Healy 
2009). 
 A shift from a 'compliance' to a 'concordance' paradigm in prescribing practice 
(Sandman, 2012) 
 Serious and enduring side effects associated with psychiatric medication. As such, side 
effects may create a set of new problems and act as a deterrent to taking the medication 
on a continuous basis. Furthermore, a number of the side effects are irreversible, such as 
memory loss, or involuntary hand and leg movements, liver and kidney functioning etc 
(Healy, 2009)  
 High dose prescribing and poly pharmacy are known problems in the field (Ito et al 
2005) 
 Changes to self identity in psychiatric medication taking (also see point 10 below) 
 Psychiatric medication does not offer a ‘silver bullet’ for mental illness 
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 Recent shift in values towards recovery oriented prescribing and the adoption of the 
‘recovery model’ in mental health  
 Shift in values and attitudes towards the role of medication in mental health treatment 
programs and the growth of the bio-psycho-social model of understanding mental 
illness (e.g. see Whitaker, 2004) 
 Stigma surrounding use of psychiatric medication (Malpass, 2009) 
 The enduring nature of mental illness. 
 
This remainder of this section will review the research that has explored shared decision 
making in mental health services. Preferences and perspectives of service users and 
practitioners towards involvement and practice of decision making will be presented, 
exploring the known barriers and facilitators. In addition, studies, which have explored the 
current practice of psychiatric medication management, are described. 
 
Overall, four categories of research have been undertaken in this area:  
 Exploring the preferences of service users in decision making process 
 Exploring the views of mental health practitioners  
 Investigating current decision making practice in mental health 
 Exploring the efficacy of interventions or decision aids aimed at increasing levels of 
participation in decision making.  
 
In this section I focus on reviewing the literature in the first three areas. Although the 
development of decision aids and bespoke interventions aimed at promoting shared 
decision making in practice is a worthwhile and practical application of theory in this area 
I argue that the knowledge base in this area is limited. As such this study has the aim of 
building theory, focusing on preferences, experiences, views and attitudes towards 
decision making alongside an examination of current practice. Increasing knowledge in 
this area will enable interventions to better target change in this field. Consequently, this 
review will not incorporate the decision aid and other intervention research. 
  
2.7. Service user views and experiences  
 
As alluded to above, there is mounting evidence that mental health service users (MHSUs) 
value participation in decision making and endorse models such as shared decision 
making (Adams and Drake, 2006; Deegan and Drake, 2006; 2008; Drake Deegan and Rapp, 
2010; Hamann, 2005; Patel, 2008, Loh et al, 2007a; Say, Murtagh and Thomson, 2006). It 
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has been suggested that the desire for increased involvement in decision making may in 
fact be greater than in other areas of medicine (Douglas 2004; Hamann, 2005). 
 
Motivations for this appear to be based on: 
 past experiences 
 a desire for recovery and a recognition of strengths (Mahone et al, 2011) 
 The existing evidence concerning the achievements of the recovery approach (see 
context chapter) 
 Types of decisions that are made are complex and multifaceted 
         (Patel, 2008). 
 
This being said there is relatively little actual research which explicitly explores MHSU 
views in-depth about decision making for psychiatric medication management; or the 
facilitators and barriers to achieving a shared dialogue. Although the research suggests 
that service users want to be more involved in the decision making process, the 
exploration of meaning for service users in the context of making decisions about 
psychiatric medication needs expansion. However a few studies of note are important to 
consider at this point: 
 
Simon et al (2007) undertook qualitative interviews with people receiving services from 
their GP for depression. This study highlighted that service users had a number of unmet 
expectations in their consultations regarding treatment. The first concerned expectations 
for more time in consultations, and the establishment of a trusting relationship with the 
GP. The formation of a trusting relationship was seen as very important during more 
difficult times, when service users reported wanting the doctor to take more of a 
leadership role. In addition service users expected the GP to be the main source of 
balanced information about depression treatment options, yet felt that, in general, they did 
not receive enough information, especially concerning side effects of proposed medication 
options. Fears and concerns about side effects alongside fear of stigmatisation of 
medication taking were raised as concerns by service users.  
 
Tanenbaum (2008) used focus groups to explore types of information MHSUs value and 
what role it serves in decision making. The results showed that service users have a strong 
desire to know more about their condition and be involved in making decisions about 
treatment. People gathered information from multiple sources including the care team, 
other professional groups (such as pharmacists), peers and the internet. In general people 
valued scientific evidence although this also did create some problems in that this 
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sometimes reduced the value of the individual accounts. Most importantly, perhaps, focus 
group members referred to the importance of individuality and the need to treat it as part 
of the recovery journey where they are themselves an expert. Here again having trust with 
the practitioner was essential to success. 
 
Mahone et al (2011) in a mixed stakeholder focus group study found that MHSUs 
supported SDM, and in particular the value it placed on 'putting consumers at a place 
where their voice is heard' (ibid; p. 9). Service users valued being respected and listened to 
in the decision making process, although acknowledged that this was associated at times 
with raised fears about the increased responsibility this implied. Barriers raised to SDM in 
this study  included previous experiences of coercive practice and the associated trauma 
for the service user. 
 
Tee et al (2007) presented results from a cooperative inquiry study of student community 
psychiatric nurses and service users which explored service user participation in decision 
making. Themes that emerged as inhibiting participation included stigmatization and 
paternalistic approaches where diagnosis was used as the basis for clinical judgments. 
Factors enhancing participation included a respectful culture that recognised service 
users' expertise and communicated belief in individual potential. The importance of 
recognising power issues in these helping relationships was highlighted.  
 
Finally, Whitley and Woltmann (2010) conducted 16 in depth qualitative interviews 
exploring the views of mental health consumers towards SDM.  The results of this are 
interesting in that, whilst on face value, the results endorsed a shared approach to decision 
making, the meaning assigned to SDM was not necessarily congruent models presented in 
the previous section. Instead  a slightly more complex picture emerged.  The authors found 
that consumers often describe the preference for a two phase process which first 
prioritises autonomy but then, if that is not possible, defers to the clinician’s judgement in 
more challenging or complex decisions.  
 
According to both Simon et al (2007) and Woltmann and Whitley (2010) then, MHSUs are 
mostly concerned with SDM in respect of the level of control and autonomy over decisions, 
but are also suggesting the need to be flexible about this depending on the nature and 
complexity of the decision to be made. Trust and the importance of the therapeutic 
relationship in this process remain important themes throughout all of the above 
mentioned studies.  
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Davidson Miller and Flanagan (2008) further highlighted helpful relationships. This study 
was a synthesis of qualitative narrative interviews with service users, focussing on 
perspectives regarding the utility of treatment.  Personal narratives focussed on the 
positive and helpful role of relationships for medication management. People discussed 
the prolonged process of first finding the right doctor or nurse, and then eventually the 
right medication. This study found that  the right prescriber was someone who listened to 
the person, was willing to try different things and who viewed the medication as more than 
just a way to reduce symptoms (ibid, p.180).  Involvement in decision making then is seen 
as reflecting the ideals of a trusting, open and honest relationship with clinicians where 
the service user is empowered and treated as an equal in the decision making process. It 
has indeed been suggested that the mechanism by which the therapeutic relationship 
positively impacts on recovery outcomes in mental health, is via its influence on increased 
agency and empowerment in decision making (Street et al, 2009).  
 
Other research in this area has explored MHSU’s experiences of psychiatric medication 
taking in the context of the recovery journey. This research emphasises that the decision 
making process is complex and varies according to the individual, their goals, priorities 
and values, in addition to their previous experiences of the mental health system. Research 
suggests that service users appear to value the importance of medication in mental health 
treatment programs. Yet, medication while being helpful at times, at other time may 
hinder recovery both as consequence of adverse side effects, and by undermining 
individual autonomy and responsibility (Baker et al, 2013). Medication may also 
negatively impact self image and identity (Malpass, 2009; Kartalova-O’Doherty and 
Tedstone Doherty, 2010). The influential writings of Deegan, Drake, Adams and Mistler 
explore the concepts of recovery in relation to medication decisions further (Deegan and 
Drake, 2006, Deegan, 2007; Deegan et al 2008, Adams and Drake, 2006; Mistler and Drake, 
2008; Drake et al, 2009). Service users may develop and refine medication strategies over 
time, gradually accumulating expertise, customising their medication use in response to 
mental states and life events, and integrating flexible medication use into broader 
“personal medicine” strategies (Deegan, 2005; 2007; MacDonald-Wilson et al, 2013). Here 
medication is viewed as one tool in a larger toolbox of personal medicine, where the 
person finds the right balance between what they do to be well and what they take to be 
well (MacDonald-Wilson et al, 2013, p. 263). Many personal strategies are highlighted, 
which may not fit into medically advisable methods of medication taking, such as only 
taking medication at certain times or moving to intermittent use or even non compliance 
as a positive attempt regaining control (Britten et al 2010; Pound et al 2005; Cooper et al, 
2007). Worryingly Read (2005), in a mixed methods study, found that service users would 
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often not inform or even consult practitioners with the serious decision to come off 
psychiatric drugs, highlighting a lack of trust.  Participants also described not receiving 
adequate advice or information, indicating a lack of open discussion and dialogue.  
 
It may be internet forums could offer increased opportunity for exchange of personal 
experiences and other knowledge sources in the wider community and it is likely that 
service users may have sophisticated and nuanced understandings of the use and effects of 
psychiatric medication (Pestello and Davis-Berman, 2008). In addition a growing number 
of community groups have been organised in recent years in different parts of the UK, with 
a focus on psychiatric medication and a sharing of experiences and knowledge 
(Nottingham Mind Medication Group; Leicester Living with Psychiatric Medication Group, 
both cited in Coles et al, 2013). As such, knowledge and expertise about psychiatric 
medication may be extensive but it may not necessarily form part of the formal 
consultation about psychiatric medication with clinicians. 
 
2.7.1. Summary 
 
In summary, the research exploring MHSUs views towards decision making shows a 
general increased desire for involvement. However the decision making process is 
complex, multifaceted and a protracted process of trial and error (Davidson, Miller and 
Flanagan, 2008). The values of choice, self determination and empowerment are central to 
recovery (Deegan and Drake, 2006). The key element for service users would appear to 
maintain a trusting, honest and open therapeutic relationship, where service users’ 
expertise (both from previous experiences of using medication, knowledge gained through 
difference sources, and individual preferences) is valued in an encounter, enabling 
increased levels and experiences of being in, or taking back control. Nevertheless, there 
remains a lack of detailed studies exploring preferences and experiences of psychiatric 
medication management and further research is needed. 
 
2.8. Practitioner views and experiences 
 
According to the review of literature conducted by Patel (2008) there is a cautious 
willingness towards concepts such as shared decision making in mental health treatment 
decision making. In particular, SDM is seen by practitioners as an important tool for 
service users to gain increased control, supporting recovery oriented practice and person 
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centred care (Mahone et al, 2011). However, there is more focus within this literature on 
the barriers to implementation of SDM. Practitioners have expressed barriers including: 
 Competence of SUs to participate 
 A preference for practitioners to rely on intuition regarding patient interest in SDM 
 Fears around impact on medication use/uptake 
 Time 
 Communication and relationships with other team members 
 Focus on risk avoidance management in MH service delivery, at the expense of positive 
risk taking. 
 Coercive practice and enforced compliance 
(Gravel, 2008; Legare et al 2008; Patel et al 2008; Torrey and Drake, 2010).  
 
Interestingly, some of these concerns may not have a strong foundation. For example, 
implementing SDM may not automatically increase consultation time (Loh et al, 2007b).  
 
Seale et al (2006) conducted 21 qualitative interviews exploring decision making for 
medication management with consultant psychiatrists working in adult mental health 
services in the UK.  They concluded that the psychiatrists had a genuine commitment to 
democratic and shared decision making. A number of approaches and practical strategies 
were referred to by psychiatrists to promote shared decision making including: listening 
to people’s views about their current situation and experiences of medication use, 
showing empathy and understanding, having respect, using language thoughtfully, 
tolerating conflict and managing hostility. Once again the importance of establishing a 
relationship over a long period of time was mentioned.  
 
However a number of obstacles particular to psychiatry appeared to prevent 
opportunities for the psychiatrist achieving a fully concordant relationship with service 
users.  At the fore front of these was a judgement of competence or insight.  This is at odds 
then with research which demonstrates that consumers of mental health services are 
generally capable of making decisions related to their care, despite decisional impairments 
which are characteristic of many chronic mental health disorders (Loh, 2007a). In the 
Seale et al study (2006) psychiatrists acknowledged that, at times, more persuasive and 
directive strategies are employed and sometimes deception is necessary.  
 
 However the psychiatrists interviewed were very aware of the potential damage using 
coercive measures had on the longer term therapeutic alliance with the service user and 
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tried to adopt strategies to limit this damage.  Alongside this, there was also doubt that the 
service user was being fully honest and open. The psychiatrists interviewed often referred 
to adopting strategies to overcome this including persuasion, bargaining and deception, 
thus also indicating a lack of trust in the encounter. A key dilemma for psychiatrists was, 
on the one hand, psychiatrists strongly valued and believed in medication treatment as 
helpful, yet on the other hand, they were worried about the impact on non adherence, if all 
adverse side effects were presented. The heavy reliance of psychiatrists on medication to 
control symptoms may therefore impede psychiatrists from fully engaging in a 
collaborative decision making. As such these results point to the fact that the psychiatric 
encounter is unbalanced in terms of powers and fits with research which shows that 
service users often will present a false picture of compliance (Britten et al, 2010), thereby 
allowing the psychiatrist to continue to believe the decision was a concordant one.  
 
In McCloughlen et al’s (2011) study of psychiatric nurse and service users' views and 
experiences of collaborative decision making, a similar picture emerges. This Australian 
focus group study found that while both service users and nurses strongly valued a 
collaborative relationship, the experiences of collaboration between the groups was 
inconsistent. Many of the nurses felt they employed collaborative decision making with 
service users. Nurses referred to perceived barriers associated with multi disciplinary 
working resulting in a lack of autonomy to make decisions, thereby influencing the ability 
to form a fully collaborative relationship with service users. The service users, however, 
did not express such an opinion, yet only half felt that they had a collaborative relationship 
with the nurse. Instead the strong theme for service users was concerns that their ‘voice’ 
was not heard in discussions and personal experiential understanding was not valued in 
the decision making process. Notwithstanding this, often service users would continue to 
portray a false picture of compliance in order to maintain the ongoing relationship with 
the nurse and therefore allow for a facade of shared decision making to be built and 
maintained (also see Barry et al, 2007).   
 
2.8.1. Summary 
In summary, research exploring practitioner’s perspectives of SDM in psychiatry is limited. 
Research suggests that practitioners have a strong commitment to the values of shared 
decision making and a democratic approach to decision making in psychiatry, but that this 
may not implemented in practice. The systematic power imbalances present in the 
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psychiatric system13 are perceived as key barriers in being able to achieve an equal 
partnership in psychiatric medication management encounters.  
2.9. Research exploring current decision making practice in mental 
health 
 
Very little research has explored how decisions are currently being made in psychiatric 
medication management. Most of this research has either focused on examining the extent 
to which SDM is occurring in practice or  more generally, the degree to which a therapeutic 
relationship is established, using quantitative tools of measurement, such as; the 
Observing Service User Involvement in Treatment Choices Instrument (OPTION) scale 
(Elwyn et al, 2003;2005) and  the Scale To Assess the Therapeutic Relationship in 
community mentalhealth care (STAR) scales (McGuire et al, 2007).  
 
The research which has explored the model of SDM  in psychiatric practice does not paint 
a particularly positive picture. Loh et al (2007a) found that decision making is only 
happening, at best, at the first stage of information exchange (as defined by the Charles, 
Gafni and Whelan model, 1997, p. 10). In addition, a recent study conducted in a 
community mental health team found that while 61 % of recorded consultations reflected 
the practitioner perspective, less than 10% reflected both the service user and 
practitioner perspective (Matthias et al, 2012).  
 
Goosensen (2007), on the other hand, offers on the face of it, a slightly more positive 
picture of SDM practice within mental health services, in a multi site European study. 
Using the OPTION scale to assess SDM in psychiatric consultations during outpatient 
clinics, the results showed that observers rated some items highly (see table 2). For 
example, providing opportunity to ask questions and indicating the need for a decision 
was highly rated. However clinicians did not regularly explore service users’ expectations 
and concerns. In addition, service user preferences towards involvement were not 
requested. Thus, whilst on the face of it these results may suggest a more positive picture 
towards the practice of SDM,  the key elements of SDM (see S. 2.4)  of placing an equal 
value on different types of knowledge (through the genuine exploration of patients 
expectations and concerns) was not observed in this study. 
 
 
                                                             
13
 See chapter three for further discussion 
52 
 
 
 
 
 
 
HIGH scoring items from 
OPTION scale 
Mean 
observed 
score (0-4) 
LOW scoring items from 
OPTION scale 
Mean 
observed 
score ( 0-4) 
Clinician offers patient explicit 
opportunities to ask questions 
3.44 Clinician explores patient 
expectations 
1.30 
Clinician indicates need for a 
decision making stage 
2.87 Clinician explores patient 
concerns 
1.18 
  Clinician asks for preferred 
level of involvement in 
decision 
0.20 
  Clinicians ask for preferred 
approach to receiving 
information 
0.10 
 
Table 2: Findings taken from Goosensen (2007) indicating high and low observed scores from OPTION scale 
These pessimistic findings have been replicated in other recent studies (e.g. Goss et al 
2008; McCabe et al, 2013). Indeed the study by McCabe et al (2013), which videotaped 72 
meetings with psychiatrists, found lower observed levels of involvement (OPTION scale) 
than found in both the Goss et al (2008) or Goosensen study (2007). However, one 
explanation proposed by McCabe et al (2013) was that decisions were often made over 
multiple meetings. This is perhaps is not compatible with the OPTION scale's focus on a 
single decision point14. In this study, psychiatrist characteristics were related to the level 
of involvement observed, with, in particular, female clinicians showing increased SDM 
behaviours. 
 
 Findings from qualitative studies also suggest that SDM in not fully operational in 
practice. Indeed, in an intervention study by Rogers et al (2003), which explored the views 
and experiences of people who had a diagnosis of schizophrenia, the findings are stark. 
Two interventions were investigated: one being a traditional paternalistic approach to 
medication management, the other employing shared decision making principles. The 
                                                             
14
 The OPTION scale fits with transactional models of SDM, which may be less applicable for psychiatric 
medication management. See S. 2.5 for further discussion. 
53 
 
 
findings showed that both groups experienced positive responses from service users, in 
comparison to their prior routine experience with services. This was mainly due to the 
increased communication with practitioners during both groups. Thus, during routine 
practice, service users received little information or instruction about the nature or effects 
of their medication and that, at least in this study, psychiatric medication management 
does not attend to core principles of communication and patient centeredness. 
 
Although this research investigates how practice compares to the ideal models of decision 
making and collaboration discussed in the previous section, it does not seek to explore 
how circumstances relate to strategies employed by practitioners and service users, in 
psychiatric medication management. In addition these studies provide limited insight 
about how decisions concerning psychiatric medication are negotiated in practice. 
 
Previous research in this area indicates that degrees of pressure are applied by 
psychiatrists in decision making encounters (Lidz et al., 1993; Szmukler and Applebaum, 
2001), with persuasion being, by far, the most prevalent techniques employed by 
psychiatrists (that is, stating a preference or invoking expertise). This is compounded by a 
fear of more explicit coercion and compulsion to adhere to treatment. It is thought that 
more directive but subtle pressure exerted in outpatient clinics has a negative impact on 
service users fully engaging with mental health services or achieving concordance (Day et 
al, 2005). In a conversation analytical (CA) study, McCabe et al (2002) found that 
psychiatrists used various interactional strategies to both resist engagement and avoid 
conflict surrounding patients’ concerns or questions about their experiences of  hearing 
voices  (McCabe et al., 2002).  Seale et al (2007) found a similar pattern in their analysis of 
psychiatric medication review meetings. Here, in response to service user concerns about 
sedation and mental clouding (a side effect associated with anti psychotic medication) 
psychiatrists commonly either; construed the symptoms as positive (e.g. helpful for sleep); 
avoided an open discussion about the concerns (e.g. offered no response) or; questioned 
the validity of the service user’s interpretations (e.g. suggesting concerns may be 
unrelated to the anti psychotic medication). These results suggest a range of strategies 
employed by psychiatrists to guide conversations concerning particular side effects, 
thereby avoiding overt conflict in the encounter concerning psychiatric medication, and 
encouraging adherence.  This pattern was also highlighted in a study by Mendel et al 
(2009). This experimental study found psychiatrists more likely to focus on medication 
benefits rather than risks when presenting information about anti psychotics to service 
users, thereby guiding the conversation towards adherence.  
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However, and interestingly, in a recent re analysis of the same 92 recorded meetings 
referred to in the Seale et al (2007) study above,  it was found that when non adherence is 
disclosed by service users, it is often responded to positively by psychiatrists and results 
in an open dialogue about medication choices (Quirk et al, 2012).  A spectrum of pressure 
has been proposed to account for the diversity in the encounters (Quirk et al 2012; Quirk, 
2007). This analysis highlights that whilst a roughly equal number of decisions regarding 
psychiatric medication were initiated by the service user, as by the psychiatrist, how 
'shared' the dialogues were in practice, differed.  As shown in Figure 4, the conversation 
analysis findings suggested a variety of different ways of reaching a decision. This study 
found that consultations were often highly negotiated, with little evidence of direct 
coercion or compulsion by the psychiatrist. However the manner of the conversations 
were such that the service user may have felt they had very little influence over the 
outcome and when looking in detail, shared decision making as an ideal was not 
conformed to. 
 
Figure 4. Types of negotiated decisions positioned on a spectrum of pressure. Abbreviated from Quirk (2007, 
p.174) 
  
 
Low          High 
Open decisions    Directed decisions          Pressure decisions 
 
Doctors actions  Doctors actions  Doctors actions 
The doctors preferences The doctor marks a given      Preferences communicated 
are not communicated or  treatment option as   clearly. Doctor does not 
communicated weakly and  preferred ‘steers’ talk   back off in the face of  
constructed such that  and reinforces preferred  resistance 
it is open and easy to  option 
reverse 
 
Patients actions  Patients actions  Patients actions 
The patient takes the  Patient cooperates and  Patient overtly resists  
initiative  to some degree follows recommendations proposals, attempts at  
         persuasion 
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Thus for a high proportion of meetings analysed, while medication options and relevant 
information about side effects is presented, the decision is nevertheless directed by the 
psychiatrist, through the use of conversational strategies (e.g. use of the caveat 'but' to 
rule out options) thereby encouraging selection of the 'preferred' option. Quirk (2007) 
notes, however, that at no point does the service user suggest that the psychiatrist’s 
actions are a form of manipulation or are unwanted by the service user. According to 
Quirk (2007) this is. 
    
… a negotiated decision in which the participants are ‘letting the patients have  
it the doctors way’ – a meaning produced collaboratively, by the diplomacy of the  
consultant and absence of resistance by the patient...   
                                          (ibid, p.164) 
 
Such an approach, as discussed previously, may allow the psychiatrist to genuinely value a 
collaborative approach and maintain the self image of working according to SDM ideals, 
but in practice there may be a restricted freedom of choice over the decision, as 
experienced by service users. 
 
One other finding of note from this extensive work is the tendency for psychiatrists to 
‘back off’ when resistance or pressure is applied by the service user. Avoidance of conflict 
and the importance of maintaining the ongoing therapeutic relationship was highlighted in 
this analysis. However, whilst making an important contribution to understanding the 
processes of decision making about psychiatric medication, this study ignored situations 
of tacit non or false compliance, as mentioned above15, which is one of the strategies open 
to patients who disagree with their prescriber, but choose not to communicate openly 
about this. This may be particularly poignant to community based psychiatric medication 
management, where non adherence rates are high (see context chapter).  
 
2.9.1 Summary  
The research exploring SDM in practice in psychiatry has mainly used quantitative tools 
for observational measurement and suggests that SDM is not fully being employed in 
practice. The research which has explored the behaviours and strategies employed by 
service users and psychiatrists  suggests that a spectrum of pressure exists within a typical 
consultation meeting, such that meetings, whilst not being directly coerced, vary in the 
                                                             
15
 See Seale et al, 2006; Britten et al, 2010 
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level of information service users receive or in the amount of freedom to decide the 
service user feels they have.  
 
 
2.10. Concluding remarks and areas for further exploration 
 
Shared decision making is proposed to be the ideal model of practice in psychiatric 
medication management and is regarded as a tool for recovery. The model of SDM and 
research exploring its utility however has originated in other fields of medicine and 
conceptual understanding of what SDM means is not fully agreed upon.  Little research has 
explored the views, preferences and experiences of service users and practitioners 
towards making decisions about psychiatric medication or explored what factors are 
important towards achieving shared decision making in practice.  The research suggests 
that on the face of it, key stakeholders endorse shared decision making as an ideal 
approach to making decisions, however certain barriers and contextual factors, specific to 
psychiatric medication management emerge. A fuller conceptualisation of shared decision 
making for mental health medication management is needed.  
 
Even less research has explored the current practice of decision making in medication 
management in mental health. SDM does not appear to be fully operational in practice and 
a level of pressure is applied by psychiatrists (if not practitioners more generally) and, to a 
certain extent by service users, when negotiating decisions in this area. The inherent 
power imbalances present in the psychiatric system results in a specific dynamic of 
practice for decision making in mental health. Both practitioners and service users claim 
to value the ideals of a meeting between experts and conform to the idea of differing 
knowledge having equality, yet the differing power imbalances and structural components 
in the mental health system appear to be a barrier to achieving these ends. The 
subsequent chapter explores these issues in more depth, presenting the theoretical 
underpinnings and conceptual framework for the thesis. The theoretical construct of 
power is considered and influential theories evaluated, focussing on their applicability to 
the context of psychiatric medication management. 
 
2.11. Research Questions 
This thesis explores the views and experiences of both service users and practitioners, 
allowing for a more comprehensive understanding of the everyday realities of shared 
decision making for psychiatric medication management. Barriers to and enablers of SDM 
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for psychiatric medication are investigated, as a more sophisticated and multi-faceted 
construction of shared decision making for psychiatric medication management is sought 
for. 
 
There are two overarching research questions for this thesis: 
What are key stakeholder views about shared decision making for psychiatric 
medication management? 
How are decisions about psychiatric medication made in practice?  
 
Within these overarching research questions, some key research themes are identified: 
 The enablers of and barriers to shared decision making for psychiatric medication 
management. 
 Current medication management practice in community-based mental health services 
 Similarities and differences in how SDM is conceptualised between stakeholder groups 
 Acknowledgement of a need for change, making recommendations for practice based 
on the findings. 
  
58 
 
 
Chapter Three.  Theoretical underpinnings and conceptual 
framework  
 
 
 
 
 
 
 
 
3.1. The concept of power and its relevance to shared decision making 
in psychiatric medication management 
 
The review of the literature and research context chapter points strikingly towards the 
need to explore the concept of power.  This chapter describes some theories of note in this 
huge area of literature, pointing to relevant aspects to consider for medication 
management practice in contemporary mental health services. This does not offer the 
reader a critical evaluation or thorough examination of the power literature.  It does not 
even offer a whistle stop tour.  Rather, it reveals the different forms of power that may be 
applicable to consider when exploring SDM, as well as presenting useful theoretical 
representations of this construct in order to provide a sense of structure and meaning 
relevant for considering SDM in psychiatric medication management. 
 
Weber (1864-1920) conceptualised power as 'power over' - as something that can be done 
unto someone, with person A having power over person B. In the context of mental health, 
it has been suggested that those who possess power (i.e. the professionals and particularly 
the prescribers / psychiatrists) would need to surrender or hand over some of their own 
power if shared decision making is to take place and as such this is 'a reason to resist 
genuine service user empowerment'  (Masterson and Owen, 2006, p.21). Within this form of 
power, professional power and the understanding that certain types of knowledge have 
more weight is still applicable, suggesting that for this form of power,  expertise can only 
be challenged with expertise (Gaventa, 2008).  As such there is an overt conflict, but 
domination, of the powerful (mental health professionals) over the powerless (service 
users) with ideas such as compliance to medication regimes being particularly relevant. 
This form of power is often recognised as overly negative, and as having associations with 
Chapter Outline. 
This chapter explores the theoretical construct of power in the context of psychiatric 
medication management practice.  It considers influential theories of relevance to the 
thesis. Drawing on this literature, the chapter concludes with a conceptual framework 
for psychiatric medication management. 
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terms such as coercion (Veneklasen and Miller, 2002).  Studies of the asymmetrical 
psychiatric encounter and the role of status and authority on the dynamic of decisions 
about psychiatric medication fit with these conceptualisations of power, focussing on how 
power claiming strategies are employed, and how adherence or compliance to medication 
routines is encouraged by prescribers16. 
 
Many modern theorists, however, look beyond this simplistic or hierarchical picture of 
how power imbalances are played out in the context of the mental health system. The 
important work of Lukes is widely regarded and has received some attention for its 
applicability in considering the mental health context (Brosnan, 2012; Masterson and 
Owen, 2006).  
 
Lukes proposed that the Weberian or 'behaviourist models' of power are inadequate 
because: 
....although A may exercise power over B by getting him to do what he does not want 
to do, he may also exercise power by determining his very wants. 
          (Lukes, 2005, p.107) 
 
Instead Lukes has proposed a three dimensional view of power. The first dimension is 
comparable to the Weberian form described above, that of power over and associated with 
scenarios of conflict where one party has power over another.  However in the second and 
third faces of power, more covert forms of power are described.  The second face, also 
described as 'non decision making', is power that is exercised by the powerful (the 
professionals or prescribers), but by controlling what is on the agenda for discussion, or 
more specifically, by controlling which particular options are open for discussion. So, in 
the case of psychiatric medication management, this may involve which types of 
medication are described by professionals as options, or whether non medication 
alternatives are in fact considered at all.  The central issue of side effects is also important 
to consider at this level of power. Side effects and the risk benefit profile of different 
psychotropic medications are central to the balanced weighing up of the pros and cons of a 
shared decision concerning psychiatric medication. The presentation of the side effects is, 
however, in the hands of the psychiatrist, whose competing interests and limited time 
available, pose a challenge for the full disclosure of information needed for a fully shared 
dialogue. Whilst the internet and other 'open access' forms of knowledge, may assist the 
                                                             
16
 See chapter eight for more details 
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full disclosure of information to mental health service users at this level, this remains 
inconsistent, potentially misleading and influenced by structural factors such as education 
levels, class and age (Preston, 2013). Other factors may also be important to consider at 
this level of power, such as expense of medication and direct marketing incentives, 
influencing which options are presented in the psychiatric medication encounter.   
 
However, this second dimension of power still maintains the idea that the exercise of 
power involves conflict between parties, or rather between the powerful (prescribers) and 
powerless (mental health service users) over recognised areas of conflict.  Lukes' defining 
contribution to the literature was to explore a third dimension of power, which challenges 
this, instead suggesting the most insidious form of power is that which prevents conflict 
from emerging in the first place.  Thereby linking power with ideas associated with the 
work of Friere and others; exploring power via wider repressive cultures and internalised 
or self stigma.  At this dimension of power, identities and roles are manipulated so that 
certain groups do not question and accept certain situations without conflict. This is highly 
poignant to much of the critical psychiatry literature where it has been argued that this 
form of power is present in the dominating bio medical model of psychiatry. In particular 
for psychiatric medication management a dominating bio medical model may hinder the 
recovery ideals of the service user taking back control and empowerment, via the 
mechanism of distancing the value of experiential knowledge (Masterson and Owen, 
2006). 
 
In summary, the three dimensional view of power presented briefly above is a useful way 
of exploring how power is played out in a psychiatric encounter, both overtly through 
authority and power over in decisions about psychiatric medication, but also and perhaps 
more importantly how more covert forms of power represent themselves in the 
medication management encounter - through deciding which options are discussed (the 
second dimension of power) and by considering what is deemed socially acceptable as 
relevant knowledge for the decision in the first place (the third dimension of power). This 
is relevant in considerations concerning equality of knowledge, a meaningful weighing up 
of options; and experiences of control by the service user. 
   
Taken together in the context of psychiatric medication management, 'power', as an 
obstacle to the defining aspects of SDM, is an important theoretical construct to 
incorporate.  
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 There are strong links with Lukes' third dimension of power and foucauldian approaches 
to power, which, in addition, emphasise the positive aspects of power in social relations. 
Foucault's widely quoted phrase 'knowledge is power', is often misinterpreted as meaning 
how knowledge can be used as a form of power. However, this actually refers to how 
power is constructed, and subsequently maintained through discourses and institutional 
practices that frame action and govern what is seen as possible. For Foucault there wasn't 
a distinction between knowledge and power, both being inherent upon social relations, 
affecting every person in every role, both the service user and professional alike. Thus, 
whilst linked to Lukes' third face of power, it also refers to positive aspects of power, 
emphasising that within institutions, such as mental health service delivery, hierarchies of 
knowledge are created which place certain people in certain roles (i.e. psychiatrists and/ 
or prescribers) as having more control over decisions concerning psychiatric medication.   
Unlike Lukes, however, power for Foucault was not seen as something possessed by those 
who exercise it. Instead, power is a strategy and network, and mental health professionals 
are just as much a part  of this network of social relations, as service users. Thus, for 
Foucault, power is exercised by actions, as oppose to being exercised by a particular 
person in a certain position or role (Couzens - Hoy, 1986). Applying this notion of power 
in the context of psychiatric medication management, the meeting itself is of importance 
to consider, with power being exercised through use of  strategies employed by all 
participants as part of the wider social relations of the meeting.  Doctor - patient 
asymmetry and patterns of social relations may be important to consider at this level, 
then. Indeed, Foucault's work has been used extensively in areas of health and medicine, 
exploring both the caring profession and traditional doctor patient studies, focussing on 
how medicalised forms of knowledge impact on identity and behaviour in medical 
encounters (Petersen, 2010). 
 
Medicalised discourses and diagnosis are important hierarchies of knowledge at this level 
and are played out through the pattern of social interaction in the psychiatric medication 
encounters. A contemporary example is illustrated by the recent controversy following the 
release of the new Diagnostic and Statistical Manual (DSM 5) in 2013. Its release was 
associated with a much public debate and discussion. In particular, new diagnostic 
categories incorporated into the DSM 5 highlight the increasing medicalisation and, 
further pathologising of emotions and behaviours (Jacob et al 2013; DCP, 2012).  This 
pathologisation and the increasing trend towards creation of new distinctions between 
what is seen as normal and abnormal is proposed to be a form of power and control, via 
the mechanism of voluntary compliance (Foucault, 2005). As such, societal expectations 
and the dominance of medicalised perspectives of emotions, behaviour and distress may 
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be an important structural factor in the psychiatric medication management encounter, 
resulting in the less powerful enforcing the aims of the powerful, through self surveillance.  
.....there is no need for arms ,physical violence, material constraints. Just a gaze. An 
inspecting gaze, which each individual under its weight will end by interiorising to 
the point that he is his own overseer, each individual thus exercising this surveillance 
over and against  himself.        
        (Foucault, 1980, p. 155)  
 
Studies which have adopted foucauldian framework in their analyses have particularly 
emphasised how information presentation is framed and how documentation is used to 
create a consensus.  This links again to the ideas of avoiding overt conflict in the encounter 
by the creation of subtle constructions of argument about psychiatric medication, further 
impacting on the shared decision making process.   
 
However, one of the main criticisms to the foucauldian approach to power is, whilst seen 
as a form of critical theory, it does not construct a new systematic set of principles of 
power, but instead reconciles to criticising other theories. His work has been criticised as 
overly fatalistic, not encompassing the idea of universal progress. However, Foucault 
maintained his position that emancipation or empowerment was still possible, if taken at 
the local level, in terms of pockets of resistance to exercises of power.   
 
Another important aspect of power relevant to psychiatric medication management 
encounters, but paid little attention by Foucault, is the influence of industry and wider 
economic structures in shaping discourse.  Petersen (2012) argues neo liberalism is a 
manifestation of late, free market capitalism and we need to better understand how the 
particular forms of governance associated with contemporary health and medicine and 
healthcare reflect and are shaped by the dynamics of the political economy (ibid: p,17). For 
example, as applied to psychiatric medication management, Rose (2003) critically 
explores the influence of the pharmaceutical industry (see Chapter one). 
 
Lukes' ‘three faces of power’, have however also received criticism. For some, it ignores 
other types of power such as power with, power to and power within, associated with 
empowerment and transformational change. Power with is seen as achievable through 
working together in groups, for advocacy and change. Power to act relates to this but also 
links to ideas of agency and autonomy (or power within). These other forms of power are 
largely ignored by Lukes, but it is suggested, remain highly relevant within the psychiatric 
encounter theories (VeneKlasen and Miller, 2002).   
63 
 
 
 
There is also a body of research which has explored the importance of acknowledging the 
resistance and strategies employed by the less powerful in the encounter. The importance 
of exploring false compliance to medication regimes is particularly poignant to the 
medication management encounter in mental health. Scott (1990) explores the 
importance of the 'hidden transcript of the subordinate' as a way of explaining the 
phenomenon of passive resistance.  Here, the main premise is that the discourse of a 
subordinate group is vastly different when in the presence of a dominant group as 
compared to when in the company of peers.  This is highly relevant to considering 
psychiatric medication management practice. That is, the idea of  ‘acting' or presenting a 
false picture of compliance in order to avoid confrontation and conflict in the medication 
management encounter. However active non compliance strategies are not seen as the 
only subversive form of power. 
 
..the conflict will (also) accordingly take a dialogic form in which the language of the 
dialogue will invariably borrow heavily from the terms of the dominant ideology 
prevailing in the public transcript.....We may consider the dominant discourse as a 
plastic idiom or dialect that is capable of carrying an enormous variety of meanings, 
including those that are subversive of their use as intended by the dominant.   
         (Scott, 1990, p. 102). 
 
Thus, not only are the covert or passive forms of power associated with subversive 
actions, such as not taking a prescribed medication and active non compliance, but also 
within dialogue itself,  through redefining the use of the dominant discourse. In other 
words, impacting on how mental illness is conceptualised and what are deemed the social 
norms of mental health prescribing practice, through the use of using dominant discourse 
(e.g. language and norms associated with the dominant medical model in psychiatry).  
 
On another level, it is important to recognise movement, change and resistance at a wider 
cultural and system level of understanding. Over the last half a century there has been 
significant critique of  the bio medical model in psychiatry, labelled as oppressive and an 
insidious component  of contemporary mental health services. Movements of resistance 
have emerged over the same time period. For example, Crossley (2005), in a sociological 
examination of the mental health field from 1950 - 2000 identifies five distinct but inter 
related social movements over this period: 
1) Mental hygiene movement 
2) Civil rights movement 
3) Anti Psychiatry movement 
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4) User / survivor movement 
5) has no label but comprises of a movement where families / carer are critical of  2,3 and 
4 and support diagnoses. 
 
Having considered some of these additional complexities and avenues that are relevant to 
power in medication management practice, we can now return to Lukes'  three 
dimensional model of power. One of the seen benefits of this model is its simplicity in 
presentation of the ideas surrounding power.  Gaventa (2006;2008) expanded on Lukes' 
work, to make it more applicable to ideas of encouraging empowerment and change in a 
development context. Here, Gaventa's aim was to make more explicit where power can be 
acted upon (or as Gaventa calls them - engagement spaces) within a participatory 
framework to encourage change in organisations. By making these 'spaces' more explicit, 
challenges to these barriers may emerge, such as being able to prevent certain issues from 
arising, as well as the increased mobilisation of less powerful or excluded voices / 
knowledge. Gaventa represented these ideas using a power cube which he defined as a 
framework for analysing spaces, places and forms of power and their inter relationship 
(Gaventa, 2006, p.26). 
 
                           
Figure 5. Gaventa's power cube, levels, spaces, and forms of power operational in mental health service-user 
involvement. Adapted by Brosnan, 2012, p. 14. 
 
Brosnan (2012) has adopted this framework (see Figure 5 above) to explore user 
involvement in mental health services in Ireland, suggesting it is both applicable to the 
mental health context and useful for making more explicit the role of power as an obstacle 
to user involvement in mental health. Lukes' representation of both overt and more 
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hidden forms of powers are presented as layers to the cube, occurring on different planes; 
the strategic, operational and individual levels. Ideas of creating new spaces within these 
planes is also explored: closed, invited, and created spaces, to emphasise how change may 
happen on the different planes. Finally by presenting the layers and spaces as a rubix cube, 
complexity is emphasised, presenting numerous combinations of forms, levels and spaces. 
 
Whilst useful, this representation does present a rather static picture of power. Although it 
enables the appreciation of how and where strategies can be employed to 'tackle' power in 
the context of psychiatric services, it does not really talk about the changing or dynamic 
context of power or of the strategies already employed by the less powerful in the context 
of a dynamic changing social relationships, as alluded to in the below quote: 
 
Power can be defined as the degree of control over material, human intellectual and 
financial resources by different sections of society. The control of these resources 
becomes a source of individual and social power. Power is dynamic and in 
relationships, rather than absolute...,but neither power, ideology, not the state are 
static or monolithic. There is a continuous process of resistance and challenge by the 
less powerful and marginalised sections of society, resulting in various degrees of 
change in the structure of power. When these challenges become strong and 
extensive enough, they can result in the total transformation of a power structure.  
       (Veneklasen and Miller, 2002, p. 41) 
 
In this quote the dynamic nature of power is emphasised, with the idea of continual 
change and review being important to the concept of power. This idea of power and its 
impact on systems and change is explored in depth by Clegg (1989) who discusses circuits 
of power, thereby moving the concepts of power towards a more dynamic idea of power, 
than those presented by Lukes or Gaventa. 
 
3.2. Structure and agency in medication management practice 
 
At this point, it is also useful to consider the concepts of structure and agency in 
psychiatric medication management practice. The definitions of structure and agency are 
contested and depend on the school of thought.  The characteristics of structures vary in 
the following ways: 
 
- In character (for example, in purpose, organisation, the role informal networks and the 
existence of a sub culture) 
- Scope (local - global) 
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- Dynamism (stable - unstable) 
- Durability  (long - short duration) 
         (Sewell, 1992) 
 
The above characteristics allow for an appreciation of the overlapping, diverse and 
intersecting aspects of structure, which is particularly relevant for SDM in psychiatric 
medication management. Adopting this perspective, differing, overlapping and potentially 
conflicting structures are acknowledged in modern mental health medication practice. In 
other words a multiplicity of structures are present and acknowledged. The historical and 
contextual factors of contemporary mental health services have been briefly explored in 
Chapter one.  For instance, diagnosis and the medicalisation of mental illness are 
dominating structures, often associated with concerns over a depersonalisation of 
experience and creating stigma. This has the potential to be a significant challenge to 
achieving the ideals of shared decision making and is therefore is an important structural 
factor to consider for psychiatric medication management. However this is intersected by 
the recovery model, which is mainstream in modern mental health policy17, and the 
broader historical movements linked to this (eg. the survivor movement, the social model 
of disability, and growth in neoliberalism in health care provision) . These structural 
components may be associated with increased personal control, provision of choice and 
empowerment for mental health service users, bringing service user perspectives more to 
the fore and encouraging increased personalisation of care, and a move away from a 
deficits based perspective. Linked to this, positive psychology has also emerged as an 
influential knowledge base in the last couple of decades, emphasising the importance of 
wellbeing and a focus on strengths as oppose to treatment of illness, in delivery of mental 
health services (Slade, 2010). Indeed the WHO declaration of mental health also reflects 
these recent developments in mental health structures: 
 
'a state of well being in which the individual realizes his or her own abilities, can 
cope with the normal stresses of life, can work productively and fruitfully, and is able 
to make a contribution to his or her community'  
           (WHO, 2004) 
 
This definition also emphasises the growing appreciation of meaningful relationships, 
social inclusion and wider communities as essential components for mental health. Slade 
(2010) goes on to suggest that mental health professionals will need: 
                                                             
17
 See Chapter one for further details 
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'to focus on  improving  social inclusion, becoming social activists who challenge 
stigma and discrimination, and promoting societal wellbeing [and this] may need to 
become the norm rather than the exception for mental health professionals in the 
21st Century.’ 
          (ibid, p. 2)  
 
These structural components and their intersection in modern mental health system is 
highly relevant to consider for shared decision making in psychiatric medication 
management. This intersection of structures is discussed in Archer's (1995; 2003; 2012) 
seminal work and her theory of morphogenetic cycles. In this work, Archer explores the 
variety and dynamic societies of late modernism.  
 
... structure and culture have each become morphogenetic and are coming to stand in 
a relationship of positive reinforcement towards one another. The new generative 
mechanism entailed by this is for variety to produce still more variety because, in 
pure form, nothing restrains it (such as defensive attachment to previous quasi 
traditional interests and ideas or adherence to prior forms of routine action). Even 
more importantly, in pure form, it can develop because the very novelty of new 
variety means that no group has commandeered it an acquired vested interests in it.  
Indeed the rapidity of change means that the very notion of vested interests will 
become outdated if and when morphogenesis becomes truly unbound’.   
          
          
        (Archer, 2012, p.31). 
 
This offers a dynamic perspective on structure, but one that reflects the diversity, as well 
as representing the uncertainty, change and movement of structures in the mental health 
system.  Although power or social capital may remain, the links are less direct and 
according to Archer (2012) are often via indirect routes, such as the transmission of 
confidence in being able to pursue opportunities. Applying this to psychiatric medication 
management this suggests that whilst vested interests and power remains, there are a 
multiplicity of structures which potentially enables greater flexibility in how people 
(individually or as a groups) move forward and take action (agency). 
 
There is a lot of debate in the literature as to how agency and structure interacts. On the 
one side, theorists propose a fatalistic stance of agency, such as Bourdieu's habitus, where 
structure is all encompassing and mutually reproducing. For example, in Scrambler's 
exploration of the Bourdieu's habitus for decision making in healthcare: 
 
...choices may be rendered meaningless to those who lack the resources to make a 
meaningful choice. This has particular resonance if one considers the changes to the 
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national health service .....In the field of health, habitus has been characterised as one 
of passivity and compliance. The power structure of the field within which health, 
habitus is enacted is one in which medical and allied professionals take the position 
of power and control the interactions. Thus the passivity is structural.  
        (Scrambler, 2012, pp.75-76) 
 
Whilst the issues of passivity are highly relevant to mental health medication 
management, as suggested, this stance potentially ignores the dynamic and intersecting 
aspects of structure and the potential for agency to be brought further to the fore.  This 
position therefore 'assumes a far too rigid causal determination in social life' (Sewell, 1992, 
p.2) where agency has little influence. Thus this is at odds with the dynamic picture of 
structure presented above. 
 
At the other end of the spectrum, theorists propose agency only is viewed in relation to an 
individual's decision making process. This, again, is less relevant to psychiatric medication 
management practice, where the historical, economic, and social context are all highly 
poignant and strongly influence wider psychiatric medication management practice.  
 
Instead, in the middling position endorsed by theorists such as Giddens (1979) and Archer 
(1995), structure and agency are seen as interacting in determining psychiatric 
medication management practice. In other words, agency is necessarily structured but not 
structurally determined (Scrambler, 2012, p.131).  This is a useful position to adopt in 
considering psychiatric medication management practice. 
According to this perspective:  
 
'to be an agent means to be capable of exerting some degree of control over the 
social relations in which one is enmeshed, which in turn implies the ability to 
transform those social relations to some degree' 
         (Sewell, 1992, p.20) 
 
Archer (2012) proposes that there are four modes of agency possible.  These are; 
communicative reflexivity (internal conversations need to be confirmed and completed by 
others); autonomous reflexivity (internal conversations are self contained, leading to 
action); meta reflexivity (internal conversations critically evaluate previous inner dialogues 
and are critical about effective action in society) and finally fractured reflexivity (internal 
conversation cannot lead to purposeful action, but intensify distress and disorientation).  In 
Archer’s model, (Archer, 1995), the interaction and change between structure and agency 
is a process through time as a cycle (called the morphogenetic cycle), consisting of societal 
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interactions and structural elaborations (where conflict and negotiation between societal 
groups further impacts structural change). 
3.3. Conceptual framework 
 
Reflecting on this literature, Figure 6 presents the conceptual framework for the thesis, 
highlighting levels or layers of analysis for exploring SDM in psychiatric medication 
management practice. This diagram has the added aim of making more explicit the notion 
of power as a core concept for shared decision making, and emphasising the dynamic 
nature of the decision making process.  Whilst it is highly useful to consider different 
dimensions of power as well as different levels of analysis, as shown by Gaventa's power 
cube, this diagram aims to also emphasise movement, resistance and in general, present a 
dynamic representation of medication management decision making, with the relationship 
between the layers in flux.  
 
Interaction
System
Relationship
 
 
Figure 6. Conceptual framework: Levels of analysis for psychiatric medication management practice. 
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Different levels of analysis are presented in an onion diagram to emphasise that power 
exists on different planes, both at the system (or macro) level, the relationship level, and 
the interaction (or micro) level. The diagram illustrates that power is embedded within 
each of these levels. For example, at the system level the dominant ideology of the bio 
medical model is present, as are other forms of established norms, such as Aescuplian 
power (or the power to heal) applicable in all medical encounters. However, other 
structural components are also embedded at this level, including amongst others; the 
personal recovery model with its roots in the survivor movement, contemporary shifts 
towards neo liberalism and a rhetoric of choice, changes in expectation towards increased 
patient involvement in decision making, and management of risk and the legal framework 
within which mental health services operate. These embedded structures directly impact 
on the inner layers.  In fact the relationship and interaction levels are seen to sit within the 
outer system circle, presented as an onion based diagram. This represents ideas from 
Foucault, and Lukes’ 3rd face of power, i.e. that power is ever present and sits within 
wider structures and discourses, impacting covertly what is possible at the interaction 
level, where decisions about psychiatric medication occur. At the interaction level, SDM 
may be impeded both overtly through authority and ‘power over’ in decisions about 
psychiatric medication, but also through deciding which options are discussed in the first 
place (the second face of power) and by considering what is deemed socially acceptable as 
relevant knowledge (the third face of power).  
 
Taken together in the context of psychiatric medication management, 'power' as an 
obstacle to the defining aspects of SDM i.e: equality of knowledge; a full considered 
weighing up of options; and control by the service user, is an important theoretical 
construct in psychiatric medication management. However, the feedback arrows 
represent how both active resistance strategies and the interaction itself is important for 
also shaping the outer layers. The interaction and reflection at this level shapes the 
dominant discourse at the system level, both directly and indirectly via the relationship 
level.  This is represented as being a continual process in flux, with movement and change 
occurring at each layer.  
 
This Figure serves to structure thinking about how to explore the complex nature of SDM 
for psychiatric medication management, and acts as a framework for considering how 
power is enacted in this context.  Ideas of experiential knowledge holding weight and a 
sharing of expertise, are fundamental to recovery focussed mental health service provision 
and for shared decision making, yet are often not explicit in models and policy. By 
exploring the construct of power in this context, it is hoped that increased insight into the 
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realities, and a grounded construction, of shared decision making for psychiatric 
medication management emerge. 
 
The historical and policy context, literature review and conceptual framework for the 
thesis have been presented. The next chapter discusses the methodological choices for the 
research, attending to the underlying assumptions and research design of the study. 
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Chapter Four: Methodology  
 
 
 
 
 
 
Contents 
 
 
 
 
4.1 The Research Paradigm  
4.1.1 Critical considerations  
 
“Methodology is an area that connects issues at the abstract level of epistemology 
and the mechanical level of actual methods”.  
(Morgan, 2007, p. 123) 
 
The chosen methodology has innovative qualities, seeking to apply established methods to 
new areas of investigation as well as offering an original approach to research 
methodology. Before the overarching paradigmatic approach is explored in more depth, 
key critical considerations of this research project which have strongly influenced the 
methodological choices, are considered. 
 
Firstly, the research question and context have not been previously extensively examined. 
Therefore, this was predominantly an exploratory study, seeking to build understanding 
and knowledge, as opposed to confirming existing hypotheses. There was also a need to 
incorporate and embrace multiple perspectives from diverse participant groups. The 
following aspects were important considerations: 
 
 A focus on both meaning and constructions, in addition to exploring overt behaviours. 
 The acknowledgement of power inequalities between different groups in the study and 
the potential for this to hinder and limit exploration. For example the power imbalance 
between outsider researcher and participants, clinicians and mental health service users. 
Chapter outline. 
In this chapter the beliefs, values and philosophical assumptions for the research are 
explored. The design of the project is presented, identifying some tensions that arise as 
well as highlighting the potentially illuminating aspects of the chosen methodology. 
The first section describes the ontological and epistemological position of the research. 
This is followed by an examination of participatory ethos of the research, exploring how 
this enhances the knowledge produced. The third section focuses on an examination of 
the chosen data collection processes; semi structured interviews and recorded meetings. 
The fourth section discusses key decisions made in the approach to analysis.  Ethical 
considerations and validation for the study are considered in the final section. 
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 The recognition that power and stigma may influence interpretation of findings is 
especially relevant to this research context. There was a need to increase the visibility 
and voice of member communities who have traditionally been marginalised in 
research, with appreciation of a wider value of enhancing social justice.  
 
In addition, my background knowledge and beliefs are relevant to consider. I am an 
‘outsider’ to the context being explored for this study and have very limited experiential 
understanding of mental ill health. I have come from a traditional academic background in 
the field of Psychology which influences my approach to understanding and choice of 
methodology. This contrasts with the background to this research. That is, the roots of this 
PhD lie in the wider local community which led to the formation of the research agenda, 
prior to my arrival to the PhD studentship.  As such, there was a requirement for this 
research to acknowledge the need for change and make recommendations for practice.  
 
4.1.2.   Defining ‘Research Paradigm’ 
 
Questions of methods are secondary to questions of paradigm, which we define as the 
basic belief system or world view that guides the investigator, not only in choices of 
method but in ontologically and epistemologically fundamental ways.    
       (Guba and Lincoln, 1998, p.195) 
 
The term ‘research paradigm’ has a number of meanings (Morgan, 2007; Kuhn, 1970).  The 
dominant view and expression of the research paradigm employed by social researchers 
over the last 30 years has been to focus on the version of a paradigm as an epistemological 
stance at the metaphysical level (Denscombe, 2008). The research paradigm in this sense 
refers to acknowledging the higher level belief systems underlying this study and 
exploring how this links with the research question.  
 
Following this tradition, the paradigm includes the philosophical issues of ontology (or 
what is the nature of the social world we study), epistemology (or what counts as 
knowledge), methodology (or how to generate and justify such knowledge) and axiology 
(or what is the nature and role of values in social inquiry) (Greene and Hall, 2010). These 
levels of understanding will be explored in relation to social constructionism as the chosen 
paradigm for this thesis. First though, a brief overview of the broader historical context of 
key concepts within paradigm discussions is presented.  
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4.1.3. Historical context 
During the 18th Century, Kant (1724 – 1804) influenced a new era for understandings of 
science and the creation of knowledge, through the appreciation of interpretation and 
understanding of beneath the surface or ‘inside the head’ processes. Kant’s criticisms of 
Cartesian objectivism, which relied heavily on science and reality only being that which is 
overtly observable and measurable, allowed researchers to also focus on the importance 
of interpretation, to knowledge production.  As shown in the below quote, this era also 
resulted in a divergence away from traditional scientific reason and causal determinism, 
moving instead towards increased attention on complexity, in understanding of the 
applied social world. 
 
The world of nature known by science is a world of strict causal determinism 
whereas the world of moral freedom (e.g. applied social research) is governed by 
autonomous principles which man prescribes to himself.    
(Vidich and Lyman, 1998, p. 117) 
 
Another important development in this time period was the development of the concept of 
lived experience and its role in understanding reality and knowledge (for example, see 
Dilthey, 1833 –1911). During the more recent history of the last 50 years, many critiques 
have emerged about both the Cartesian paradigm and neo Kantian research. Post 
positivism, along with other movements have in some senses resulted in a blurring of the 
historical and epistemological boundaries between qualitative and quantitative research. 
One outcome from these debates has been a re-emphasis of Kant’s interests with human 
freedom and social emancipation in research. Influential authors during this period (e.g., 
see Habermas, 1972) proposed social research to be understood in terms of an interaction 
rather than as a controlling process, with participants aiming for mutual understanding 
and for coordination of subsequent action.   
 
4.1.4. Ontology and Epistemology 
 
Drawing on the critical considerations proposed above in S. 4.1.1, it was essential to 
explore in depth multiple perspectives and identities, from diverse stakeholder groups, 
thereby increasing understanding of decision making practice in community based 
psychiatric medication management. This research acknowledges differing realities, 
explores the context and complexity surrounding these and consequently moves away 
from positivist notions of ‘one external observable truth’. I have therefore broadly adopted 
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a social constructionist18 research framework, with the aim of building an informed and 
sophisticated construction of medication management in mental health.  In other words, 
this study has explored multiple intangible mental constructions, which are socially and 
experientially based and are dependent on the content of both the individual person and 
group to which they identify with (Guba and Lincoln, 1998; Burr, 2003). Knowledge in this 
sense is created as investigation proceeds, and is transactional in nature, with an emphasis 
on the collective generation of meaning (Guba and Lincoln, 1998, p. 240).   The personal 
and variable nature of social constructions means that there is an emphasis on this 
knowledge being built through interaction and dialectical exchange between myself, co 
researchers and research participants. Thus, findings have been developed and explored 
throughout the entire research process, in an ongoing interaction. 
   
However, while epistemological questions are paramount to the approach of this thesis, I 
do not argue that this automatically includes or excludes certain methods from being used. 
I rather adopt the view proposed by Guba and Lincoln (1998) that both qualitative and 
quantitative methods may be used appropriately with any research paradigm (p. 195). 
What is important is that the values and purpose of the research are made explicit through 
the justification of the methods employed. The aim of this thesis was therefore to explore 
multiple and diverse constructions of reality and compare and contrast these in an 
ongoing dialectical process with the end product being a more informed construction of 
psychiatric medication management (than those of previous constructions). However, this 
includes as a priority, the emic (or meaningful to the actor) perspective of the participants 
and researchers through the process. 
 
4.1.5. The role of theory  
This is an exploratory study with emphasis on building theory from the socially 
constructed realities, in this context. However, as part of the theory building component of 
this research, there is also part of this study which explores etic (observed or culturally 
neutral) concepts of understanding (for example, shared decision making).  However this 
sits within a social constructionist framework which aims to use this aspect of the process 
to broaden and inform a more sophisticated construction. 
 
                                                             
18
 The term Social constructionism/ist (as oppose to constructivism/ist) was seen to represent the research 
framework most appropriately. For further discussion see Burr, 2003; Lock and Strong, 2010; Crotty, 
1998 
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To clarify then, I reject the positivist notion that it is possible to obtain one real truth and 
as illustrated in the below quote, I do not aim to reach one single overarching theory. 
 
...it might be possible given a coherent theory to derive by deduction what facts ought 
to exist, it is never possible, given a coherent set of information, to arrive at a single 
ineluctable theory.     
       (Guba and Lincoln, 1998, p.199). 
 
Therefore, the concepts or models explored in this thesis are not being used with the aim 
of establishing real truth, but rather to assist with the process of broadening how shared 
decision making for psychiatric medication management is framed within the social, 
political and cultural context. Within this framework there is a focus on a call to action and 
social change as one of the goals. I adopt Habermas’ perspective that social research is an 
interactive rather than controlling process.  
 
Participants aim for mutual understanding over the coordination of their subsequent 
actions. Applied research, therefore is not about social conformity but about social 
justice.  
                                                                                                         (Habermas, 1972, p. 117) 
 
Within social constructionism there are a number of different versions and strands which 
have emerged. I believe this thesis sits within Guba and Lincoln's (1989) constructionist 
paradigm which values a pluralist and relativist approach. That is, recognising that 
multiple and conflicting constructions are potentially meaningful. 
 
The role of language needs to also be accounted for in this study.  Although I acknowledge that 
experience is a socially constructed process and language is at the heart of this 
construction process, I am less interested in how language structures thinking. Instead this 
study focuses more on how language is used by people to actively construct accounts, and build 
defensible identities and versions of events in the interaction (Burr, 2003). Additionally the 
study acknowledges that conversation has locally determined meanings (Lock and Strong, 
2010). 
4.2 Methodology 
 
It is not easy to say something new; it is not enough for us to open our eyes, to pay 
attention, to be aware, for new objects to suddenly to light up and emerge out of the 
ground.      
(Foucault,1969/1972: pp.44-45) 
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A participatory methodology has been adopted for this study. A participatory 
methodology is compatible with and sits within the social constructionist framework. The 
study emphasises multiple identities and favours an approach which emphasises 
interaction and reflection throughout the research process.  
  
4.2.1. A definition of Participatory Research 
 
Participatory research (PR) rests on the recognition of power differences and the 
implications of these differences for problems of discrimination, oppression, 
misrepresentation and marginalisation (Mertens, 2009). It acknowledges that versions of 
reality are socially constructed and emphasises that the relationship between the 
researcher and participants is a critical determinant in achieving a sophisticated 
construction or understanding. The nature of the relationship is characterised by close 
collaboration between researchers and participants attempting to reduce the power 
differential, with specific attention given to issues of communication and power. 
 
The importance of examining power inequalities is especially relevant in mental health 
research. The conceptualisation of mental illness has a long and infamous past and stigma 
remains a key challenge. In addition, historically, mental health services have been 
associated with paternalistic and coercive practice.  See chapter one for further discussion. 
For the purposes of understanding for this chapter, it is sufficient to state that a specific 
power dynamic is applicable to the context of the study.  The methodological choice of 
adopting a participatory methodology encourages these power dynamics to be challenged 
and made more explicit, through reflection and involvement, with the aim of bringing new 
insight to the research questions. 
  
4.2.2. Historical context of Participatory Research. 
 
The origins and development of PR are broad and complex. This is not only because the 
term is used loosely, and interchangeably with concepts such as action research, but it is 
also because participatory research is a blend of a broad range of research approaches and 
epistemologies that include: participatory action research, emancipatory research, action 
research, feminist critical approaches, transformative education and critical ethnography 
(Sarch, 1996).   
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It is nevertheless possible to outline some roots over the previous few decades. For 
example, Friere (1970) focused attention on how social science research could be used as 
a tool to relocate the everyday experiences and struggles of the marginalised in society, 
from the periphery towards the centre of inquiry. Embracing emancipatory principles, the 
aim of this research was a process centred on what Friere called conscientisation where 
the marginalised were to become agents of social transformation aimed at creating more 
democratic societies (See Sarch, 1996 for an overview). Another strand in the 
development of PR is related to its action component and a branch of PR known as PAR 
(participatory action research). What is distinctive about action research is that rather 
than the focus being on a process of description, the research is focussed on the process of 
action, via action cycles. The main aim of participatory action research is not only to 
improve the understanding of a situation, but to attempt change, learning and building 
knowledge during the change process (Munn Giddings and Winter, 2013). 
 
Although the history of action research is connected with the development of PAR, it 
nevertheless can be distinguished from it as: having European/American origins; having 
academic origins; and focusing on the improvement of professional practices. Action 
research has been adopted in some areas of the social sciences (for example, 
organisational psychology and sociology) and has been criticised in this context as 
excluding some of the emancipatory principles paramount to the participatory research 
ethos. For example, research adopting PAR methodologies in the area of management 
practice or organisational change programs with aims to further strengthen existing 
power and dominant conceptual practices.  
 
As such, the role of language and mainstream concepts and frameworks need to be 
mindfully employed by practitioners of PAR and other forms of PR.  According to Sarch 
(1996) these have to be carefully considered when looking at the construction of the 
research questions, the methods employed and the analysis of contexts explored. It is also 
acknowledged that the power differential between the professional researchers and 
participants will not necessarily be overcome through increased participation alone. Thus 
researchers need to approach studies that claim a participatory methodology cautiously 
and not assume that just because participatory methods have been used, that this 
necessarily bestows the research with emancipatory features.   
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4.2.3. Participatory methodology and knowledge development in mental 
health 
 
One of the most important aspects of conducting a participatory study then is to set up the 
research process in such a way that it enables the research to challenge conventional 
hierarchies of knowledge, instead embracing perspectives which may have previously 
been ignored using other methodological approaches (Munn Giddings and Winter, 2013). 
The involvement of service users in the research process is therefore fundamental to this 
study. The concepts of involvement of service users in health and social care research has 
been on the increase since the 1980s, with a number of movements by mental health 
service user, carer and other advocacy groups campaigning for their perspectives be 
incorporated into mainstream policy and research. 
 
Since the early 1990s, Health and Social Care legislation and research governance in the 
UK has put in place measures to encourage involvement of service users and carers in 
research, with, for example, the RandD body ‘Involve’ leading initiatives in the NHS.  In 
addition, statutory research networks, such as the mental health research network 
(MHRN) now have a requirement for user involvement in research, and findings have 
started to find their way into international peer reviewed journals.  However there has 
been scepticism in some areas of academia and resistance to claims that such inclusion 
adds any value. It has been suggested that a tokenistic, ’tick the box’ consultation approach 
is often pursued (Beresford, 2002; Turner and Beresford, 2005; Cotterell et al, 2008). 
Nevertheless, there appears an ongoing positive shift. For example, recent NIHR19 funded 
mental health research projects have received prestigious accolades for their 
emancipatory focus (e.g. Brandon et al, 2013). 
 
                                                             
19
 National Institute for Health Research 
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Figure 7. Faulkner and Thomas (2005) - The competing values and traditions of participation in research  
In summary and as represented by Figure 7 above, participation in itself does not 
necessarily result in a sharing of power. Consumerist approaches may be employed where 
information gathering approaches to participation lead to ‘objective’ distant and neutral 
approach to knowledge and understanding. It has been criticised that participation in this 
context may actually, ‘embody inequality in power which result to the disadvantage of 
service users’ (Turner and Beresford, 2005; p.vi).  
 
Reflecting on the participatory elements of this research then, I am conscious about the 
limitations imposed by the context of this research (theory building for the purposes of a 
PhD) and my knowledge and skills (I come from a traditional academic background with 
limited experiential understanding of mental illness). I therefore cannot claim a fully 
emancipatory purpose or value to this project. However I feel it important to focus on how 
increased participatory methodologies may add original insight to the research question, 
may assist the research process, and may encourage reflection on practice and promote 
subsequent change. Acknowledgement of existing power imbalances is important for this 
research, with the aim of maintaining, where possible, a more democratic theoretical lens 
to knowledge and theory development. As such, there is a need for me to bridge the gap 
between what may be considered a traditional PR study embracing democratic values on 
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the one hand, and a consumerist approach to participation in research on the other 
(Beresford, 2002). The quote from Faulkner and Thomas (2005) in Figure 7 is useful in 
this respect, acknowledging the importance for the research to respect an equality of 
knowledge and view the co-production as a joining of ‘expertise by experience with 
expertise by profession’. It is by adopting these values that I hope to be able to embrace 
participatory methodologies.  
 
In summary there is a variety of participatory approaches. The participatory approach 
utilised in this study aims to generate knowledge and to analyse accounts in a 
collaborative way.  
 
Within mental health the benefits of participation to patients and providers in service 
development and evaluation is well documented, including, amongst others, 
empowerment of individual researchers and improved communication between service 
users and providers (Simpson, 2008). Research is also emerging which emphasises the 
benefits of participatory approaches on knowledge production, which as discussed above, 
is an important consideration for this research. Studies have shown that service user 
researchers enhance rapport and reduce participants inhibitions and may overall boost 
recruitment and quality of data (Faulkner et al, 2008). Rose (2003) suggests that service 
user researchers offer new types of evidence and offer fresh insights through a reduced 
distance between direct experience and its interpretation. Other research in this area also 
shows that peer researchers may produce qualitatively different findings than traditional 
academic researchers, with co interviewers focusing more on experiential understanding 
and traditional academic researchers focusing more on process and policy implications 
(Gillard et al, 2010; Neil et al, 2013). 
 
Following on from this, it is important to consider how to pair these potential differences 
in the analysis and move towards a new and shared understanding?  Figure 8, adapted 
from Gillard (2011), shows the proposed approach to knowledge production, sought for in 
the participatory elements of the PhD.  
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Figure 8. Participatory input to knowledge creation (adapted from Gillard et al, 2011) 
On the left diagram a more traditional consumerist approach is illustrated, with the 
service user contributions being very much on the periphery of knowledge produced, 
having little control over this aspect of the research. The model on the right reflects more 
the situation I have aimed for in this research. Here my expertise as the traditional 
researcher overlaps with co researchers’ contributions, combining to produce co created 
knowledge. It is in this aspect that new and fresh insight to the research questions may be 
gained. 
 
As such there are two aspects to consider in relation to the participatory ethos of the 
study; the type of activities that mark a participatory research project and the values 
implicit to the project.  
 
4.2.4. Key decisions relating to participatory methodologies in the study 
Key elements which seek to embrace the values and methodologies of participation in this 
study include: 
 The formation of the research advisory steering group 
 Use of co researchers 
 Training provision from South Essex Service User Research Group 
 Collaborative data analysis 
 Collaborative dissemination and reflection phases 
 
Further details of the first component: 'formation of the advisory group', is presented 
below. Other aspects are explored in some more depth, in section.4.3.4 and 4.4.1.  
 
 
 
Co created 
knowledge 
Traditional 
research 
team (e.g. 
academia) 
User 
input to 
research 
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Formation of the research advisory group 
The research advisory group was formed early in the research programme, in June 2010. 
This group consisted of one community psychiatric nurse, one psychiatrist, three service 
users and one carer. This mix was chosen to reflect the participant groups which form part 
of the study, with a weighting given to contributions from service users in the group, 
providing key experiential understanding of the topic. All members, except one, remained 
part of the group for the full lifecycle of the project.20Attendance was good, with most 
members attending each meeting.21 
 
Recruitment for service user members of the group took place via an advertisement sent 
through the RandD team within the local NHS foundation trust.  Initial response to the 
advert was good and therefore a selection process was necessary. Informal interviews 
were conducted by the RandD manager and myself, focussing on the persons’ interest and 
relevant personal experience to the topic. Less importance was placed on other skills for 
the role (e.g. research experience and skills).  All recruited service user members had 
personal experience of being prescribed psychiatric medication, falling into the categories 
of anti psychotics and mood stabilising medication. All members have had varied and 
numerous experiences of decision making about psychiatric medication. 
 
Since its formation the group met approximately once every two months22. In these 
meetings I provided relevant updates and facilitated discussions on current research 
processes. Although some initial planning had been put into place prior to the formation of 
this group, the group also had some input into the preliminary planning phases. On 
reflection, however, and given the context of this research process sitting within my PhD, 
it would be true to say that initial key decisions surrounding the research questions and 
data collection remained in my control during these early phases with more of a 
consultative ethos being present. More collaboration was achieved in the later stages of 
planning, for example while planning the recruitment strategy and designing topic guides 
for research interviews.  See appendix I for minutes taken from an advisory group meeting 
in this phase of the research process.  
 
                                                             
20
 The psychiatrist member left the group six months after its formation due to a change in personal 
circumstances.  
21
 One service user member was unable to participate as a co researcher due to a period of illness, but 
returned to the group during the later phases of the research. 
22
 In the planning phases meetings were held more frequently. In the latter phases, post analysis, meetings 
occurred less frequently. 
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During the research process I strived for an approximate democratic approach, 
maximising choices and decision making where possible. Throughout the research life 
cycle, the group maintained its focus on sharing knowledge based on experience as people 
who have been prescribed psychiatric medication, as a carer to someone being prescribed 
psychiatric medication or as a medic involved in the decision making about psychiatric 
medication. The research remained relevant and in tune with the experiences of members. 
However, over time the group developed, and identities of individual members and the 
group as a whole, changed. Familiarity and confidence grew and friendships were formed, 
and by the end of the research cycle the group existed as a collective identity for the 
project, as opposed to a group of individuals with particular roles. See appendix II – the 
research diary23.  
4.3 Research Design 
4.3.1. The research context. 
 
The study has been conducted in Cambridgeshire, in the East Anglia region of England. 
Cambridgeshire as a growing population recorded at approximately 600,000 in 2010  
(Cambridgeshire County Council Research Group (CCCRG), 2010). The vast majority of the 
sample (minus 3 service users and 1 psychiatrist) were recruited within Cambridge itself. 
Cambridge is a highly affluent city, hosting two universities and resultantly has the highest 
proportion of its population aged between 16-39.  It is a growing city with a reputation for 
small start up and high tech industry, with the wider area of Cambridge known as 'the 
silicon fen' in the business community. Medicine is one of the growth areas of the IT 
development and of pharmaceutical initiative in Cambridge.  It is estimated that the City 
will grow by 28% by 2031 (CCCRG, 2010). Education levels are far higher in the local 
population than other parts of the UK.  Almost double the national average of residents are 
educated to degree level, or above (CCC, 2012). Other parts of Cambridgeshire are rural, 
and suffer from poor transport networks. 
 
The remainder of the participants from this study were from Huntingdon (n=3) and 
Peterborough (n=1). These dwellings both have different socio-demographic contexts.  
Huntingdon is a smaller market town, with a good rail and road network and a high 
proportion of its people are economically active (CCC, 2012).  Peterborough is a larger city, 
and has a population of 189,000. (Peterborough County Council, (PCC, 2011). It is also 
                                                             
23
 Also in appendix VII a transcribed group meeting during the collaborative analysis phase is presented 
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economically active, but with higher than average numbers of people with no formal 
qualifications and other unrecognised forms of qualifications (PCC, 2011).  
 
The wider Eastern Region of England has the fifth largest population of non White-British 
residents in the UK, with 7% of the non White-British population.  However it has slightly 
smaller proportions of all Black and Minority Ethnic (BME) groups than are present in the 
overall population (Dunn, 2005). Cambridge hosts the largest number of people from the 
Chinese community and one in five of the city's residents are foreign nationals (Oxford 
Migration Observatory, 2013).  Peterborough has a higher than average proportion of 
white: EU (non British) residents (PCC, 2011).   
4.3.2. The treatment setting 
 
The study took place within a NHS foundation trust that provides secondary care mental 
health services. Participants were recruited from within a community mental health team 
/ pathway (CMHT). The pathway served approximately 260 people with diverse needs, 
who were broadly considered to have severe and potentially enduring mental illness. This 
diversity was an important consideration for choosing which pathway to focus the study 
within. Multidisciplinary working was employed, and each person was assigned a care 
coordinator. The pathway operated in the context that a standard maximum time for 
treatment was in the region of eighteen months for any one point of contact. This is not to 
say that some people wouldn’t have had extended contact beyond the eighteen months 
period, but if this was the case it was likely to be through repeated separate contacts with 
the service over a number of years. As such there were close links with other parts of the 
mental health service provision and primary care provision (e.g. GPs).  The service 
provision was diverse although its broad aim was to act as a first point of contact for 
people with secondary care services. It is important to note that there were on going re-
organisational changes in the provision of care pathways during the time of the study. 
Changing accountability and relationships between primary and secondary care, alongside 
many cost cutting pressures, resulted in a highly unstable period during which the study 
took place. 
4.3.3. Data collection process 
 
To recap, there were two overarching research questions for this thesis: 
What are stakeholder views about SDM for psychiatric medication management? 
How are decisions about psychiatric medication made in practice? 
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As shown in Figure 9, there were two phases to the data collection process. Throughout, 
data collection procedures were qualitative in nature (semi structured interviews and 
digitally recorded meetings).  Data analyses techniques were also informed by a 
qualitative approach (namely thematic analysis and an applied conversation analysis). 
Phase two (recorded meetings), represented using a smaller box in Figure 9, 
supplemented findings from the thematic analysis in phase one (research interviews). 
Initially, a supporting role (indicated by the internal box shown in the diagram) was 
planned for a quasi quantitative analysis method, namely the OPTION scale, in the analysis 
of phase two recorded meetings. The OPTION (acronym for “observing patient 
involvement”) scale is aimed at measuring the level of Shared Decision Making behaviours 
of psychiatrists. The scale was chosen for inclusion in the analysis to supplement the 
theory building elements of the analysis process. However following initial analyses using 
this scale, I decided that it added little value to the overall data and subsequently removed 
it from the overall findings. Please see appendix IV for further details. Throughout the 
research, a participatory theoretical lens was present, guiding the research process and 
methods employed.  
  
       
                                                                                                     
 
 
 
 
 
 
    Data              Data 
    Collection          Analysis                             
 
     
 
 
 
 
 
         Figure 9. Data Collection Process 
PHASE TWO 
 
 
 
 
 
Data 
Collection         Analysis 
 
PHASE ONE 
 
 
 
 
 
 
 
Data      Data  
Collection     Analysis 
Semi 
Structured 
Interviews 
(Service users, 
CPNs, 
Psychiatrists)  
Recorded  
Meetings 
Thematic 
 Analysis 
 
(Including 
collaborative 
analysis) 
 
    
Applied CA* 
OPTION 
scale 
FINDINGS 
87 
 
 
4.3.4. Sampling and recruitment. 
 
Phase one 
Thirty interviews were undertaken. Interviews were conducted with mental health service 
users (n=15), psychiatrists (n=7), and CPNs (n=8).  These three participant groups were 
chosen for inclusion following a scoping review with key stakeholders within the NHS 
foundation trust24 in addition to discussion with the research advisory group (see above). 
Although the role of other key stakeholders (for example GPs, carers, other mental health 
practitioners and pharmacy services) is acknowledged, these groups were not included for 
feasibility reasons. Equal weighting was given in data collection for service users and 
practitioners.  
Practitioners 
All psychiatrists (n=8) and CPNs (n=9) from the CMHT pathway in the local city where the 
study took place, were approached for participation25. Informal networks and 
communication between myself and staff within the pathway, assisted the initial 
communication and invitation process. I attended a team meeting to provide some initial 
information to the wider group of practitioners. To promote recruitment I also met 
individually with senior members of the team (consultant psychiatrists and CPN team 
leaders).   
Service users  
Psychiatrists and CPN care coordinators within the team were asked to identify suitable 
potential service user participants for inclusion in the study. The inclusion and exclusion 
criteria is shown in Figure 10. 
 
 
 
 
 
 
 
 
Figure 10. Inclusion criteria in the identification of service user participants 
                                                             
24
 Meetings were undertaken with the chief pharmacist, chief psychologist, two consultant psychiatrists 
and the director of psychiatric nursing, in addition to observing a ward round in an inpatient setting.  
25
 One psychiatrist from another nearby town (from the same pathway) also formed part of the sample. 
Identification of Service User participants 
Key inclusion criteria. 
The practising psychiatrist and/or CPN care coordinator will be asked to recommend 
people for inclusion who, in their professional opinion: 
 (1) have adequate mental capacity for informed consent. 
 (3) receive services from within the specified care pathway. 
 (4) have had contact with secondary mental health services for a minimum of 6 months 
 (5) are an adult 
 (6) have had prior discussion and decision making with mental health professionals 
about psychiatric medicatio . That is, individ als who have been offered or have been in 
receipt of psychiatric medication. 
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First contact about participation was made by the practitioner or psychiatrists' secretary, 
where a full participant information pack, invitation letter, reply slip and self addressed 
envelope was provided.  This process did incorporate a level of bias into the identification 
and recruitment process in that practitioners may have identified potential participants 
based on other factors (e.g. existing good relationship established etc). However, the 
chosen identification process conformed to relevant data protection legislation and best 
practice guidelines. Throughout the process, clinicians were encouraged to adopt an 
inclusive process of invitation for their client base (within the criteria set), and I 
emphasised the importance for this study to explore the views and experiences of service 
users.  
 
Nevertheless there were challenges in the strategy to recruit service users, via 
gatekeepers. Originally I had planned for 30 interviews to be conducted with service users, 
but 15 interviews were actually undertaken. Although various strategies were 
incorporated to promote relationships with clinicians in the team, including; regular 
contact via email and phone calls; escalation meetings with senior clinicians and 
management; dropping in and standing in the team office; nevertheless a research fatigue 
appeared to hinder the recruitment of service user participants to phase one. This 
subsequently impacted phase two recruitment possibilities.   
 
Even when support for recruitment was directly offered by gatekeepers, this often did not 
result in the actual invitation packs being sent out to service users. Practitioners 
mentioned being involved in multiple research projects during this time period, and a 
general time pressure appeared to hinder the ability and willingness to ensure 
information packs were being sent out to potential participants. This is discussed further 
in the Limitations section of the Conclusion chapter (10.4) and relevant research diary 
entries in appendix II.  
 
Consequently a second phase to the recruitment of service users to phase one was also 
undertaken, following these initial recruitment challenges. Leaflets were created and left 
in the reception area of the CMHT outpatient clinic, as well as the locally based mental 
health organisations. Interested potential participants subsequently contacted me directly, 
before the specific inclusion criteria was considered. This therefore conformed to the data 
protection requirements of the process, while avoiding some of the bias and challenges 
associated with use of gatekeepers in the original recruitment process.  
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Phase two 
A convenience sample was adopted for phase two of the study (recorded meetings). 
People who participated in phase one (and who gave consent) were approached at a later 
date inviting them to participate in phase two. Service user participants then provided 
details of a forthcoming meeting where medication was to be discussed. I contacted the 
relevant practitioner to seek consent for the proposed meeting to be recorded. Written 
consent was obtained directly prior to the meeting.  All participants in this phase had also 
participated in the interview (phase one). 
 
A diverse range of meetings (n=10) was sought for in this phase, incorporating meetings 
between the psychiatrist and service users (for example, as part of a routine outpatient 
clinic) as well as more informal meetings between service users and CPNs (as part of home 
visits, for example). However there were ‘knock on’ recruitment challenges for this phase 
also.  In particular, a far smaller pool of potential participants were available, given the 
recruitment difficulties in phase one. In addition, phase one recruitment was a protracted 
process over a number of months, and as such often significant time had passed and 
consequently people were no longer receiving services26, at the time I contacted them 
about participation for phase two. As a consequence of these difficulties, only four 
meetings were recorded between one psychiatrist and four service users27.  
 
4.3.5. Data collection methods 
The chosen methods are suited to the research questions. Qualitative data collection 
methods were chosen for both phases of the research, with the aim of bringing to the 
surface hidden meanings and social constructions of psychiatric medication practice. 
These methods are suited to investigations, such as these, which are currently under 
researched, having a strong theory building emphasis. 
 
The combination of interviews and recorded meetings allowed for both views and socially 
constructed attitudes to be explored, in addition to examining overt discourse in 
psychiatric medication management practice. Overall the combination of these methods 
allowed for a rich and insightful picture to be drawn about medication management 
practice in a community based psychiatric service. 
 
                                                             
26
 From the team within which the study took place.  
27
 Further discussion on the sample for phase two is presented in the Conclusion chapter 
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Phase one: Qualitative interviews  
The first phase of the research explored the socially constructed views of key stakeholders 
about the involvement of service users in psychiatric medication management. The 
interviews were semi structured using open ended questions. The overall focus of the 
interview was to explore the participants' views and (recent) experiences of psychiatric 
medication management. Interview schedules were developed in conjunction with the 
advisory group and consisted of a separate version for practitioners28 and service users. A 
copy of the interview schedules can be found in appendix III. Both interview schedules 
comprised of three main sections: Section one explored general background questions 
relevant to the topic. Section two explored the participants’ general views and experiences 
of medication management, perceived enablers of and barriers to SDM, and opinions 
around involvement of service users in decision making about psychiatric medication. 
Section three explored some recent examples of meetings where medication was 
discussed. These critical incidents or concrete events were specific meetings that had 
occurred recently (within 6 months) and were poignant to the participant. The use of this 
style of questioning is known to be effective at bringing to the surface more subtle and 
hidden views, less likely to be retrieved along a more general line of questioning 
(Flanagan, 1954). Participants were asked to focus on one positive and one negative 
meeting where psychiatric medication was discussed, that had an impact or stood out for 
the participant. After establishing the details of the event, participants were asked if, in 
hindsight they would have done anything differently?  This allowed for values and views of 
collaborative decision making to be explored and for current practice to be better 
understood.  
 
Interviews with service users lasted for approximately 30 minutes - 1 hour29. Interviews 
with practitioners lasted approximately 45 mins – 1 hour 15 minutes. The decision for a 
shorter interview with service users was jointly made as part of the research advisory 
group where tiredness was considered a potential issue for wellbeing of participants. All 
interviews were recorded using a digital audio recorder and transcribed using standard 
conventions. For interviews with service users, there was a small token of thanks (£10 
cash). Interviews in phase one took place in a neutral location, on university premises or 
in NHS sites30. 
 
                                                             
28
 The same interview schedule was used for CPNs and psychiatrists 
29
 Initially 45 minutes maximum time limit was proposed by the advisory group, but this was exceeded 
for some of the service user interviews 
30
 All practitioner interviews took place within NHS sites 
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Co researcher team 
The decision to use co researchers in the data collection phases of the research was made 
towards the end of 2010 in collaboration with the research advisory group. Initial interest 
in these roles was expressed by the three service user members of the advisory group and 
the carer member of this group31.The role of co researchers was to conduct interviews 
with other service users in phase one of the data collection. Co researchers acted as the 
lead interviewer and I was present as a second interviewer. In the majority of these 
interviews, my active role was very minor, usually only asking a maximum of one or two 
questions, at the end of the interview.  
 
It was initially envisaged that co researchers would act as sole interviewers. However, 
following challenges in the recruitment of participants, this strategy was changed.  The 
reasons for this were that there were less interviews than planned, taking place over a 
longer time period. Co researchers expressed that given the longer time periods between 
interviews they would prefer myself as CI to also be present. Given the reduced number of 
interviews, I also was keen to attend as many interviews as possible.  
 
A debriefing and reflection session took place following each interview. The debriefing 
session comprised of a discussion of key themes emergent from the interview and 
reflection and feedback on the interviewers' questioning and style. Reflection about 
wellbeing and or distress caused by the interview also formed part of this session. 
 
Training provision 
Interview skills training was provided to co researchers. I decided to employ the South 
Essex Service User Research Group (SE SURG)32 to assist with the initial training. SE SURG 
have been involved with many service user led research projects nationally and provided 
invaluable insight and specialist training, bespoke to this project. The use of SE SURG also 
benefitted the project in that I was able to participate equally as one of the group in the 
training session, thereby reducing initial power imbalances between myself as both chief 
investigator and trainer, and co researchers. This was an interactive one day session 
which drew on existing experiences of the co researchers and reflected on some common 
pitfalls in co researcher led interviews. The use of role play, discussion, feedback and 
reflection was incorporated into this initial session. The session received positive feedback 
from all members of the team. 
                                                             
31
 One service user member was later unable to undertake research interviews due to a period of illness. 
32
 An expert service user research and consultancy group, affiliated with Anglia Ruskin University 
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This training day was followed by three further sessions, facilitated by myself, applying 
the learning and skills from the first training session to the interview schedule. Role plays 
and practice of interview scripts were especially useful in this aspect of the training.  
 
Further one to one training was conducted with co researchers, depending on levels of 
confidence and ability prior to undertaking the first interviews. All co researchers opted to 
act as the second interviewer for the first interview undertaken. For these first research 
interviews I acted as the lead interviewer, with the co researcher asking additional 
questions when desired. All subsequent interviews were led by co researchers (see 
above). 
 
 Phase two: A study of current practice  
This phase examined current practice in psychiatric medication management, focussing on 
the dynamics of the conversation. As mentioned above (S. 4.3) four practitioner – patient 
meetings were audio recorded and transcribed. These meetings were review meetings, 
taking place during outpatient clinics, on NHS sites. The four meetings involved the same 
clinician, a consultant psychiatrist operating with the community care pathway. Each 
meeting involved a different service user. Both the practitioner and service users had 
participated in the research interview (phase one).  A researcher was not present in this 
phase, allowing for less intrusion and contamination of the data. The digital recorder was 
operated by the clinician in the meeting.   
        
 This part of the research supplemented the findings from phase one, by comparing 
discourse in action (in this phase), with the views and experiences explored in phase one. 
A case study approach to the analysis was adopted (see below). A particular focus of this 
phase was to explore the power claiming and power giving strategies employed by 
participants, thereby examining the extent of involvement and shared dialogue between 
the psychiatrist and service user, when medication options were discussed.  
4.4 Data Analysis and Validation 
4.4.1 Analytical techniques employed. 
4.4.1.1. Thematic analysis 
Thematic analysis is a method for identifying, analysing and reporting patterns 
(themes) within data     (Braun and Clarke, 2006, p.82).  
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Thematic analysis was employed for phase one (the research interview). According to 
Braun and Clarke (2006) a ‘theme captures something important about the data in relation 
to the research question and represents some level of patterned response or meaning within 
the data set’ (ibid: p. 82). Thematic analysis is, however, a broad term and may result in 
many interpretations and approaches to the analysis process.  
 
A key decision in the chosen approach to thematic analysis for this thesis was the focus on 
providing a rich description of the entire data set as oppose to a detailed account of one 
particular aspect. An inductive approach (Patton, 1990) was employed. Therefore themes 
are strongly related to the data, with less importance placed on the relationship to specific 
questions that were asked in the interview33. The themes were continually reviewed in 
relation to the research questions and a collaborative approach to theme building was 
chosen (see S. 4.4.1 below). 
 
Although the process of analysis was recursive (as oppose to linear) it is useful to map out 
key phases to the analysis process. I followed the Braun and Clarke's (2006) phases of 
thematic analysis:   
 Familiarising with the data 
 Transcription of verbal data in verbatim and checking against audio recordings 
 Generating initial codes. Here codes refer to the most basic segment or element of the 
raw data that can be assessed in a meaningful way regarding the phenomena 
 Searching for themes. Here a collection of candidate themes and subthemes are 
identified and all extracts of data are coded in relation to them 
 Reviewing themes 
 Defining and naming themes, providing a description of the essence of what each theme 
is about 
 Producing the report. 
          (ibid, p. 88) 
 
The software package ‘N Vivo’ (version 10) was used as a tool to assist the coding process. 
In the region of 450 pages of writing were transcribed from the 30 research interviews 
that took place between June 2011 and July 2012. Themes were explored for each 
stakeholder group (Service user, CPN, Psychiatrist). See appendix V for N Vivo coding 
frames and themes, for each stakeholder group. Relevant entries from the reflective diary 
(appendix II) also details how themes were developed over time. 
                                                             
33
 Although note below, regarding incorporation of dual coding process. 
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Whilst an inductive analytical approach was pursued, during the coding process I decided 
that, for increased organisation and exploration of particular aspects of the interview, 
coding by interview structure would also be helpful34. As such, a dual coding process took 
place, where text was coded according to data driven themes and also by what part of the 
interview it took place (so termed structural coding). I didn’t see the need to adopt a 
question by question coding strategy. Instead the structural coding was comprised of five 
sections with sub sections, incorporating specific questions, where appropriate. This is 
illustrated in the N Vivo screenshot taken from the psychiatrist structural coding, shown 
below: 
 
           Section 1 - Intro - roles in med management 
 
                Other practitioners 
                 role of carer 
                 role of cpn 
                 role of psychiatrist 
              Section 1 - Intro and background 
 
                   Intro - changes over time 
                   Intro - how important is psychiatric medication in mental health treatment 
                   programs in ITT 
                   Intro - Q How would you describe your approach or style in consultation  
                   meetings 
                Section 2 - conceptualising SU involvement 
 
                   Ideal world, how involved should SUs be 
                   Problems with involving people in decisions 
                Section 3 - Examples of success 
                Section 4 - Examples of failure 
Table 3. N Vivo screen shot of psychiatrist structure based coding 
 
Themes emergent from critical incident questions (positive and negative meeting 
examples) were embedded within the data driven themes. However, where differences 
                                                             
34
 Also see relevant entries from the research diary, appendix II for further details 
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emerged between the critical incident and general questions component of the interviews, 
these were highlighted in the presented findings.  
 
4.4.1.2 Collaborative data analysis 
In keeping with the participatory methodology for this study, I decided upon a 
collaborative analytical approach. I have followed the suggestions of Cotterell (2007) and 
his seminal participatory work on the needs and experiences of service users with life 
limiting needs, and adopted a two stage collaborative analysis process.  
  
Training in the analytical process was provided for the advisory group in a one off 
workshop, facilitated by myself. The focus of the work shop was to encourage discussion 
and reflection as a group, focussing on practical discussions about good practice in 
analysis and the role of the researcher.  The process of thematic analysis also formed part 
of this training session. Additional guidance notes were provided to members of the group, 
following the session.   
 
For stage one, I conducted initial thematic coding of interview transcripts, occurring 
during the data collection phase, in phase one. Stage two occurred after data collection and 
was a collaborative analysis.  The emphasis in this phase adopted some of the perspectives 
favoured by Munn Giddings and Winter (2013), focused on learning and new ideas, rather 
than on description and pure interpretation. As such this phase to the research was 
especially relevant to encouraging fresh insights into the phenomenon as opposed to 
confirming existing thoughts around the topic. The collaborative analysis process was only 
adopted for the analysis of service user interview data, in phase one35.  
 
In total, eight collaborative analysis meetings took place with members of the research 
advisory team. Good attendance was observed throughout this phase, with the CPN, 
service user and carer members attending the majority of meetings. The collaborative 
phase consisted of coding and interpretation of transcripts and theme building sessions. 
Differences as well as overlaps between my initial coding and the groups’ interpretations 
were explored, building consensus through discussion.    
 
                                                             
35 A collaborative approach was not adopted for practitioner interviews (where co researchers were not 
directly involved in the interview process), or phase two (as a result of the lengthy additional training 
requirements needed). 
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The first six of these sessions involved the reading of an interview transcript36  and 
exploration of emergent themes. Members were sent a transcript in advance of the 
meeting, for reading and preparation, along with preparatory guidance notes. I facilitated 
the meetings in a structured way, assigning turns to speak and ensuring each member of 
the group presented their individual interpretation of the transcript, before a more open 
discussion ensued. I was careful not to guide the discussion and did not present my initial 
coding for the transcript until the end of the meeting, at which point any differences 
between my individual coding and the group were explored. 
 
The style and content of these meetings, however, developed over time. The first meeting 
was lengthy (over two and a half hours) and involved a detailed coding of the transcript. 
At times, in these early sessions, I spent time ensuring that the themes and interpretations 
discussed were grounded in the transcripts being explored. Often discussions of emergent 
themes were highly poignant to advisory group members’ own personal experiences, and 
this added to the interpretation and discussion of themes. Conflicts and differing 
interpretations from the transcript were also explored as a group, requiring, at times, 
more structured facilitation37. However, towards the end of the six sessions, less 
structured discussion was needed. Instead these latter meetings focussed on comparisons 
of the transcript to previous transcripts analysed, and emergent themes were explored as 
a group. 
 
These collaborative analysis meetings were recorded using a digital recorder and later 
transcribed. By adopting this approach I was able to return to the content of these 
meetings and compare themes emergent from the group meetings to the initial thematic 
analysis I had already undertaken on the transcripts. Please see appendix VII for an 
example transcript from one of the collaborative analysis meetings, and the associated 
coding framework which was later incorporated into the findings. 
 
For the final two collaborative analysis sessions, reflection of broad themes and content 
was discussed. I was again conscious not to overly dominate these sessions by presenting 
my existing analytical work. However I was also concerned that by not offering any 
structure, these sessions would become confused. As such I decided to ask the group at the 
start of the session of their preference for the structure of the meeting. All members opted 
for me to present some initial theme and sub theme headings, before subsequent 
                                                             
36 Six service user interview transcripts, out of 15 in total were subject to this process. 
37 For further reflection on the collaborative analysis process, please see the appendix. 
97 
 
 
discussion. This worked well, probing exploration of the themes in relation to previous 
transcripts. As a consequence of these sessions, the thematic analysis developed and 
themes were adapted, added or changed in response to the group discussion.   
 
 
4.4.1.3 Applied Conversation Analysis 
An applied conversation analysis (CA) was adopted for phase two of the data collection 
process. Applied conversation analysis, and more generally, discursive analysis is 
concerned with how particular versions of reality are manufactured, negotiated and 
deployed in conversation. The social constructionist paradigm for this thesis resulted in 
applied CA being a compatible and informative approach to adopt (Willig, 2008). A key 
feature of social constructionism is the recognition of the fact that different constructions 
of the world sustain different kinds of social action.  It is widely thought that within this, 
our constructions of the world are founded upon language, and as such language 
underpins the form of action that it is possible.  
 
The focus of using applied CA within this thesis was to explore the situated use of language 
in social interactions. (as oppose to adopting a more deconstructionist position on 
language)  (See Burr, 2003 for further discussion). As such, an emphasis was placed the 
importance of accountability and stake in conversation (Edwards and Potter, 1992). Here, 
discursive devices and constructions are seen to be used in conversation in order to 
further the participants’ interpersonal and social objectives. Consequently, the recorded 
conversations were analysed to understand how conversation and discursive repertoires 
were being used strategically to pursue the participants’ objectives, acknowledging that 
conversation has locally determined meanings (Willig, 2008; Labov and Fanshel, p.273, 
cited in Lock and Strong, 2010). 
 
In recent decades there has been a blurring of distinctions between different forms of 
Discourse Analysis (DA) and Conversational Analysis (CA).  According to ten Have (2007) 
applied CA is asking why it makes sense, for participants, locally, in their practical context, to 
do things as they are done, even if this is at odds with how these practices are planned, 
evaluated or accounted for ‘elsewhere’ ‘in theory’ or at higher hierarchical levels in an 
organisation (ibid, p. 196).  The key distinction between this form of CA and more ‘purest’ 
forms of CA is the emphasis placed on the broader consideration of the participants’ 
context, goals and perspectives, as opposed to a traditional CA study which would be 
interested in the micro speech activities in their own right. The chosen analytical approach 
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makes use of the knowledge of speech activities, turn taking and linguistic patterns in the 
analysis of four recorded meetings, whilst keeping focus on the important contextual 
information further informing the understanding of how the pattern of discourse may be 
relevant for the participants in this context. Interview data was incorporated into the 
analysis, to provide additional depth and discussion of the data in this phase. A case study 
style for presentation of findings was also adopted, allowing for a rich and contextualised 
analytical approach (see Chapter Eight, for further discussion).  
 
In summary, CA (and DA) has been criticised because it does not explore ‘why’ particular 
participants pursue certain objectives. This thesis uses applied conversation analysis to 
explore the ‘what’, in conjunction with 'why' through use of  both a case study based 
presentation of findings in phase two and the thematic analytical approach for phase one. 
This enables a comprehensive and rich construction of psychiatric medication 
management to emerge. 
 
An important consideration for this thesis was the amount of time required to transcribe 
the original data into a written format suitable for the analysis. A relatively small sample 
of four recorded meetings was beneficial in this regard. Also a reduced adaptation of the 
traditional CA transcription (Atkinson and Heritage, 1984) was used, which, whilst 
retaining the key features of the original notation, is less labour intensive (see Potter and 
Wetherell, 1986, for further discussion). In addition, only those aspects of the 
conversations recorded which related (directly or indirectly) to the research topic (i.e. 
psychiatric medication) were selected for transcription. 
4.4.2 Strategies for validating findings 
 
“The language of themes emerging can be misinterpreted to mean that themes reside 
in the data, and if we just look hard enough they will emerge like Venus on the 
halfshell.  If themes ‘reside’ anywhere, they reside in our heads from our thinking 
about our data and creating links as we understand them” 
        (Ely et al 1997, pp. 205 – 206).  
 
In order to explore how the validity of the research can be addressed, it is necessary to ask 
what criteria are appropriate for judging the goodness or quality of an inquiry which 
adopts a social constructionist paradigm?  focusing on how the role of the researcher 
influences interpretation of data. 
 
This has been the subject of much discussion in the qualitative methodology literature.  
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According to Guba and Lincoln (1998), there is a need to explore the authenticity of the 
research project. That is the creation of a sophisticated, but temporary construction of 
what is considered true by participants. Guba and Lincoln (1998) specify the concepts of; 
ontological authenticity (creates a more sophisticated construction of the phenomenon 
being studied); educative authenticity (leads to improved understandings of 
constructions); fairness (or represents a range of perspectives in the construction) and 
catalytic and tactical authenticity (stimulates to action and empowering action) (ibid, 
p.213).   
 
A number of features of the research design of this thesis support the authenticity of the 
construction of psychiatric medication management practice and add credibility to the 
project. For example, the continued emphasis on participation from both service users and 
practitioners, via the creation of the advisory group, as co researchers and in the 
collaborative analysis process ensures that the research process remains sensitive to the 
differing realities presented in the research and consequently presents a high level of 
credibility.  
 
In addition, as Seale (1999) notes below, the incorporation of different types of data also 
informs an authentic construction. 
 
'theory generated from just one kind of data never fits or works as well as theory 
generated from diverse slices of data on the same category'  
(Seale, 1999, p. 55) 
 
As such, the incorporation of differing stakeholders, differing data collection methods and 
differing analytical approaches enables a sophisticated construction of psychiatric 
medication management to emerge in this thesis. 
  
In addition, the following best practice advice illustrated in the bullet points below has 
been followed in the approach to building knowledge in this thesis:  
 
 Credibility and the importance of fitting the data. Here the need to write an explicit 
clear and comprehensive account of why phenomena have been labelled and 
categorized in particular ways 
 Reflexivity: the role of the researcher needs to be acknowledged. 
 Documentation   
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 Sensitivity to negotiated realities. The researcher needs to attend to the ways in which 
the research is interpreted by the participants who generated the data in the first place.   
 Transferability. Explore the extent to which the study may, or may not, have 
applicability beyond the specific context within which the data were generated, the 
researcher should report the contextual feature of the study in full.  
(Henwood and Pidgeon, 1992, pp. 150-151). 
 
Many authors have suggested that member validation is one of the most crucial techniques 
for establishing credibility of the data (Seale, 1999; Guba and Lincoln, 1995). However this 
is not to suggest that through the use of such techniques alone, a true or valid picture in of 
itself emerges, but instead suggests that such techniques are potential aids to a “deeper 
and more layered understanding, rather than final adjudications of the truth” (Seale, 1999, 
p. 99).  
 
The use of co researchers during the analyses phases thus supports the validation process. 
Also, the use of a research diary and reflective components of this thesis strengthens the 
authenticity and documentation of the analysis (Munn Giddings and Winter, 2013).  While 
a structured approach to diary writing was not ensued through the research process, I 
found keeping a reflective writing log especially helpful way of documenting learning and 
reflection on the collaborative aspects of the projects. This was also highly useful during 
the analytical phases, where I was able to refer back to earlier notes and build a defensible 
account for the analytical decisions made over time, both and as a way of documenting 
contributions from the collaborative analysis sessions.  An added component of the 
research process which added rigour and authenticity was the transcription of the 
collaborative analysis meetings38. By adopting this approach I was able to return to the 
content of these meetings and compare themes emergent from the group meetings to the 
initial thematic analysis I had already undertaken on the transcripts. 
 
Finally the supervisory team maintained a close 'eye' on both the analytical process and 
thematic findings, probing both the sensitivity to realities the findings represented, as well 
as the transferability and credibility of the analytical process. These validation 
components of the research design ensured that a multi layered and rich conceptualisation 
of medication management emerged.  
 
                                                             
38
 Collaborative analysis meetings of an interview transcript were later transcribed and coded using N 
Vivo. 
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A final aspect to consider concerns ensuring the sensitivity of the findings to negotiated 
realities, as mentioned above.  The participatory components and ethos of the study 
ensured that everyday realities and experiential knowledge of people receiving mental 
health services remained at the fore of the knowledge production processes in this project 
39. It could be argued therefore, that less emphasis has been placed on ensuring the data is 
sensitive to the negotiated realities of the practitioner groups. However, the dissemination 
phase to this research, added credibility and sensitivity of the data to the practitioner 
perspective. 
 
Dissemination and reflection towards change 
The advisory group (and myself) presented emergent findings to different audiences. As a 
group we presented to: 
practitioners within the community mental health team, where the study took place 
the service user and carer researcher meeting within the local NHS Foundation Trust 
the Research into Recovery network, at the Institute of Psychiatry, London  
the academic community within Anglia Ruskin University.  
 
These presentations were planned as a group and an equal spread of involvement was 
observed. For the practitioner presentation (bullet one, above), a particular emphasis was 
placed on reflection and discussion. This both allowed for the authenticity of the data to be 
explored with  practitioners and also allowed reflection about current practice, with the 
aim of promoting change.   
 
In addition, I independently have presented findings to the international academic 
conference, ENMESH, Verona (2013), the ShiMMe conference, Cambridge (2014),  and I 
am in the process of writing for articles for publication in books and academic publications 
(Kaminskiy, Ramon and Morant, 2013; Kaminskiy, (submitted)).  
4.5 Ethical Considerations 
 
The research received full NHS ethical approval (Hertfordshire REC, December 2010). 
Please see appendix VI.  
 
                                                             
39
 While a CPN was a member of the advisory group and collaborative analysis,  the remainder of the 
groups comprised of service users and a carer. 
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The methodology adopted (social constructionist research paradigm, participatory 
methodology) is associated with certain ethical considerations being less, while others 
becoming more prominent, than in traditional designs. For example, the methodology 
adopted for this study provided an increased incentive towards open and honest dialogue, 
revealing sophisticated constructions, and therefore safeguarded against problems of 
deception.  However there were other ethical considerations which became more 
prominent. Confidentiality and anonymity of data was particularly important.  Following 
standard good practice, personal references were removed in the transcription process 
and quotes used from interviews were not identifiable. In addition personal data (such as 
names and contact details) were kept securely and separately from the research data 
obtained.  Nevertheless the close personal collaboration in data collection and analysis, 
required by the methodology, did at times produce specific considerations of 
confidentiality and anonymity. For example, one co researcher had previously received 
services from the team where the study was being conducted. It was therefore necessary 
to ensure that the co interviewer and interview participant were unknown to each other. 
In addition, during the collaborative analysis phase, it was important to ensure that 
transcripts did not unwittingly make identifiable references to practitioners, or other 
service users, whom co researchers may have had personal relationships with. These 
reflections are referred to in the research diary excerpts (see appendix II).  
 
Risks and burdens to the research participants were present, as with any research. But 
perhaps more so given the sensitivity of the issues the research explored, and the likely 
vulnerability of some of the participants. Interviews may have caused distress, raising 
thoughts of painful and distressing experiences. Indeed a small minority of interviews did 
require additional sensitivity by the interviewers40. To manage this, the interviews were 
conducted in an environment that was comfortable for the participant and they had the 
option of bringing along a supporter to stay with them during the interview. In situations 
where a participant became upset, I or a co researcher used strategies to deal with the 
situation, by acknowledging their distress and the causes of it, giving thanks for raising a 
difficult issue, offering to discuss it further with a trusted individual following the 
interview, and suggesting another question or topic which the participant was more 
comfortable with. The researcher reminded participants that they were free to withdraw, 
or have a break, at any time. In addition, the researcher offered all participants, including 
professional staff the opportunity for a debriefing.  
 
                                                             
40
 See the relevant research diary excerpts in appendix II.  
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However it should be noted that overall, the interviews were overwhelmingly received 
positively by participants. Many participants were keen to share difficulties or describe 
examples of success and appreciated the opportunity to participate. Others wanted to 
understand what may prevent or enhance greater involvement. Many practitioners and 
service users commented on the positive impact of the research interview on being able to 
reflect on either their own professional practice, or how to best utilise the services they 
received. This was a hugely rewarding aspect of the research for me personally. This is 
well illustrated by an example. During the recruitment process for phase two, I called 
Holly, a service user who had participated in phase one. She explained that she was no 
longer able to assist with the research as she had been discharged from secondary care 
services. I congratulated her and she reflected that soon after the research interview, she 
had further considered how she wanted to approach future meetings with her 
psychiatrist. She said that being involved in the research interview had assisted in her 
taking back control and feeling able to exert her opinion and preferences. She explained 
that shortly after the research interview she had a meeting with her psychiatrist and that 
at this meeting she was able to state how she would prefer to participate in the decisions 
concerning her medication. Shortly after the meeting, Holly and the psychiatrist jointly 
agreed that discharge from the team was appropriate. 
 
The research process may also have resulted in disclosures from participants that have 
ethical and professional implications, for example 'dangerous' practice, or possible harm 
to others. Participants were made fully aware of the limits to confidentiality and the steps 
the researcher would have to take should such information be disclosed or uncovered. The 
information was clearly set out in the participant information sheets and consent forms 
and again at the time of the interviews. 
 
The risks and burdens to the researchers themselves should also be acknowledged. 
Formal support networks were available via three PhD supervisors and other informal 
support was also present. I also provided additional support to co researchers on a one to 
one basis. It was stressed that co researchers may choose to withdraw from the research 
process at any time, without any repercussions. The debriefing session following the 
interview allowed initial reflections to be explored, as well as assisting with the 
preliminary phases of analysis of the data.  
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4.6. Chapter summary  
 
In summary, this study adopts a social constructionist research framework, with a strong 
focus on participatory values. It is an exploratory study.  The participatory values and 
components, in addition to the incorporation of different stakeholder group perspectives 
has allowed for a comprehensive and rich understanding of the key concepts in this thesis 
to emerge.  
 
There were two phases to the data collection process (a research interview and digitally 
recorded meeting) exploring in depth the research questions set out in the literature 
review chapter. A qualitative approach to data collection and data analytical methods has 
been employed with the aim of building theory in this under researched area. The 
methodological decisions have been made to enhance the knowledge produced from this 
thesis and enable fresh insights into psychiatric medication management practice. 
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Chapter Five. Thematic findings from interviews with service 
users 
 
 
 
 
 
 
 
 
 
 
5.1. Introduction - Three levels of conceptualisation  
 
The emergent themes are presented at three levels of conceptualisation:  the interaction, 
the relationship, and the system.  This is represented as an 'onion' diagram, shown in 
Figure 11 below, fitting with the conceptual framework presented in the theory chapter. 
The decision to incorporate a three layered approach was made following the initial data 
driven theme building process41.  I decided it was important to maintain consistency 
throughout presentation of themes for the different stakeholder groups, maintaining a 
coherent flow and allowing for more structured comparisons between the stakeholder 
groups to be made.  I was also influenced by my involvement in the writing of an article 
during this time period which adopted a three level framework in conceptualising shared 
decision making (Morant, Kaminskiy and Ramon, in preparation).  In addition, the 
conceptual framework developed for the thesis also influenced the final decision to adopt 
a multi layered approach. This was based on previous models of power (e.g.  Brosnan, 
2012; Gaventa, 2006, Lukes, 2005) and more general conceptualisations of reality (e.g. 
Archer, 1995). It is especially relevant in representations of complexity. 
 
 In summary, after initial themes were built from the interview data, a decision was taken 
to adopt a levels structure in presentation of themes, consistent with the conceptual 
framework adopted for the thesis. However, this is of illustrative use only.  Themes are 
presented for each stakeholder group separately (service users, CPN, Psychiatrist. To 
                                                             
41
 see appendix II for relevant research diary entries  
Chapter Outline. 
This chapter presents the thematic findings from research interviews undertaken with 
service users, in phase one of the data collection process. Findings are presented at 
three levels analysis: the interaction, the relationship, and the system. A summary of the 
commonalities and areas of difference in the findings are provided in section 5.6. Later 
chapters explore the findings from practitioner interviews and recorded meetings from 
phase two.   
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assist this process, a summary section is included, emphasising the commonalities and 
differences within each stakeholder group.   
 
Figure 11. Three levels of analysis 
5.2. Participant information  
 
A brief summary of background information for the service user participants (n=15) is 
presented in table 4, below.  Information was 'current' at the time of the research 
interview. All names are pseudonyms42. As can be seen from the table, all participants 
were in receipt of psychiatric medication.43 All, except one, were in receipt of anti 
depressants, and four were being prescribed anti psychotic medication. Other types of 
psychiatric medication being prescribed to participants included mood stabilisers (n=2) 
and sleeping tablets (n=1).  6 out of 13 were in receipt of two or more types of psychiatric 
medication.  The mean age of participants was 36 years old and 9 out of 15 were female. 
All participants were receiving services from one community mental health team (the 
same care pathway) within the local NHS foundation trust (see section 4.3.1) and most 
were recruited from the Cambridge area (n=12). However two interviews took place in 
                                                             
42
 Chosen by myself as chief investigator 
43
 For two participants, medication related information was not recorded 
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Huntingdon and one took place in Peterborough. Interviews lasted between 30 minutes – 
1 hour.  Service user co researchers were interviewers in all but three interviews (where I 
was the sole interviewer44). 
 
                                                             
44
 Due to feasibility reasons 
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Participant 
name  
Age Gender Class/type of 
medication 
currently 
prescribed 
Name of medication, if 
known 
Also 
known 
as 
Approx. 
time in 
pathway 
(CMHT) 
Length of time taking psychiatric 
medication or since medication 
changed   
Discusses 
medication with.. 
Natasha 31 F Anti depressants Unknown SU1 Unknown Six months taking current 
medication 
CPN, GP 
Holly 36 F Anti depressants 
Mood stabliser 
(for pain) 
Trepidone, 200 mg  Efexor 
(or known as Venlafaxine), 
300 mg. Also Gabapentin for 
pain 
SU2 Unknown Taken psychiatric medication on and 
off since 19 years old. (17 years 
approx) 
Clinical Psychologist, 
GP 
Carrie 38 F Anti depressants 
and an anti 
psychotic 
Fluoxetine, Mirtazapine, 
tryptophan, Aripiprazole 
SU3 Over 12 
months 
Taken psychiatric medication on and 
off for around 10 years. Most recent 
change 4 months ago 
Psychiatrist, GP, 
Social worker 
Carl 28 M Anti depressant  SU4 Unknown Just over a year GP, CPN, Psychiatrist 
Noel 47 M Anti psychotics  + 
anti depressant 
Haloperidol, Amitriptyline, 
Resperidone, Depixol 
SU5 Unknown Since 1981. Psychiatrist, CPN, 
Social Worker 
Ziggy 34 F Anti depressant Amitriptyline SU6 12 months 2 months since new medication CPN, Psychiatrist, GP 
Linda 22 F Anti depressant Venlafaxine SU7 Unknown 2 months since new medication Psychiatrist, GP, CPN 
Terry 31 M Atypical anti 
psychotic 
Closapine 400 mg SU8 Unknown 2 years. Reduction in dose 9 months 
ago 
CPN, Psychiatrist 
David 23 M Unknown Unknown SU9 4-5 months 4-5 months Psychiatrist, CPN 
Lara 42 F Anti depressant Venlafaxine SU10 Unknown 2 weeks since new medication GP, Psychiatrist 
Peter 50 M Unknown Unknown SU11 Unknown Unknown GP 
Andrew 49 M Anti depressant Unknown SU12 Unknown Since 2010 Psychiatrist, GP 
Lizzy 54 F Anti depressant, 
mood stabiliser 
Venlafaxine, Lithium 
(1000mg) 
SU13 Unknown Venlafaxine: Unknown. Lithium - 6 
years since dose changed. Total 10 - 
15 years been taking Lithium 
CPN, Psychiatrist 
Casey 28 F Anti depressants 
Sleeping tablets 
Fluoxetine, (60 milligrams) 
merotratine (200 
milligrams), sleeping tablet 
SU14 Unknown Has been taking psychiatric 
medication for approximately 2 and 
a half years 
GP, Psychiatrist, 
nurse (GP) 
Rosie 24 F Anti depressant  
Anti psychotic 
Venlafaxine, Abilify 
(Aripiprazole) 
SU15 Unknown Abilify changed recently but has 
been prescribed anti depressants  for 
8 years 
Psychiatrist 
Table 4. Service user participant background information.
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5.3. Service users - themes at the interaction level 
5.3.1. Being ill as a barrier 
The vast majority of service users discussed finding it more difficult to be involved in 
decisions when in crisis or during periods of illness. In particular, cognitive impairments 
in concentration, memory and motivation were seen as problematic for processing 
information and weighing up the pros and cons of medication options.  In addition,  
distress during periods of crisis was mentioned as impacting feelings of being able to fully 
participate and communicate effectively in the decision making process.  
 
Carrie: I think when I was particularly ill, I found the meetings very difficult, I didn’t 
know what to say, I really didn’t know how to express how I was feeling. 
 
Lara: When I first turned up at the GPs, I wasn’t feeling very well at all, so um, it was 
actually physically hard for me to have a conversation, communicate and understand 
what was being said to me really.  
... Well again it’s a funny thing because of the nature of the illness, the exchange of 
information is difficult, because you send me off with 6 or 8 names of drugs and tell 
me to do research and because I can’t really read when I’m ill..... because my brain is 
not processing information properly its very it’s like confused skimming and there’s 
not a lot that you can do about that, you can provide all the information in the world 
but can I take it in, do you know what I mean? 
 
Valuing guidance in a crisis - A dilemma? 
During these more difficult times, most participants discussed valuing increased guidance 
from a practitioner.  For some participants, receiving more directive guidance was 
positively valued. For example, Carl's quote below describes an unsuccessful meeting with 
his psychiatrist. He refers to not being well enough to ask more questions and describes 
wanting to be led by the psychiatrist. Other participants refer to the dilemma which 
emerges during these more difficult times. Holly refers to strongly valuing being involved 
and taking ownership over decisions about psychiatric medication, but feels that, at times, 
she is unable to. Importantly, being treated as a person, respect and longer term 
partnerships were seen to facilitate the problems of not being involved in the short term. 
These issues are explored further in the ‘relationships level’ section below.  
 
Carl:  Um, I think if I’d been in a better place mentally at that time I might have 
pulled up some questions, um but given how I was at the time, um I don’t think I 
could have done much more because I was looking  to be informed by her [the 
psychiatrist] as much as anything and, you know, that didn’t really happen at that 
point in time 
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Holly:  Yeah, it’s kind of strange when you’re really unwell, I feel very helpless 
because I can’t even get out of the house by myself. And I find it very difficult to just 
be told what to do, I don’t deal with authority, but on the other hand, I’m so ill that I 
don’t really have a choice, but I find it uncomfortable. When I’m more able to be part 
of a conversation about it than I’m a lot more comfortable, I tend to open up a bit 
more I think.  I mean, I try to tell whichever doctor and saying everything but 
sometimes you know, you can be kind of… sometimes you’re actually just talking.  It’s 
easier when it’s more of a partnership with a more experienced person, instead of just 
a doctor, you know, a knowing person in the relationship. 
I: ...what is it that makes it more difficult? 
Holly:  Either, when I’m kind of unable to do much about it myself, that I’m very 
grateful that somebody is taking over and telling me what I need, but it just kind of 
makes me kind of… I really don’t like to be just told what to do without being 
consulted but I know, at those times, I can’t, so I know I need it but I don’t like it..... 
....obviously I need someone - whatever I need to get capable.  Yeah, sometimes the 
sad truth you just need someone to treat you but… 
 
5.3.2. Overcoming barriers -  Gaining control  
Service users strongly valued being informed. In general, receiving a full explanation of 
options and gaining detailed information about psychiatric medication and associated side 
effects was related to feelings of increased control.  Being given time to digest information 
and discuss medication options with the practitioner was seen as helpful. Both Holly and 
Claire refer to how receiving detailed information assists with feelings of being in control, 
when unwell. Holly's quote follows on from the previous excerpt above. 
 
I: And in those times, when you need someone to, you know, treat you; is there 
anything that’s really important during those periods? 
Holly:  To explain what they’re doing not just, you know...  I find some medical people, 
they tend to assume that if you’re depressed or whatever, they assume that you’re 
stupid, it doesn’t follow and I like to know why I’m being given… I’m a scientist you 
know and I want to know all the details and I might not be able to hold on to them at 
the particular time, I would like it to be explained to me but if I can’t handle the 
explanation I’ll say; actually, that’s fine, don’t worry about it, tell me in a few months, 
yeah. 
 
Claire: There and then, yeah, because fair enough in a crisis you can’t do that, action 
has to be taken but I just think if I’d been given that information and going through it 
yourself and having time to discuss it, you’re going to understand.  I just think you’d 
feel like you had more control and you know, that might reduce stigma as well about 
you feeling you know, you can take control of what’s going off. 
 
In comparison, not feeling informed was described as a barrier to collaboration in the 
decision making process and was associated with feelings of helplessness and a lack of 
control. Participants refer to wanting more discussion about different options.  
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CO I: OK. Um yeah um is there a time when you’ve found it more difficult to be 
involved in decisions about your medication? 
Rosie: Yes, actually, the last time that I saw her [the psychiatrist], my medication 
was increased, and I my mood was low but I didn’t really know like, I wanted more 
options and I thought that it would have been better if I had talked it through with 
her a bit more about increasing the dose and instead she just increased the dose and 
that’s it, kind of thing. 
CO I: So she wasn’t really giving you lots of options it was just she was making a kind 
of decision yeah for you really,. 
Rosie: Yeah, yeah 
 
CO I: I was just wondering when you said decisions, you’re not explained or given the 
reaction you want; what do you feel when that happens? 
Holly: Out of control, like I’m being looked down on and you know, when you're 
depressed, you already think you’re useless and a waste of space. 
 
Under this umbrella of 'gaining control', the following sub themes are presented by 
participants as important: gaining self management skills; information about medication 
side effects; language and communication; and finally, but no less importantly, valuing 
experiential knowledge. 
 
Self management 
A large sub group of participants discussed gaining increased understanding of how 
medication helps them and learning self management skills. In the quote below Carl refers 
to the learning how and when medication is helpful.  Participants also refer to learning 
from previous experiences of taking or not taking psychiatric medication in an ongoing 
experiment. 
 
Carl: yeah, yeah, yeah, just remembering the names of what I’m taking how much I’m 
taking um and how I feel before and after I take it so that’s like how I felt for certain 
drug, for one drug or another how I felt three hours before I take it, and how I feel 
three hours after I take it and so on 
Co I: Very insightful yeah so uh , you’ve realised what helps and how it helps  
Carl: Yeah, and so we’ve tried to within the GP myself, the psychiatrist and CPN we’ve 
tried to balance a way to find out when its best to take the drug and when its best not 
to as it were um, yeah  
 
Side effects 
Receiving information about side effects was seen as particularly important, with the 
majority of participants mentioning this. Some participants also referred to not always 
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receiving enough information. Most participants referred to previous negative experiences 
of psychiatric medication side effects. 
Carrie: I  think I’ve always been fairly involved because of the side effects I’ve had on 
other types of medication, so I’ve always been quite concerned about the potential 
side effects that I might have, um, so there’s always been a discussion about that,  
 
Andrew: One thing is that you are never given enough information about the side 
effects. 
 
Participants refer to a number of sources and methods for finding out about the side 
effects of psychiatric medication. Some participants find it helpful to receive information 
leaflets or sheets via the psychiatrist or pharmacy. 
 
David:  A lot of the information that was provided for me was provided by my 
psychiatrist and also the chemist as well which was a big help. They gave  me a 
printout ...which I read through myself, so I've got a bit more understanding what the 
medication is, and what potentially could go wrong with it like side effects etc.. 
 
Other participants mention doing their own research on side effects and this often 
involves searching the internet.  
 
I: So, it’s just been you researching the side effects and things and; how do you do 
that? 
Casey:  Pretty much, I just go and have a look on the internet, I have a look in books 
and have alook on the sheets really. 
However, for a minority, doing their own research on the internet was less helpful, with a 
handful of participants instead preferring to ask questions of the psychiatrist or GP. 
 
Natasha:  yeah, I don’t know, because I know you need to be really careful.  I’d rather 
speak to a doctor than go by what I read on the internet kind of… 
 
Language and communication 
Language and communication formed part of this umbrella theme, with a few participants 
talking about how body language and using clear and simple language is helpful when in 
crisis. Being fully informed and receiving a copy of letters was mentioned by Rosie as a 
helpful tool. More generally, the importance of reinforcing information and increased 
discussion about psychiatric medication was especially valued by participants.  
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Linda: I think when the discussion is very sort of, um, scientific language….but 
occasionally it has got quite complex and that I just don’t understand it, it doesn’t 
mean anything to me....so talking in simpler language and um, sort of describing the 
effects that it would have, sort of its supposed to um, to level out your mood 
fluctuations rather than say it will sort of regulate some sort of hormone in your I 
don’t know your cortex or something, sort of it just sort of easier to understand when 
its described in terms of what it’s going to effect, how it’s going to affect you, your 
mood, your feelings, and thoughts should change with the medication rather than its 
biological role.  
 
Rosie:  Um, I should write list, but I haven’t yet. That would be helpful. Feedback, 
more feedback on well she sends me a letter of a copy of a report which goes on file. 
.... Yeah, I’d like to be more informed and have more time spent explaining what it 
could do, because there’s a lot to talk about when you start taking medication. Like I 
don’t know how long I’m going to be on this medication for? And um, there are some 
people, there’s so much information out there these days that you don’t know what 
the right information and what’s the wrong information is, so um, sort of very 
confusing [laugh]. Just more time.  
[laugh] would be helpful. 
 
Valuing experiential knowledge 
The vast majority of participants mentioned the importance of feeling listened to and this 
often related to the theme of being treated like a person and respect (see section 5.4.2). 
However, a sub group of participants explicitly mentioned the importance of service user 
experiential knowledge. Service users' having expertise and being treated with value in 
the conversation increased feelings of control for some participants.  
 
 
Linda: Um, I think ideally it should be um, a collaboration between the um, 
psychiatrist or prescribing doctor and the service user, so there’s sort of the 
knowledge of the different types of medication on the one side and then the service 
user knows how they are feeling, they know, sort of whether they’ve got sort of 
patterns to their moods that sort of certain types of drugs are more able to help with 
so its sort of a feedback situation, with both of them contributing 
 
 
Holly: He was really great, I’ve had a lot of psychiatrists, and you know other doctors 
that you know pronounce from on high and he was very interested in my opinion 
about medication and how I was doing, which was really nice because you didn’t feel 
like, you know, god, you know, coming out and saying, you will take this, [laugh], it 
makes you feel more in control when you’re not really in control of anything 
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5.4. Service users – themes at the relationship level 
 
The vast majority of service users interviewed referred to the facilitating role of a 
supportive, caring and trusting relationship between the service user and the practitioner.  
Service users refer to how a therapeutic relationship enables broader collaborative 
decision making processes.  Sub themes at the relationship level comprise: trust and 
honesty, respect, shared journey and continuity. 
 
5.4.1. Trust and Honesty  
The importance of achieving an honest and open dialogue where trust is established was 
seen as very important, by the majority of service users.  
 
Carrie: I think the main thing is to be as honest as possible. I think um it’s no good 
sort of if you are having side effects, it’s no good trying to brush over it .....the honesty 
and the trust I think as well, and you know you kind of build up a relationship with 
somebody and you get to trust them and I’ve certainly found that with my present 
consultant.  
 
David: I have to do everything I can to allow myself to get better but if it means I 
have to trust somebody that I don’t know, which is very, very difficult for me to do, 
then so be it. 
 
Conversely, within this theme, a breach of trust was seen by some participants as 
particularly damaging to the ongoing collaborative relationship. The following quotes are 
Linda and Terry's recollections of a negative meeting. 
 
Linda: that was quite difficult as then obviously my parents knew which I hadn’t 
really wanted them to, so ..... But when um, the doctor told my parents the thing there 
wasn’t much I could do....Yeah it came out of the blue really. 
 
Terry: Probably because they didn’t really listen to me, like I was annoyed. I mean, it 
was probably quite a good thing to have my parents come but I said I didn’t want 
them. 
5.4.2. Respect  
Another subtheme that emerged at the relationship level refers to respecting each other as 
people and being treated as a person. This was mentioned by some participants as 
particularly important during periods of crisis.  Feeling pre judged, not being listened to 
and not being respected in a conversation was mentioned by many participants, when 
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recollecting negative meetings.  However, participants' previous experiences of feeling 
respected and listened to varied greatly according to the practitioner (see Holly). 
 
Holly: Treat me like a reasonable person when perhaps I’m not because I will be 
again.. 
Co I: Do you think there is anything to change this something in the system? 
Holly Talking down to patients, even if you’re completely crazy, babbling about 
random stuff, which I have done a couple of times.  Treat them as though they are 
reasonable people because underneath they’re probably already going, you know; oh, 
I’m useless and if they’re treated as useless, then you just feel worse.  If it’s depression 
then I doesn’t know, you know. 
CO I: But as you said there, you don’t get the same reaction out of everyone. 
Holly: It seems like some of the younger doctors, seem to be more open to treating 
you like a person while a lot of the older ones, not all of them obviously but they seem 
to have this; I’m God, you’re patient. 
 
Natasha:  ... someone that you trust and that you’ve seen, rather than it’s some 
specialist that you may have seen sort of once or twice or some psychiatrist that 
doesn’t know anything about you, I don’t know, ....you know, that’s still a person 
however mixed up their head is, they're still a person. 
 
This theme also relates to respecting each other as people and respect for different 
opinions.  Ziggy's account below refers to a recollection of a positive meeting with her GP 
when a decision was made about psychiatric medication.   
 
Ziggy: Um, so firstly there was a good relationship already there. Secondly they made 
time for me and I mean I didn’t even have an appointment I don’t expect that 
normally. Thirdly there was a real respect for my opinion although I think she 
actually disagrees with some of my opinion she let me get it all off my chest, and um 
cry and be upset and then she intervened. And she intervened calmly and rationally 
and slowly, so she brought the mood down, back to a normal one, she pointed out a 
few things, that I knew had been difficult, so I remembered that, actually medication 
could be helpful,  
 
Within this theme a minority of participants emphasise the importance of the practitioner 
'going above and beyond' what is expected. This was seen as indicative of a good 
relationship having been forged. This also related to reference of 'being on the same side'.  
This is eloquently described in a later excerpt from Ziggy, when describing her 
relationship with her GP: 
 
Ziggy: I have a very good relationship with my GP. She is exceptional... She has gone 
above and beyond the whole time, her home number, her mobile number and she 
came up to the hospital in June 0 9 ... so she’s always fought my corner as it were. 
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5.4.3. Shared journey and continuity 
The vast majority of participants placed importance on the concept of walking a shared 
journey over time in partnership with a practitioner, with familiarity increasing feelings of 
safety. Different practitioners, including CPNs, Psychiatrists and GPs were referred to and 
many examples of positive and helpful relationships were mentioned by participants. A 
supportive, long term relationship with a practitioner was seen as especially important 
during periods of crisis where participants felt less able to be involved. The practitioner 
knowing the person and being able to relate to each other was emphasised (see Rosie, 
below).   Hope also formed part of this theme, with growth and recovery over time being 
mentioned by participants (See Carl and Natasha). This theme was particularly apparent 
in participants' recollections of positive meetings, which most commonly referred to 
meetings when there was joint reflection on the service user’s recovery journey, receiving 
feedback on progress over time and the practitioner knowing and listening to the person. 
 
 
Natasha: I don’t know, I think it’s because he [CPN] kept comparing to how I was 
and how I am.  So, you know; look how far you’ve come, it was all just really positive, 
rather than;' okay, you’ve taken it, well done'.  Yeah, it was real; I don’t know it just 
felt like, yeah, I’m not just like another person that you see because you have to.  
You’ve remembered things, he’d like give examples of what I wouldn’t do before and 
what I’m doing now, so it was all very...and he was like; 'well done, you know, before 
you would have stopped and that would have  been it but I’m glad you have, you 
know, I’m really proud of you, you’ve done this, you’re doing so well'.... 
I: Yeah, okay then; so what was it about this meeting that, you know, sticks in your 
mind, in terms of why it was positive?  What was it about this meeting that was really 
positive for you? 
Natasha: I think the fact that it was sort of like; okay, actually I’m getting a bit of 
control and taking the medication, you know,  Mark [CPN] could see improvements 
and saying; okay, maybe we’re getting there and maybe everything might be okay, it 
was sort of a bit of a turning point. 
 
 
Carl: because I felt positive but also because the key thing being she [GP] felt positive 
and that for me is a big thing because if someone thinks is thinking positively about 
me and my situation I go ‘Oh, I must be good,’ and so its almost a placebo effect 
CO I: Yeah, that’s how people work, yeah, 
I: Can I ask a tiny bit more about that then, so why, for you that meeting sort of 
stands out as being particularly a positive meeting ?[cross talk] 
Carl: I felt so good and it was positive for her[GP] and for me because it showed 
though I know now I had another bad spell after that, but it showed looking back on 
it now that I can be better, I can get better, and I can at times sometimes in the near 
future I will be able to lower my medication again which is which means I’m less 
reliant on that which is a good thing and that’s why it was positive now looking back, 
because it was a it was a sign that I won't be suffering from this for ever, hopefully, 
that’s the point. 
 
 
117 
 
 
 
CO I: So, if it was an ideal world, um, how would you prefer for the decisions to be 
made about your psychiatric medication? How would you, you know if you were in an 
ideal world, 
Rosie: I just wish there was a way of like, I suppose I go in and I would be able to 
express myself properly, and say, what I think is going on. I’d have more insight into 
my illness, like completely, and um, she would somehow ask questions that I can 
really relate to and say yes I’ve experienced that, or no I haven’t. And kind of test me 
in a way in order to find out about what’s going on and um, then give me feedback. 
And that’s all I want really.  
 
5.5. Service users - themes at the system level 
 
5.5.1. Power 
An overarching theme of power was created to encompass themes associated with 
experience of aspects of the current mental health system that hinder service user 
involvement. Within the overarching theme of power, there are three distinct subthemes: 
fear of coercion; diagnosis, labelling and stigma; and doctor-patient asymmetry. Notably, 
all sub themes were associated with the service user withholding information, feeling 
scared and being unable to express their opinion. Service users refer to these sub themes 
as obstacles associated with encounters when there is a lack of openness and honesty (by 
both service users and practitioners). 
 
Fear of coercion  
Fear of coercion and the legal context of compulsory treatment was mentioned by 
participants as hindering open dialogue. Often this was based on direct previous 
experience (see Terry).  However, even for participants who had not had direct experience 
of being sectioned or treated against their will under the Mental Health Act, fear of 
coercion was nevertheless acknowledged as something that prevents shared dialogue (see 
David). Fear of coercion was directly associated to holding back information in a 
conversation. 
  
Terry: …I kept saying I was hearing voices and the home treatment team 
immediately called a psychiatrist and he said if you keep telling us this, we’ll keep you 
in hospital.  So I thought to myself; if I get these things going on in my brain, I won’t 
tell a psychiatrist because I don’t want to be in hospital. 
But then, I sort of started to deal with it myself and realised that what’s going on in 
your brain probably isn’t real and these people aren’t speaking to you 
telepathically..So, they said that, you know; if you say that to the psychiatrist, you 
know, you’ll end up in hospital!  
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I: Did that change what you sort of say in these meetings or not a lot? 
Terry: No, I’m normally fairly honest actually, to be honest with you but sometimes I 
think, maybe I shouldn’t say that because they’ll look at me a bit different and think 
I’m worse than I am. 
Because I think in the past, you can be a bit too honest, yeah.  
I: So that’s something you’ve learnt then, you know? 
Terry: Try and be as honest as you can but hold back a little bit because you don’t 
want to sort of end up in hospital when you look different to society. 
 
 
David: Well, whenever I think of psychiatrists, I think that they’re paid to get inside 
my head and control me.  Yeah, so at first I built up this barrier and I was basically 
letting very little information out.   
 
Diagnosis labelling and stigma  
Whilst some participants valued greater understanding of their diagnosis, a few 
participants referred to an over reliance on psychiatric medication as a primary treatment 
within current mental health services, limiting choice in the decision making process and 
reducing opportunities for open dialogue (see Noel). Other participants instead referred to 
feeling labelled and judged by their psychiatric diagnosis, this once again acting as a 
barrier to engaging in open dialogue and feeling listened to (see Ziggy and David).  
I: .. you are saying, that it could happen, that, you know, you 'could be taken off the 
street', so does that affect how you feel about having a conversation with your 
psychiatrist. 
Noel: yeah, it does do, yeah. That’s what I’m saying. I might as well go along with 
what the psychiatrist is saying and the drugs they are prescribing because there is no 
alternative, the only alternative is to come off the drugs altogether, become seriously 
ill, you might feel a little bit more life in your blood stream …..but  yer GP, 
psychiatrists just look at that in a really really severe way, they  
I:   Still now, and you think that’s the case now? 
 P:  Oh yeah, definitely, yeah.  
 
Ziggy: The negative meeting is one where I feel pre-judged. I feel that somebody is 
coming in, this may or may not be the case, but they are coming in they’ve looked at 
my paperwork, they’ve made a decision, and then it feels like they are not really 
listening to what I am saying. And there are some semblances of listening, but it’s not 
really going in because in their mind they’ve already put a label on me. 
 
David: hence why I didn’t talk about it because I thought I was going to be judged, I 
was going to be labelled, so I shut it off. 
 
Self stigma was also mentioned by a few participants. For Ziggy, being labelled with 
‘psychosis’ was seen as particularly unhelpful. For her, this label represented a personal 
failure, thereby making conversations about medication more difficult. Holly instead 
reflects on the wider issues of stigma and discrimination associated with psychiatric 
labels. 
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Ziggy:   It was that use of labelling me that I found too much...... because of the labels 
and distressing episodes that have happened, particularly when I was in hospital 
when I’ve been manic um, I approach  meetings, although I try to approach them 
calmly I approach them with underlying fear….. but I couldn’t handle the label 
psychosis. .......but for people to say those things to me, I found as a huge personal 
failing, um and so I didn’t use to be able to say psychosis 
 
 
 
Holly: who was a terrible supervisor and said; look, this is what happened, I’m 
recovering but I’m not better just to let you know and he acted a bit like; I can’t really 
deal with that kind of problem…  
... He seemed really uncomfortable and I thought, surely .....There was like silence 
around the table and I said; it’s fine, it’s just depression, it’s not a big deal, there are 
other people in this lab who have it......  So I started talking about it after that because 
I thought, well this is ridiculous, you know, there’s got to be other people here who 
are having problems, it’s insane that people feel that way. 
 
Doctor - patient asymmetry 
Another sub theme related to some participants’ comments about the unequal power base 
during the psychiatric encounter; feeling inferior and patronised in the conversation and 
scared to express their view in the conversation. A minority of  participants also talked 
about presenting a false picture of feeling better to the doctor (See Carrie). This was 
associated with feelings of failure and wanting to please the doctor.  Of note, this theme 
reappears in the interviews with CPNs, but not psychiatrists (see subsequent chapters). 
Interestingly, three of the quotes below are taken from the critical incident (negative 
meeting) component of the interviews (with the exception of Holly). 
 
Holly:  no, I don’t work well when I’m obviously not her equal, she has more training 
but I don’t work well when I’m being treated as, you know, an inferior… I’m an 
intelligent person,  ...., a parent and child I suppose is what it feels like … but they 
seem to have this; I’m God, you’re the patient. 
 
 
Lizzy:  Just trying to patronise me. Trying to tell me that he knew better than I knew. 
I:  and then what happened? 
Lizzy Nothing, he gave me a prescription for something else and I just went. 
 
 
Andrew: It was the doctor. His style, his attitude really. He just decided the dose, 
there was no discussion. It is all about their style I suppose. 
 
 
Natasha: I felt like I was being attacked and I don’t know, it was like I was coming to 
them for help, it just felt like I was just being attacked and judged and sort of looked 
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down on and it just made me feel really uncomfortable, upset. The fact that I was too 
scared to say anything, it was, you know, just horrible, it made me feel even worse 
 
 
Carrie ..I think I got to the point where I almost felt as if it was my fault that I wasn’t 
getting better so there was a part of me, I desperately wanted to come into the 
meeting and say, yes, everything’s getting better things are great, this medication 
worked and time and time again, it just didn’t happen so I found those conversations 
quite difficult.... I was scared of saying anything. 
 
5.5.2 Multi disciplinary working 
Finally, at the system level of analysis, a few service users referred to how having input 
from multiple stakeholders impacts decision making. In table 3 (section 5.1), it can be seen 
that most participants (n=13) had contact with multiple practitioners regarding their 
psychiatric medication.  
 
For some participants, disagreement between professionals was mentioned, but this was 
not necessarily seen as impeding the conversation. For some service users multiple 
opinions were seen as a positive experience, where new ideas or solutions were presented 
or discussed (See Carl, Carrie). However, for other participants, it was seen to create more 
confusion in the conversation, especially when relationships with practitioners were not 
established (See Linda). 
 
Carl:  Yep, OK, I think because within the medical team which looks after me, they 
partly disagree on the levels of medication, how much I should be taking, or when. 
Especially maybe um about 6 months ago, maybe there was an argument that the 
medication I take in the evening I should be taking some in the morning and so on, 
and kind of, that way, there was a disagreement. My doctor So-and-so, thought I 
should be taking another ...um but because I met with all them on a regular basis as 
much as possible, um I was able to keep up to date information, so they were able to 
come to an overall eventual decision basically.  
I:  Oh, so that took some work on your part? 
Carl: Yeah, it took some work on my part as much as anything  
 
 
Carrie: we’ve tried all these medications, we’ve tried various treatments, therapies 
and I felt that things were never going to get any better, um, but um, so at that point 
[pause 2 secs] I was sent for a second opinion and for a fresh pair of eyes sort of 
helped. 
 
 
Linda: There was the doctor from Fulbourn I'd only met once, and that was for quite 
a difficult session, so I didn’t feel particularly comfortable. And the doctor from my 
GP surgery,  I'd never had an appointment with her, Id only been introduced to her 
very briefly, so I didn’t really feel that she had anything to contribute, that there was 
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any point of her being there. It was just another person when its already quite 
difficult to express exactly how you’re feeling.  
 
5.6. Service Users – Commonalities and Differences 
 
Commonalities across interviews with service users are presented in this section, followed 
by an examination of differences that emerged between service user interviews.   
 
5.6.1. Commonalities across interviews 
In appendix V, the N Vivo coding framework is presented showing themes by number of 
coded references.  This provides an indication of the frequency in which themes emerged 
from the data. There are a few themes which emerged strongly in the interviews with 
service users. That is, they were mentioned frequently by participants, with a high level of 
consensus.  
 
The most commonly occurring theme is coded under the 'barrier' heading, and refers to 
the theme presented at the interaction level of analysis - 'being ill as a barrier' (See S. 
5.3.1). This theme refers to problems of being ill hindering how participants feel able to be 
involved. In particular, participants discuss cognitive impairments of concentration and 
memory, as well as a lack of energy and motivation, as particularly problematic for both 
feeling informed and processing information about psychiatric medication. In addition, 
during periods of distress service users found it more difficult to fully express themselves 
in meetings.  Thus, in summary, a key barrier for service users surrounds difficulties of 
involvement during periods of crisis. Importantly, most service users value increased 
guidance during these more difficult times, acknowledging that they are less able to take 
control. For a sub group of participants, however, this reduction of control also represents 
a particular challenge or dilemma. These participants strongly value control over 
decisions about psychiatric medication, yet, at times, feel unable to assert this control. For 
other participants, this dilemma was less apparent, instead referring to feeling 
comfortable with the prescriber taking a leading role45. 
 
Another commonly occurring theme at the interaction level concerned gaining knowledge 
and information seeking45.  This theme was mentioned in relation to both facilitators of 
                                                             
45
 See 'areas of difference across interviews' below 
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and barriers to (for an absence of information) SDM.  In particular, service users strongly 
value receiving full information concerning side effects, many having previously 
experienced negative associated effects of psychiatric medication. The provision of this 
information was associated with feelings of enhanced control and being able to more fully 
weigh up the pros and cons of psychiatric medication options. This theme also emerged in 
participants' descriptions of meetings (the critical incident component of the interview).    
 
The vast majority of participants mentioned themes at the relationship level of analysis 
(section 5.4). Establishing trust, feeling listened to, being treated with respect and walking 
the journey together in a longer term supportive relationship with a practitioner was 
described as an important enabler for collaborative decision making. In addition, the vast 
majority of participants' descriptions of positive meetings46 related to these themes. 
Feeling supported and receiving feedback from a practitioner, as part of a longer term 
therapeutic relationship, was particularly apparent in the descriptions.   
 
At the structural level of analysis, feeling labelled, pre judged and patronised is frequently 
mentioned by participants as a barrier to collaborative dialogue, suggestive of more 
insidious challenges to SDM being present.   
 
5.6.2. Areas of difference across interviews  
Key areas of difference across the interviews with service users centre on levels of 
ownership over decisions concerning psychiatric medication. This diversity is present for 
both participants’ previous experiences of being involved (from feeling very involved 
through to feelings of not being involved at all), and for participants' expressed 
preferences towards different models of decision making47. 
 
These differences are illustrated in table 5 below, which identifies how participants' 
respond to questions that explore both how decisions are made in practice (Question: In 
general, who usually makes the decision about your psychiatric medication?)  and 
participants preferred level of participation (Question: In an ideal world, how would 
decisions be made?).  
                                                             
 
47
 See chapter two for description of different decision making models  
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Question responses concerning level 
of involvement 
Who usually makes 
decisions about 
psychiatric medication? 
(*) (**) 
In an ideal world, how would 
decisions be made about 
psychiatric medication? 
(*)(**) 
The psychiatrist/prescribing doctor 
take the lead on decisions 
Carl, Rosie, Andrew, 
Casey, Terry, Noel, Ziggy, 
David 
Rosie, Lizzy, Carl, 
Joint decision / collaborative Linda, Holly, Terry, Noel, 
Ziggy 
Lara, Ziggy, Linda, Holly, 
Casey,  Carl, Terry, David 
The service user takes the lead on 
decisions 
Natasha, Lara, Lizzy, 
Carrie,  David 
Ziggy,  Lara 
(*) Some participants are recorded in multiple categories, reflecting diversity of response within an 
interview 
(**) Where the response was unclear or did not fit within a category, the participant response is not 
recorded.  
Table 5. Participant responses for perceived and preferred levels of involvement. 
As can be seen from this table there is a fairly equal spread in responses in perceived 
levels of involvement over decision about psychiatric medication (shown in the first 
column). In other words, for some participants, the psychiatrist is seen to lead the decision 
making process, and for others, the service user perceives that they hold ownership over 
decisions concerning psychiatric medication. 
 
There were also differences between participants' preferences of participation (as shown 
in the second column).  This was often related to what participants viewed the practitioner 
(and their own) role to be in an ideal world.  While there was a spread of response 
observed, the majority of participants discuss their preference for a shared dialogue, 
feeling involved and forming a longer term partnership in the decision making process.  
This is illustrated in Holly's quote, below. However a sub group of participants instead 
valued a paternalistic approach where the practitioner (and in particular, the psychiatrist) 
perform the role of the expert, leading the decision making process. For these participants, 
the service user viewed their own role as providing relevant information. This is 
illustrated by the quote from Carl, below. 
 
 Finally, another smaller sub group of participants describe a preference for a more 
informed model of decision making. That is, the role of psychiatrist or practitioner as 
someone who has expertise in medication, but who has no say over the decision. This view 
is illustrated in Lara's quote below. However to note, whilst Lara refers to a highly 
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informed dialogue of being given ownership of the decision (and the psychiatrist taking an 
advisor role), later in her transcript Lara also refers to valuing the opinion (or gut feeling) 
of the practitioner. This is, as oppose, to just receiving the relevant information to weigh 
up independently.  Thus, even within the same interview, there was some degree of 
variability, perhaps indicating that such preferences towards involvement may vary 
according to the situation. 
 
Carl: my psychiatrist .. she, as leader of the project that is me, , she is very much 
more led by my GP, ..my GP and her exchange notes ..she’s kept up to date with any 
relevant information regarding my medication.  They take on board what I say, but ... 
she is looking at the longer term,  
Co I: Great insight into all this, yeah [joint laugh] isn’t it, are different options 
presented, so would you say you have many, uh, much information about all of this, so 
have you explored all that can be done or  do you leave some to them? or [cross 
talk] 
Carl: I leave it partly to them. I have looked at other ways of  dealing with..my illness, 
which would down to me, which is based on physical exercise and general wellbeing 
in terms of certain environments. ...[On] the medication side I will generally leave 
up to them but I will give as much information as I can because they’re the 
ones who spent eight years or so learning you know learning how to deal with 
the illnesses, I’m only the patient so I try to give as much information to them 
as possible... 
CO I: .... So in an ideal world, how would you prefer for decisions to be made about 
your psychiatric medication? Stay the same, change, maybe a new way? 
Carl: I think this way is a good way.  
 
 
 
Holly: As time has gone on  it is much more of a partnership, very much more of a 
conversation. So, you know, 'how's that working', 'oh its pretty good but I don't 
know if its strong enough I am still having trouble sleeping',' Oh really, well we could 
put it up a bit more -do you want to go up 50 or 100',' maybe 50 because it zones me 
out so much'.... so it was much more conversational.  Like obviously he's the expert, I 
don't know that much about drugs, but it felt really nice to be able to have a 
conversation with a psychiatrist rather than just 'OK, yes sir' 
 
 
 
Lara:  I went and did what research I could about it and chose one and he[the 
psychiatrist] was like, 'OK that’s fine',  
I: Was any kind of preference presented to you then? You know 'well this is possibly 
what I think might be preferable?'  
Lara: Not really, not at that point, I mean he [the psychiatrist]  suggested there were 
two options - either I could go on anti psychotics right away and keep taking the anti 
depressant I was already on, or change anti depressant and not take the anti 
psychotic. 
I: Yeah, I’m quite interested in talking about this,. You said you were given these 7 or 
8 options, but before that there was some sort of conversation about whether to 
come off the medication you were on, or to add a anti psychotic, -these two, kind of, 
options. 
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Lara: And again, Dr Percy presented them to me as, sort of, two ways that we could 
sort of go forward and you know he sort of said, 'you’re getting these symptoms it 
depends on [you] how well you think you can tolerate these symptoms, or whether 
you’d rather start taking the anti psychotic and see if that changes the symptoms 
that you’re getting, or just change the anti depressant and see if that kind of takes 
care of .. So I decided not to take the anti psychotic and to take the SSRI instead..... 
I:.....In an ideal world, what would happen? 
Lara: Well I think in an ideal world I think the psychiatrist or the person that has 
more intimate knowledge of psychiatric medication and how they work, um, was able 
to put, sort of distil that knowledge into a form that was easily understood by the 
person that was kind of going to be taking the medication, 
I: OK 
Lara: Um, and allow them to make the decision, based on that information that the 
psychiatrist has by which I mean not just OK, this is an SSRI etc...... but also I think 
um, in my experience... most people who work as psychiatrists .. end up having a gut 
feeling about oh, this person looks like the sort of person who would be helped by x y 
or z without really having any kind of scientific um it’s more of a hunch thing, but I 
personally would be happy if somebody would kind of share that information 
with me... 
I:... So presenting their opinion? 
Lara: I would be happy for them to present their opinion I would not be happy 
for them to say, you know you have to take this or you know you don’t know enough 
to but I’ve never really known enough to experience anyone actually do that to me, 
you know I’ve had people say to me, you know I’m going to give you this, but I’ve 
never felt that I didn’t have an input  
 
5.7. Chapter summary 
 
In this chapter, the emergent themes from interviews with service users are presented at 
three levels of analysis; the interaction, relationship and system.  The chapter concludes 
with a summary of commonalities and differences in the data. 
 
 Service users commonly report challenges of feeling involved during periods of crisis, and 
during these more difficult time value increased guidance. Receiving comprehensive 
information concerning medication side effects was strongly valued by participants.  
Themes at the relationship level are apparent in the data, where a longer term trusting 
relationship is established and knowing the service user is at the fore. The themes of trust 
and honesty, respect and being treated as a person, as well as a shared journey, are 
presented.  Themes at the system level centre on the barriers of feeling labelled and pre 
judged in conversations where medication was discussed. Power as an obstacle to SDM is 
explored, consisting of the sub themes; fear of coercion; diagnosis, labelling and stigma; 
and doctor - patient asymmetry. An additional theme 'multidisciplinary working' is also 
described.  
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Differences between interviews with service user participants also appeared in the 
analysis. These differences represent a diversity in participants experiences of being 
involved in decisions about psychiatric medication, as well as differences in participants' 
preferences towards levels of participation in the decision making process. For some 
participants preferences were seen to differ according to situation, over time.  
 
The following chapters present findings from interviews with practitioners. This is 
followed by an exploration of some of the similarities and differences between the 
emergent themes from each of the three stakeholder groups. 
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Chapter Six. Thematic findings from interviews with psychiatrists 
 
 
 
 
 
 
 
 
 
 
 
6.1 Introduction- Psychiatrist background information 
 
Seven consultant psychiatrists from one CMHT pathway participated in research 
interviews. Eight consultant psychiatrists were practising in this pathway during the data 
collection period. One psychiatrist did not respond to an invitation to participate. 
Interviews lasted between 45 minutes and 1 hr 15 minutes.   The majority of participants 
(5/7) had been working within the pathway for over six months. See table 5 for more 
details. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter outline 
This chapter presents thematic findings from interviews with psychiatrists.  As with 
findings from service user interviews (Chapter five), themes are presented at three 
levels of analysis: the interaction, the relationship, and the system. This is followed by a 
summary of areas of commonality and difference between interviews with psychiatrists. 
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Psychiatrist 
number 
Pseudonym Job title and length of time working in 
the CMHT pathway (at time of interview). 
Other background information 
Gender 
Psychiatrist  1 Dr Loh Consultant Psychiatrist for over 2 years in 
this pathway. Qualified as a Consultant a 
number of years ago and has worked in 
different mental health teams locally. 
M 
Psychiatrist 2 Dr Percy Consultant Psychiatrist in this pathway for 
approximately 8 months. Previous role was 
also community based psychiatry. Relatively 
newly qualified. 
M 
Psychiatrist 3 Dr Black Consultant Psychiatrist in this pathway for 
approximately one year. Qualified as a 
consultant a number of years ago and has 
experience of many parts of MH services 
locally. 
F 
Psychiatrist 4 Dr Bloggs Has acted as a Locum Consultant 
Psychiatrist in the pathway for 
approximately 2 months. Previously has 
worked in many different MH teams and 
contexts (acute/community) across 
different parts of the UK. 
M 
Psychiatrist 5 Dr Kos Consultant Psychiatrist on specialist 
register.  Unknown length of time in 
pathway, but has worked in the NHS for a 
number of years.  
F 
Psychiatrist 6 Dr White Consultant psychiatrist in this pathway for 2 
years. Number of years experience in other 
parts of MH service.  
F 
Psychiatrist 7 Dr Green  Consultant psychiatrist in this pathway for 
approximately 3 months. Newly qualified. 
F 
 Table 6.  Background information for Psychiatrist interviews.  
6.2. Psychiatrists – themes at the interaction level 
 
6.2.1. Service User Ownership  
The majority of psychiatrists stressed the importance of the service user having 
ownership of the decision. Psychiatrists viewed themselves as advisors to the process, 
presenting information and options in a balanced way and encouraging the service user to 
take increased control in the decision making process, learning skills of self management 
(See Dr Percy, Dr White and Dr Black, below).  Sub themes under this heading include; the 
importance of allowing time for decisions and; the dilemma of false compliance. 
 
Dr Percy: uh [exhales] I would see it as how involved should we be in that 
decision making, because its theirs, if I'm the patient, I'm the person taking the 
medication, I'm the one who's going to feel drowsy not the doctor. So it's my decision, 
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it's my life, its affecting me, um an obviously yes, if I have trust in the doctor then I 
will want to you know get their views about it, but primarily that decision making 
is the patients responsibility, unless they are not able to make that decision or 
they make it clear that they don’t want to make that decisions. 
 
 
Dr White: I take a very clear approach that I can’t force anybody to take treatment, 
and I see it as my role to present the evidence for and against, and to come to 
dialogue and understanding. If some of my recommendations are about the 
options of treatment and maybe I would, sort of, ere on the side of  possibly most 
helpful for you to understand what their hesitations are, to see whether or not there 
is something that one can do about that. But sometimes it’s just a difference of 
opinion and I guess I feel very strongly that unless people are convinced about the 
usefulness of medication I’m not there to give it to them every day and I’m not there 
and it’s their life and actually very much their decision.  
 
 
Dr Black: Well, .... they are in charge of it completely. They come to me as an 
expert of medication. My job is to put for them my best opinion and to give them the 
tools to make a cost benefit analysis on that and to be able to choose to do it or not to 
do it.** 
 
Allowing time for a decision 
The importance of allowing time for decision making and for the pros and cons to be fully 
considered was emphasised by a number of psychiatrists as a crucial aspect of the service 
user gaining increased ownership over the decision. 
 
Dr Percy: I usually ask them not to make any immediate decision but say that, you 
know, these are the range of options, um actually if they use the internet then I give 
them the links for each of them to try and explore, talk to other people they want to, 
talk to and write down what the possible options are, a brief overview, what the pros 
and cons are with each of them, and then either tell them, if you think you want to 
pursue any of these then ring back and we'll talk further about this or, if you say that 
you don’t want to that's fine, but these are the pros and cons of using medication 
versus not using medication, that's your decision.  
 
The dilemma of false compliance 
Some psychiatrists however referred to a dilemma that emerges from being seen as an 
expert or advisor in the medication management process. On the one hand, whilst 
genuinely valuing the service user gaining increased control and ownership of the process, 
psychiatrists also feared that, on occasion, service users may paint a picture of false 
compliance or agreement, in order to preserve the status quo and save face in the 
encounter.  This is presented eloquently by Dr Black. 
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Dr Black: I cannot be absolutely sure that people are being absolutely honest with 
me and would say, I don’t like the sound of that, [laugh] I don’t want to take it, I 
mean some of them are going to say, 'I got out of there and all she said was I ought to 
go to the GP to get that stuff. I don’t want it, but I’ve got of here without losing face'. 
'Um, I’ll have to think about how I face her again when I haven’t taken any of it', and 
that’s the problem .. I don’t want people to go away and not take the drug because 
they can’t face me, but they will, some of them. 
 
6.2.2. Presenting information  
All psychiatrists referred to the importance of providing relevant information to service 
users about medication choices, giving details of side effects, as well as consulting with the 
service user about the pros and cons of different options. However, the type and amount of 
information psychiatrists provided varied and was dependent upon a number of factors, 
suggestive of a complex interactional process. This theme consists of sub themes; side 
effects; helpful tools; and giving the service user choice. 
  
Side effects 
All psychiatrists stressed the importance of presenting information to service users about 
common side effects. However most psychiatrists referred to not always being able to give 
detailed information on side effects as part of the meeting.  Instead, referring service users 
to printed leaflets, or recommended resources on the internet was a common experience 
for psychiatrists. 
 
Dr Percy: I think I’d usually say the commonest side effects that other people have 
mentioned to me about medication, but I usually tell them to look it up on the leaflet I 
provide,  or the internet, because there's no way I can go through all the side effects 
and I don’t know which of the side effects might be important to them. Which is why I 
think it is important for them to look it up. Also I explain to them that there are some 
side effects mentioned that might not be that common, so the frequency with which 
each of those happen. So if they want to talk about any of those concerns they have or 
talk to me about those issues, they can.  
 
Whilst, in general, psychiatrists did not think they would deliberately hold information 
back on certain side effects, there was acknowledgement by some participants that the 
level of information provided did vary, depending on the service user (see Dr Black's 
quote). One psychiatrist (Dr Loh) also referred to being less comfortable talking about 
sexual side effects and the longer term side effects associated with antipsychotic use. 
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Dr Loh: I think I’m quite bad at telling people about sexual side effects ...and I’m 
probably not great about telling people about possible longer term side effects about 
things and particularly anti psychotics I suppose 
 
 
Dr Black: but I’m afraid it is a bit of a judgement call all the time, so I may and 
maybe the most intelligent people still get more information than the people on the 
other hand, I can’t pretend that I’m not influenced by that if people keep asking me 
questions, then I’ll answer them, if people say, whatever you say doctor, then I’ll say 
less, it’s human nature. 
 
Helpful tools 
A few psychiatrists described helpful tools they use to assist the involvement of service 
users in decisions about psychiatric medication. One psychiatrist discussed the usefulness 
of service users preparing for meetings and bringing along a friend for support. Two other 
participants referred to providing a written plan and sharing this with the service user, as 
helpful. Sending a copy of a letter to the service user following the meeting, detailing the 
outcomes and points from the meeting, was also seen to assist collaboration with the 
service user. 
 
Dr Black: and what I found was it was really helpful for them to have the medication 
written clearly, and how they were going to use it, its name, its drug dose, and I wrote 
that to the GP, but then if I copied it to the patient, they had it too,  so they knew what 
exactly I thought they should be taking, not just what I recommended to the GP.... I 
found that actually sending the letter to the patient was a very powerful 
collaborative tool, not perfect, because sometimes I wanted to say things that I didn’t 
want the patient to know about straight away, you know opinion that the patient 
didn’t agree with, so that has modified how I communicate with my GPs. 
 
Choice   
All psychiatrists strongly valued giving the service user choice and the importance of 
weighing up the pros and cons of different options.  However there was acknowledgement 
that this choice was, at times, limited, based on the psychiatrist’s perception of what is 
deemed most relevant. Participants also referred to presenting a backup plan or a plan 'B' 
as a common approach. Thus, whilst on the face of it, ideals of providing choice were 
valued many caveats were described. Instead psychiatrists referred to constructing 
arguments concerning medication options, thereby limiting the amount of perceived 
choice service users feel they may have. For example, in Dr Loh's quote below, there is 
reference to presenting a couple of choices and then using the term 'but' to further guide 
the discussion. 
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Dr Loh: I mean the choice maybe a little bit limited so, it maybe, here are a couple of 
choices but I don’t think we should do this one because  facts, and you know it may be 
a kind of limited discussion, but no, I’m quite happy for uh people to have choices. 
Certainly things get more complicated, what I fairly frequently do is give people 
choices in advance, so you know, well this is what it's like today but if it’s no better 
with this, these are the options we are looking at.  
 
6.2.3. Service user expectations 
A sub group of participants referred to problems associated with some service users 
having set or pre conceived expectations for a meeting. Having a set agenda and not 
listening was seen as disruptive to the conversation (see Dr Blogg's quote below). A few 
psychiatrists also expressed the concern that some service users  create pressure for the 
psychiatrist to fix or offer a definite solution to a problem, thereby encouraging the 
psychiatrist to adopt a more paternalistic stance (see Dr. White's quote below). 
Interestingly, both quotes refer to the critical incident component of the interview, where 
a poignant but negative meeting is described.  
 
Dr White: but it’s also I think the sort of decision making power that she, sort of, puts 
with you and sort of 'tell me what to do, tell me what to take to fix it', and that’s a 
sort of pressure and I suppose my overall view of this is that 'this is not the thing that 
is going to help you the most', but I think it somehow the inability of me to convey 
that to her, ....there is something about the pressure that anxious people put on you to 
fix it that really makes it very hard to have that conversation. 
 
Dr Bloggs: ....the first thing she wasn’t listening. It’s not that she didn’t have the 
capacity to listen,.... I wasn’t saying what she wanted to hear. 
 
6.2.4. Being ill as a barrier 
Lacking insight  
Most participants referred to the problems of engaging in collaborative decision making if 
a service user was seen to lack insight into their illness. Formation of a joint dialogue and 
presenting information about psychiatric medication was seen as more difficult in these 
circumstances. Lack of insight was also related to changing the information that is 
presented and constructing a different argument to avoid conflict in the encounter. Dr 
White's quote below mentions the problem of referring directly to the term 'anti 
psychotic' medication and Dr Loh's first quote emphasises the need to change the focus of 
a conversation towards other secondary symptoms, focussing less on potential long term 
side effects of the medication. Thus, psychiatrists refer to a relatively sophisticated 
process of constructing conversations about psychiatric medication when someone is 
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deemed to lack insight.  Dr Loh's second quote, below, is a recollection of a negative 
meeting (critical incident component of the interview). Here, Dr Loh suggests the service 
user is very anxious, possibly as a way to construct and open the conversation towards a 
decision about medication, without having to openly explore the service users experiences 
of  his 'brain not working properly'. For this meeting, this change in construction about 
medication is not well received by the service user, resulting in a lack of shared 
understanding.   
 
Dr Loh: so I guess kind of I guess if someone’s psychotic and think being persecuted 
by the names have got bugs in the house and then start talking about tablets then 
people just think you know you haven’t grasped the situation and what you need 
to be doing is talk to the police... 
....then a conversation about medication can go a slightly odd way and tend to focus 
on symptoms that might be otherwise quite secondary. So if people are 
particularly anxious about being chased by MI5-  if you enter a conversation about 
what you might expect from these tablets in terms of getting rid of delusions about 
being chased by MI5, then it might go extraordinarily badly ...whereas conversations 
that this might help with your anxiety and your ability to wind down it might help 
you sleep a bit, might go better and you know it might avoid an admission to hospital 
and all kind of things and that rather kind of spoils it if you then say, 'oh by the way if 
you keep taking these for ten years, you might get kind of um problems' 
 
 
Dr Loh: so it's almost like we end up having kind of two separate kind of 
conversations so I’m having a conversation about you know maybe asking questions 
trying to feed a bit back, so it sounds like you're  very anxious at the moment 
and things aren’t working well and then he’s having a conversation where he 
holding his head in his hands and saying my brains not working, no one 
understands, this is just terrible I just can't possibly go on like this ... 
..there’s never quite a meeting of so even when I’m trying to kind of say I understand 
that things are terrible and you’re very anxious and so on then it never, we never, 
quite meet the conversation which is a bit disconcerting really...  
 
 
Dr White: ...they don’t necessarily see as part of being ill, and then it becomes quite 
difficult to involve people um on the same level because you have to walk a fine line 
between giving information that is correct and factual um but also if you start 
talking about this is an anti psychotic drug  
...People start saying, but I’m not psychotic and so it’s often about a fine line not. It’s 
not about giving the wrong information but giving information that would lead 
people to consider perhaps the options more carefully 
 
 
However, whilst the majority of psychiatrists mentioned the problems of involving people 
when they are deemed to lack insight, one psychiatrist (Dr Kos) emphasises that 
ultimately the service user has the ownership over the decision about whether or not to 
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take the medication, and as such lacking insight was not a direct barrier to involvement by 
this psychiatrist.  
 
I: Are there things that affect the ability to involve service users in the decisions? you 
know are there situations or um specific things that hinder service users being 
involved in the process? 
Dr. Kos: I think the only issues are just the capacity. ........ 
I: So, capacity in terms of uh insight the illness, or are we talking capacity to consent 
sort of?  
Dr. Kos. Capacity to consent, and have a clear understanding, what decision to make, 
it someone doesn’t understand the difference between two medications because 
doesn’t have the capacity, again it hasn’t happened to me that will be the case. It’s 
not about insight, I think if someone hasn’t got an insight and I feel that very 
strongly he suffers from a mental illness he needs to take medication, again it 
would be a decision made by him if he doesn’t want to take, he doesn’t take it. 
 
Periods of crisis as a barrier 
Other barriers to service user involvement were described as   service users being less 
able to process information during periods of distress and crisis (see Dr Green, below), 
although this was mentioned less by participants, as compared to problems of lacking 
insight. Of note, lacking insight was described as a separate issue to severity of illness by 
some of the participants, as illustrated in Dr Blogg's quote below.   
 
Dr Green:   The difficulty I sometimes have is when they come to me they’re anxious 
and sometimes their mental state, more often than not, I see people that are 
depressed and anxious, so they just aren’t registering half the things that I tell them 
in the consultation.  So, I can tell them as much information as I like but I don’t know 
how much of it goes in and gets registered. 
 
I: What factors affect peoples' ability to be fully involved in the decision making 
process about their psychiatric medication?. Is there anything, and if so, what?. 
Dr Bloggs: [laugh] Yes there’s factors. If you’re very ill for instance uh somebody who 
is very agitated somebody who is so psychotic they don’t even understand the 
medication, makes it difficult for you either to discuss at length or for them to 
understand the information you are passing across. 
..That is one. Even when they’re not that ill, their insight is still very important, 
because there are those of them which see that they are ill, but they don’t have any 
insight into the illness and so they don’t want anything to do with you about 
medications sometimes [laughing]. So insight is very important. The severity of the 
illness is also very important.  
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6.3. Psychiatrists - themes at the relationship level 
6.3.1. Achieving open dialogue 
Psychiatrists valued achieving good rapport, a sense of trust and open and honest dialogue 
with the service user. This theme was often associated with descriptions positive meetings 
that stood out for the psychiatrist (the critical incident component of the interview). Here, 
psychiatrists emphasised the importance of achieving an open, honest and constructive 
dialogue, where trust has been established. There is little mention of the more caring 
aspects of the therapeutic relationship, such as listening, supporting or walking the 
journey together with the service user. Instead there was a focus on the importance of 
service users being open in conversation, listening to guidance but expressing their 
opinions/ preferences. The theme consists of sub themes; the importance of honesty, the 
role of the carer and; having a personalised approach. 
 
The importance of honesty 
Many participants emphasised the importance of the service user being able to express 
their preferences openly. This appeared paramount to the psychiatrists' 
conceptualisations of a constructive relationship for decision making about psychiatric 
medication and was associated with the service user taking increased ownership and 
control over decisions. 
 
Dr Black: I thought it was really good that she was able to talk frankly about the 
pros and cons of the medication and she felt she could say she needed this 
stuff.....Yeah, good rapport, trust, a sense that she could say what she really wanted, 
she came with her mum, I don’t know if that made it more possible, maybe I would 
need some persuading. 
 
The role of the carer 
Interestingly in the quote above, the carer48 is seen as helpful in achieving open dialogue. 
However, there was acknowledgement from psychiatrists that the role of the carer was 
highly dependent on the situation. Sometimes the relationship between the carer and 
service user was seen as helpful for increasing involvement, but at other times it was seen 
as a hindrance to establishing a honest open dialogue, creating instead more hostility in 
the conversation. 
 
                                                             
48
 The term carer was defined very broadly in interviews,  as a 'loved one, friend or family member' 
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Dr Loh.  ..I mean you’ve got to be aware of how the person how much influence the 
person has or what their relationship is like, so sometimes, they can be a bit of an ally 
if someone is not keen on tablets and you think they should be on it, they can be there 
saying' this is your doctor, you’ve got to take them, you cant possibly go on unless you 
take them', uh, and sometimes that can create a bit of hostility. I suppose, where 
there needn’t be any. So, you know, if I’m trying to get someone to take tablets to 
improve and they're not terribly for it, then having their spouse also coming on my 
side it, kind of,  makes it more fraught and not particularly helpful so I guess you 
have to be aware on the effect your discussions are having on the wider situation.  
 
A personalised approach? 
Only one psychiatrist directly mentioned that having a personalised approach and 
knowing the person, is beneficial for conversations about psychiatric medication. Dr Kos, 
below, in her description of a positive meeting (in the critical incident component of the 
interview), refers to the importance of knowing the person, assisting her effectiveness in 
tailored presentation of information and provision of explanations.  
For most psychiatrists, however, there was acknowledgement that building a partnership 
over time / regular contact was not necessarily present or required49.   
 
 Dr Kos:. I think that because I know her well I think I can read her well as well I 
think I know what she means and she is very straight forward and I think I can 
understand her, I think that’s why I was also able to present her with quite balanced 
argument because I knew what she would respond better yeah, so I think that it 
might not happen in every case because sometimes I am meeting people who I saw 
first and I’m not so aware of how they behave or what is the easiest way to explain 
them things, because some people need a different type of information, or giving 
different types of examples, 
 
6.4. Psychiatrists - themes at the system level 
 
6.4.1. Mental Health Act and Fear of Coercion 
The Mental Health Act and being treated against a person’s will were acknowledged as 
barriers to involving people in decisions about medication.  A minority of psychiatrists 
mentioned that, at the explicit end of this, compulsory treatment impedes involvement, as 
consent is not required (See Dr Blogg's quote, below). However within this pathway, the 
vast majority of psychiatrists highlighted that, in general, compulsory treatment and 
coercion was not relevant to medication management practice (See Dr Black, below). 
                                                             
49
 this is explored further in S. 6.4.2 'the changing role of the psychiatrist' 
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Instead, some psychiatrists interviewed suggested that service users may experience fear, 
based on previous coercive experiences of the psychiatric system.  It is this fear that was 
seen to prevent honest dialogue (see Dr Loh's quote, below).  
 
Dr Bloggs: There are times when you don’t need to get their consent because they 
are that ill you just have to say, look this is what you want, ..but in those times, if it is 
in a different setting, and they are being treated under the mental health act, 
obviously , again, it depends, for some it’s an act for treatment, you still discuss with 
them as much as possible, but you don’t need their consent to start treatment.  
 
 
Dr Black: Well, in the intake and treatment team, where people are competent 
and people are capable and there is no element of coercion to their 
management, so they’re insightful etc, they are in charge of it [the decision] 
completely. 
 
 
Dr Loh: He might be a bit scared because the last time he stopped taking it he 
became quite unwell and ended up in hospital so he might be worried that people will 
cart him off to hospital if he says he’s stopped taking it  
 
A minority of psychiatrists also acknowledged that, in situations where service users were 
seen to lack insight or not understand they are ill, different constructions of arguments 
concerning psychiatric medication may be employed. These scenarios may be more in 
keeping with ideals of compliance, being manipulative in style. This may serve to avoid 
overt conflict in the encounter, created by discussion of people’s understanding of their 
symptoms.  For example, in the quote below Dr Percy highlights the future possibility of 
the service user being treated against their will under the Mental Health Act. This leaves 
little room for further exploration of the service user perspective.  
 
Dr Percy: you don’t think you need to take medication and you don’t think that some 
of the experiences are part of a mental illness, and that’s fine but my concern is that if 
the status quo continues and as you can see, already your parents seem to be really 
worried, and they seem to be more and more concerned my worry is that if you don’t 
take medication further down the line the possibilities are that you might actually 
end up in hospital uh against your will.  
 
In summary, some psychiatrists acknowledged a general fear of coercion indirectly 
hinders full involvement in decision making about psychiatric medication in this 
community based team.  This may relates to the service user holding back certain 
information, or result in the psychiatrist constructing and directing conversations, so to 
avoid conflict in the encounter. 
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6.4.2. Mental health services structure 
 
The changing role of the psychiatrist 
There was widespread recognition that change in structures of mental health services 
over recent time has influenced decision making for psychiatric medication management. 
There was reference by five psychiatrists that modern mental health services are now 
more consultative in operation, with psychiatrists performing the role of an expert advisor 
in the decision making process. GPs were described as being at the centre of the process, 
providing continuity of care and having an ongoing relationship with the service user.  
Psychiatrists in this setting were unlikely to see service users on a regular basis, but more 
on an as and when basis, depending on the complexity of the decision making process (See 
Dr Percy and Dr White, below). When questioned about the role of the psychiatrist in the 
medication management process, all seven psychiatrists referred to medication expertise 
as being a central part of the psychiatrist role (See Dr  Black, below).  
 
Dr Percy: I mean because of how the mental health services are structured currently, 
compared to the past, where you would see a patient and would continue to see them 
for a good length of time, you’d build a relationship and you are overseeing the 
treatment for a long period of time. From there to now it's moving towards the GP 
being the centre managing the patients and the consultant psychiatrist providing a 
sort of consultative model... and there are sort of pros and cons with either. But 
currently model is one of where you don’t see the psychiatrist unless its um, extremely 
complex, extremely risky.,  
 
 
Dr White: So I have a quite flexible approach but I think often that I have to really 
see what the added value is that um and the patient has to see what the added value 
is. Not just my view, it’s also what’s the patients view, and is there anyone else that 
could potentially do that just as well? 
 
 
Dr Black: Because actually however much we are supposed to be generic workers, 
the doctors are kept for the people who want medication and I may disagree with 
that but that’s the way it is at the moment.  
 
 
The role of diagnosis. 
There was some diversity between psychiatrists' responses regarding the importance of 
diagnosis for initial decisions about medication. Some psychiatrists emphasised diagnosis 
and formulation is an important aspect in medication management practice, ensuring from 
a medical view, the person receives the most appropriate medication. For example Dr 
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Percy (see quote below) acknowledges that research and evidence base is centred on 
diagnosis and therefore is a significant factor in the process. A sub group of psychiatrists, 
however, referred to an overly medicalised or biological perspective as distancing 
experiential knowledge, and consequently, a problem in medication management practice 
(See Dr. White's quote below).  Overall, most psychiatrists viewed medication as one tool, 
as part of a bio psycho social understanding of mental illness.  
 
 
Dr. Percy. key role in use of medication in any person who has a mental health 
problem from a psychiatrist point of view is that it always focuses on diagnosis 
mainly because all the medications are trialled studied experimented, everything, 
based on diagnosis, so it's a significant factor, uh in discussing any medication, 
 
 
 
I: Do you see yourself as having any difference in style or approach to your 
colleagues. 
Dr. White..I think so, not to everybody, but I’ve got some colleagues who have got 
very specific views and  I call it biological but I guess who come from a kind of view 
that um, symptoms can be targeted by medication and that when people keep 
representing with symptoms then all you need to do is increase the drug and it is 
about finding the right drug for the right person at the right dose or the combination. 
I think I see myself less as a, uh, I don’t prescribe to that view in psychiatry and I 
haven’t seen it work.  Um, so I think I am different from some of them, but I also have 
colleagues that have very similar views to what I have. 
 
 
Psychiatric training 
A few participants expressed concern that training for psychiatrists is dominated by an 
overly medicalised approach (See Dr Green, below).  In addition, one psychiatrist referred 
to the need for junior psychiatrists to have a greater appreciation of the longer term 
consequences of prescribing. Short term rotations and  placements, were seen by this 
participant,  as creating less chance for trainee psychiatrists to see longer term outcomes 
for service users (See Dr White's quote, below). This was seen as particularly problematic 
for engaging in collaborative decision making, and adopting a more holistic approach in 
medication management practice.   
 
Dr White. I mean when I was a junior doctor I was much more convinced that maybe 
drugs could be helpful. I think they still could be helpful, but I’ve seen probably 
because I think the difference between being a junior doctor and consultant is that 
you’ve got people over a lot longer period of time. So one of the weaknesses of 
psychiatric training is that you rotate all the time and you don’t often see the 
consequences of your decision making and you also don’t see that over time the 
140 
 
 
 
things that make a difference are maybe not the things that you’ve prescribed and 
actually the improvement is to do with something very different. Um and also you 
don’t see the consequences of your prescribing habits so you know some medication 
has got huge consequences for weight and if you’re not the one who has to think 
about that in 2 years then maybe your prescribing is about now here and there, and 
you don’t see the consequences of having to wean people off medication that maybe 
in the long run wasn’t necessarily so helpful, so I think my view has changed over 
that. 
 
 
Dr Green:  but I do think as starting off [as a psychiatrist], I think I was a little bit 
more direct in my recommendations maybe or choice and that may well be because I 
didn’t have the exposure  .. and also perhaps there was that very medical approach 
where you kind of said; this is the drug.  You’d still talk about the side effects and 
everything but I think it was more of a direct recommendation, rather than, you 
know, being flexible with the patient perhaps, less flexible than I am now I suppose. 
 
 
Recovery oriented services 
Changes in mental health services towards a recovery oriented approach were also 
mentioned by some participants. This was associated with a change towards greater 
service user autonomy and responsibility. However, one psychiatrist questioned the 
drivers for this change, suggesting they may not necessarily be for patient centred reasons. 
 
Dr Green:  I think it’s a measure of everything isn’t it?  I think we are becoming more 
recovery focused and recognising the need to give the patient more autonomy and 
responsibility but, on the other hand, whether that need is being driven by true 
recognition of the patient’s skill, or because we don’t now have enough resources and 
that’s why they’re coming..... that is the question to be answered. 
 
 
Increasing medicalisation of emotions  
Of final note in this section, a minority of participants mentioned that changing attitudes 
and outlook towards mental illness and distress influenced the medication management 
encounter. The quote below reflects that there has been an increasing trend towards 
medicalisation of certain behaviours, impacting expectations during the psychiatric 
encounter 50. 
 
 
                                                             
50
 Also see S. 6.2.3 
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Dr White: there’s a strong medicalisation of emotions that’s going on, so we’ve got a 
cohort of young people who are coming through with a diagnosis of ADHD or some 
kind of pervasive development disorder that I’m not quite sure whether those dis 
regulation of emotions are purely fixed by tablets and I think there’s quite a push for 
society to see um, emotions as abnormal and there for needing treatment and I think 
that’s certainly increased in the last couple of years where I see people who are under 
distress and find it very difficult to deal with emotions that um, that are probably um 
a combination of social changes and um, kind of breakdown of society’s normal 
coping strategies so that’s my sense. 
 
6.5. Psychiatrists – Commonalities and Differences 
 
Number of coded references for themes is shown in appendix V. However, given that there 
were fewer number of participants for this stakeholder group (i.e. 7 as compared to 15 
service user interviews), an investigation of the number of coded references alone is of 
less value. Instead, it is useful to explore where consensus exists (or does not exist) across 
the psychiatrist interviews. This is particularly revealing, given that the all psychiatrists 
from the CMHT pathway, apart from one, were interviewed.  
 
6.5.1. Common themes from psychiatrist interviews 
The overall impression from this data is that a large part of the interviews with 
psychiatrists refer to themes at the interaction level. Presenting information, offering 
choice, the process of making decisions, and barriers and facilitators to an interaction, 
formed a significant part of these interviews. Themes that emerged at the relationship and 
system levels of analysis were less apparent.  This trend in the data may be linked to how 
modern mental health teams are structured. In particular, the conceptualisation of the 
psychiatrist's role as an expert of psychiatric medication and consultative in focus may 
explain this trend. This is discussed further in section 6.4.2. 
 
Looking at the themes by number of coding references in appendix V, the theme entitled 
'Choice' is, by far the largest. Under this umbrella theme, the largest single sub theme 
refers to the importance of presenting information on a range of options, and exploring 
the pros and cons of these different options. This links to the themes presented in sections 
6.2.1 and 6.2.2, and the service user having ownership and power to decide whether or not 
to take a prescribed medication. Indeed the value placed upon service users having 
ownership over the decision and the psychiatrist presenting information to enable choice, 
was apparent through the general question section of the interviews. However, while 
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valuing the importance of presenting information to service users, psychiatrists did 
acknowledge, that at times, choice may be either be limited or presented as a plan 'B', and 
at times arguments were constructed so as to avoid conflict in the encounter.  
 
As alluded to above, however, this does not necessarily indicate that consensus was 
present, across the psychiatrist interviews. Looking for consensus in the data, one 
overarching theme was coded for all seven psychiatrists. This refers to the barrier of 
service users being ill as hindering involvement. Within this group, a majority (but not all) 
refer to 'lacking insight' as problematic for open dialogue. This is discussed further in 
section 6.2.4. 
 
6.5.2. Areas of difference across interviews 
As mentioned above, providing information was valued strongly by psychiatrists and seen 
as a crucial aspect of involving people in decisions about psychiatric medication, enabling 
greater control and allowing more informed decisions to be made. In particular, providing 
information on the side effects of psychiatric medication was seen as very important. 
There were, however, contradictory aspects to the theme of valuing full provision of 
information. Many psychiatrists acknowledge that the amount and type of information 
about psychiatric medication changes according to the situation. In addition, a sub group 
of participants confess that, at times and during certain encounters, information about 
psychiatric medication is withheld. This was, in the most part related to circumstances 
where the service user is deemed by the psychiatrist as lacking insight into their illness. In 
addition, a minority of participants discussed challenges of openly discussing sensitive or 
potentially embarrassing side effects, such as sexual dysfunction. However, there was not 
consensus across interviews in this view. Instead, other participants, when asked, strongly 
disagreed that information would be held back under any circumstances. See section 6.2.2 
and 6.2.4 for further discussion.   
 
Another aspect of difference relates to the critical incident component of the interviews. 
That is, in the recollections of positive meetings, a spectrum of response in service user 
involvement  is observed in the data. For some psychiatrists, recollections of positive 
meetings were related to an example when the service user took the lead in the decision 
making process, and the psychiatrist presented balanced information, without unduly 
influencing the outcome. This is shown in the quote by Dr. Kos below. Other psychiatrists 
refer to a positive meeting that is more representative of ideals of a shared dialogue. For 
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example, the quote by Dr. White emphasises building a joint understanding and reaching 
consensus over the final decision, in a working partnership with the service user. 
However, other psychiatrists discussed positive meetings that were more reminiscent of a 
paternalistic style, where guidance is given and service users are more passive in the 
process. This is illustrated in Dr Blogg's quote, below. 
 
 Dr Kos:  I think that I hope that I was able to present two medications in a 
balanced way, that really , although I felt quite strongly about uh the lithium, I 
really felt that I presented it in a balanced way that both has pros and cons and I 
think um in terms of thinking about her wellbeing I was pleased, I was quite pleased 
she took, it was not my advice because I didn’t advise her to take either of them, 
but she really made the choice that I would have made as well..  
 
 
Dr White:. I think what’s positive is that you know we came into a joint 
understanding, that we agreed to disagree on some points but that we did manage 
to get to a point that maybe well we could work on this and I felt that in future if 
things would deteriorate then maybe she would hear my voice and my advice so I 
think that was positive that she didn’t feel in anyway. And you know often people 
come here and say, oh you’re not going to tell me to take or reduce my drugs or take 
this and I find that a very interesting view because I wonder where that comes from , 
this idea that I am going to tell them what to do 
 
 
 
Dr Bloggs: I think what stood out .....is that he was the sort of person that would 
believe you. His insight was limited, but he was the sort of person who would say if 
you think this will help me then I will take it, yes and he is also the type that has 
been ill for some time and .. he hadn’t received a lot of help 
 
As such, contradictions in the data have emerged. On the one hand, the theme of valuing 
increased service user ownership, choice and control over decisions is present in these 
findings (see section 6.2.1).  On the other hand, during the critical incident section of the 
interview, a more diverse spectrum of service user involvement is presented. This is 
suggestive of a gap between more abstract ideals and principles (in the main section of the 
interview) and actual practice (the critical incident component of the interview), perhaps 
indicative of hidden and insidious barriers present to achieving SDM in practice. 
 
Finally, there were some differences in perspectives surrounding the role of the 
psychiatrist, and value placed on diagnosis and medicalised approaches in medication 
management practice. All psychiatrists viewed medication expertise as an important and 
defining aspect of their role. Moreover, whereas the majority of psychiatrists viewed 
medication as one tool in a wider bio psycho social approach, some psychiatrists placed 
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increased value on diagnosis as an important consideration for the final decision, guiding 
choice and also linked to the academic evidence base for medications. Others however 
raised concerns that there is an overly dominating role of diagnosis for medication related 
decisions, thereby distancing experiential knowledge and the service user perspective, and 
hindering collaborative dialogue. See section 6.4.2 for further discussion.  
 
6.6. Chapter Summary  
 
Thematic findings from interviews with psychiatrists have been presented at three levels 
of analysis: the interaction, the relationship and the system. At the interaction level  the 
themes; presenting information; service user expectations; descriptions of being ill as a 
barrier and; valuing service user ownership  are discussed. At the relationship level the 
theme of achieving an open dialogue is presented. At the system level, themes comprise; 
the mental health act and fear of coercion; and mental health service structures.  There 
was less consensus in themes for the psychiatrist interviews and some contradictory 
aspects of the data emerged. These centre around: perceived ideal levels of involvement 
service users have in medication encounters, the value placed on service user perspectives 
and expertise, and how to maintain choice and present full information about the pros and 
cons of psychiatric medication, during more difficult times, or when a person is deemed to 
lack insight into their illness. 
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Chapter Seven. Thematic findings from interviews with CPNs. 
 
 
 
 
 
 
 
 
 
 
7.1. CPN interviews - Background information 
Eight interviews were conducted with CPNs, out of a possible total of nine within the 
CMHT pathway.  One CPN did not respond to an invitation to participate. Interviews lasted 
between 45 minutes and 1 hour. Seven were female. All were experienced members of this 
community team. 
 
CPN number Pseudonym Job title and Length of time working in ITT 
(at time of interview). Other background 
information 
Gender 
CPN 1 Hazel Worked in pathway for approximately two years. 
Extensive previous experience of psychiatric 
nursing.   
F 
CPN 2 Heather Worked in pathway for over two years. Extensive 
previous experience of community psychiatric 
nursing 
F 
CPN 3 Allison Team leader and community psychiatric nurse. 
Worked in pathway for over two years and 
extensive previous experience of psychiatric 
nursing 
F 
CPN 4 Barbara Worked in pathway for over two years. Extensive 
previous experience of community psychiatric 
nursing 
F 
CPN5 Mark Worked in pathway for over two years. Extensive 
previous experience of community psychiatric 
nursing 
M 
CPN 6 Emma Worked in pathway for approximately two years. 
Extensive previous experience of community 
psychiatric nursing. 
F 
CPN 7 Elsa  Worked in pathway for over two years. Extensive 
previous experience of community psychiatric 
nursing 
F 
CPN 8 Anna Worked in pathway for over two years. Extensive 
previous experience of community psychiatric 
nursing 
F 
Table 7. CPN participant information 
Chapter Outline. 
This chapter presents thematic findings from research interviews undertaken with 
CPNs, in phase one of the data collection. Findings are presented at three levels 
analysis: the interaction, the relationship and the system. A summary of the 
commonalities and areas of difference in the interviews with CPNs follow this. The 
chapter concludes with an exploration of the similarities and differences observed 
between the themes for the three stakeholder groups: service users, psychiatrists and 
CPNs.    
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7.2. CPNs – themes at the interaction level 
7.2.1 Service user gaining control 
Alongside service users and psychiatrists, most CPNs also referred to the importance of 
the service user taking increased control and ownership over the decision making process 
(see Hazel, below). The sub theme of using medication as a tool, learning how medication 
is helpful and gaining self management skills emerged  from interviews with CPNs (see 
Barbara, below). This linked with how many CPNs viewed their own role in medication 
management. Mark, in the quote below refers to his role as providing skills to encourage 
the service user to take greater control.  
 
HAZEL... I think it’s always positive when a patient can come along and sit there and 
say, look, this is what I think would work for me, this is what I would like, and to be 
able to talk about it, and both of us to be able to talk about it, and both sit there and 
think, yes, this is an excellent idea and let’s look at that and let’s take it away, and I 
think, you know, it was all done in a very... yeah, in such a way that was... I mean she 
negotiated it very well. 
... And she was absolutely right with what she wanted. It was a really good plan. 
 
 
 
BARBARA: Because I think she gained an understanding about how medication 
could be useful and, how, you know, it had its place. But she was... but she was taking 
control appropriately for when she took it. I felt, yeah, she’s got it now, and that left 
me feeling reassured about her coming off it this time. 
 
 
MARK: What you really want, what I would really want is someone just to say, yeah, I 
get it, I, you know, I understand it, I recognise what I would be feeling would make 
me stop, I know what I’d be feeling that might make me want to increase it or to talk 
to someone about it  and I recognise what a side effect would be, I know the best time 
of day to take it, I know that whatever, the various special indications or whatever, 
that they’d understand that.  
...So the job is about giving people skills really. 
..Less than feeding them, because it’s community rather than ward so it comes back 
to the idea of training and teaching I think. 
  
7.2.2. Being ill as a barrier 
All CPNs acknowledged that during periods of crisis, the level of involvement a service 
user has in the conversation, decreases. Similar to psychiatrists, 'lack of insight', or a 
service user not understanding they are ill, was mentioned as a particular barrier by the 
majority (but not all) CPNs.  Heather, in the quote below, suggests that communication 
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may change during these more difficult periods, referring to the need, at times, to 
‘encourage concordance’, but in the context of a trusting relationship (see relationship 
level, section 7.3).  In Elsa's recollection of a positive meeting (the critical incident 
component of the interview) she reflects on the importance of knowing the service user 
and having established trust as being particularly helpful during these more difficult times.  
The importance of reinforcing information during difficult times is also mentioned by 
participants (see Mark, below). 
 
HEATHER: And particularly if someone’s very ill and their insight is very poor, and 
you think, this person really does need to take medication, they're really unwell, it 
getting on the brink of maybe a delusions. Or somebody with depression, with 
psychosis, people losing touch with reality, it’s important to find out, .. to support and 
listen and advise and yet encourage concordance. Without a trusting relationship 
there’s no way because people will tell you they are taking it and they won’t or they 
will tell you because they think that’s what you want to hear. So, you know, when you 
have the patient in your hand, when actually, they know if they say, 'I’m not taking 
[the medication], it’s disgusting it's crap', then actually.. you’ll listen again and be 
there but you  still try and encourage, because people are unwell, so you have a 
responsibility. So that’s encourage not force   
 
 
 
MARK: Well, obviously their state of mind while they’re ill, if they’re completely 
bonkers it’s going to be difficult and you want to feel that you’re having a rational 
conversation, that people are understanding what it is you’re talking about. 
... They’ve got to be able to retain the information. 
... But I do think... I don’t want to give the impression that we go, right, they’re not 
well, we’re not going to tell them, I don’t think it’s a matter of that, I think it’s often 
more a matter of just keep repeating the information.  
 
 
 
ELSA: The conversation, you know, when someone’s as ill as that you’re not going to 
really... [pause]..  I think  she wasn’t really caring, because she wasn’t well 
enough, but on the other hand I think she could see that at one level that things were 
not right, but someone was trying to help. 
I:  ..but what was it about that, that for you was a positive meeting,?. 
ELSA:  I think because... I think there was something there about a therapeutic 
relationship when I started with... we had that sort of relationship, so she was going 
to trust me and I think that’s what it was, and that’s kind of a nice feeling... So she 
was terrified about all things... the hallucinations  instead of what the... but she could 
sort of relate to that, yeah. ... Yes. I think that’s the essential thing really, I think that 
the relationship is so important that you establish that, so when people are like ill 
they will sort of listen to what you’re saying, realise that you are there to try and help 
them, not to force them into doing something they don’t want. 
I: Yeah, yeah. yeah, no, I think that’s a great example! 
ELSA: Well I had been seeing her a long time and we had, yes, so she knew me pretty 
well, yeah, that was good…… Longer than she should have been, but there we go. 
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7.3. CPNs - themes at the relationship level 
 
Themes at the relationship level and the importance of the helping and therapeutic 
relationship emerged most strongly within the CPN interviews. Themes are comprised of: 
walking the journey, building an honest and open dialogue, and valuing service user 
expertise. 
 
7.3.1. Walking the journey 
The theme of walking together with the service user in a journey towards recovery was 
mentioned by all CPNs. CPNs referred to the importance of a supportive, long term 
relationship with service users.  Heather's quote below refers to an example of a positive 
meeting (the critical incident component of the interview). Here, a journey through time 
and formation of a partnership is emphasised.  Supporting service users through difficult 
times and celebrating success was also mentioned (See Anna and Heather). In addition, the 
importance of genuinely caring about the service user was emphasised as an important 
aspect of collaborative care.  
 
 
HEATHER : So there’s a kind of walking the journey together, and sometimes he’s 
pulling back a bit and I’m pushing forward and we were at different paths pulling in 
different directions, but actually kind of, slowing down, going back to his level, even 
going up to, that kind of thing together, that kind of push pull kind of stuff, but 
probably the success is about two people building up a mutual respect and real 
affection for each other and thinking I really care about you and I want you to be 
happy and I want you to experience peace and have a good life and when you are not 
well, you end up banging your head against a brick wall and trying to cut your wrists, 
kill yourself in prison and I have to really work hard for that not to happen, because I 
don’t want to see you ill. That’s the kind of thing, I know that’s a very didactic 
approach but it’s a kind of push pull.  
   
 
 
ANNA: Yeah, yeah, but it’s kind of, you know, it’s more... I think it’s more about, it’s 
actually, you know, we’ll walk shoulder to shoulder down this path. 
 
7.3.2. Building trust and honesty 
Similar to the interviews with both psychiatrists and service users, CPNs emphasised the 
importance of building trust. Honesty was seen as crucial to a partnership being forged, 
which in turn was essential to a shared dialogue about psychiatric medication.  
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BARBARA: ... you build up a strong therapeutic relationship with somebody so that 
you can work together and it is essential that you have trust and you have honesty in 
that relationship, with a constructive relationship. 
 
7.3.3. Valuing service user knowledge 
Most CPNs also emphasised the importance of valuing knowledge the service user brings 
to the conversation. As part of this, CPNs accepted that disagreement was possible. Anna, 
in the quote below, refers to expressing her opinion, but is happy when she 'gets it wrong'. 
 
MARK: But as long as you’re clear in your own mind that that’s the decision you’re 
making, I think that’s the point... ...is that people come from a point of knowledge. 
 
 
ANNA: I think the thing I’ve learnt probably most of all is that you can’t dictate or 
prescribe to somebody, it has to be collaborative, and even if sometimes you think, 
that wasn’t the wisest thing you’ve decided to do, you have to go along with, and I 
will be honest with people and say, 'it’s perhaps not what I would do......let’s hold on 
and see how it goes.' And learning to know that sometimes I’m wrong, you know, 
the service user will come back and say, 'no, that was fine actually'. 
..'Oh, OK, I got that wrong'...'You know, that’s great, I’m really glad that I got it 
wrong'. 
 
To note, psychiatrists and service users also emphasised the importance of honesty and, at 
times, disagreement was considered a success51.  However, as illustrated in Mark's quote 
above, CPNs also refer to service users coming from a point of knowledge, suggestive of a 
shared dialogue and sharing of opinions. Acknowledging fallibility (see emboldened 
section in Anna's quote) is also suggestive of more priority placed on valuing service user 
preferences and expertise, with genuine respect for differences in opinion.  This was less 
explicit in the psychiatrist interviews. 
 
CPN as the go between? 
Within this theme, most CPNs referred to an important aspect of their role as relaying 
information to the prescribing doctor. CPNs emphasised their role as acting as an advocate 
for the service user in meetings, as well as being the 'go between' with the service user and 
                                                             
51
 This emerged as a theme for service users: S. 5.4.2. Psychiatrists discussed the importance of honest 
open dialogue, although less reference was made to disagreement See S. 6.3.1  
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psychiatrist. This was seen to enable service user preferences and experiences to be better 
represented in the decision making process.   
 
ELSA: And I feed back to the prescriber about what the patient tells me and my view 
on whether it’s helping or whether... maybe that something else similar needs to be 
tried... 
....Usually I feel I’m a bit of a go-between between the psychiatrist or the GP who’s 
doing the prescribing. 
 
7.4. CPNs – themes at the system level 
There were two emergent themes from CPN interviews at the system level: value placed 
on psychiatric medication, and doctor - patient asymmetry. 
 
7.4.1. Value placed on medication 
Medication was valued by CPNs as an important therapeutic tool that formed a significant 
part of mental health service offerings. However, for most CPNs, psychiatric medication 
was seen as one tool, as part of an integrated approach to care. Here, the role of 
medication was seen to vary according to person, their values and experiences, and 
according to the severity of illness.  
 
 
HAZEL: I think it’s significant but it’s not the be all and end all. I mean the people 
that have severe enduring mental illness, it just have a significant place, with people 
that have more sort of neurotic conditions, it’s... it’s played less of a part but it has to 
be a consideration and again it has it’s place, because I think its importance is 
different. I do think it has a place but you have to use it as part of a sort of integrated 
approach to care, its... medication alone isn’t enough. 
 
Many CPNs also suggested that there had been a significant shift towards a more holistic 
approach in nursing over recent years, with the CPNs role in medication management 
moving from one of monitoring compliance to medication regimes, towards increased 
social and psychological intervention work. This was seen as a positive change towards 
service user involvement in medication management (See Mark, below). 
 
MARK ...and actually nursing is much... It used to be all about medication, it used to 
be, go and see this person, make sure they’re taking the damn tablets and while 
you’re at it if there’s anything else go on and deal with it... Well, now, it’s much more, 
well look, let’s look at psychological, operational interventions and social 
interventions and help people make a sense of where they’re at,  
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Challenges to collaborative decision making were mentioned within this theme. These 
consist of a pressure to prescribe, concerns over side effects and a lack of review of 
medication decisions. To note there were differences between CPNs interviewed in these 
sub themes. 
 
Pressure to prescribe 
For a minority group of CPNs, there was an increased pressure on psychiatrists and GPs to 
prescribe medication. This related to a cultural over reliance on the biological model of 
mental illness. This theme also emerged in interviews with psychiatrists (S. 6.4.2). 
 
 
BARBARA:... I think society expects to be ever so happy now, so people go to the GP 
wanting rather than kind of managing that changing their mood themselves.  
 
 
ALLISON: I mean I think it’s easy to call medicine the villain, but it’s just what we’ve 
got, and I think it’s how we use it that’s the problem......because I think there’s that all 
or nothing thing about psychiatric medication while, you know, sometimes it’s just a 
useful tool.. So I don’t think we manage it for... I think, you know, I don’t think we 
have the honest conversations and I don’t think we manage it very well in the long 
term. 
 
Concerns over side effects  
This sub group of CPNs also expressed concerns about the lack of open discussion and 
challenge about the serious and enduring side effects of psychiatric medication within 
mental health services. For example, Allison (see below) worries that there is denial 
amongst practitioners about the reduced life expectancy of clients being prescribed anti 
psychotic medication.  This was related to a lack of alternatives (to psychiatric medication) 
being available. 
 
ALLISON: I mean, you know, it’s a very conflicting story is psychiatric medication, 
because sometimes I see it as a necessary evil..... [but] it worries me how much we use 
and what we do to the life expectancy of clients .......and that we seem to be in denial 
about largely. But sometimes, for  instance, if somebody is absolutely distressed 
we don’t have a system that we work in that we can provide a safe place, you know, 
we have no alternatives. ..I don’t believe in mental illness kills you......I think it’s more 
likely to be the toxicity of the substances that we’re giving people. 
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However consensus across interviews was not apparent. Instead, other CPNs emphasised 
the helpfulness of psychiatric medication. A sub group found the use of analogies to other 
medical conditions useful in conversations with service users, playing down the potential 
long term or serious effects. Use of these analogies constructs psychiatric medication 
decisions as similar to that of general medical illnesses and treatment, thereby reducing 
the perceived dilemma in choice to take the prescribed treatment, and therefore 
potentially reducing the amount of full discussion likely about the pros and cons of 
psychiatric medication use. For example, Anna, below, uses the analogy of a chest infection 
and antibiotics, when describing anti depressant use to service users.   
 
 
ANNA: Just the same way as if you came to see me and you’ve got a chest infection, 
we’d look at all the ways you might have been able to work it out for yourself, you’ve 
obviously tried those and that’s why you’re here and so you need to take the 
prescribed medication in exactly the same way as you would if you’d got a chest 
infection. And normally with a chest infection a course of antibiotics shifts it and 
you’re back to your old self, and I’m hoping that with a course of antidepressants will 
have the same result and we’ll do the same thing, we’ll review you regularly, see how 
you’re getting on and then, you know, if necessary we can change it, just like you 
would with an antibiotic. So... and that sometimes helps people to kind of get it into 
their head that it’s an illness just like any other illness and it needs treating. 
 
Lack of review for psychiatric medication decisions 
A number of CPNs acknowledged a problem that decisions were often made during 
periods of trauma or crisis. However, there was concern that less emphasis is placed on 
reviewing the decision once the service user feels better (or is more able to be more fully 
involved). This was seen as a concerning aspect of medication management practice.  
 
ALLISON: once somebody’s starting to feel OK, how you think about moving it 
on…and I think there still is a reluctance, you know, if it ain't broke, don’t fix it. 
7.4.2 Doctor patient asymmetry 
 
A number of CPNs suggested that changes in the system over the last decade had resulted 
in a more collaborative style of prescribing (See Mark, below). However,  a sub group of 
CPNs referred to a passivity by service users and a culture of 'doctor knows best' as still 
impeding shared dialogue in medication management practice (See Allison and Heather, 
below). For Heather, structural factors such as class and education level were important 
influencing factors in how involved service users were likely to be. 
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MARK: No, I mean it does seem to me that there is... the people are much more 
engaged, I think, in these decisions, than they used to be….It was very much you’d go 
and see a consultant, you’d answer a lot of questions [pause] you could be told what 
would happen to you….There wasn’t a great deal of debate. I mean now when you’re 
sitting with the psychiatrist there will usually be some discussion about, well, we 
think this, you know, we think an antidepressant may be helpful, would you be 
prepared to consider it? These are the benefits we think it might give you, these are 
the types of antidepressant available, I mean... 
 
 
ALLISON:..But I think there’s a lot of passivity about doctor knows best. 
 
 
 
HEATHER: you will be more likely to be successful in your advice about medication 
routines, than you are if you are somebody who perhaps has a more passive stance 
when it comes down to a medical model or a disease management model 
...'I haven’t got the right to say the doctor knows best', so I think that a lot of it is 
reciprocate, middle class people relate differently to middle class people, and they are 
listened to more they hear more, they can make more things happen and that can be 
adverse effects for the patient, or it can be very helpful for the patient depending on 
the individual.    
 
7.5. CPNs – Commonalities and Differences 
 
7.5.1. Commonalities across interviews 
Themes relating to the relationship level of analysis are apparent in this data. This is 
especially striking when compared against the psychiatrist data, where more emphasis is 
found at the interaction level of analysis. CPNs emphasise the long term nature of 
medication management practice, being a journey over time and an ongoing experiment.  
CPNs strongly value a longer term relationship with the service user, emphasising walking 
the journey together and supporting the service user to take more control over medication 
decisions, over time. These themes were referred to throughout the interviews, both when 
CPNS were specifically asked about what is important for involving service users, but also 
when describing positive examples of meetings (the critical incident component of the 
interview).  
 
CPNs often referred to their own role as a 'mediator', or 'the go between' with the 
psychiatrist, at times acting in an advocate capacity for the service user. CPNs also 
emphasised the caring components of the role and spending time with service users. CPNs 
154 
 
 
 
often felt they had a good  understanding of service user preferences and current 
problems to consider for decisions about psychiatric medication. As such, CPNs saw 
themselves as a conduit of information to the prescriber or more specifically, the 
psychiatrist. Interestingly, some participants referred to being a medical prescriber52. 
However, these qualifications were not being utilised in this community team.  
 
Another aspect at the relationship level which emerged strongly in this data was the 
importance of honesty in the relationship with the service user. CPNs felt they had a duty 
to impart their opinion to service users about a preferable option, whilst not controlling 
the decision.   
 
At the interaction level, the importance of choice was not mentioned by CPNs (unlike 
psychiatrists). Instead provision of information about side effects, whilst important, was 
seen as in need of improvement. There was acknowledgement by CPNs that, at times, only 
selective information is provided and, at other times, more persuasive forms of 
communication are employed.  Reinforcing information during periods of crisis was 
emphasised by CPNs. 
 
Severity of illness and lacking insight were seen as challenges to involving service users by 
the vast majority of CPNs. CPNs also often mentioned problems of involving a minority of 
service users who were overly passive in the process, not expressing an opinion or 
preference. This was linked to the concern that some service users externalised problems 
and associated medication with a quick fix. This was seen as problematic for CPNs.  
 
7.5.2. Differences between interviews with CPNs 
Views surrounding the role of, and value placed on, psychiatric medication as a treatment 
in mental health services, differed between interviewees. A minority of participants 
expressed concerns about  the ethical implications of prescribing medication associated 
with severe and enduring side effects.  However, other CPNs expressed the view that 
medication was a necessary treatment for serious mental health problems, placing 
importance on biological aspects of understanding mental illness by using analogies to 
other medical conditions in the construction. 
                                                             
52
 Two participants had undertaken relevant training and were qualified to prescribe medication. 
However, this was not being utilised in their role within this CMHT. 
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7.6. Exploring similarities and differences between stakeholder groups  
 
This section describes the similarities and differences in themes that have emerged across 
the three stakeholder groups: service users, psychiatrists and CPNs.  Exploring some of the 
apparent similarities and differences allows for some of the more subtle aspects of the 
data to be explored (e.g. what is not discussed by certain stakeholder groups). Table 8 
presents similarities and differences by levels of analysis; the interaction; the relationship; 
and the system. 
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 Service users Psychiatrists CPNs 
In
te
ra
ct
io
n
 
Similarities 
 Service user gaining control 
 Being ill as a challenge for involvement 
 Reinforcing information and checking 
understanding 
 
Differences 
 Valuing service user knowledge and expertise 
 Being ill and difficulties in processing 
information and distress 
Similarities 
 Service user gaining control 
 Being ill as a challenge for involvement 
 Reinforcing information and checking 
understanding 
 
Differences 
 Service user ownership of decision 
 Lack of insight as a barrier to involvement 
Similarities 
 Service user gaining control 
 Being ill as a challenge for involvement 
 Reinforcing information and checking 
understanding 
 
Differences 
 Valuing service user knowledge and expertise 
 Lack of insight as a barrier to involvement 
R
e
la
ti
o
n
sh
ip
 
Similarities 
 Open dialogue 
 
Differences 
 Walking the journey together and continuity 
of care 
Similarities 
 Open dialogue 
 
Differences 
 The changing role of the psychiatrist 
 
Similarities 
 Open dialogue 
 
Differences 
 Walking the journey together and continuity of 
care 
S
y
st
e
m
 
Similarities 
 Dominance of psychiatric medication in MH 
treatment programs 
 The Mental Health Act – a barrier 
 
Differences 
 Stigma as a barrier 
 Fear of coercion 
 Doctor patient asymmetry 
Similarities 
 Dominance of psychiatric medication in MH 
treatment programs 
 The Mental Health Act – a barrier 
 
Differences 
 Pressure to prescribe as a barrier 
 Fear of coercion 
Similarities 
 Dominance of psychiatric medication in MH 
treatment programs 
 The Mental Health Act – a barrier 
 
Differences 
 Pressure to prescribe as a barrier 
 
 Doctor patient asymmetry  
Table 8. Similarities and differences between stakeholder groups
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From table 8, it can be seen that at the interaction level, all stakeholder groups value the 
importance of the service user having ownership and increased control in the decision 
making process. All stakeholder groups strive towards the service user achieving greater 
self management skills and gaining control in decisions about psychiatric medication.  
 
Service users and some CPNs also refer to the value of service user expertise and 
knowledge in the decision making process.  Overall, psychiatrists referred less to service 
user expertise and knowledge and less emphasis is placed on ideals of a meeting of 
experts53. Instead, the vast majority of psychiatrists refer to the importance of providing 
choice and respecting the service user as having ownership over the final decision. Honest 
dialogue was also strongly valued (see relationship level below). The differences observed 
between the CPNs and psychiatrists often linked to practitioners conceptualisations of 
their own roles. Psychiatrists saw themselves as the medication expert and an advisor, 
providing detailed advice and choice and less focus was placed on continuity of care or 
establishing a longer term partnership. CPNs on the other hand referred to acting the 
conduit of information, helping to ensure service user preferences and problems are 
communicated in the decision making process, as a result of knowing the service user in a 
longer term and trusting relationship with the service user (see below). 
 
On the other hand, less emphasis on service user expertise by psychiatrists, may also point 
towards a continued dominance of paternalistic practice. However, valuing a paternalistic 
approach was not prevalent in interviews with psychiatrists. Instead, a diversity in 
practice was found, from an informed model at one end through to a paternalistic 
approach on the other. This diversity was mostly apparent in the critical incident 
component of the interviews, perhaps suggestive of a gap between ethical ideals 
(emergent in the general questioning component of the interviews) and actual practice.  
Nevertheless, taken as a whole, fewer psychiatrists placed emphasis on the ideals of 
shared decision making, on reaching consensus, sharing an opinion and placing value on 
experiential knowledge. Finally, these differences between practitioner groups in the 
value placed on experiential knowledge may also be suggestive of a dominance of the 
medical model of understanding for psychiatrists, where medical expertise is more and 
experiential knowledge less at the fore.   
 
                                                             
53
 this theme emerged for some psychiatrists in the critical incident component of the interview 
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All stakeholder groups refer to the challenges surround being ill or in crisis for service 
user involvement in medication related decisions. Both practitioners and service users 
appreciate that often decisions about medication are made during periods of crisis, or 
distress.  Reinforcing information and checking understanding was valued by all as 
important during these periods.  Service users also value increased guidance during these 
periods. 
 
Lack of insight, or the service user not understanding they are ill, was mentioned by both 
CPNs and psychiatrists, as a key challenge to shared decision making and was associated 
with a change in how information is presented and how medication conversations are 
constructed.  Lacking insight  was mentioned less by service users, who instead 
emphasised the problems of poor concentration, memory problems and anxiety and 
distress as being the biggest challenge to being involved during periods of crisis.   
 
At the relationship level, all stakeholder groups emphasise the importance of achieving a 
constructive therapeutic relationship for meaningful dialogue. The importance of 
achieving an open and honest dialogue was especially emphasised by all groups. 
 
Psychiatrists were, overall, less likely to emphasise the more supportive or caring aspects 
of the therapeutic relationship. In addition, less emphasis was placed on the longer term 
relationship. On the other hand, CPNs and service users referred to the importance of 
walking the journey together, establishing a long term partnership, being supported and 
feeling that the practitioner knows the person well. Service users, in particular, valued 
increased guidance during periods of crisis, in the context of a longer term trusting 
relationship. To explain these differences in conceptualisations, it may be important to 
consider the function and changing roles in mental health teams. Indeed, psychiatrist s did 
highlight the changing role of the psychiatrist towards that of an expert advisor and 
performing more of a consultative role in the medication management process. 
 
At the cultural and system level, concerns surrounding the increasing medicalisation of 
mental health problems emerged as a barrier to collaborative decision making across all 
three stakeholder groups. Within the theme, there were differences in conceptualisations 
across participant groups.  Service users referred to feeling labelled, pre judged and 
feeling stigmatised hindering collaborative dialogue. For some service users, this was 
associated with receiving a diagnosis and a dominance of the medical approach in 
psychiatry. Some psychiatrists and CPNs on the other hand, refer to the trend towards an 
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increased medicalisation of emotions as an emergent problem for a holistic and 
collaborative discussion. Here practitioners felt an increasing pressure to prescribe, from 
service users and society more generally.   
 
Service users and CPNs refer to doctor patient asymmetry as a barrier to service user 
involvement in decision making. Feeling like a child and being spoken down to is 
mentioned by service users, and CPNs refer to culture of doctor knows best as still being 
prevalent. This is less directly referred to by psychiatrists, at least at the system level of 
analysis. Service user passivity and 'wanting to be led', emerges instead from this 
participant group as a barrier, but this is more attributed as a service user preference, 
rather than a cultural phenomenon. 
 
The context of mental health services, operating within a legal framework and specifically 
the role of the Mental Health Act in removing choice and freedom in the decision making 
process was acknowledged as a barrier to collaborative decision making across 
stakeholder groups54.  However, this was seen as less directly applicable in the context of 
this particular CMHT care pathway. The resultant fear of coercion emerged as a barrier to 
shared decision making across both service user and psychiatrist participants. Fear of 
coercion was not mentioned by CPNs, again, perhaps suggestive of the differing role the 
CPN performs to that of the psychiatrist.   
 
7.7. Chapter summary 
This chapter presents emergent themes from interviews with CPNs. Themes are presented 
at the system, relationship and interaction level of analysis. Commonalities and differences 
in interviews  are explored. A particular emphasis is placed by CPNs on themes at the 
relationship level. Walking the journey together and achieving a trusting and open 
dialogue was strongly valued by CPNs. There were differences is how CPNs viewed the 
role of medication and its value in mental health services. The chapter concludes with a 
brief presentation of some emergent similarities and differences for conceptualisations of 
shared decision making between all three key stakeholder groups; service users; 
psychiatrists and; CPNs. These are described in detail above and are subsequently referred 
to in the discussion chapter. 
 
                                                             
54
 To note, this is not presented as a theme within the CPN interviews as it was only directly mentioned 
by one participant in the interviews. 
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These emergent findings are combined with the key observations and findings from the 
applied conversation analysis for phase two recorded meetings (see Chapter Eight), 
allowing for a rich conceptualisation of shared decision making to emerge.  
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Chapter Eight. Findings from phase two: an applied conversation 
analysis 
 
 
8.1. The recorded meetings - An overview 
 
Four outpatient consultation meetings were recorded using a digital recorder (operated 
by the psychiatrist). The meetings all took place within the CMHT, between the same 
psychiatrist (Dr Kos) and different service users (Rosie, Carl, Linda, Lara), over a 6 month 
period.  
 
All service user participants from phase one research interviews were invited to 
participate in this phase of the data collection. The initial aim was to record 10 such 
meetings, in different settings, with different practitioners (CPNs, Psychiatrists). However, 
the uptake for this phase of the data collection was poor55.  
 
Participants were approached individually about participation and written consent was 
obtained directly prior to the pre organised meeting.  The meetings took the form of a 
psychiatric consultation / review meeting, at an outpatient centre in central Cambridge. 
All meetings could be described as a general progress or update meeting, with all service 
                                                             
55
 For further discussion on the possible reasons for recruitment challenges please see the methodology 
chapter. 
Chapter Outline 
This chapter supplements the thematic analysis of research interviews in chapters five, 
six and seven. Four meetings, where psychiatric medication was discussed between 
one psychiatrist and four service users, were recorded (phase two). The aim of 
collecting this data was to gain further insight into how decisions about psychiatric 
medication are reached in practice.  The analysis of this data allows for a greater 
appreciation of the complexity of the medication management encounter and assists 
with building a rich picture of collaborative decision making in psychiatric medication 
management.  
An applied conversation analysis (CA) has been adopted, focusing particularly on the 
power claiming and power sharing strategies employed by both participants in the 
meeting. The aim of this approach is to build an understanding of how decision making 
is shared in the encounters. This analysis uses a case study approach, incorporating 
relevant contextual information and the content of what is discussed in the meeting.  
The final section of this chapter explores how the applied CA findings link with 
thematic findings from previous chapters. 
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users having previously met with Dr Kos56.   Researchers were not present in the meeting. 
Meetings lasted between 13 and 38 minutes. 
 
8.2. Analytical approach 
 
An applied conversation analysis was undertaken, assisting in understanding why a 
conversation happens as it does and emphasising the dynamics of the encounter. This 
analytical approach allows for the context of the meeting to be examined and (of particular 
importance to psychiatric medication management) for an exploration of what is and what 
is not discussed in the meeting. For further rationale and discussion please see the 
methodology chapter, section 4.4.1. A case study presentation style has been adopted, 
allowing for the inclusion of relevant interview data from phase one, with the aim building 
a rich picture of medication management practice. In summary, both the 'how' (the 
dynamic of the conversation) alongside the 'what' (contextual information and content of 
the meeting), is presented in this analysis, through the use of a case study format.   
 
Within CA in general, it is important to clarify which type or 'genre' of meetings are being 
explored, as this influences which discourse cues are deemed as usual or unusual in this 
context. The medication management meetings recorded fall within the genre of an 
'institutionalised' dialogue between medical practitioner (the psychiatrist) and mental 
health service user (Heritage and Clayman, 2010). There has been a significant amount of 
previous research which has explored the doctor patient institutional interaction, 
although less CA research has occurred in the psychiatric context (Mikesell, 2013; Drew et 
al, 2001). The central tenet of this body of research, is that an institutional interaction is 
systematically asymmetrical, in contrast to what is seen as the ideally equal nature of 
every day (non institutionalised) conversation (Hutchby and Wooffitt, 1999).  Here, 
standard activities are suffused with the exercise of authority, from patients first having to 
justify the medical visit to a more knowledgeable clinician, through to diagnosis, where the 
human experience of symptoms and suffering becomes a medically ‘validated’ disease and 
treatment is proposed (Heritage and Clayman, 2010; Heritage, 2013). It is suggested that 
this authority has two main sources, - the dependency of patients who are unable to solve 
their problems and the cultural authority of science (Starr 1982). 
 
                                                             
56
 For Linda, this was only the second meeting with Dr. Kos, whereas all other participants had a longer 
established relationship. 
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Regardless, the literature shows that there is a direct relationship between status and role, 
on the one hand, and discursive rights and obligations on the other. In the process of the 
psychiatric encounter, status is reinforced by claiming 'speaker rights' such as the right to 
finish a point, take a turn, or to pursue a topic. For instance, there is extensive research 
which shows that doctors typically ask far more questions than patients and those 
questions tend to be much more topic directing than the few that patients do ask (McCoul 
and Hapley 2001; Hutchby and Woofitt, 1999; Drew and Heritage, 1992). In psychiatric 
consultation encounters, psychiatrists are likely to construct and control topics in a 
conversation and often choose not to maintain certain topics proposed by service users 
(Quirk, 2007, McCabe 2002).The analytical approach in this chapter draws on this 
research.  However, as opposed to exploring the overt asymmetry, through the 
examination of doctors’ discourse cues and strategies alone, I have also incorporated an 
examination of the active and power claiming strategies that service users employ 
(Cordella, 2004; Ainsworth Vaughn, 1998). This emphasis on a two way interactional 
process was deemed to be relevant for this analysis, where an exploration of shared 
dialogue is necessary.  Ainsworth Vaughn's research, conducted in chronic medical care 
contexts (1998) focuses on both the active power claiming strategies service user's 
employ as well as exploring the power enabling approaches clinicians adopt. Her research 
suggests that, at times, the doctor patient encounter moves towards the genre of a 
'conversation', with terms such as co-constructed knowledge becoming more applicable to 
the discourse encounter between doctor and patient. Other CA studies have focussed 
exploring the voice of the lifeworld in medical encounters, where patients present relevant 
medical information in context to their own lives and goals. Here a greater value is placed 
on the service user's experiential knowledge and increased respect in the encounter 
(Barry et al, 2001; Mishler, 1984; Ainsworth Vaughn, 1998) 
 
The analytical approach builds on this work and explores the power claiming activities 
and strategies employed by both participants; the psychiatrist and the service user.  I 
explore how the four meetings compare to what is known about institutional talk 
(questioning, control and social status) and investigate whether more power sharing 
forms of communication are employed in these encounters( e.g. more conversational 
strategies).  By making explicit the discourse cues the psychiatrists and service users use, 
the complexity of shared decision making for psychiatric medication management is 
explored. This complexity is supplemented by a presentation of the striking contextual 
features of the conversations and the  incorporation of interview data from the 
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participants to assist interpretation of the existing enablers and challenges for 
collaboration in the decision making process. 
 
The key power claiming and power enabling discourse strategies incorporated into this 
analysis are shown in table 9, below. References to relevant literature are provided.  
Included in this table are the power claiming strategies undertaken by the psychiatrist 
(e.g. McCoul and Clayman, 2001; Hutchby and Woofitt, 1999; Heritage and Clayman, 2010) 
and the strategies employed by the service user to assert power in medical encounters 
(e.g. Cordella, 2004; Ainsworth Vaughn, 1998). Finally this table includes discourse 
strategies proposed to be supportive of more co-constructive dialogues, associated with 
the 'conversational genre' (as oppose to an institutional interaction) (e.g. Mishler, 1984; 
Barry et al 2001; Ainsworth Vaughn, 1998). 
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Power claiming resources applied by doctors Power claiming strategies by service users  
(Adapted from Ainsworth Vaughn, p.181)  
Strategies to promote co 
constructive dialogue 
(Adapted from Ainsworth Vaughn, 
p. 175) 
Interruptions that either disrupt the topic or claim the 
flow (James and Clarke, 1993). This would not for example, 
include, affirmatory gestures such as 'yeah, uh hum' which 
do not disrupt speaker rights and may indeed be 
supportive to topic maintenance. 
Carrying out potentially face  threatening acts through the use of 
resources, such as ambiguous rhetorical questions with an 
ambiguous voice, to either get cooperation or to question 
competence of the doctor. This is seen as a highly aggressive and 
unusual act in institutional dialogue such as this. 
Repetition, furthering questions, 
inference to promote topic 
maintenance 
Questions are an important aspect of  how psychiatrists  
maintain power in the dialogue, controlling the topic and 
speaker turn in the conversation (West, 1984), and are 
used by psychiatrists a tool to deflect or disengage with a 
unwanted topic (McCabe et al, 2002).  
Questions are an important aspect of how service users exert 
power by controlling topics and speaker turn. Also the use of 
treatment questions to propose treatment. These are suggested 
to be one of the major ways patients propose treatment whilst 
not threatening the psychiatrist’s social identity  
Rephrasing to promote 
reciprocal topic transitions   
Invoking structural affiliations, or referring to position 
and structural forms of power in the encounter, create 
more of an asymmetrical encounter between the 
psychiatrist and the service user (Ainsworth- Vaughn, 
1998). 
Offering a candidate diagnosis through the use of  narrative, 
allowing for a greater appreciation of experiential understanding 
in the decision making process and allowing a plausible 
alternative candidate diagnosis by the service user. 
Formulations of shared cultural 
knowledge and story telling 
 
 Co Construct diagnosis. As above, but building a shared 
understanding and consensus over the decision 
 
 Framing the medical encounter as 'friendly' invoking 
favourable cultural schemas of self. 
 
Table 9. Discourse strategies of importance to the chosen analytical approach
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8.3. The meetings 
 
Dr Kos 
All meetings recorded took place with Dr Kos57, a consultant psychiatrist in the CMHT.  Dr 
Kos has experience of practising psychiatry in a number of different settings and has 
worked within the NHS for a number of years. Quotations from the research interview 
with Dr. Kos are presented in chapter six, pages, 134, 136 and 143.  In particular, Dr Kos 
discusses the importance of service users having ownership and taking increased 
responsibility for managing mental health problems. Dr Kos sees her own role as 
presenting a balanced argument for the pros and cons of different psychiatric medication 
alternatives (see page 143). She was the only psychiatrist interviewed who disagreed that 
lacking insight would not prevent a person being involved in decisions about psychiatric 
medication. 
 
Transcription process 
Only sections of the recordings where psychiatric medication is discussed have been fully 
transcribed, with researcher notes included for the remainder of the meeting content. The 
Jeffersonian approach to transcription was employed to retain the characteristics of 
speech delivery, such as, pauses, overlap, stress, intonation and pace (See Atkinson and 
Heritage, 1999). Transcription symbols and conventions are described in appendix VIII. 
An example of a full transcript from this phase of data collection is provided in appendix IX 
(Rosie).  
 
8.3.1 Case 1: Rosie 
Rosie (female, 24) has been in contact with Dr Kos for a number of months, but has 
recently missed a few scheduled routine appointments. Rosie has previously had contact 
with an occupational therapist, but does not currently have a CPN or contact with other 
practitioners from the team. Rosie has recently been in contact with the out of hours crisis 
team.  At the time of the meeting, Rosie was being prescribed an anti depressant, 
Venlafaxine and the anti psychotic medication, Aripriprozole. Rosie has been prescribed 
various psychiatric medications for approximately 8 years. Quotations from the research 
interview (phase one) are shown on pages 111, 113, 117.  In particular, Rosie mentions 
that she doesn't feel very informed about psychiatric medication and she would value 
                                                             
57
 all names are pseudonyms 
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more time to talk about the pros and cons of taking psychiatric medication. Rosie refers to 
conversations not being 'on her wavelength' with a lack of shared understanding of her 
problems. Specifically she mentions that she would like more discussion about hearing 
voices and her experience of this. Rosie also suggests that, at times, she is not very 
assertive in conversations, preferring the psychiatrist to take the lead. Rosie, when asked, 
responds that the psychiatrist is the person to make decisions about her psychiatric 
medication. 
 
This meeting lasts 22 minutes, of which 8 minutes have been transcribed58 as the 
conversation concerns psychiatric medication. At first glance this meeting looks like a 
typical psychiatric encounter. It is asymmetrical in power, with Dr Kos asking questions 
and Rosie providing short answers around medication, being rather passive in the 
conversation. However at the point later in the conversation when the decision is made 
about medication, Rosie does take a more active stance, using many power claiming 
activities. In addition, the psychiatrist cooperates with Rosie’s claims to power. This 
suggests the encounter moves, at this point, towards a shared dialogue.  
 
The key decision concerning psychiatric medication in this meeting is to change the type 
of anti-psychotic medication. This is shown in the following except, at approximately 12 
minutes into the conversation. Medication had been talked about previously, at two prior 
points in the encounter (at 6.00 mins and 9.40 mins).  
 
Time: 11.58  P=Dr Kos; R=Rosie (+same for cases 2-4) 
 
38. P:  But at the moment  you don’t fee::l that uh they are excluding you or or they seem to be or  
39. R:  =I don:::t kno:::w I find it so::o difficult to get past my own moo::d [ 
40. P:         [ yes yes 
41. R:  and the voices as well  
42. P:    [hum um 
43. R:  which leads me to my next que::stion (.) would it be::e possible to try a different  
44.  medication at sometime?  
45. P: Yes I think it might be a good idea to see whether you have any (.) uh (.) I mean  we switched  
46.  to aripripozole simply because of the side effects you had on on a amisulpride and uum (.)  
47. and it might be worth to to try something different because even the combination of the  
48.  two when you were taking a very low dose of amisulpride then it seemed to work (2) 
49.   because of the side  effects 
50. R: = because of the [side effects] 
51. P:   [side effects exactly (.) so u::m (.) in terms of other medication I mean are  
52.  you happy on Venlafaxine in terms of the mood do you think thats that working 
                                                             
58
 Rosie’s full transcript is provided in appendix 8, as an example transcript.  A summary of the content 
for remainder part of the meeting is detailed in this transcript.  
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53. R: Yes= 
54. P: YES yes we we will not change that so really the question is whether we should change he  
55.  aripriprozole uh the afilofy to something different (.) in terms of uh (.) a group of medication  
56.  which are the same group of medication you you you've taken amisulpride and it has side  
57.  effects and the other ones are olanzapine uh quetiapine resperidone have you had any 
58.  experience with any any of these = 
59. R:  Unfortat:::ely [ 
60 P:    ^ALL OF them= 
61. R:   Most of them [ 
62. P:   Most of them 
63:R =no:::ot  [olanzapine] but all the rest Ive tried risperidone I find quite str[ange] 
62. P:  [ uh hum]          [huum] 
63. R:  quetiapine I got (.) I felt quite [fra:::ile] with it and um (2) what was the other one?= 
64. P:     [hummm] 
65. P: Uh (1.) uh olanzapine I think olanzapine what you mentioned  
66. R:  Olanzapine I haven’t tried 
67. P: Yes yes[ 
68. R:  [Ive heard that makes you eat lo:::Ads so  
69. P: Yess I mean this this can this can be a side [effect] yes 
70. R:         [humm]   OKay (.) mayb::e a low dose would be Okay= 
72. P: Yes yes yes and in terms of the uh the problem you had with the amisulpride I think it's less  
73.  likely with olan::zapine (.) so your prolactin level was quite high even on the small  dose of 
74.  amisulpride I hope that much less likely on olanzapine BUT I think what we should do we  
75.  should have a prolactin level tested now just to have a baseline level and probabl::y ab::out  
76.  a couple of weeks later just to see whether you have any problems on olanzapine and well  
77.  keep an eye on your uh on uh your eating and on your weight as well. SO IF you if you would  
78.  join the gym no::w that would be a very good idea because then then uh (.) then you might  
79.  be able to to kind of control the the weight gain, the weight gain unfortunately can be side  
80.  effects with the olanzapi::ne= 
81. R  Would the la::dy in the social inclusi::on (.) help me with that? 
82. P:  Yes  I think I think what we should do just uh (.) because um Charlie is no longer Charlie is on  
83.  sick leave and you don’t really need THAT kind of support that you have been receiving from  
84 Her 
 
Time: 15.10. 
 
In this excerpt, the initial topic change is initiated by Rosie (see lines 38-45). This is in 
response to a question asked by Dr Kos, in such a way that a new topic is introduced. 
Previous to this excerpt, the conversation for a few minutes focuses on Rosie's concerns 
about  peer pressure from her housemates to drink  alcohol. The question in continuation 
of this topic (line 38) leads Rosie to raise a new topic (hearing voices) which Dr Kos 
maintains by affirmative overlapping talk (yes, hum um) thereby allowing Rosie to 
continue the new topic.   
 
This topic change strategy to claim her speaker rights is directly followed up by Rosie by 
proposing a treatment using a treatment question in line 43 and 44 (emboldened) by 
asking if she can change her antipsychotic medication. Here, Rosie is able to ask for a 
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review of her anti-psychotic medication, without directly stating that she is unhappy with 
a previous decisions concerning this medication (and thereby threatening the 
psychiatrist's social identity).  
 
Dr Kos immediately supports and agrees to the  treatment question  (lines 43 and 44), 
whilst, at the same time, returning the form of conversation  to that more in line with a 
traditional doctor patient encounter, through the  presentation of treatment 
proposals/options and by asking questions. Saving face and preserving social identity is 
maintained at this point by Dr Kos (lines 46 – 47) by restating the  previous rationale the 
current medication, before returning to Rosie's question and  presenting new medication 
options. At one point in the subsequent conversation Dr Kos seems a little taken by 
surprise (line 60). Her voice is raised and higher than normal (unusual for this person in 
dialogue). This follows the presentation of possible treatment choices and Rosie's 
response that she has unfortunately already tried the proposed medications. The 
expression at this point in the conversation serves to prompt Rosie to explain further her 
experience with previous medications and Rosie proceeds with the narrative of different 
medications she has tried and their side effects. The final decision to try a low dose of 
Olanzapine is proposed by Rosie (line 70). 
 
From a discourse perspective, this dialogue is relatively shared, with Rosie using some 
power claiming discourse strategies to reclaim her speaker rights. Dr Kos seems very 
happy to allow Rosie to take more control in the meeting, whilst at times preserving social 
identity rights and saving face in the encounter.   
 
However, it is worth considering the broader topic of conversation in this meeting in order 
to understand how ‘shared’ the decision making process is. Whilst Rosie does assert 
herself at times during the conversation, it is relevant to note that little attempt is made to 
explore Rosie's concerns about side effects which Rosie raises in line 68 - 'I’ve heard this 
makes you eat loads'. Dr Kos responds  and states  this is a side effect, without further 
exploring how important a consideration this may be for the decision. Instead the 
conversation proceeds with Rosie directly stating 'a low dose may be OK' (lines 70) and 
the conversation then quickly moves to discussion of management strategies for the 
possible weight gain (lines 73 - 80). One of the fundamental aspects of SDM as described 
by SDM theorists (see literature review chapter) is the priority placed on jointly weighing 
up the pros and cons of any option. In the above excerpt, considerations of serious and 
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common side effects associated with an anti-psychotic medication are not fully explored 
and this absence of discussion is apparent. 
 
This lack of further discussion about potential weight gain as side effect of the proposed 
medication is further evident, when examining it in the context of the excerpt below, 
which occurs at the onset of the meeting. 
 
7. P:     [yeah HOW do you find uh the aripriprozole do you have any problems at all and the side  
8.  effects with the [ 
9. R:    [ UUM I get quite sle:::py [ 
10. P:    [ uh hum 
11. R:    =um in the mornings its very difficult to g::et u::p[. 
12. P:      [ uh hum 
13. R: =E:ven if I go to bed at t::en I could still (.)[wake up] at te:n or twelve e:ven (.) u:::m (2) nnn  
14.P:      [uh hum]     
15. R:   apart from that  its OKay.= 
16. P:   Its OK. So (.) Umm so there was also concern about we::ight gain when you went on  the 
17. amosulpride DO you find that you uh might have lost some weight since you are on the   
18 aripriprozole 
19. R:  Yeah= 
20. P:   yes:s 9.) so it defina << ley but the voi::ces are slightly [bit worse] 
21. R:                   [uh hum] 
22. P:  Do you think it is because of the medication ofor? because you had a job at that ti::me and  
23.      were more busy busier [ 
24. R    [ UUHH actually I have to admi::t that I have been dri::nking alcoho::ll aswell  
25.       s:::oo 23. u:::mm that’s pro::oba::bly the thing to consider = 
 
In the above excerpt in lines 16-18, Dr Kos  refers to a previous  medication (Amosulpride) 
and Rosie's previous problems of  gaining weight as a side effect from this medication. Dr 
Kos states that the change to her current medication (Aripriprozole) was related to this 
adverse effect. As such, the absence of discussion about weight gain later in the 
conversation (see previous excerpt) is concerning, given Rosie's previous problems with 
this side effect. 
 
In summary, the dynamic of the conversation about medication appears relatively shared, 
given its institutional nature, with Rosie asserting speaker rights at different points, and at 
times, directing the topic and exerting her preferences towards making a change in her 
anti-psychotic medication, due to continued problems related to hearing voices. However, 
there is less evidence of a full discussion about the pros and cons of making a change and 
in particular the adverse side effects of weight gain are not fully discussed or considered in 
the decision. In addition, the list of options Dr Kos presents (i.e. other medication in the 
same class of second generation anti-psychotics), may be somewhat limited. For example, 
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there is no exploration of both, other medication types, or other, non medication 
alternatives for the problem that Rosie presents (hearing voices).  As such, whilst the 
dynamic of the meeting was partly shared, and Rosie is able to, at times, exert control and 
express her preferences, the full requirements of a shared decision making process are not 
conformed to. 
 
8.3.2. Case 2: Carl 
Carl, (24, male) has been in contact with Dr Kos for a number of months and also receives 
services from a CPN and occupational therapist.  Many decisions concerning psychiatric 
medication have been made in collaboration with the psychiatrist and GP.  At the time of 
the meeting, Carl was being prescribed an anti psychotic, Quetiapine, and an anti 
depressant, Sertraline. Quotations from Carl's research interview (phase one) are shown 
on pages 109, 116, 120. In particular Carl refers to valuing guidance from his GP and 
psychiatrist when making decisions about psychiatric medication and sees his own role as 
being open and honest, providing all relevant information, enabling the decision to be 
made by his psychiatrist/GP. He strongly values his ongoing positive relationship with his 
GP and appreciates feedback on his progress, in a longer term relationship with his 
prescribers. He mentions past disagreements between practitioners concerning 
psychiatric medication, yet sees this as positive, illustrative of an open honest dialogue. 
 
This meeting was a review meeting to discuss Carl’s general wellbeing and progress. The 
meeting lasts a total of 13 minutes, of which 3 minutes were spent discussing psychiatric 
medication.  Most of the meeting was spent discussing Carl’s progress in looking for new 
career opportunities and a recent voluntary position that he hopes to start in the near 
future. Carl reported feeling generally positive and talked about plans for the future. The 
psychiatrist often made positive comments such as ‘very good’ throughout the encounter 
and reference to how things have improved. No change to psychiatric medication was 
made at this meeting. 
 
As the following excerpt shows, the encounter appears asymmetrical in power. Carl makes 
no real attempt to claim speaker rights or take power in the conversation. Congruent with 
the interview, he seems happy to conform to the traditional 'patient' role and provide 
information to the psychiatrist, as requested.  
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This excerpt forms part of the first of two instances in the meeting where medication is 
discussed. The second instance is very brief, with the psychiatrist reinforcing no change to 
medication routine. 
 
Time: 6:00  
32. P:   yes yes (2) do you have any problems with any side effects with the medication [quetiapine]at all? 
33. C := U:::MM 
34. P:      [ you take se::rtraline as well and 
35. C:     [ um, yeah no but I don’t think there is any problem, any  
36.        possible effects from the side effe u:::h medication I think that at times I try (1) u:::h (1) f fight  
37.        against it but in the sense of I’m starting to feel tired and NO NO I’ll  just do five more minutes  
38.        five more minutes  
39. P: = uh ye::ess 
40. C:   and I think that sense of its happening but otherwise yeah I'm trying to get as much as uh  
41.        think  just to reme::mber to take my medication at certain times uh in the e::vening definitely (.)  
42. P=  In the evening what time to do tend to take  
43. C = I t::ry and take it by half nine 
44. P = half nine oh right and when you wake up in the morning that’s when you start feeling a little  
45.        bit dro::wsy or or ? 
46. C: = um NO (.) in the morning I’m generally uh generally alright it takes me only ten fifteen  
47.        minutes to feel aw::ake 
48. P = that’s not too [bad] 
49. C:   [ UM u....hh its (2) generally maybe in the evenings after I’ve taken it that I feel the 
 50.       drowsiness coming on, but I do::n’t take myself off to bed in the evenings us::ually  
51. P:          [uh hum, hum] ,  
52. C//  th::AT  I think that’s the attitude that I have possibly got to change about it really = 
 
Time: 7.36 
 
The asymmetry in power in this excerpt is illustrated by the use of questions in the 
encounter. Here Dr Kos uses multiple questions thereby controlling the topic and asserting 
turn taking power (lines 32, 42 and 45). Carl does not ask any questions in any of the 
excerpts transcribed. 
 
However, throughout the meeting, Carl nevertheless changes the focus of the topic and the 
new topic is readily adopted by Dr Kos, through topic maintenance strategies. The excerpt 
below is a good demonstration of this: 
 
Time: 5:00 
 
1. P: =  Um and no problems with your sleep eith::er? 
2. C: =    um NO, no, not not not since uh ((.) (laugh) so I’ve found recently just after Christmas started  
3.  taking the right amount of queti::apine [ 
4. P:        [Yes 
5. C:  I only had seventy five milligram t:able::ts  
6. P:        [ yes 
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7. C:  No 25 milligram tablets and I thought they were f::ifty’s 
8. P =  ^OH right  
9. C:   [so  
10. P: [SO you were taking actually seventy [five] 
11. C:       [ye::s, yeah but yeah ] 
12. P:   yeah, ye::s And since Christmas so it's about  [two months] that you were taking  
13. C:      [uh hum] 
14. P: = about[ one hundred and fifty] 
15. C:   [yeah ye:::ah] (yawns) 
16. P: =  And uh you are sleeping better 
17. C: = U::::H I’m generally sleeping bett::er  I::m more able I'm I'm more ABLE to wake up= 
 
 
So here, in response to the question (line1) about sleep, Carl goes on to change the topic 
(dose of quetiapine). Dr Kos responds with affirmatory gestures (yes, yes) and topic 
maintenance strategies, such as rephrasing (lines 10) and anaphora (or rephrasing 
information using a question - lines 12, 14) to encourage Carl to continue this new topic. 
When this topic appears to be exhausted by Carl, (lines 15 and a yawn), the psychiatrist 
returns to the previous topic (sleeping, line 16). 
 
As such, whilst the character of this meeting appears  asymmetrical in power, when looked 
at in terms of use of questions to control the dynamic and topic, , there is, nevertheless, 
evidence that topics are being co constructed . Carl maintains some power over which 
topics are discussed and Dr Kos appears happy to maintain new avenues or topics that 
Carl proposes.   It is possibly important to note, however, that no problem is identified in 
this meeting and subsequently, no decision about medication is required. Therefore the 
weighing up of pros and cons is not necessary and the potential amount of conflict is 
limited.  
 
8.3.3. Case 3: Linda 
This is only the second meeting between Linda and Dr. Kos. Prior to this, Linda has seen 
psychiatrists in other teams. Also, at the time of this meeting Linda was seeing two other 
psychiatrists in the eating disorder team and rehabilitation and recovery pathway teams. 
To note this is not usual  in the context of this care pathway and may be indicative of 
either a period of crisis at the time  of the meeting and/ or complexity of the problems. 
 
Linda was being prescribed 450 mg Venlafaxine, an anti-depressant and Gabapentin, a 
mood stabiliser. Both prescriptions were issued by other psychiatrists, prior to this 
meeting. Linda has a number of years experience of psychiatric medication and has also 
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previously received Electro Convulsive Therapy (ECT), a  rare and controversial therapy in 
this context, often used only as a last resort (NICE, 2010). Quotations from the research 
interview (phase one) are presented on pages 113, 120. In particular, Linda refers to 
valuing a shared discussion with prescribers about psychiatric medication, which is 
personalised to her situation and where different forms of knowledge (experiential and 
medical) are appreciated. She states, when asked that decisions are usually made in 
collaboration between herself and the psychiatrist and also values the ideals of building 
consensus in the final decision.  Receiving comprehensive information about side effects, 
as well as the biological mechanisms through which medications work, was emphasised. 
Linda refers to a previous negative meeting where she experienced a breach of trust with 
her previous psychiatrist. Unlike the majority of other interviews, however, Linda does not 
talk about specific helpful relationships as being an important aspect of being involved in 
decisions about psychiatric medication, and in general, less themes are present at the 
relationship level of analysis. 
 
The meeting in total lasts for 38 minutes, by far the longest of the recorded meetings. 
Medication related conversation lasts for approximately 8 minutes. There is no direct 
change to prescription as a result of the meeting. However, the time of day the medication 
is taken is changed in this meeting. Plans for future possible changes are also discussed, 
including the introduction of tryptophan, an amino acid supplement and the future 
consideration of the anti-psychotic, Quetiapine and/or a course of ECT. 
 
This discourse is highly asymmetrical in speaker rights, with Dr Kos asking all of the 
questions throughout the dialogue. Dr Kos also makes direct treatment proposals on a few 
occasions, as illustrated in the following excerpt. 
 
Time: 29.30  
 
16. P:  So at the moment you take (.) let's just see if it's in here yeah uh you are taking a Venlafaxine 
17.   four  hundred and fifty milligrams um and the  dose has just been increased about ten days  
18.  ago a week ago  
19. L:  yea::h 
20. P:   (.)= uh are you happy with the medication? Do you have any side effects at all or? 
21. L:  I haven’t noticed any (2) 
22. P:  And you have been taking Venlafaxine in the past so it's actually the second time you are  
23.  taking (.) [sigh] but in the past you were also taking it with a combination of different  
24.  medication 
25.  L: um ye::s I was on it was (.) um (4)  
26. P:  mirtazapine 
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27. L:  (.) yeah, and [um ] L: and I think I was also on ?[premasasine]?[promazine]? at the same time 
28. P:      [yeah] 
29. P: = [hum] AND um um 
30. L:   [so]  
31. P:  = and uh (2) if you you took different combination different medication uh (.) do you  
32.  remember which of those you find the most beneficial at all? 
33. L:  um (7) from what I rem::ember um they were all (3) seemed to (2) work for uh short while  
34.  but  then the effects just stopped and my mood went down again (3) so 
35.. P:  [sigh} I mean (.) at the moment because you just increased the dose I think we have to wait a  
36.  little while to see to assess how things are going. You are taking other medication as well,  
36.  gabapentin, why gabapentin  was prescribed for you? 
37. L:  = Um, (.)  I had really (2) bad (1) muscle pains 
38. P:  Yes 
39. L:   in my legs and I couldn’t really do anything (1) so it <was for that 
40. P:  And do you still take the gabapentin 
41. L:  yeah 
42. P:  yeah and what dose do you take? 
43. L:   a hundred 
44. P:  a hundred 
45. L:  daily 
46. P:  yeah a hundred daily. You have it once a day 
47. L:  Um Once a day=  
 
In this excerpt (lines 16 - 47), Dr Kos asks  a total  of nine questions, thereby having 
control over who speaks and control of the topic. In lines 34 and 35 Dr Kos also makes a 
statement that no change to medication can be made today, in order to give the previous 
change a chance to take effect. This is immediately followed by another question in line 36, 
thereby continuing the pattern of controlling and changing the topic.  As mentioned above, 
this was only Dr Kos' second meeting with Linda, so the use of many questions may also 
indicate that formulation and assessment of Linda's mental health problems is a key 
aspect of this meeting. 
 
On the face of it, Dr Kos is maintaining a highly asymmetrical form of dialogue and 
extensively using many power claiming strategies through the conversation. However, 
there are also many demonstrations in this short excerpt, of Dr Kos attempting to engage 
in a more conversational style and encourage more shared dialogue. For example, in lines 
40 through to 47, Dr Kos repeats Linda's responses providing encouragement for 
additional narrative by Linda. Dr Kos, at no point interrupts Linda’s speech. At other 
points, Dr Kos maintains a significant pause or allows a silence to continue, thereby 
encouraging Linda to take speaker rights and introduce more narrative into the dialogue.  
For example, in line 30, Linda has finished her previous sentence with 'so'. This was at a 
point of overlap in talk, but Dr Kos attempts to allow Linda to continue by pausing for two 
seconds (a significant pause in speech), yet no further interruptions are made by Linda.  
176 
 
 
 
Indeed and interestingly, at no other point in this excerpt does Linda's talk overlap with Dr 
Kos', which is rather unusual in spoken dialogue and in contrast, for example to the other 
recorded meetings presented in this chapter (e.g. see Carl, page excerpt 14, where Carl is 
seen to regularly interrupt during the dialogue). As such, this excerpt suggests a more 
strikingly passive stance being taken by Linda in this dialogue, with a sense emerging that 
Linda may have no preference to have increased say or power over process of the 
dialogue. 
 
This pattern continues through the subsequent excerpt: 
 
48. P:  = Yes. Um (3) you mentioned that  you are purging in the morn::ing and you are supposed to  
49.  take the medication in the morning, so when you take the medication do you tend u::h (2)  
50.  make yourself vomit after that^ or how long do you tend to purge yourself after medication? 
51. L:  Um (2) why u:::m (1) I take my medication after I've had breakfast so that’s normally about  
52.  eight  O clock [um] and (.) then its normally sort of about mid morning that I would (.) binge  
53.  and purge  
54. P: [Yes]   
55. P: = So about 10 O clock 
56. L:  (1) yeah  
57. P:  yeah So um so I think we might have to to look into that whether the medication actually  
58.  absorbs (1) until then or (.) you are no::n responsive or partially responsive that that on  
59.  some of the days you are not getting any medication sometimes I mean you mentioned that  
60. purging  happens about three times a week four times you get the right dose but but three  
61: times you might not get the full dose and would you (.) would you be able to take the  
62: medication u::h after you purge yourself like at twelve  O clock rather than then  after  
63: breakfast. 
64. L:  yeah 
64. P: =  Can we try this way to see uh um to see uh whether you will get actually u:::h a proper  
65.  dose of medication (.) and uh (3) and uh I think we should leave probably a week, at least  
66.  another week at this dose, but if you feel that the mood is still plateaued at all then I think to  
67.  discuss with Dr Shara as well and probably adding something in addition [might] be a good  
68:  idea 
69. L:           [yes] 
 
In this excerpt, Dr Kos makes a direct recommendation, which is agreed to by Linda (lines 
60 - 65) about plans for to change the time of day for the medication. This follows on from 
a series of questions and short answers provided by Linda about her binging and purging 
behaviour. It is striking to note that the topic of the eating disorder behaviours are not 
further investigated by Dr Kos, and are instead seen as something to be worked around in 
the discussion of medication. It appears from this that Dr Kos does not see the eating 
disorder problems as part of her remit, and instead focuses on performing her role as the 
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medication expert59. This may, in part, be explained by Linda's contact with another 
psychiatrist from the eating disorder's team, thereby restricting Dr Kos' broader remit to 
explore Linda's experiences of an eating disorder.  Once again, however, Linda makes no 
attempt to either introduce more narrative into the dialogue, take control of topics, or 
assert her preferences in the conversation. 
 
However, later in this dialogue, there is evidence that Linda does take more of an active 
stance. In the following excerpt, Dr Kos seeks Linda's opinion on future plans (lines 69 - 
70) which she responds to by making a treatment proposal ( future use of Quetiapine / 
ECT - lines 71-72),  thereby claiming some speaker rights, but nonetheless, in a highly 
mitigated way. Here, Linda mitigates her preferences by distancing herself from the 
proposal, instead making use of a third person in the dialogue (Dr Shara, another 
psychiatrist - a person with social status). This line of questioning is supported by Dr Kos, 
who maintains the new topic through additional maintenance questions.  When asked if 
Linda has found ECT helpful (line 76), Linda again mitigates her response.  In other words, 
although Dr Kos asks for Linda's opinion directly (did you find it helpful), Linda chooses to 
respond by attributing to a third party, distancing her ownership from the response (Dr 
Shara said..). This is a strikingly passive approach in continuation of the topic. 
 
69. P: (2) = uh do you have any plan at the moment what you would prefer to take if you have to  
70.         take something in addition to the (1) 
71 L:   [um Dr Shara suggested um (2) either adding quetiapine (1) or um (3) um (1)  
72 .        uh a ^course of ECT again^ cuz thats helped in the past sp 
73. P:  [hum]    [hum] 
74. P:  = How would you fe::el about a course of ECT again? 
75. L:   Um (6) I’m not really (.) sort of worried (.)about ECT cuz I've had it quite a few times already  
76. P: // And did you find it really helpful actually or did you  
77. L:   Um (2) yeah and like the people I was seeing and stuff and Dr Shara has (2) like said it  
78.        definitely improved [my] mood so 
79. P:   [ uh hum] 
80. P: = Have you tried medication (cough) called lamotrigine in the past? 
81. L:    No 
82. P:   And there was [cough] also one I (.) was thinking and there’s a um uh (1) an amino acid called  
83.       tryptophan which is also used uh as an anti depressant kind of not like medication but keeping in  
84.       addition to medication and some people who doesn’t get enough nutrition might data might lack  
85.       of tryptopha:::n and the its really more a kind of supplement  than medication so (.) I think we  
86.       might assess how you respond to Venlafaxine and uh (2) and if you are willing before you start  
87.       on quetiapine and even during that time adding some tryptophan to your (.) almost to your diet  
88.       we might see if you respond if you respond better. (1) Are you due to see Dr Shara next ^week? 
 
Time: 35.40 
                                                             
59
 See chapter six, S. 6.4.2 for further discussion of the role of the psychiatrist 
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(Asked about the other psychiatrist she sees Dr Rom weekly). 
Time: 36.00 
 
89. P:  And and she already sent me her assessment so we will keep in touch and uh if you're(.) agreed  
90.      I will mention tryptophan in my letter so if she agrees as well then then we might start it (.) its  
91.      re::ally (.) very little side effects you will take normally with your food and I would suggest you to  
92.      take it just because if you are purging you might not get enough tryptophan and this is the  
93.      element (.) which kind of (1) starts a bit later on (1) can't change into body and if you have less  
94.      serotonin then you might more likely develop depression as well  
95. L: Ok 
96. P:  Yep^?  So uh I've made this suggestion you are seeing her next week if you decide at that time  
97.      and she agrees you might start on on tryptophan If you f:::eel it's not appropriate in your  
98.      treatment (.) or if you do not want then (2) and your mood is still quite kind of plateau’d then (.)  
99.      you might agree on quetiapine or ECT  
100. L: = OK 
101. P: = and we will arrangement a calling [sigh] so let's meet in two weeks time..... 
 
Time: 37.04  
 
In summary, a strikingly passive stance is being adopted by Linda. There is very little 
evidence of Linda expressing her own knowledge or experience, choosing not to partake in 
a more shared conversational encounter. When her preferences or knowledge is 
expressed, it is done so in a mitigated way to maintain the position of passivity in the 
encounter.  This is especially stark given the content of what is being proposed by Linda at 
these points. She presents the treatment proposal for ECT and or Quetiapine, without 
expressing  her preference towards either of these options. Both options are associated 
with significant side effects and ECT is a highly controversial and rare therapy in this 
context. Throughout, there appears to be no consideration of options, by Linda, about the 
pros and cons of medication.  Linda doesn't directly express her preferences towards 
medication or any other option discussed in the encounter. There is a strong feeling of 
helplessness in this encounter and Dr Kos' attempts to move the encounter towards a 
more shared dialogue fail.  On the face of it, these findings are at odds to the interview 
responses given by Linda in phase one, where there are multiple references to the 
importance of a sharing of different forms of knowledge in psychiatric medication 
management encounters. However, perhaps the lack of reference made in the interview to 
helpful relationships as an important enabler for SDM, is an important consideration for 
interpretation of these findings.  This was, at any rate, a distinguishing factor of Linda's 
interview, with the vast majority of other participants spending significant time discussing 
helpful relationships as a key enabler for collaborative psychiatric medication 
management. 
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8.3.4. Case 4: Lara. 
Lara  (female, 42) has received services from the team for a number of months and the 
recorded meeting  is a review meeting with Dr Kos, whom Lara has been seeing  
approximately once per month. Lara was seeing another psychiatrist, prior to Dr Kos, and 
this changed when the psychiatrist left the team. A male friend / family member is present 
with Lara in this meeting. Lara has had her psychiatric medication changed in recent 
months, and is currently being prescribed Lamotrigine, a mood stabiliser.  Quotations 
from Lara's research interview in phase one are shown on pages 109, 124. In particular, 
Lara refers to being given a lot of control over previous decisions about her psychiatric 
medication. Lara is the only participant who refers to being given a list of  7 or 8 options to 
consider by the psychiatrist,  processing and leading the decision herself. However, when 
asked, Lara stated that at times, she values receiving an opinion from the practitioner and 
showed a preference towards SDM as an ideal. In the interview Lara refers to the difficulty 
of processing information when in a crisis and valuing increased guidance during these 
more difficult times. She also discusses valuing professional opinions and guidance and 
emphasises the importance of a longer term collaborative and supportive relationship 
with practitioners, where trust and mutual respect is formed.  
 
This meeting lasts 20 minutes, of which 10 minutes are spent discussing medication and 
were transcribed. Overall, this transcript gives a different perspective on the decision 
making process, with Lara taking a far more assertive stance than seen by service users in 
the other recorded meetings. Lara seems comfortable to express her opinion and at times 
directs the topic of conversation, using 'treatment questions' and candidate diagnoses 
through storytelling to assert control in the meeting.  The following excerpt occurs at the 
onset of the meeting. 
 
Time: 0.18 
 
1. P:  So how have you been doing since last month? 
2. L:   Um (.) quite a lot better act::ually 
3. P:   Very good 
4.. L: Yeah um I was (.) not quite right for a:ey while and I stepped the (.) the dose to um I   
5. think  ^three [hundred]^?  
6.P:    [Um yes] 
7.L:  =one of the two little ones  
8. P:  =YES  
9. L:   um I've definitely been fe::eling more more myself [ 
10.P:       [Very good very good 
11. L:  [ Since I stepped up the dose. Would you agree, yeah^? 
12. P: =Very good. 
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13. L: [ OKay. Um, so yeah, I mean I'm still a little but (.) menta::lily (.) um (1) um I feel like   
14: I’ve  ^dropped about fifty IQ points basically^ (laughing)  
15: P:       [Oh right] 
16. L:  [ I'm having difficulty following other peoples convers::ation 
17. P:        [oh right 
18. L:   Um I'm (.) um (.) I think my memory is probably worse than it normally i:::s 
19. P:  =uh hum 
20. L: [ Um and I'm a little bit disorg:::[anised ]and I’m making an effort to  (.) pay more  
21. attention to be:ing  
22. P:      [uh hum] 
23. L:  organised bec[asue thats] very important for my business basically  
24. P:   [uh hum]     [ yes 
25. L:  And uh you know  I've managed to sort of like keep up with my commitments and  
26.  uh not miss out anythi:::ng so 
28. P:  Great Very good 
29. L:    [ so thats been OK but yeah I do fe:el (.) fuzzy headed and a bit  
30.  blocked but  my mood is much improved 
31.P:  Very good very good. Do you feel it is much improved because it is more stable or   
32. uh as well so its the fluctuation are the [phone rings] I'm sorry 
 
In this excerpt, from the outset, Lara sets the topic (medication and side effects) in 
response to Dr Kos' first general question in line 1 (How have things been going?). Lara is 
quick to offer information without being asked (previous change the dose of medication - 
lines 4 and 5), thereby taking control and proposing a new topic (medication). Lara then 
uses a narrative approach to provide information relevant to her experiential 
understanding and life world. For example, Lara refers to needing to concentrate in her 
work (line 24).Dr Kos is happy to maintain this topic , with the use of supportive speech 
gestures (yes, uh hum).  
 
Later in the conversation, Lara often interrupts Dr Kos, sometimes in mid sentence and at 
times Lara actively disagrees with Dr Kos’ proposals. This is shown in the following 
excerpt: 
 
Time: 13.00  
 
133: L: [ yes alright (laughing jointly) 
134.P.    yes yes oh right yep yep (.) so u:::m but still I think because your mood  
135. improved  although they are (.) what you mentioned about duh being  disorganised   
136.  and the problem with the concentration can be st:::ill uh the symptoms of th::e of   
137.  the of the mood so it still  might be still just a bit u:h under uh under normal and and [ prese 
138. L: [ it feels (?) like that but its not as m::uch under normal as it was last time [I saw you]  
139. P:          [yes yes] 
140.L:  uh I'm sure the last time I saw you I am probably coming across differently  to when    
141: [I last saw you] 
142. P: [yes yes absolutely absolutely  
143. L: = so yeah I think it is better but is it at t:he ^top end of how much^ [ you should take] 
181 
 
 
 
144. P:          [No no its not no its its its still at  
145.  least at least hundred milligrams that we can increase to four hundred milligram is  
146.  the medically the dose that we recommend but you can go even high::er [because]   
147.  there ar::e differences between yeah  
148. L:            [ O:Kay] 
149. P: = how different people tolerate the medication but at the moment considering the   
150.  uh the skin condition and also that your mood is a::lready started to improve I would   
151. leave to the  three hundred u::h with a view of increasing if you feel that winter is   
152. coming if the mood starts to dip and is is its again getting u::nstable and you can   
153. increase again [ by fifty  milligrams 
154. L:         [ yeah ye::ah I don’t think I normally have much of u::h much of  
155.  seasonal  [change particularly] 
156.P:=        [seasonal oh right] 
157.L:=  in that its u:h I've been re:ally really low in the summer [and  
158.P:           [summer yeah exactly when we met 
159. L:=  so but I don’t fe:::el that there’s a uh there might be a first time use optimus but I   
160. find  that I don’t have th::at much uh awareness of it because again cuz like my   
161.  memory is sh:::ot (.) um[ 
162. P:    [ but I think again its a vicious circle [so] once you eat   
163. properly you drink properly your memory might simply just improve because you   
164. are not you  are h::ydrated and then uh an and and we [ 
165. L:  [ueu (stutter)]        [yeah thats possible I mean I  fe:::el that I  
166.  would  qui::te like to take the risk of the eczema and go up a bit [ if your:::e OK with  
167 that] 
168. P:       [ OH right OK thats that's fine] yeah I agree yeah I'm fine with it [ 
169 L:              [ doctor wool   
170.  wasn’t [a::ware that I was ] 
171. P:    [ on three hundred] I know I emai:::led I [I sent] yes I  
172. L:         [you did] 
 
In this above excerpt, Lara is often claiming speaker rights through both direct 
interruptions (e.g. lines 138, 154, 169) and the use of questions to change topic and 
treatment proposals to propose medication changes. For example, in lines 143, 165 and 
166 Lara repeatedly suggests increasing the dose of medication and this is done in a 
unusually direct and unmitigated fashion. In total in the above excerpt, Lara asks three 
questions (lines 141, 143, 166), which is far higher proportionally than for Carl, Linda or 
Rosie’s transcripts.  In addition, Lara appears comfortable challenging Dr Kos’ initial 
suggestions or explanations. For example in line 149 – 153, Dr Kos proposes that it would 
be useful to leave the medication with view to increasing it, if affected by mood in the 
winter months. Lara interrupts this speech by Dr Kos (lines 154) by stating she doesn’t 
have seasonal change.   
 
Throughout Dr Kos seems happy for Lara to claim power in the meeting using these 
strategies, whilst also expressing her own opinion. So, for example, in line 144, in response 
to Lara asking if the medication can be increased, Dr Kos readily reassures her she is not at 
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maximum and would be able to increase it, but goes on in lines 149 – 153 to express her 
opinion for it to remain the same. Lara’s disagreement and different ‘candidate diagnosis’ 
from lines 154 – 166 results in Lara directly asking to increase the dose, at which point Dr 
Kos immediately agrees. 
 
In summary, Lara appears to be happy to take a very assertive stance and adopt an 
unusual number of power claiming discourse strategies. 
 
Further exploration of the contextual information is useful here. In the phase one research 
interview with Lara, it had emerged that Lara did not feel her initial experience with the 
pathway and team was satisfactory. In fact it took two to three months after initial 
referral, and repeated calls / chasing for Lara to see a practitioner. Dr Kos was part of 
Lara's contact with the team only a few months after this. As such, Lara's unusually 
assertive approach in this discourse may be partly due to her previous lack of contact with 
the team. However it is also worth noting that during Lara's contact with the previous 
psychiatrist (Dr. Percy) Lara was given multiple medication options to review. She had 
established a relationship with Dr Percy that fitted more with an informed model of 
decision making.  
 
It is also worth exploring whether the role of the carer/ family member may have been 
important in this aspect. Out of the four meetings recorded, only Lara brought someone 
with her to the meeting. The carer's role is explored in the following excerpt, occurring 
earlier in the conversation, at the point where Dr Kos asks about side effects of 
medication: 
 
Time: 7.15 mins 
 
46. P:  Oh right OK (1) Um ? do you have any side effects on the 300 mg or lamotrigine any  
47. problems at all? 
48. L:  Um, nothing that I’m awa:::re of. I mean like I said, I do feel sort of a bit mentally  
49. incompetent and  
50. P:   [uh hum 
51. L:  but  I don’t know whether that’s down to m::e or (.) the dr::ugs  
52. P:=  yes exactly or or  just simply being on the on the on the more 
53. C:      [ there are something’s I mean your  
54.  sinuses are kind of playing [up ] 
55. P:     [U::mm] 
56. L:=  ye:ah I 
57. C [  I’m guessing  
58. L:  [ Yeah dry mouth and 
59.C:  and your eczema is playing up and you’re feeling  [nervous?] 
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60. L:       =[ Yeah I haven’t had eczema since I was an  
61. (.) an adolescent  
62. P:=  and the eczema has just started again 
63. L:  ye::ah 
64. P: [ YEAH  
65. L:  [and I don’t know if that’s liable to b::e 
66. P:  [ It CAN be 
67. L: [Does it make you dry in general my skin is dry my throat is dry my eyes are dry and  
68.  you know I think my eczema has come up I don’t know if that 
69. P: = I think it might might interfere with the if normally you are vulnerable to the kind  
70. of allergies or even [even] it might it might be the case that its flaring up or it might  
71. be due to something some  
72. L:    [eu {stutter} 
73. P:   else uh  (.) uh I think uh h:ow did you uh tre::at your uh eczema in the past just  using uh (1) 
74. L: [Well when I was a child it was very very severe [so it ]tended// to be things like  
75. P:       [ Oh right] 
76. L:  having  your:::e  hands covered in tar and then bandaged up [and covered in plastic bags] 
(laughing) 
77. P:      [oh my god yes ^(laughing)] 
78. L:   [you GO TO SCHOOL and you’ve got your pencil so it's (laughing) it varied I mean there 
79.  was u::h steroid creams and u:::m you know (laughing)^ my mum had to tie my  
80.  hands and feet to the bed posts so  that I wouldn’t scratch ^ 
81. P:     [ Oh my god 
82. L:      [until I was like you know below the skin   
83. u:::m but yeah (.)  there was a variety of different treatments 
 
In the excerpt above, in line 53, the carer (labelled as C and emboldened) prompts Lara to 
talk about her eczema problems. These have not been mentioned so far by Lara in 
response to Dr Kos's questions. In this context, the additional person in the rooms seems 
to assist Lara in directing the topic, acting in an advocate capacity at this point in the 
meeting. Whether this dynamic has resulted in more power claiming strategies being more 
readily used in this encounter is an interesting possibility to consider. 
 
However in terms of what is discussed, whilst Lara maintains an assertive stance, the 
topics associated with possible side effects from the medication are nevertheless swept 
over in this dialogue. Both problems with concentration and memory (mentioned at 
multiple points by Lara over the course of the meeting) and the skin condition are not seen 
as directly related to the medication by Dr Kos, and little exploration about possible 
medication discontinuation as a result of these symptoms is given. Dr Kos indeed steers 
the conversation away from exploring the possible side effects of medication towards 
management strategies. For example in lines 70 - 73 (shown for reference below),  Dr Kos 
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both suggests the eczema may be unrelated to medication60 and instead directs the 
conversation towards how this symptom can be managed: 
 
70.P of allergies or even [even] it might it might be the case that its flaring up or it might  
71. be due to something some  
72. L:    [eu {stutter} 
73. P:   else uh  (.) uh I think uh h:ow did you uh tre::at your uh eczema in the past just 
 
 
Nevertheless, Lara does seem more than happy with the content of the meeting, and later 
on herself offers her opinion that she would ‘prefer to keep the eczema and have good 
mental health’. 
 
One other aspect of note from this meeting is the rapport apparent in the encounter. In 
lines 76 - 83, shown in the excerpt above, Lara is retelling the story of when she had 
severe eczema as a child. Lara then starts to laugh. Dr Kos embraces conversational rules 
and uses expression to show listening and empathy with the story, Dr Kos also laughs and 
makes statements such as 'Oh my god' in lines 77 and 81, thereby assisting with the 
encounter moving more towards a conversational genre. This rapport appears towards 
the end of the meeting also (see below excerpt), when Lara is more overtly claiming power 
over topics and treatment proposals. 
 
A friendly conversational stance remains during these more assertive periods in Lara's 
discourse. At no point does Dr Kos try and reassert power over the encounter through the 
use of interruptions, questioning, or topic control. 
  
Time: 16.00 mins  
 
190 P: lette::r (.) Yes OK uh so can we meet in uh about one month's time again just to   
200. review how things are going with you yes 
201.L: = Um ^I was just wanting to ask you a uh ^que::stion as well do you think um its  
202.  like::ly that I’m going to have to stay on u::h psychiatric medication fo:r the rest of   
203. my li::fe o:r for long periods of tim:e or whether I::m going to be:e able  t:o tail it of:f   
204. or just how it normally works with people who present like I do~^? 
205. P: = I think^ there’s no::rmally we would take these medications like like people take   
206. diabetes so we recommend them to take the medication as long (.) uh as long as it   
207. takes but like with diabetes and special diabetes to people lose weight they might   
208 not need [that] uh uh that uh dose of medication or  
                                                             
60
 although eczema is known to be one of the common side effects of this particular medication - see 
Healy 2009, page 110 
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209.L:       [uh huh] 
210. P: they might come off the medication or with the higher blood pressure medication if   
211 they lose weight or something in in bi polar disorder what I would say is that the   
212. lo::::nger you are sta:ble the more likely you will remain sta:ble [ 
213.L:             [uh hum 
214.P: = in women there are periods of time when they are gettin:g (.) they’re vulnerable to   
215. increase significantly and this is the time when they are pregnant or definitely after   
216 delivery so the post  
217. L:   [uh hum 
218. P    parten period they are very very vulnerable [ 
219L:      [ y::es I remember that 
220. P:         [yes exactly so   
221. within a year they are just rocket high probably the most vulnerable time and als::o   
222. the time when when you are reaching um kind of menopause so once you are over   
223. the menopause you have been taking the medication you don’t have side effects   
224. your mood has been stable for long ti::me and you really uh probably would like to   
225. come off the medication very gradually probably within kind of (2) couple of months   
226. or almost half a [year] you gradually come off the Lamotrigine I think it might be   
227. worth a  
228. L:   [uh hum] 
229. P: tri:al at that point so the longer you have a stable mood 
230. L:       [ yeah but that’s unlikely to b::e any  
231. time soon uh I would say like all the female members of my fam:ily do:nt have    
232. menopause until about si::xty 
234. P:=  sixty oh right. (joint laughing) then if it did occur [ but even if 
235.L:       [(?) do you know what I mean 
236. P:  [ in this way if you say after about say two or three years you have about    
237. compl::etely stable mood or you are happy with your mood the way it is managed   
238. and you feel that you no longer want to take medication (.) you would like to give it   
239. a try n(.) the first would be to just reduce whether you need uh a lower dose of the   
240. medication actually you don’t need this three hundred and fifty uh (.) and and very   
241. very gradually reduce the dose and just see whether you would be able to come off   
242. it or just stay on like a fifty one hundred milligrams dose for a bit longer . 
243.L: = OK 
244. P: But this point um your mood started to improve you’re still a little bit under the   
 under normal so I would wait to the point when your mood is (.) normal and count two years 
 after that and then then see what is happening [yeah]  
245 L:        [OK] 
Time: 17.30 
 
In the excerpt above, Lara is claiming power in the conversation through the use of 
questioning to direct the topic and speaker turn (lines 201 – 204). Lara also frequently 
interrupts and uses  ‘but’ to rule out and disagree with Dr Kos’ previous suggestion of 
waiting to the end of the menopause to review medication (line 230). Throughout, Dr Kos 
appears comfortable with the power claiming strategies being adopted and there remains 
laughter and conversational cues being employed throughout (e.g. line 234). Having said 
this, Dr Kos' use of a medical analogy is interesting (lines 206 - 211) and may have served 
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to reinforce the idea of the biological roots of Lara's mental health problems61, also serving 
to reinforce Dr Kos' status as a medical prescriber, preserving her social identity. Later in 
this excerpt, Dr Kos asserts that medication is something for life, or at least the long term, 
beyond the menopause62, suggesting again that there is limited choice over the decision to 
take the medication.  Dr Kos embraces a relatively long narrative through this excerpt 
reinforcing the message that coming off medication is a slow gradual process, not relevant 
to consider in the near future.  In comparison to the other excerpts then, whilst 
conversational cues remain, Dr Kos uses more structural affiliations to claim power and 
reduce open discussion on the topic raised by Lara. 
 
In summary, Lara’s recorded meeting provides the most evidence of a shared encounter 
out of the four cases analysed, both in terms of direct treatment proposals, direct 
challenges and interruptions in the dialogue, all of which assist Lara in maintaining control 
over topics and speaker turn. Whilst Dr Kos provides medical opinion and expertise about 
psychiatric medication, this guidance is influenced strongly by information and 
preferences presented by Lara. Lara is happy to assert her preferences and frequently 
offers her experiential knowledge in the dialogue. At the discourse level, Lara also adopts 
many storytelling / narrative strategies and both participants appear engaged, having 
achieved a level of rapport, thereby moving the encounter more towards a conversational 
genre. However, similar to previous cases examined the content of the meeting and what 
is and (more importantly) is not discussed, suggests only a limited discussion of side 
effects and options.   
 
8.4. Discussion 
 
All four recorded meetings in this analysis involve the same psychiatrist, Dr Kos, and all 
occur in the same treatment setting. 63 Given the contextual similarities of these meetings, 
it is perhaps sensible to expect a level of similarity between these dialogues and the 
discourse cues employed. 
 
                                                             
61
 . Indeed using physical analogies is mentioned by a minority of practitioners as being particularly 
helpful when providing information about medication (see chapter seven, S. 7.6 for further details
61
) 
62
 although this was then reduced to a period of 2 years from being stable as a result of Lara’s direct 
confrontational actions 
63
 See chapter four, 4.3.2 and chapter nine.  
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Looking at the content and context of each meeting, certain patterns emerge. There is 
evidence from these meetings that aspects of the shared decision making process are not 
fully adhered to. A full or complete set of options are not presented by Dr Kos in any of 
these meetings. The weighing up of pros and cons and, in particular, the important 
considerations of side effects, and how these relate to the service users ‘life world’, is not 
fully considered in these meetings. There is some evidence that experiential knowledge is 
valued by Dr Kos in these encounters, and the idea of a ‘meeting of experts’ applies to 
some of the excerpts analysed (e.g. see Lara and Rosie).  
 
Looking at the conversational strategies employed by Dr Kos there are also similarities 
between the meetings. In all meetings,  Dr Kos maintains good rapport keeping a similar 
tone of voice, pace and style through each of the four meetings, only on rare occasions 
resorting to strategies  associated with traditional institutional encounters such as  saving 
face and preserving social identity (e.g. see Rosie, S. 8.3.1. lines 43-50). Dr Kos does, at 
times become more directive in the decision making process, through the use of treatment 
proposals and treatment questions, but in general is happy to ‘led’ by the service user’s 
proposals about medication, when given (e.g. in the case of Rosie, Lara and Linda). 
 
 In summary, whilst Dr Kos provides opportunities for several aspects of SDM (valuing 
experiential knowledge and supporting service user preferences), these opportunities are 
not always taken up by the service user. In addition, none of these meetings demonstrate a 
full weighing up of the pros and cons of psychiatric medication and certain information is 
brushed over by Dr Kos in the encounter. This overview is slightly at odd from the 
summary of Dr Kos's interview findings. In the interview Dr Kos discusses the importance 
of service users having ownership and taking increased responsibility for managing 
mental health problems. Dr Kos sees her own role as presenting a balanced argument for 
the pros and cons of different psychiatric medication alternatives (see page 143) . She was 
the only psychiatrist interviewed who disagreed that lacking insight would not prevent a 
person being involved in decisions about psychiatric medication. As such, Dr Kos appears 
to value an informed model of decision making,  and perhaps more so than her colleagues. 
However, this is slightly at odds to the findings from the applied CA, in that a full 
investigation of the pros and cons of medication options was not fully explored. 
Nevertheless, as mentioned, Dr Kos does provide opportunity for other aspects of SDM 
(exploring service user preferences) and when opportunities are pursued by the service 
user (e.g. in the case of Rosie and Lara), Dr Kos is happy to be guided by service user 
preferences. 
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There are also large differences in the conversational dynamic between these meetings. In 
particular, when analysed for power claiming and power sharing strategies, exerted by 
service users, there is little similarity between the meetings.  The four meetings represent 
a wide spectrum of service user involvement in decision making about psychiatric 
medication. To represent this idea, the four meetings have been imposed onto the diagram 
below (Figure 12 - initially presented in the literature review chapter), to show the 
spectrum of participation observed in the discourse.  
 
In Figure 12 below, Linda's passivity in the encounter may be represented at the foot of 
the arrow, in the realm of a paternalistic model of doctor patient communication. Carl's 
dialogue is more similar to interpretative decision making, where the 'patient' has the role 
of presenting as much information as possible, including preferences and opinions, before 
the doctor suggests treatment. Rosie broadly sit more towards the shared end, exerting 
treatment proposals and jointly weighing up the pros and cons to reach consensus. Lara's 
discourse, at times, has similarities with the principles of shared decision making, ie. 
expressing opinions, valuing different forms of knowledge, building consensus towards a 
joint decision. However, at other times (e.g. S. 8.3.4. lines 163-170) Lara's discourse is also 
suggestive of the informed model participation, over riding Dr Kos' opinion and taking 
ownership of a decision.  
 
Figure 12. CA Cases imposed on models of doctor - patient decision making. 
Linda 
Lara 
Rosie 
Carl 
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This diversity in participation is interesting, given the strong institutional norms and 
power inherently present in this setting. One explanation could lie with the 
acknowledgement of the importance of service user preferences towards involvement.  
This is supported, in part, in the re-examination of key themes from the interviews with 
each of the four service users.  For example, Lara discusses valuing a shared approach and 
is also the only interviewee who mentioned receiving multiple medication options, being 
left to decide independently. Carl, on the other hand, refers to valuing the psychiatrist and 
GP taking a leading role, seeing his role as being honest and providing all relevant 
information. However, Rosie and Linda provide a less straight forward link. Rosie, in her 
interview, refers to not feeling informed and not having a say or being assertive, yet 
demonstrates a number of power claiming strategies in the recorded meetings. Linda, on 
the other hand, refers in the interview, to valuing collaborative approaches which value 
her experiential knowledge in the decision making process, yet in these dialogues, remains 
strikingly passive, not, for example, using any narrative or story telling strategies to 
promote co-constructed topics in the recording. 
 
Another interpretation of this diversity, is the importance of the recovery journey for 
changes in discourse dynamics. Across all interviews with service users, there was 
acknowledgement that increased guidance was valued when in a crisis. Processing and 
retaining information and expressing preferences or opinions was seen by service users as 
problematic during these more difficult times. At these times service users value increased 
guidance from practitioners and at times feel less able to take an assertive role in the 
encounter. Increasing control over decisions and being informed, was seen as a longer 
term goal and part of the recovery journey.  On the face of it then, there is a relationship 
between stage of recovery and participation in the dialogues observed in this chapter. For 
example, in the first excerpt, Lara refers to feeling much better and doing well.  Lara is 
happy to assert control over plans for the future and approaches Dr Kos as an expert of 
medication, but not as holding any particular 'power over' these plans for the future.  
Indeed, the fact that Lara directly questioned Dr Kos about the long term role of  her 
medication suggests Lara is perhaps farther down the path of recovery and more able to 
see beyond initial distress.  In contrast, it is possible that Linda was experiencing more 
difficulties when this meeting was recorded, thereby reducing the levels of her 
participation in the meeting and increasing the value she places on guidance from the 
psychiatrist.  Indeed, at the time of this meeting, Linda was in frequent contact with three 
psychiatrists from different teams, which may be indicative of current or recent acute 
problems. 
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Alternatively, it may also be important to note that, in contrast to most other interviews 
with service users, Linda places little value on the importance of an ongoing supportive 
and positive relationship with practitioners, instead focussing on the interactional 
components of shared decision making. Perhaps the strikingly passive stance adopted by 
Linda is therefore indicative of not having established a therapeutic bond with a 
practitioner. This is corroborated by the contextual background, in that it is only Linda's 
second meeting with Dr Kos.  
 
Regardless of the reasons, Linda's case does present particular challenges for SDM. This 
dialogue appears a highly asymmetrical encounter, yet Dr Kos does attempt, at times, to 
move the meeting towards a more shared dialogue also exerting cues which are 
reminiscent of dissatisfaction with the meeting dynamics (e.g. sighing in line 101, S. 8.3.3). 
This may link with the concern that emerged from a minority of psychiatrists in the phase 
one interviews;  of feeling a certain pressure from a minority of service users to be ’fixed’ 
or ‘cured’.  For example, the quote by another psychiatrist in phase one may be relevant to 
explore: 
 
Dr White: but it’s also I think the sort of decision making power that she sort of puts 
with you and sort of tell me what to do, tell me what to take to fix it, and that’s a sort 
of pressure on and I suppose my overall view of this is that this is not the thing that is 
going to help you the most, but I think it somehow the inability  of me to convey that 
to her maybe because she’s quite agitated and therefore it becomes very difficult to 
have a conversation whose continuously agitated and remain patient I think, There is 
something about the  pressure that anxious people put on you to fix it that really 
makes it very hard to have that conversation 
 
Related to this, it may also be important to consider a theme presented at the system level: 
the increased medicalisation of mental illness and societal expectations of prescribing. In 
other words structural factors may be important to consider when interpreting cases such 
as Linda's (and perhaps to a certain extent Carl's), who either prefer or expect a more 
traditional paternalistic encounter. This may be influenced by the structural dominance of 
an overly medicalised perspective of mental illness, thereby devaluing experiential 
knowledge and reducing preferred and actual levels of involvement. 
 
One conclusion that can be drawn from this discussion is the importance of considering 
both participants (practitioner and service user) in a shared dialogue. Much of the SDM 
literature is dominated by skills and communication requirements needed by doctors or 
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medical professionals. The diversity represented in only four meetings explored here, 
emphasises the need to instead  view SDM as involving two participants or ‘a meeting of 
experts’ achieving a sense of what meaningful involvement is for psychiatric medication 
management practice, and focussing, in particular, on what enables increased control in 
the longer term recovery journey.  
8.5. Chapter summary 
 
In summary, the four meetings have been analysed using an applied conversational 
analysis, examining power claiming and power sharing cues employed by both 
participants in the encounter, and thereby exploring how decisions are shared about 
psychiatric medication in practice. In addition, the use of a case study approach and re-
examination of interview data, has enabled increased insight into the challenges and 
opportunities for collaborative psychiatric medication management.  
 
The four meetings presented show that most participants were happy to employ power 
claiming cues and Dr Kos, at times, assisted this by employing cues more associated with a 
'conversational genre' of discourse. Whilst the encounters remained somewhat 
asymmetrical given their institutional setting, service users showed multiple instances of 
directing the topic and speaker rights in these meetings. Often decisions could be 
considered to be 'shared' by both valuing experiential understanding from service user 
participants and the medical expertise of the psychiatrist.  
 
Nevertheless the meetings did not conform to the ideals of shared decision making, in that 
a full set of options were not presented and the pros and cons, especially the consideration 
of important  side effects were not fully considered in these meetings. 
 
 In addition, the levels of service user participation varied greatly between meetings.   The 
possible reasons for some of these differences have been briefly discussed. Through 
exploring this diversity and complexity, a rich conceptualisation of shared decision making 
for psychiatric medication management is emerging.  
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Chapter Nine.  Discussion  
 
 
 
 
 
 
 
 
 
9.1. Overview of findings 
 
There were two overarching research questions for this thesis: 
 
What are stakeholder views about SDM for psychiatric medication management? 
How are decisions about psychiatric medication made in practice? 
 
Looking across findings from phases one and two of this study, broad support for 
collaborative ways of managing psychiatric medication has been found across all key 
stakeholder groups.  All participants were able to recall examples of positive meetings 
where decisions about medication took place. In addition there were similarities across 
stakeholder groups of valuing open and honest dialogues. In part, this was supported by 
the applied conversation analysis findings (phase two). Here rapport was observed and 
power claiming activities were frequently asserted by some service users, which were in 
turn readily supported and maintained by the psychiatrist.  The institutional asymmetrical 
norms of the encounter, at times, were far less apparent and the ideals of a meeting of 
experts was applicable.  
 
Nevertheless while pockets of best practice were observed in the findings, many barriers 
to shared decision making emerged. When looking in more depth, a more ambiguous and 
nuanced approach to shared decision making emerged. A wide amount of diversity and 
complexity is observed, both within stakeholder groups, between stakeholders groups and 
across the recorded meetings in phase two.   
Chapter outline 
The chapter begins with a summary of the key findings from the thesis, linking these to 
models of shared decision making presented in the literature review chapter. The 
remainder of the chapter explores the diversity and complexity emergent in the data, 
relating this to relevant empirical research and theoretical concepts.  Three levels of 
analysis are employed to structure the discussion: the interaction, the relationship, 
and the system. 
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9.1.1. Linking findings back to models of SDM 
Comparisons to transactional models of shared decision making show that the combined 
findings across data collection phases do not fit well with the established models 
presented in the literature review chapter. For instance, Charles, Gafni and Whelan (1997; 
1999) contend that for SDM to exist, four stages are required, resulting in consensus over 
the final decision. Other theorists have offered alternative interpretation but retain the 
priority on transactional requirements for practitioners: offer choice;  explore (with the 
service user) a full range of pros and cons and;  consider service user preferences towards 
participation (Makoul and Clayman, 2006; Edwards and Elwyn, 2009).   
 
On the whole, this data sits outside these prescribed models of SDM in that: 
 
1. Participants reported that relevant information is not always shared, either by 
the psychiatrist, who delivers minimum levels of information (e.g.  side effects), or 
by the service user (who at times may conceal or withhold clinically relevant 
information). 
2. At times, pressure is applied by the psychiatrist to encourage consensus on a 
preferred outcome (thus satisfying one criterion for SDM). However, this is not 
necessarily experienced by the participants as building consensus, but instead is 
illustrative of a more traditional asymmetrical encounter. 
3. Explicit checking (by practitioners) of service user preferences towards active 
involvement in decisions about psychiatric medication does not emerge in this 
data64  
 
 SDM as a model, focused on requirements and actions, may relate well to other medical 
arenas where, for example, there are several well known treatments with equivalent 
outcomes and a onetime decision is needed. However, a far more dynamic and 
interactionally complex picture of service user involvement, shared dialogue, and 
collaboration in psychiatric medication management has emerged from this thesis.  
 
Instead a broader conceptualisation of SDM is supported by the findings.  A non-specific 
conceptualisation of SDM, where individual decisions are part of a longer-term dynamic 
process, is highlighted by stakeholders interviewed in phase one. This is similar to models  
proposed by other authors, for example, Entwistle and Watt (2006), Olthuis, Leget and 
                                                             
64
 Described as a ‘meta’ component of SDM. 
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Grypdonck (2012), Matthias et al (2013) and Moreau et al (2012). In these broader 
conceptualisations, emotional and affective components of the decision making process 
were emphasised. For example feelings and views about roles and contributions to the 
process emerged from the data, suggestive that reflective processes such as feelings of 
being in or giving control and having an influence were at the forefront of 
conceptualisations of SDM.  Values associated with medication decisions sitting within the 
ongoing recovery journey were also illustrated (Corrigan et al, 2012; Deegan and Drake, 
2006).  For example, promoting service user control, real choice and increased 
empowerment towards ideals of self management were positively reinforced by 
participants.  Medication decision making as a protracted process of trial and error was 
also emphasised (Davidson, Miller and Flanagan, 2008).  Conversely, support for 
paternalism and compliance, whilst occurring in a minority of cases, was not a dominant 
trend in themes from interviews.  However there remained a gap between idealised values 
on the one hand and actual practice on the other.  
 
A high degree of complexity was present in the data, pointing to more subtle and insidious 
barriers still being prevalent for SDM in psychiatric medication management. It is this 
complexity which forms the focus of the remainder of this chapter. The enablers of and 
barriers to meaningful service user involvement in psychiatric medication management 
practice are presented at the interaction, relationship and system levels of analysis65. 
Many points of discussion emergent from the findings are interlinked and cannot be 
separated into three clear layers. The layers serve to provide structure and assist with the 
discussion of the findings.  
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 the three level onion diagram is used as a framework for presentation and discussion. 
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9.2. The Micro (interaction) level.  
Valuing        Encouraging
Autonomy        Adherence
Reinforcing    Limited info 
information            about side
effects
Valuing SU            Asymmetry
Expertise
Being ill
vs. Lacking 
insight
VS
 
Figure 13. Barriers to and enablers of SDM at the interaction level  
9.2.1. Areas of commonality in the data 
Firstly, themes emergent across stakeholder groups will be briefly explored, before 
examining the diversity in findings present at the micro level.   
 
Enabling service users’ greater ownership and enhancing control over decisions about 
psychiatric medication was endorsed by all stakeholder groups in phase one interviews.  
Additionally, service user input to meetings was seen as important across data sets. In 
particular, in the phase two recorded meetings, when power claiming strategies were 
employed by service user’s,  these were supported and maintained by the psychiatrist, 
giving the impression of support for the service user taking a more active role in the 
decision making process.  All stakeholder groups from the phase one interviews 
highlighted the importance of providing information clearly, using clear language and 
reinforcing information to make it easier for service users to partake in the decision 
making process about psychiatric medication.  The importance of understanding and 
weighing up the pros and cons of psychiatric medication and their associated side effects 
was strongly valued by all stakeholder groups. Thus, on the face of it, there was broad 
positive support for increased service user control, autonomy and choice over decisions 
about psychiatric medication, with all stakeholder groups suggesting that these factors are 
conducive to recovery oriented practice and outcomes. Recent research is supportive of 
this prospective link, finding that regardless of severity of symptomology, the provision of 
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choice has a strong relationship with recovery outcomes, engagement with services and 
adherence to interventions (Stanhope et al, 2013; Davidson et al, 2012).  
 
However, the findings from this thesis also point to a gap between the ethical ideals of 
SDM and actual practice. Broad support for increased service user involvement was found,  
yet the findings from both phase one and phase two suggest that only a limited 
presentation of options is occurring. Whilst notable exceptions exist (for example, see 
Lara's interview where 7 or 8 alternative medication choices were presented in one 
meeting, S. 5.3.1), the overwhelming flavour of the findings across data sets suggest an 
incomplete presentation of options and a lack of detailed weighing up of risks and benefits 
of psychiatric medication in psychiatric medication related discussions.    
 
Provision of information concerning side effects is an important consideration at this 
point. All participant groups acknowledged that at times, the information provided about 
associated side effects of psychiatric medication was limited. Similar to previous research, 
the findings suggest that although service users demonstrate sophisticated mechanisms 
for gaining knowledge about medication, including using the internet, speaking with peers 
and other medication experts, such as pharmacists, most referred to valuing the exchange 
of information in the context of the consultation with the psychiatrists’ (Simon et al, 2007; 
Pestello and Berman, 2008). Yet, in this context, service users often referred to not 
receiving enough adequate information concerning potential adverse effects for new 
medication alternatives, and many participants had had previous negative experiences of 
associated side effects of psychiatric medication. Psychiatrists also openly acknowledged 
that, at times, information about side effects are only scantily explored. Psychiatrists 
referred to focussing on secondary symptoms when describing psychiatric medication, 
often in order to avoid conflict and encourage adherence. In addition, some psychiatrists 
openly referred to withholding certain types of  information that related to longer term or 
embarrassing side effects.  For example, Dr Loh (S. 6.2.2) openly admits his difficulty in 
discussing sexual dysfunction as a potential side effect.    
 
The applied conversation analysis in phase two highlights the gap between ethical ideals 
and practice further. The analysis depicted interactions where information on side effects 
is brushed over by the psychiatrist and where a full exploration of options is not apparent 
(e.g. see Rosie and the discussion of side effects, S. 8.3.1).  The findings are therefore 
consistent with the literature showing that real choice for decisions concerning psychiatric 
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medication is limited, often not consisting of a joint weighing up of the risk benefit profile 
for psychiatric medication options (Matthias et al, 2012; Mendel et al , 2009).  
9.2.2. Discordant discourses 
9.2.2.1. Valuing increased choice vs. encouraging adherence 
The potential reasons for the discrepancy between the values of choice and autonomy on 
the one hand and actual practice needs further investigation. This discordance is 
reminiscent of Seale et al's (2006) study into psychiatrists’ experiences where such a 
paradox was also observed66. In addition, recent research has also found juxtaposed 
discourses (by family doctors in Canada in treating depression) of doctor influence, 
professional judgement and expert knowledge alongside service user autonomy and 
ownership of decision (McMullan, 2012). In explanation it has been suggested that 
psychiatrists strongly value the role and evidence base for medication, which largely 
excludes the service user’s experience of taking medication (Chaplin et al, 2007), and that 
this is likely to reflect the view, based on training and research, that taking medication is in 
people's best interests (Baker et al. 2013; p. 4).  Thus this data indicates that components at 
the system or structural level may hinder open and honest dialogue from emerging. For 
example, McMullan (2012) concludes that:  
 
...[the] taken for granted nature of  patient choice in treatment decision making can 
be seen as paradoxical: a state of being [depression] that has become increasingly 
medicalised and, by definition, under the authority of the physicians, from the 
viewpoint of the family physician,  is ultimately under the authority of the patient. ...is 
this construction of decision making understood as a balance of power between 
physician and patient?  
         (ibid, p.247) 
It has been suggested that the two discourses of choice and autonomy alongside 
judgement and expert knowledge do not necessarily prevent shared decision making 
(Karneili-Miller and Eisovits, 2009). For one psychiatrist, this emphasis on service user 
ownership and control was promoted even when a service user was deemed to lack 
insight67 into being ill.  
It's not about insight, I think if someone hasn't got an insight and I feel that very 
strongly he suffers from a mental illness he needs to take medication, again it would 
be a decision made by him, if he doesn't want to take it, he doesn't take it. 
         Dr Kos, S. 6.2.4.  
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 See Literature review chapter for further details of this study 
67
 See S. 9.2.2.5 for discussion of lack of insight as a barrier to involvement 
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Thereby suggesting that valuing medication, in of itself, should not prevent the service 
user being at the centre of the decision making process or take away from the control or 
ownership over the decision.  However the findings from phase one interviews also 
suggest that both practitioners fear and service users acknowledge that painting a picture 
of false compliance to 'keep the peace' is still an option, thereby highlighting a lack of trust 
in the encounters.  Indeed this false compliance scenario was deemed as a particularly 
concerning aspect of medication management practice. It was often used to conceptualise 
examples of negative meetings by both service users and psychiatrists in the critical 
incident section of research interviews68, being illustrative of the deeper underlying 
problems of both not having formed trust in the longer term relationship and maintaining 
face in the encounter (Seale et al, 2006). 
 
9.2.2.2. A spectrum of participation 
Nevertheless, across both data sets, there remained a wide spectrum of participation by 
service users in decisions about psychiatric medication. For phase two, a spectrum of 
participation is apparent across the recorded meetings. This is especially striking given 
that the same psychiatrist was present in all four meetings. Nonetheless, this diversity also 
emerged from the interview data, within each of the stakeholder groups. The complexity 
of the situational specific context of the meeting, both in terms of the service user 
preferences towards participation, their current state of wellbeing and distress at the time 
of making a decision, the therapeutic alliance, as well as the psychiatrist's background, 
style and approach point to a wide range of involvement happening in medication 
management practice.  Models such as Quirk's spectrum of pressure are useful to consider 
at this point (Quirk, 2007; Quirk et al, 2012). Quirk proposes a typology of pressure 
ranging from ‘open decisions’, akin to aspects of a concordant relationship through to 
'pressured decision making', reminiscent of more coercive practices69.   
 
Drawing on this work and the related research of Seale, Chaplin and Lelliott (Seale et al, 
2006; Chaplin et al, 2007), Table 10 below presents findings from this thesis as a typology 
of potential involvement70. The typology presented aims to represent the diversity in 
participation observed across the data from stakeholder groups, constructing shared 
                                                             
68
 For example, see Dr Loh, S..6.2.4 
69
See Literature review chapter for further details 
70
 Quirk (2007) also presents the term 'tactful manipulation' which has been adopted in the description of 
the 3rd typology proposed from this data. 
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medication management practice in mental health71. Each type is presented as a 
hypothetical typical example interaction. To note, while similar, the typology presented in 
table 10 is qualitatively different from the afore mentioned work of Quirk and colleagues, 
which predominantly focuses the psychiatrist’s perspective and actions72.  
Type of involvement Examples 
Active self management Service user adopts active power claiming strategies in 
conversation, asserting opinions and preferences and 
asking questions (e.g. see Lara's recorded meeting – S. 
8.3.4). Prescriber assists process and provides 
information on pros and cons, being led by service user 
preferences. 
Final decision deferred to service user, who asserts 
preference then and there or following full review of 
relevant information (e.g. Lara's interview, S. 5.6.2, Dr 
Percy’s interview, S. 6.2.1, CPN Mark, S. 7.2.1).  
Shared  Discussion and dialogue over possible options and pros 
and cons of a new medication or coming off medication. 
Psychiatrist presents opinion on best course of action, but 
in consideration with service user. Service user brings 
experiential expertise to the meeting and this is reflected 
upon in the encounter. There remains a conversational 
style with little asymmetry (e.g. Dr. White, S. 6.2.1, 6.5.2, 
Dr Black, S. 6.3.1, Holly and Lara S. 5.6.2)  
Tactful manipulation Psychiatrist steers patient towards new medication, 
possibly avoiding concerns raised about side effects (e.g. 
Rosie's recorded meeting , section 8.3.1). Service user, 
whilst participating in conversation and at times direct 
topics in conversation, happy to be led by psychiatrist 
expertise on final decision. No objections raised and 
mutual consensus (e.g. CPN Heather and Elsa, S. 7.2.2, 
Carl, 5.6.2, Dr Bloggs, 6.5.2). 
Fractured passivity In one offshoot of this typology, the service user remains 
overtly passive in conversation and avoids opportunities 
to direct topics or assert preferences towards goals or 
problems to be discussed. A sense of helplessness 
emerges. (e.g. See Linda's recorded meeting, 
8.3.4).Psychiatrist uncomfortable and unsure how to 
progress conversation (see Dr White, S. 6.2.3).  
 
                                                             
71
 CPNs are directly mentioned less in this part of the discussion. Reference to specific meetings about 
psychiatric medication often centred around prescribers (psychiatrists only in all cases locally in this 
setting) and service users. However thematic findings from CPN data forms part of the typology 
presented  
72
 In Quirk et al’s (2012) article the service user’s actions are considered in the analysis, but with more 
emphasis on either agreement and or resistance to the psychiatrist actions. 
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Another scenario in this typology is if the practitioner 
deems the service user to lack insight into being ill. The 
practitioner is unlikely to explore range of options and 
embarks on tactful manipulation above (e.g. Dr. White, S. 
6.2.4). The service user may be less willing to express 
their views, may adopt more subversive strategies and 
'false compliance' is a possible outcome (e.g. Dr. Black, S. 
6.2.1. Terry, S. 5.5.1) 
Table 10. Typology of service user involvement, across data sets 
 
Notably, unlike Quirk (2007), findings did not emerge that fall into a typology so named 
'pressured decision making', where the service user actively resists and the psychiatrists 
'presses on’, falling more towards the ideas of overt coercive encounter ( p. 310). This is 
likely to be related to contextual differences between the studies. Most notably, this study 
has been conducted in a treatment setting where people are likely less likely to have 
received coercive practice and problems  associated with historical institutionalisation are 
rare (see chapter one for further description).  
 
In its place I refer to the typology I have labelled 'fractured passivity'. This term has been 
adapted from the recent work of Margaret Archer (Archer, 2012), a British sociologist, 
who has explored social identity and the role of reflexivity in the relationship between 
human agency and social structure. Archer uses the term fractured reflexivity to describe 
one of four modes of reflexivity practised by all of us, including in the internal conversation 
we hold with ourselves (Archer, 2012, p. 12). She defines it as taking place when internal 
conversations cannot lead to purposeful courses of action, but intensify personal distress and 
disorientation resulting in expressive action (Archer, 2013, p.13). This term was adapted for 
its poignancy, suggestive of those meetings where there is no orientation towards 
purposeful action by service user and a lack of reflexive response to opportunities, 
indicating a suspension of personal power.  
 
The spectrum seems to link well to established ideas of agency and participation in the 
literature (e.g. see Tritter and McCallum, 2006; Gabe, Bury and Elston, 2004; Arnstein, 
1969), highlighting how different aspects of agency are available to service users in the 
encounter.  Thus, these findings point towards a need to explore the dynamic process 
further. In other words, why is such a spectrum of involvement observed in this data?  
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There are various ways in which an answer to this question could be approached. The 
argument could be presented that individual differences in service user preferences to 
participation and decision making are important to consider. The recent and ongoing 
work of Puschner et al (2013), in the pan European CEDAR study has developed measures 
to explore clinical decision making style (CDMS) alongside involvement and satisfaction 
scales (CDIS) to measure service user and practitioner preferences towards participation. 
A few observations from this study link to the discussion of the diversity found in the data. 
The findings from the initial phases of the CEDAR project indicated that a majority of 
service users prefer shared (as oppose to passive or active) participation and wish for a 
high level of information (as opposed to moderate requirements expressed by 
practitioners) (Pushner et al, 2013).  This fits with a sub theme emergent from the 
qualitative data from interviews with service users; the importance of timely, accurate 
information, especially for side effects, delivered in a way which is easily accessible and 
personalised to the situation at the time. In the Pushner et al (2013) study, a preference for 
participation was shown to be a trait like stable component of the person influencing 
preference for decision making style, supportive of previous research which has also 
found stable demographic differences in individual preferences of participation (Say et al, 
2006; O Neal et al 2008; Hamann, 2005).  However, the sub scale, preference for 
information, was separate to the participation component of the scale and positively 
correlated with stages of recovery measures (e.g. STORI model; Anderson, Oades, Caputi, 
2003; 2006). This thereby suggests that preference for information may be particularly 
and positively related to stages of recovery with aspects such as desire for increased 
control and self management being less applicable to consider as a stable individual 
difference.   
 
 Hence it appears that the typology, rather than just an underlying stable preferences 
towards participation style in an encounter, may also relate to what stage a person is at in 
their recovery journey.  This impacts on preferences about how much information a 
person desires and feels able to process at a specific time. Indeed there is a conceptual 
overlap with the typology presented and the validated STORI model73 (Andresen, Caputi, 
Oades, 2006). In particular, the stages of moratorium (stage 1) map onto the fractured 
passivity, associated with hopelessness and withdrawal, and the active self management 
typology links with the later stages, 4 and 5; rebuilding and growth. Of note, such models 
give an impression of linear progression through stages, which is potentially misleading. 
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 See chapter three for further details of this model 
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But if viewed as a typology, with overlapping and qualitatively different components, this 
connection is potentially useful to consider in exploring the diversity in the data and ideas 
of an iterative journey, over time.   
 
The typology may also link with ideas of the process of recovery and the consequential 
changes in identity.  Buck et al (2013) suggest that the recovery process itself creates 
challenges and a sense of loss alongside the acceptance of agency. The typology 'fractured 
passivity' may therefore represent challenges associated with the acceptance of agency in 
the recovery journey. By accepting agency, there may be experience of no longer being 
unique and losses to previous sense of identities, or making meaning of the world.   'At 
times the return of a sense of agency empowered him, but at other times it was terrifying and 
filled him with anxiety and uncertainty, particularly when he struggled with reclaiming his 
identity’. (Buck et al, 2013, p. 138).   
 
9.2.2.3. Valuing guidance in a crisis and the importance of reinforcing 
information 
A strong theme from interviews with service users in this study was that a key barrier to 
being involved in decisions were the problems of being able, in a crisis, to process 
information, as well as increasing problems with communication and expression, 
impacting on how involved it was possible to be. Clear communication and the need to 
reinforce information during these more difficult times was recognised by all, so that the 
service user may consider the options fully. Providing multiple methods of information 
provision, but with an emphasis on clear communication about the pros and cons in the 
context of a conversation with the practitioner, was valued, as was the need to revisit 
information.  For service users, a particular emphasis was placed on valuing guidance 
from the practitioner during these more difficult times, but in the context of a longer term 
relationship74.  This sat alongside the ideals of the longer term goal of increased control, 
awareness and self management in the medication management process.  The value placed 
on reinforced information during these more difficult periods was seen to enable feelings 
of increased control. Many participants referred to specific tools, such as a written letter in 
follow up to the meeting, provision of additional leaflets and access to online resources, 
enabling the service user to 'revisit' the information. Also the use of advance directives, 
crisis plans and establishing views and preferences towards medication was seen as 
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possibly helpful for involvement, during these more difficult times (although to note, 
advance directives did not emerge as common practice). The findings therefore support 
literature which has shown decision aids and reinforcing information may be of particular 
importance to assisting service user involvement during more difficult periods (Hamann, 
2006; 2011; Duncan et al, 2010; Drake et al 2009; Ben-Zeev et al, 2012). The value placed 
on dialogue and receiving information in the context of existing relationships points to 
coaching as a tool as particularly relevant for medication management practice (O Connor, 
Stacey and Legare, 2008; Coulter and Ellins, 2007).   Regardless of approach or strategy 
focused upon however, according to Coulter and Ellins (2007) in the review of this 
literature ‘health information materials, decision aids…and other technologies or patient 
engagement are most effective whether they supplement, rather than replace, interactions 
between patients and professionals (ibid, p.27). 
 
In summary, these findings point to all stakeholder groups valuing the ideals of medication 
management operating within a recovery oriented practice.  'Hope, agency and 
opportunity', as guiding principles seem widely supported by these findings, yet as 
mentioned above, there is nevertheless a significant gap between ethical ideals and actual 
practice (Shepherd, Boardman and Slade, 2008; RCPsych, 2010; Ranz, 2008).    
 
9.2.2.4. An asymmetrical encounter 
Differences between service users conceptualisations of SDM as compared to psychiatrists 
and care coordinators are worth consideration. Service users often describe feeling 
patronised, feeling like a child and being spoken down to. This points to the perception 
that the doctor knows best as still common in modern day psychiatric practice, together 
with an explicit notion that users of services may not have the capacity to decide for 
themselves, or that their understanding of the situation is not valid (Zisman-Iliani et al, 
2013). Psychiatrists were less likely to acknowledge these barriers in the interviews. This 
points to an asymmetrical encounter between the psychiatrist as the prescriber and the 
service user as recipient.  The asymmetry is touched upon in chapter eight75, although as 
discussed above, a slightly more complex picture emerges, instead suggesting that service 
users, at times, feel able to embark on a far more assertive stance in the interaction and 
that, at least for this psychiatrist in this study, this was supported in meetings. 
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 The applied conversation analysis for phase two recorded meetings 
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9.2.2.5. Being ill vs. lack of insight 
A second but crucial difference between stakeholder groups in the data concerns how 
illness symptoms are conceptualised. As mentioned above, all stakeholder groups mention 
that being ill or in crisis hinders involvement. But psychiatrists and to a lesser degree CPN 
care coordinators frequently emphasise that that a lack of insight, perceived as a deficit, is 
a key barrier to service users engaging in collaborative dialogue. Practitioners 
acknowledge that when working with a person deemed to lack insight into being ill, 
communication style may change, less information is provided, and at times discursive 
practices are used that could be described as subtle forms of persuasion(Chaplin et al, 
2007; Seale et al, 2006;Quirk et al, 2012).  For service users on the other hand, lack of 
insight was not mentioned frequently as an important barrier to full participation in 
decisions about psychiatric medication.  When, it was mentioned, lack of insight was not 
prioritised as a particular barrier over other issues. Instead, the emphasis is on the impact 
of increased distress and lower levels of concentration and other cognitive functions such 
as memory and motivation, as being by far the biggest challenges to both feeling involved 
and fully participating in a shared and open dialogue. These may be consequences of 
either the illness itself, or side-effects of taking medication, although the latter appears not 
to be recognised as a barrier to SDM by practitioners in the interviews.    
 
This discrepancy needs further exploration. Recent research by Wei Wen Chong et al 
(2013) has also highlighted differences in perceived barriers of SDM related to notions of 
competency and insight. This study, which undertook qualitative interviews with both 
general  health and mental health practitioners, including medical practitioners 
(psychiatrists and GPs) as well as pharmacists, nurses, psychologists, occupational 
therapists and social workers,  found that only mental health practitioners frequently 
perceived a lack of competence to be a primary barrier to shared decision making, 
whereas clear information provision was highlighted by all as an important enabler. Lack 
of insight, as a perceived barrier to SDM, is particular to decision making in mental health 
settings, most of which revolve around psychiatric medication (Moncrieff, 2009). In 
addition and according to my data, this view is emphasised by practitioners, as opposed to 
being a more general concern shared by service users, indicative perhaps of wider 
negative attitudes towards mental illness by professional groups (Hansson, 2013). 
 
Nonetheless, despite practitioners’ reservations, insight into illness should not, in itself, be 
seen as a pre-requisite to engaging in SDM. In the literature review chapter, research was 
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presented which showed that service users are capable of participating in most decision-
making situations (Loh et al, 2007b).  When additional support is required, recent 
research has suggested that training in 'meta cognition' may assist with increasing levels 
of service user involvement in decision (Chan and Mak, 2012). This is in addition to the 
research which has conversely found a relationship between 'having insight' and more 
negative outcomes for mental health, suggestive that acceptance of a diagnosis may in fact 
be related to issues such as internalised stigma, which in turn are detrimental to longer 
term prognosis (Lysaker, Roe and Yanos, 2007). 
 
‘Lack of insight’ so termed  by the practitioners in the findings, whilst being described as a 
symptom of the mental health problem in question, could also be seen as a ‘symptom’ of 
the wider system and one tool in the existing power structures of a psychiatric system 
dominated by overly medicalised perspectives.  One of the implications of this finding is 
linked to the ideas of having 'capacity' to make decisions. According to Davidson et al 
(2012b):  
'....by viewing patients as unable to make their own decisions, set their own goals, or 
pursue  their own dreams, until or unless they have recovered. However one of the 
several important things missing from such an approach is any recognition that 
making one‘s own decisions, setting owns goals and pursuing one's own aspirations 
are all crucial components of the recovery process itself.  By discouraging this, 
mental health services have unfortunately relegated the person to and kept him or 
her trapped within a passive, dependent, disabled and despondent role.  
          (ibid, p. 85) 
 
9.2.2.6. Service User Knowledge vs. Medical Expertise 
The emphasis placed by practitioners on lack of insight as a barrier may then instead point 
to experiential knowledge as present only at the periphery of the decision-making process, 
and diagnosis, labelling and othering at the fore.  According to Zisman - Iliani et al (2013, 
pp 151-152) there is a bias in psychiatry that persons with serious mental illness cannot be 
reliable reporters of their own experiences and that they cannot be valuable contributing 
partners to research, treatment, diagnostic processes. This is mostly represented in the 
findings by consideration of individual experiences and how these are explored in the 
context of psychiatric medication management decision making. It should also be noted 
that collective experiential knowledge that is built over time in groups, is also not referred 
to in these findings (Borkman, 1999). There appears both a lack of critical group reflection 
from practitioners, in that this did not emerge as common practice by practitioners in the 
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interviews. In addition, there was little or no mention of service users groups76 or 
collective mechanisms of involvement. In fact, I was keen to explore the role of medication 
support groups, but none were operational at the time of the study. An overly 
individualistic approach to mental health services in the UK, as compared to other EU 
countries, may explain these observations (see system level, S. 9.4 below). 
 
 Finally, another emergent difference in themes between stakeholder groups relates to 
emphasis placed on the importance of service user knowledge and expertise. Service users 
alongside CPNs were seen to emphasise the importance of valuing service user knowledge 
and expertise. This was less the case for the psychiatrists interviewed, who instead placed 
more emphasis on giving choice, handing over control and presenting information in a 
balanced way77.   These differences and the possible reasons for them are also explored 
below, at the relationship and system level. 
9.3. The relationship level  
Trust
Person
Centred
Breach 
of Trust
Being an
expert
Walking the
Journey
Roles & 
accountability
VS
 
Figure 14. Barriers and enablers at the relationship level 
                                                             
76
 To note, some SU participants did mention informal relationships with other peers as helpful  
77 See S. 9.2.2.1 above - Valuing increased choice vs. encouraging adherence 
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At the relationship level, enablers (left hand side of circle) and barriers (on the right hand 
side) are presented in Figure 14 above.  
 
The findings highlight the enabling role of the therapeutic relationship for ensuring 
continued and increased levels of service user control and ownership in medication 
management practice. All stakeholder groups refer to the establishment of trust as central 
to a meaningful shared decision making process for psychiatric medication management. 
Trust was seen to enable honest open dialogue which in turn enabled increased 
involvement.   It would appear that the establishment of a relationship plays a helpful role 
in the negotiation process for psychiatric management, both by encouraging the service 
user perspective to be better understood and through impact on open and honest 
dialogue. These findings support previous research which highlights the importance of the 
therapeutic relationship (TR) for service user control and increased agency over decisions 
(Simon et al, 2007; Davidson, Flanagan and Styron, 2008; Davidson et al, 2012;  Street et 
al, 2009; Farelly and Lester, 2014; Stanhope et al, 2013). In Stanhope et al's (2013) study, 
the therapeutic relationship played an important role in the impact of choice on recovery 
outcomes. According to the authors decisional conflicts or disagreement could be 
understood differently and have different outcomes, if they occur within the context of a 
trusting relationship between the service user and psychiatrist (ibid, p.199).   
 
The findings from phase one interviews also point to differences in how relationships are 
conceptualised by different stakeholder groups. Service users and most CPNs highlighted 
the importance of supportive nurturing aspects of the relationship, where 'knowing' the 
service user is at the fore. CPNs and service users refer to walking the journey together 
and formation of a partnership, where there is joint reflection on the recovery journey.  
Supporting service users through difficult times and celebrating success was also 
mentioned, in addition the importance of genuinely caring about the service user. These 
aspects of the TR were seen to buffer against problems of fully weighing up option and 
processing relevant information during periods of crisis. In these situations strong TRs 
were helpful through the acknowledgement that increased guidance was likely, but also as 
a way of tackling institutional stigma in the system (Denhov and Topor, 2011).  'Walking 
the journey' aspects of the TR were mentioned far less by psychiatrists, who instead 
viewed the role of the psychiatrist as providing expertise and advice to service users.  
 
At this point then, it is relevant to consider the differing roles of psychiatrists and CPNs in 
the conceptualisation of therapeutic relationships.    
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9.3.1. Walking the journey vs. Being an expert 
A dilemma for psychiatrists is the tension between the value placed on ideals of choice and 
self management for recovery but acknowledging their role as being 'the medication 
expert'; consultative and wielding power. Psychiatrists are the prescribers78.  In 
interviews with psychiatrists, the majority refer to recent changes in organisational 
structure impacting their role in psychiatric medication management, moving away from 
overseeing treatment and establishing long term relationships with service users, towards 
performing a more consultative role. Psychiatrists often were not seen to offer continuity 
of care but instead act as more remote experts.  
 
This is an interesting observation and does on the face of it present challenges towards the 
ideals of shared decision making which is built on the foundation of different forms of 
knowledge having equality and a 'meeting of experts' being applicable. For example, Fukui 
et al (2013) found that the incorporation of service user's perspective and preferences 
was the most important factor related to achieving agreement in an encounter. In order to 
encourage increased SDM, Roberts and Wolfson (2004) have emphasised a shift from staff 
who are seen as remote, in a position of expertise and ‘authority’, to the position of a 
personal coach or trainer: “offering their professional skills and knowledge, while learning 
from and valuing the patient, who is an expert by experience” (ibid, p. 38). 
        
 Whilst in of itself, these observations do not limit the possibility of such an encounter, a 
lessening of continuity of care and longer term relationships with service users and 
psychiatrists is likely to reinforce structural power in the encounter and a greater 
asymmetry, where medication information is withheld, options are not discussed openly, 
and where service users feel threatened and unable to express themselves.  The timely 
review by Farelly and Lester (2014) is also indicative of these challenges for achieving 
person centred approaches to care. The authors suggest that broader social and policy 
factors are associated with practitioners exerting control and limiting service users  
opportunities for service users to self determine (ibid, p.9). This is an under researched area. 
Some previous research suggests continuity of care is a particular concern for service 
users (Laugharne et al 2011; Noyes et al, 2011; Rose et al, 2009). However while some 
psychiatrists interviewed acknowledged the challenge of these changes, some positive 
implications were also expressed. These included links to increased personalisation and 
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 In this sample, some CPNs were also 'non medical prescribers'. However in the interviews conducted 
these skills were not being utilised. Only psychiatrists or in a small minority of cases, GPs were 
prescribing psychiatric medication. 
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self management in mental health services and giving the service user more control, as for 
example described by Dr. White in section 6.4.2. the patient has to see what the added value 
is..not just my view, it's also what's the patients view, is there anyone else that could 
potentially do that just as well.  Hence from this perspective the changing role of the 
psychiatrist may also enable the service user to take more ownership and increased 
control over the wider services they receive, deciding who is best placed to provide 
support. These values link well to the current and ongoing changes occurring across 
health care. For example, the Royal College of Psychiatrists released a statement in 
support of the introduction of personalised health budgets in March 2013 (RCoP, 2013). 
Repper and Perkins (2003) have neatly summarised this change to professionals being, 
“on-tap, not on top”. It implies a very different power relationship between professionals 
and the people they are there to serve. This also links to the related trend towards the GP 
being at the centre of a person's experience with the mental health system alongside 
increased provider and treatment choice. While personalisation is part of the wider 
economic neo liberal agenda, it also has the aim of encouraging greater service user 
control in interactions with mental health services. (DH, 2012b; 2010;2009). 
 
Nevertheless, there remains an incongruence between values of increased control, 
personalisation,  choice and ownership, and the strong emphasis placed by service users 
and CPNs of knowing the service user, building trust and support in the building of a 
longer term therapeutic relationship.  Indeed, Mind's (2012) publication reflects on these 
issues in their response to the huge transformational change underway throughout the 
NHS. The following quote is from Mind’s recent response to the government's second 
consultation document under the title 'no decision about me without me' referring to the 
changes towards providing choice in provision of GPs (Mind, 2012). 
 
Building this trust and creating a stable doctor-patient relationship is a result of long 
term contact with the same practitioner over numerous appointments….in general 
the ability to register with different GP practices is not a priority for people with 
mental health problems if they have spent many years building a trusting 
relationship with their GP. 
          (Mind, 2012, p.12) 
9.3.2. The therapeutic relationship and the role of the CPN? 
These concerns withstanding, this study highlighted many positive illustrations of 
relationships with psychiatrists and other practitioners, including GPs. No one ideal style 
or a list of competencies were described, but instead positive descriptions emerged of a 
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dynamic process over time with a joint formation of trust, respect, but also support 
understanding and listening as important elements.  This was supplemented by service 
users’ descriptions of 'going above and beyond the call of duty'.  This was seen as 
particularly poignant of a positive relationship with a practitioner, but interestingly has 
only received scant attention in previous research (Denhov and Topor, 2012). In addition, 
as mentioned above, the importance of 'knowing the person' was seen as especially helpful 
during more difficult times when more guidance was seen as necessary.    
 
The role of the psychiatrist and the move towards increased responsibility of GPs in  
medication management practice has briefly been explored. Given these findings, it is also 
important to explore the potential supportive role of the CPN in the medication 
management encounter.  
 
As discussed CPNs, often alongside services users, place importance on 'walking the 
journey together'. For the majority of service users, the practitioner knowing the person 
and seeing them over time in the journey of recovery with the CPN (or other practitioners) 
was a hugely helpful and enabling aspect for involvement in decisions about medication 
(e.g. see S. 5.4.3, Natasha). As mentioned the TR is a key enabling component for SDM, 
buffering against the challenges presented at the micro and macro levels of analysis.  
There is well established literature exploring the characteristics of helpful / therapeutic 
relationships and person centred approaches to care (e.g. Carl Rogers, 1902 - 1987). For 
community mental health service provision there is a growing interest in the components 
of TRs  and its links to concordance (e.g. Farelly and Lester, 2014; Davidson, Miller and 
Flanagan, 2008; Borg and Kristiansen, 2004; McGuire - Sniekers, et al 2007; Thompson 
and McCabe, 2012; Denhov  and Topor, 2011; Laughorne et al, 2011). Components of 
strong TRs emphasised by service users and CPNs support the previous research which 
have highlighted the importance of; ongoing reliable support through regular contact; 
active listening, and; the process of 'really knowing ' the service user, through repeated 
interactions. These components enable practitioners to help support service users in 
decision making during these more difficult periods (Kirsh and Tate, 2006; Laughorne et 
al, 2011; Markwick, 2013). Markwick's framework for recovery oriented relationships is 
particularly poignant here and is supported by the CPN findings. The framework 
incorporates the themes: walking the journey, tough love, panning for agency and finally, 
letting go. Sitting within each of these characteristics practitioners need to hold a belief in 
a person's ability to develop and recover as well as hold a genuine curiosity in the 
developing relationship (Markwick, 2013; p.10).  
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However, in addition, CPNs also discuss acting as the go between or advocate for the 
service user with the prescribing doctor. Thus findings support the notion of knowing the 
person in the nursing role, although this does come with particular demands. For example, 
it could also be superficial and might lead to a self fulfilling prophecy. The demands of so 
called toggling between the professional and ordinary identity, as laid out by Barker et al 
(1999; p.280), may be particularly difficult in the context of medication management 
practice.  Indeed research has suggested a creation of 'us and them' and movement away 
from person centred aspects of nursing practice in other health care contexts (Barker et al 
1999; Bolster and Manias, 2010). Thus the importance of the CPN in the medication 
management process may be a double edged sword:  On the one hand, CPNs reference to 
acting as the go between may in itself add distance to the control and agency of the service 
user, instead allowing for dominant structures such as the medical expertise and resultant 
othering issues to propagate, thereby further distancing service user knowledge and 
expertise to the periphery. On the other hand however, the CPN interviews indicate a sub 
theme of passion within the transcripts, of a real desire to walk with the service user on 
their recovery journey. This may actually serve to bring the service user perspective more 
to the fore of decision making for psychiatric medication management, both through the 
reduction of stigma and othering and through advocating on behalf of the service user to 
the more distanced psychiatrist. It may then that critical reflective practice may be 
particularly important for this aspect of the nursing role to be realised. This would, at any 
rate, be an interesting avenue for further research to explore.  
 
Finally, the importance of other relationships are also implicated by the findings, both as 
part of wider services (occupational therapists, psychologists, pharmacists, peer support 
workers) and beyond (family and friends, community support groups etc). The 
introduction of peer support workers are of particular note (Repper and Carter, 2011). 
The ImROC (see chapter one)  suggests that the introduction of peer workers may, in 
addition to providing hope and inspiration to service users and promoting recovery,  also 
challenge negative attitudes of staff and bring the service user perspective more the fore 
of decisions about psychiatric medication (Pitt et al 2013; Repper, Aldridge and Gilfoyle, 
2013). The findings are also congruent with approaches that emphasise open dialogue as a 
form of treatment, where wider therapeutic networks may assist in ongoing negotiated 
decisions about medication (e.g. the Open Dialogue approach, see Seikkula et al, 2006).  
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Figure 15. Barriers and enablers at the macro level 
Thematic findings from the interviews and observations from the applied conversation 
analysis data point to challenges at a system level of analysis, which map onto more 
hidden forms of power as key challenges for the psychiatric medication encounter.   
9.4.1. A second face of power 
In the recorded meetings phase, the applied conversation analysis reveals how a full or 
complete set of options are not presented by Dr Kos in any of the meetings. The weighing 
up of pros and cons and particularly the important considerations of side effects and how 
these relate to the service users ‘life world’79 is not fully discussed in these meetings and at 
times Dr Kos was found to take a more directive role in the encounter, offering treatment 
proposals without providing detailed information and thereby leading the decision about 
psychiatric medication.  As discussed above (S. 9.2.2.1) some psychiatrists refer to holding 
back information in certain circumstances. Psychiatrists acknowledge that certain side 
effects, such as sexual side effects or other 'longer term' side effects are not discussed as 
frequently. In addition when someone is deemed to lack insight arguments are 
constructed and information presented so as to avoid conflict and encourage adherence.  
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 a term taken from the work of Habermas (1987) 
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Taken together, the findings link well with Lukes' second face of power. This focuses on 
the acknowledgement that what information is available to discuss in the first place is an 
important consideration in how structural power is enacted in medication management 
practice in a community based setting (Lukes, 2005)80.  As mentioned previously, overt 
forms of power, 'power over' or coercion were not observed in the findings, instead having 
found support the ideals of service users having increased say and control over decisions 
concerning psychiatric medication.   
 
That is not to say that structural barriers at the system level, which result in overt 
demonstrations of power in medication management practice more generally, do not exist. 
Indeed, service users and psychiatrists in these findings both mention the importance of a 
general 'fear of coercion' which hinders an open and honest dialogue. A person's previous 
experiences of coercive practice and of being treated against their will under Mental 
Health Act legislation, was noted as having a particularly damaging impact on the 
formation of a collaborative relationship with practitioners. This supports previous 
research illustrating  the negative impact a fear of coercion has on achieving SDM, instead 
encouraging greater passivity, ‘false compliance’ and a lack of engagement with mental 
health services (Chamberlin, 2005; Campbell and Schraiber, 1989; Haglund et al, 2003).   
However and interestingly, this theme emerged even amongst those service user 
participants who had not had any personal prior experience of direct coercive treatment, 
indicating a more insidious form of structural power present in the medication 
management encounter. Thus, an underlying awareness of coercive aspects of the mental 
health system appears to hinder a fully collaborative approach.  Boyle (1993) refers to the 
need to emphasise both the juridical aspects of power in the mental health system, 
alongside structural theories such as Foucault's 'disciplinary power'.  Boyle (1993) 
suggests mental health legislation has a dual aspect, both to sanction the enforcement of  
treatment against a person's will, but also acts as a form of disciplinary power in 
constructing and producing and in using language for subtle forms of self and social 
regulation (ibid; p 71). Mental health legislation relies on scientific expertise from mental 
health practitioners, practitioners, GPs and the Approved Mental Health Practitioner 
(AHMP) and this may thereby further more insidious forms of disciplinary power.  
 
Interestingly, unlike psychiatrists, CPNs did not note the trend that fear of coercion was 
important for decision making in the CMHT.  Perhaps this is more suggestive of the 
                                                             
80
 See chapter three for further details 
214 
 
 
 
differing role CPNs are seen to perform in the medication management process, 
conceptualising themselves as a 'helping profession' emphasising caring aspects of their 
role, as oppose to components on managing risk and control (see S. 9.3.2). 
 
9.4.2. A third face of power 
Another key finding from the interviews is that, whilst some service users found receiving 
a diagnosis helpful, more often they refer to feeling labelled, stigmatised and feeling pre 
judged as important barriers to being involved in decisions about psychiatric medication. 
The acceptance of a mental illness diagnosis can be stigmatising and potentially lead to 
loss of control. Diagnosis may strengthen stereotypes associated with mental illness labels, 
intensifying the depersonalisation and otherness associated with public perceptions of 
mental illness (Corrigan, 2007).  Stigma comes not only from family and society generally, 
but also via the process of the person internalising it (Brohan et al, 2010; West et al, 2011), 
as well as the knowledge that a diagnosis may interfere with life goals, job prospects and 
social opportunities more generally. In addition, stigma is associated with label avoidance, 
where people avoid treatment and services associated with a diagnosis (Corrigan, 2007). 
Other recent research outside of mental health has found that fear of being labelled is a 
key challenge for shared decision making (Frosch et al, 2012). Taken together, the findings 
suggest that labelling is a particular challenge for collaborative psychiatric medication 
management practice. 
 
Thus, in addition to a second face of power, a more insidious form of power (or a third 
dimension) is also observed in this data. Foucault's writings and more contemporary 
research which has explored the ideas of clinical gaze, self examination and control in 
modern mental health systems, combining normative judgements and self governance, is 
relevant here, along with notions of positive power (Foucault, 1977; Terkelsen, 2009; 
Rose, 1998).  
 
9.4.2.1. Lacking insight - devaluing experiential knowledge 
The findings discussed previously in section 9.2.2.5, are of particular relevance at this 
point. For professionals, lacking insight into one's condition is an important barrier, which 
contrasts with the findings from service users. By 'insight' practitioners mean accepting 
having a mental illness and the necessity to be treated. The emphasis on acceptance of 
having a diagnosis or acceptance of illness is seen as important for recovery. Yet, the data 
from service users emphasises problems of feeling labelled in terms of reflecting stigma 
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and loss of control. This fits with research which suggest that service users who accept 
illness labels as applicable, may gradually begin to view themselves as incompetent 
(Estroff, 1993) by association of accepting stigmatising beliefs about mental illness 
(Lysaker, Roe and Yanos, 2007). The findings also point to a pivotal barrier at the system 
level for achieving a 'meeting of experts'; the capacity to reason and make effective 
decisions. This may also be applicable to other areas of medicine.   However, while in other 
areas of health, capacity may be limited by service users’ knowledge of medical conditions 
and treatments, their ability to reason is not in dispute.  In mental health, the capacity to 
reason and make effective decisions is in the hands of others rather than by the person 
themselves.  Part of this is defined in legislation and part through the social construction of 
professional practice unique to mental health (Morant, 2006). For example, in Wei Wen 
Chong et al's (2013) study (see S. 9.2.2.5), only mental health practitioners prioritised 'SU 
lack of competence' as a particular challenge for shared decision making, a factor not 
considered by practitioners in other medical contexts.  As such, a key challenge for shared 
decision making in psychiatric medication management is that practitioners (at times, at 
least) do not place equal value on service user expertise and knowledge81.  Yet, for shared 
decision making to become a reality, experiential understanding as well as an 
acknowledgement that conceptions of mental illness and treatment are contested and 
complex, need to be at the forefront of conversations. According to Baker et al (2013) 
there needs to be a: 
 
...rebalancing of the traditional focus on diagnosis and treatment with prioritisation 
on personal and self determined perspectives. A key component of this shift would be 
the value and status that is ascribed to different forms of knowledge.  
          (ibid, p. 3) 
 
The rejection of the value of experiential knowledge is related to the belief that, given the 
subjective nature of such knowledge, it is inferior in its validity to that of medical 
knowledge, which attempts to be based on scientific or objective knowledge. These 
findings suggest that such challenges still remain, and this is highlighted by practitioners' 
emphasis on the importance of insight,  without which, the service user perspective is 
ignored and devalued, thereby continuing negative cycles of resistance via non adherence 
as a positive attempt to regain control (Britten, 2010; Roe, 2009).  
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Generalised structural barriers, non specific to mental health, also appeared in the data. 
Asymmetry of the encounter and power associated with the role of the psychiatrist as an 
expert and a doctor, with higher social status, was seen to preventing open dialogue. 
Service users refer to feeling spoken down to and 'feeling like a child'.  
 
9.4.2.2. Diagnosis and the dominance of the bio medical model 
Psychiatrists and CPNs also refer to more insidious forms of power being present in the 
encounter, this hindering honest and open dialogue about psychiatric medication. 
However the content of this discussion differed from service user perspectives. 
Practitioners refer to particular trends of an increasing medicalisation of emotions and 
behaviours and increasing societal expectations for prescribing, as particular challenges in 
medication management practice.  For some psychiatrists (e.g. see Dr White, S. 6.2.3), this 
was linked with the suggestion that, in a minority of meetings the service user puts 
pressure on the psychiatrist to fix or offer a quick solution to their problems and that this, 
in of itself, is a barrier to involving people in decisions. Both these findings, alongside the 
service user interview findings, of feeling labelled and diagnosis as a depersonalising 
process, support the concerns that have been raised about increased medicalisation of 
distress and behaviour (Conrad, 2007; BPS, 2011). This supports literature in medical 
sociology describing contemporary concern of the growing power of medical expertise in 
everyday life leading to an increasing depersonalisation of experience and creation of the 
'sick role' identity; lacking agency and control (Scrambler, 2012; Estroff, 1989).  
 
In trying to answer why there is reference to people feeling 'unable to act' or psychiatrists 
feeling certain people placing pressure to prescribe, it is possible to interpret this data 
with the fatalistic view that the structural factors of the mental health system offers the 
potential [for mental health service users] to be constructed as the other (Estroff, 1989) 
which is partially observed in this data (see fractured passivity typology, S. 9.2.2.2).  This 
may present a form of learned helplessness and an inability to act, ultimately creating 
passive recipients. This position is in line with sociologists, such as Foucault and Bourdieu, 
who emphasise the more insidious forms of self regulatory power via wider knowledge 
production processes.  Such a perspective is described eloquently by the psychiatrist and  
critic, Thomas Ssasz (1922-2012) : 
the demoralisation and de politicalisation of social problems and transformation into 
problems of medicine and treatment, ....The essential aim is always the same: to 
identify, to stigmatize and control particular segments of the population.  
        (Ssasz, 1997, p.207) 
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 The recent controversy in the mainstream press surrounding the expansion of the newly 
released DSM-5 is a good illustration of this point. Alongside its recent release in 2013, 
there have been a growing and diverse body of concerns and criticisms published. For 
example, the addition of a new syndromes such as 'disruptive mood disregulation 
disorder' (which historically has been conceptualised as a normal developmental 
expression of behaviour in young children, known in lay terms as 'temper tantrums'), has 
caused widespread controversy (DCP, 2013; The Economist, 2013). In addition, there are 
growing doubts as to validity and reliability of heterogenous diagnoses such as depression 
and schizophrenia and general concerns over the dominance of a disease model as a basis 
for classification (DCP, 2013; Pilgrim, 2007)   According to the Economist (2013) in the 
eyes of many critics the DSM is a vehicle for misdiagnosis, over diagnosis, the medicalisation 
of normal behaviour and the prescription of a large number of unnecessary drugs.  Finally, 
this latest, and more expansive, version of the DSM continues to ignore the recovery 
approach (Zizman-Ilani et al, 2013). 
 
Shared decision making does not occur in a vacuum, but is a central tool in enabling 
service users to take action and exert agency and control in the mental health system. 
However, much of the SDM literature ignores the structural and system level constraints 
that SDM sits within. Some of these structural factors are applicable across many medical 
contexts (for example, asymmetry and dominance of Cartesian knowledge in the medical 
encounter) and others are more directly applicable and specific to the mental health 
context (e.g. judgement of insight, capacity, fear of coercion and diagnosis, labelling and 
stigma). These structural barriers present particular challenges of different forms of 
knowledge having equality in psychiatric medication management practice. In other 
words all of these structural factors maintain the influence and perception that medical 
expertise remains considerably more valued than experiential knowledge, thereby 
hindering open and shared dialogue in the psychiatric medication management encounter.  
By ignoring these structural factors, the terms shared decision making may be criticised as 
unachievable, idealistic and purely fictitious rhetoric (Wirtz 2006; Quill and Brody, 1996).  
A similar criticism can been made of the recovery agenda, which pursues the concept that 
the individual has control and agency over their lives, with hope and opportunity for the 
future, without really making explicit the structural factors which exist and hugely 
influence this (Shepherd and Boardman, 2009; Roberts and Hollins, 2007).  
 
Having said this, it should be acknowledged that the historical roots of the recovery 
agenda emerge from a growing awareness and movement against oppressive structures in 
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the mental health system, so in of itself the recovery approach has been seen very much as 
a critical perspective on traditional practice. Indeed many interventions inspired by the 
recovery movement, now both acknowledge and have the aim of increasing service user 
input and participation by making explicit the imbalances in power and promoting greater 
service user control82. It would appear that promoting the importance of a respectful 
culture which recognises service user expertise and communicates belief in individual 
potential is particularly important for promoting shared decision making for psychiatric 
medication management, as has been evidenced in previous research (Baker et al, 2013; 
Davidson et al, 2008; Shepherd, Boardman and Burns, 2010; Shepherd, Boardman, and 
Slade 2008; Bird et al, 2011; Tondora et al, 2005; Shera and Ramon, 2013; Fitch et al, 
2008; Tees et al 2007; Quill and Brody, 1996; Edwards and Elwyn, 2006).   
 
In summary, the findings point to an underlying culture and structure of power present in 
the system. In particular the emergent themes suggest that the largely unquestioned 
domination of the bio medical model is problematic for shared decisions. The structural 
constraints of categorising and labelling based on descriptions of experience and 
behaviour and associated with the assumptions of specific and underlying biological 
makeup continues to be prevalent in mental health services. This is a hidden and more 
insidious form of power, hindering a shared dialogue in medication management practice 
and pushing experiential knowledge to the periphery of the decision making process.  
9.4.3. A complex structural system and the role of agency? 
 
However, but importantly, the findings from this thesis also emphasise diversity in levels 
of service user participation. There was also wide spread support for giving the service 
user increased control and agency in decision making for psychiatric medication 
management. However, many contradictions emerged. There is a need to explain and 
theorise about the possible reasons for such a wide spectrum of response and the 
juxtaposed discourses seen in the data. I propose this diversity suggests a far more 
multifaceted and complex picture of the interaction between structure and agency, than 
offered by structural theorists, such as Foucault.  
 
Today, perhaps more than at any other point, there are multiple perspectives and 
discourses present in mental health services resulting in multiple dialogues about the 
causes and treatment in mental health. While as discussed above, there is a continued 
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dominance of a medicalised approach in mental health services, there is nevertheless 
widespread discourse and acknowledgement of social and psychological models.  The 
stress vulnerability model (presented in chapter three), alongside the bio-psycho-social 
model is widely cited and part of main stream discourse in mental health services (Zubin 
and Spring, 1977).  Wider trends in recent decades are also of note, such as the growth in 
neo liberalist ideals, resulting in an agenda of increased choice and competition in how 
services are delivered within mental health and beyond (Terkelsen, 2009).   This is 
particularly poignant to ongoing mental health service delivery changes towards 
increased competition and the enforcement of the 'purchaser - provider' split, apparent in 
the recent Health and Social Care Act, 2012. Neo liberal roots also link to the individualist 
nature of service delivery in healthcare, with broader collective approaches to knowledge 
and expertise very much at the periphery. 
 
Even within the 'psychiatric model' more than one discourse emerges.  For instance, on 
the one hand, there is a growing public interest and research exploring the biological (and 
in particular the genetic) markers to behavioural outcomes. Advocates propose that 
development of knowledge in this area will assist diagnosis and treatment. According to 
this discourse, there is hope that future disease classifications may be based on 
neuroscience as oppose to the current phenomenological approach to diagnostic 
categories such as depression or schizophrenia. Most notably the National Institute of 
Mental Health has launched the Research Domain Criteria (RDoC) initiative with just such 
an aim (Cuthbert, 2010; Fibiger, 2012). On the other hand , in a recent mainstream 
newspaper article, a diametrically opposed position is portrayed (Bell, Guardian, 7th April, 
2013). Here  recent research was conferred that found the same genetic risk factors were 
applicable across diverse psychological and behavioural outcomes, concluding that the 
likely outcome of these particular genetic factors are mostly a result of our life experiences 
(Tandon et al, 2013). The author concludes: 'thereby to regard [depression, schizophrenia 
and other diagnoses] as a discreet disorder, or set of disorders within specific causes, 
symptoms and consequences is no longer tenable'. Possibly more interestingly, however, the 
article reflects that the fact that these findings are in the wider media, in itself, represents 
that psychiatry is entering a mature era, where 'from diagnostic shortcomings we are 
recognising the need to treat patients as individuals' (Bell, 2013). Indeed, the recovery 
discourse links in here and its refocus on the individual and the provision of hope, 
opportunity and choice (see context chapter).  For medication management, while not 
objecting to psychiatric medication as one possible treatment strategy within a range of 
interventions, recovery discourse is concerned with the frequent and lasting adverse 
220 
 
 
 
effects of such medication (Pilgrim, Rogers and Gabe, 2011; Whittaker, 2010), the lack of 
choice by service users, the lack of consideration of experiential knowledge, and the 
search for a much wider range of intervention options. These perspectives are also 
mainstream and form part of the wider discourse within mental health medication 
management.  
 
The recovery model is not the only discourse which has emerged from social resistance 
movements in psychiatry. Where structures associated with medicalisation and psychiatry 
exist, there is also a history of resistance and of new movements. For example, Crossley's 
(2006) sociological examination, presented in the theory chapter, recognised five distinct, 
but inter related social movements over the period of 1950 - 2000, concluding these 
structures have sometimes been in conflict, but are ultimately connected, these 
connections defining their identity. He concludes that these 'fields of contention' are 
highly complex spaces. 
 
Thus, the picture that emerges is the need to explore the individual in a complex 
multifaceted and dynamic system, where high uncertainty exists and where continual 
change and interaction between structures is present. The findings of this study fit with 
the dualist perspectives of Archer and Giddens, with features of a late modernist society 
including flexible and overlapping structures, being emphasised (Giddens, 1984; Archer, 
1995)83. Thereby to understand and conceptualise what is possible for involving people in 
decisions about psychiatric medication, the concept of agency in the context of this 
multifaceted system is central.   
 
The conceptual framework adopted for this thesis took the middling position that both 
structure and agency are present and influence the sharing of decisions in psychiatric 
medication management.  
A widely cited  definition of agency is:    
'agency as power which ultimately enables them to reflect upon their social context 
and to act reflexively towards it, either individually or collectively'  
(Archer, 2000, p. 308) 
The data from interviews and the recorded meetings broadly fits with this, while showing 
that there are different modes of agency being enacted upon.  The diversity of findings I 
suggest supports the idea of a system of explanation (represented as a typology in table 10) 
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as an analytical attempt to disclose individual agency as well as cultural and social 
influences of involvement in decisions about psychiatric medication (Larsen, 2004). These 
modes of explanation are in continual flux and negotiation and different modes may be 
pulled upon in a person's recovery journey, but also in the system they find themselves in. 
Following Archer's (2012) analysis of the four modes of agency (see theory chapter),  the 
diversity in participation in these findings may, in part, be explained by difference in 
modes of agency and the idea that people draw on different modes at different times and 
are in constant negotiation. People may move from fractured passivity, through to active 
self management as part of this iterative process. 
 
I suggest then that the findings from this thesis point towards the need to incorporate a 
multifaceted, complex structural discourse and explore how agency operates in this 
context. Archer's model is useful to consider as it allows for an increased appreciation of a 
flexibility towards structural components of the mental health system, and for the diverse 
combination of different vested interests to be more explicit in understanding how people 
enact their agency. Whilst dominating structures are present (e.g. fear of coercion, 
diagnostic categories, labelling and medicalisation) and pose a challenge to SDM in 
psychiatric medication management, there is also opportunity and acknowledgement of a 
continual and changing environment. In the intersections between diverse structural 
components of the system, the individual has the opportunity to process this dynamic 
environment and reflect upon it, thereby encouraging further change, as illustrated in the 
quote below. 
 
As individuals and groups are acting in situations to defend their vested interests and 
to realize their projects, they reproduce or transform the structural and cultural 
conditions that impinge on them, but in this process they are themselves being 
transformed from involuntarily placed agents into social actors and individual 
persons.   
         (Archer, 2012, p. 31) 
 
In summary, unlike the overly fatalistic stance of people's actions being a consequence of 
the dominating structural components of the system, I think the findings also offer a 
positive and dynamic perspective on agency. However, within a multi faceted structure, 
there is continual flux with different modes of agency being drawn upon. This does also 
present a worrying perspective; the suggestion that the proportion of fractured reflexives 
may increase. 
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On a related point, this uncertainty, and opportunity associated with late modernity in 
sociology, has also been proposed to be related to a growth in health inequalities, 
suggestive again, that this high uncertainty but dynamic structural setting of mental health 
may not suit all (Scrambler, 2012).  This may be a significant challenge for shared decision 
making in medication management.  Yet, this structural complexity and uncertainty also 
offers increased opportunity for service users84 to enact their agency, and further impact 
structural and cultural components of the system.  
 
9.5. Conclusion 
 
This chapter has presented and discussed the findings, relating back to relevant theory 
and literature to build an original, rich, and contextualised understanding of shared 
decision making for psychiatric medication management. Three levels of analysis (the 
interaction; the relationship; the system) have been used to provide a coherent structure 
from which to base the discussion. The focus throughout has been to explore the 
complexity and divergent aspects of the findings, and its multidisciplinary background, 
alongside learning from the experiential knowledge of service users. It is through the 
exploration of this complexity, that a fuller, contextualised appreciation of medication 
management practice is presented. 
 
 
  
                                                             
84
 Collectively and individually  
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 Chapter Ten. Conclusion 
 
 
 
 
 
 
 
10.1 Introduction  
 
This thesis has explored the views and experiences of both service users and practitioners 
to build a comprehensive understanding of the everyday realities of psychiatric 
medication management in a community based mental health team. Barriers to and 
enablers of SDM for psychiatric medication have been investigated, building a 
sophisticated, multi-faceted construction of shared decision making for psychiatric 
medication management.  
 
The study has adopted a social constructionist research framework, with a strong focus on 
participatory values. This, in addition to the incorporation of different stakeholder group 
perspectives, has allowed for a rich understanding of the key concepts to emerge. There 
were two phases to the data collection process - a research interview and digitally 
recorded meeting.  A qualitative approach to data collection and data analytical methods 
was employed.  
 
10.2. Implications of findings for policy and practice 
Findings show SDM to be a highly dynamic and protracted process. Therefore any 
intervention to encourage greater SDM in practice would need to incorporate a 
multifaceted perspective, involving both the practitioner and service user at a number of 
different but interrelated levels. At the micro interactional level, the study highlights the 
gap between ethical ideals and actual practice. Future interventions could therefore be 
employed to target these specific gaps. For example, the lack of a detailed weighing up of 
psychiatric medication side effects was observed across the data sets and themes from 
stakeholder group interviews. A key challenge for SDM is how service users are to best 
access full and balanced information concerning psychiatric medication and be supported 
Chapter outline 
This chapter concludes the thesis. Implications of findings are discussed, and original 
theoretical and methodological contributions to knowledge are presented. This is 
followed by consideration of limitations of the study and suggestions for further 
research. 
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to take control over the process, making an informed choice. It may be that ‘patient 
focused quality interventions’ would benefit practice (Coulter and Ellins, 2007). Tools to 
improve health literacy (e.g. leaflets and provision of internet based medicine 
information) alongside decision aids may be help service users process and direct these 
complex decisions.  However these findings also point to the importance of discussion and 
dialogue in helping service users feel more informed. Therefore tools with a particular 
focus on improving dialogue and open communication as part of existing interactions are 
strongly implicated by these findings. Coaching sessions before and after formal 
consultation meetings may increase a person’s confidence and skills in the preparation 
and deliberation process (O Connor, Stacey and Legare, 2008). Techniques such as 
motivational interviewing have proven effective and may be useful to consider (O Connor, 
Stacey and Legare, 2008). 
 
Increased support and training for health professionals in person centred communication 
and recovery oriented prescribing is also indicated in the findings.   An example of such 
work currently underway is the ShiMMe project (see Chapter one).  The roll out of 
Recovery Colleges as part of the ImROC program may also improve training skills building 
and awareness in this area, alongside the potential for peer support workers to undertake 
coaching duties affecting outcomes at all levels of analysis.  
 
Service users acknowledge and value more guidance in times of crisis, and strongly believe 
that SDM can only happen in the context of walking a journey together in a trusting, 
supportive and honest long-term relationship with a practitioner.  These results support 
broader conceptualisations of shared decision making, emphasising a protracted process, 
but in the context of an established trusting relationship. In short, the therapeutic 
relationship was seen to enable increased service user involvement in decisions about 
psychiatric medication. Policy makers and practitioners could look to further emphasise 
the importance of therapeutic relationships for shared decision making, promoting 
increased reflection, awareness, support and training for all mental health practitioners. In 
particular, the practitioner’s role in supporting recovery and self determination may be an 
important avenue for future mental health policy and practice (Markwick, 2013; Farelly 
and Lester, 2014). In addition, promoting continuity of care in policy and practice may be 
an important implication of the findings (NICE, 2014). 
 
Finally interventions to encourage greater shared decision making in reality need to tackle 
structural and cultural components of the system. Overall, the findings point towards a 
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multifaceted complex cultural system which impact on how individuals are able to enact 
their agency. This thesis suggests that it is important to accept and acknowledge this 
complexity in the system, encouraging a more democratic and positive risk-taking culture 
with a priority on honest and shared dialogue between service users and practitioners. For 
psychiatric medication management, the continued dominance of an overly medicalised 
approach is a threat to a meeting of experts and of experiential knowledge holding weight 
in medication management encounters. Perhaps the consistency of CPNs positioning 
themselves more alongside service users suggests broadening in the types of knowledge 
within the system. The recent introduction of peer workers in mainstream UK mental 
health services may also serve to bolster the value of lived experience in knowledge 
production processes in the mental health system. The fact that both practitioners and 
service users expressed and reflected upon some of these system level barriers in this 
research is, in of itself, suggestive of change occurring. In addition there is a need to 
increase opportunities for engagement of collectives of service users in the system, and to 
move beyond individualistic solutions.    
10.3. The original research contributions 
10.3.1.Theoretical contributions 
This thesis makes significant theoretical contributions to the conceptual development of 
shared decision making for psychiatric medication management. 
 
It highlights the structural components and dynamic nature of SDM, often ignored by SDM 
theorists. It brings to the fore a consideration of some of the insidious components of the 
modern mental health system and incorporates the concept of power - a factor central, yet 
often ignored when discussing SDM models and concepts. By including an appreciation of 
terms such as second and third face of power in discussion of how SDM occurs in reality, a 
significant contribution to conceptual development of SDM is offered (Lukes, 2005).  This 
thesis also includes the important concepts of structure and agency in the psychiatric 
medication management encounter, showing how opportunities for increased agency exist 
in a complex multifaceted system, yet may at times result in modes of fractured passivity 
(Archer, 2012). By exploring the concepts of structure and agency, future models of SDM 
may incorporate a more dynamic and less static perspective.  
 
Thus, broader conceptions of SDM are supported and added to by the findings from this 
thesis. SDM is proposed to be a longer term process of trial and error, prioritising honest 
open dialogue, experiential knowledge,  and the consideration of psychiatric medication as 
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only one possible choice in a wider personal tool box approach (Davidson et al, 2008a; 
Entwistle and Watt, 2006; Deegan, 2005;2007). 
 
This thesis also highlights the enabling role strong therapeutic relationships (TR) play, for 
SDM to become a reality in community based mental health services.  Whilst TRs have 
historically been linked to many positive outcomes in mental health, its connection to 
shared decision making has been relatively unexplored.  This thesis supports research 
which suggests that positive outcomes of TRs may be mediated by its impact on increased 
involvement and shared decision making (Street, 2009; Stanhope; 2013). As such, this 
thesis supports a broader and more person centred conceptualisation of SDM for 
psychiatric medication management. 
10.3.2 Methodological Contributions 
The exploratory nature of this study has enabled a rich and contextualised picture of 
collaborative psychiatric medication to emerge. The methodological choices and 
incorporation of different stakeholder groups have allowed the findings to be grounded in 
the experiences of both people receiving mental health services, and mental health 
practitioners.   
 
The combination of data collection and analytical methods used has also enabled fresh 
insight to be gained in this topic. Two phases, with different analytical methods were 
merged to multiplicatively enhance the findings. In particular the use of the recorded 
meetings data to supplement information from interviews is a key strength of the research 
design adopted. More than merely adopting a triangulation approach to enhance 
authenticity, this combination of methods has also allowed for an in depth exploration of 
the research topic, by exploring both what research participants value and prioritise as 
important, based on their previous experiences (phase one interviews), alongside an 
exploration of how participants are involved in decisions about psychiatric medication in 
practice (phase two). As part of this analysis, discrepancies and areas of convergence 
between the interview and the recorded meeting data was explored for individual 
participants in a case study style of presentation, enabling a far more in depth 
understanding of the research topic, than just an addition of two separate data collection 
methods. 
 
Whilst participatory methodology is not in of itself new or innovative, the detail and 
planning which has gone into the participatory components of this study offers 
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contributions to participatory methodologies. Firstly, how were the goals of a contribution 
to knowledge, required for a PhD thesis, combined with the more emancipatory roots of 
participatory research? While this was not a full scale PAR study, in that change and action 
was not a primary goal, nevertheless the involvement of service users, a carer, a CPN and a 
psychiatrist, in the full life cycle of this project (including the planning, training, 
conducting interviews, analysis and dissemination phases) has ultimately had profound 
implications on what this research did, both indirectly through  encouraging my own 
personal reflection on the topic, and directly through guidance and input at each point in 
the research life cycle. Of particular note is the collaborative analysis phase to the project, 
which has not been widely adopted in a PhD research context. The detail of this aspect of 
the research process adds understanding and credence to how the collective analysis 
process is able to enhance the meaning and interpretation of data, both through  
enhancing validity, and ensuring the voice of people who have direct knowledge and 
experience of a sensitive topic, such as this one, is maintained in the context of PhD 
research.  Some of the challenges and opportunities that emerged from the collaborative 
analysis, and the impact this had on the findings is an important contribution 
methodologically. See the methodology chapter, S. 4.4.1, and appendix VII for further 
details. 
 
Secondly, being the sole researcher and facilitator for the project required sensitivity and 
reflection to ensure the participatory components of the project would be fruitful. 
Structured facilitation skills were particularly valuable in the earlier phases on the project, 
but also emerged as important later in the analysis phases, where differences in the 
interpretation of transcripts emerged between group members. The group dynamics  
between service user members and the practitioner member were more strained during 
these phases of the project, and required more structured facilitation; to acknowledge 
conflict, build consensus, or where this was not possible, respect difference.  In addition it 
was a tricky balance to ensure that my interpretations and pre existing knowledge did not 
dominate the collective analysis process. Recording and transcribing collaborative 
analysis meetings where particularly beneficial in this regard (see appendix VII for an 
example of a meeting (transcribed) during the collaborative analysis). 
 
Lastly but perhaps most importantly, is the impact the participatory components of the 
research had on me personally and on other members of the group. By building 
relationships with both service users and practitioners working in mental health, not only 
has my knowledge and appreciation of mental health and illness grown, but also my views 
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and values towards research in applied contexts more generally, have changed. I have 
changed from viewing research in abstract terms: as an objective, neutral observer 
building knowledge and theory on a topic, to an interested and passionate participant in 
research: the idea that research in of itself is a way of engaging with social nature of reality 
and promoting change and positive reflections on it. 
 
The research process has also had positive impacts on other members of the group. This 
was poignantly illustrated in a response given by one co researcher at a recent 
presentation. One co researcher (new to research at the onset of this study), was asked by 
an audience member at a recent presentation in July 2013, how has being involved in this 
project impacted you? The notes I took of his response were:  In short it has changed my 
identity. I will explain what I mean. My mind set has changed. At the start of the study, I still 
had a CPN myself. Through being involved in this study, I started to see my CPN differently - 
as a person - and they started to see me as a person. And consequently, I no longer have a 
CPN... 
 
These reflections on personal change and identity as a consequence of the participatory 
nature of this study, offer significant methodological contributions to participatory 
focused research. 
10.3. Limitations  
As with any small scale qualitative study, far reaching conclusions are not possible from 
observations of a handful of selected meetings, or from a small sample of interviews.  
However, this was not an intention or goal of this research, and the exploratory nature of 
the study is not seen as a limitation. Yet it is acknowledged that the original plan was to 
recruit greater numbers of both: service users for phase one interviews (n=30) and, 
recorded meetings for phase two (n=10).85 Additionally, the scope for an additional 
‘reflection and action’ phase was reduced following recruitment difficulties86.  The original 
plan included a third phase of three discussion groups, with service users and 
practitioners, discussing preliminary findings and encouraging reflection about current 
practice. This phase was scaled back - only one feedback and discussion group (conducted 
with practitioners from the CMHT) was undertaken.  
 
                                                             
85
 To note, practitioner interview numbers were satisfactory and as expected. Indeed in both cases, all but 
one of the psychiatrists and CPNs from within the team, were interviewed. 
86
 The possible reasons for the recruitment challenges are discussed below. 
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It is also important to highlight that the population from which this study recruited  is not 
representative of the wider UK context. The majority of the sampling took place in an 
affluent city with far higher than average education levels present in the general 
population, due to the presence of two universities. The region also has lower percentage 
of BME residents and is expanding as a commercial centre rapidly, again not 
representative of much of the rest of the UK.  It is likely that these factors had a significant 
impact on the findings of the study and further research would benefit from being located 
in other, more representative, areas.  
 
The local context also had an indirect impact of the recruitment challenges experienced in 
this study. In addition to two universities, the city hosts a regional research hub and 
teaching hospital. The regional mental health research network hub (MHRN, part of the 
NIHR87), boasts by far the largest number of supported research projects, as compared to 
the rest of the UK. This study, on the other hand, was a small scale unfunded PhD, without 
wider support than that of a supervisory team.   This was a likely reason for some of the 
recruitment challenges experienced in this study. The use of gatekeepers for recruitment 
of service users to the study was also particularly problematic. Most clinicians and care 
coordinators approached were already involved in multiple research projects, therefore 
impacting on the 'buy in' to the project, and subsequently impeding recruitment. Although 
various strategies were incorporated to promote relationships with clinicians in the team 
including; presentations and attending team meetings; regular contact via email and 
phone calls; and escalation meetings with senior clinicians and management, a research 
fatigue did nevertheless appear to hinder the recruitment of service user participants.  
Even when gatekeepers directly offered support for recruitment, this often did not result 
in the actual invitations being sent out to service users. Administration problems and 
changing priorities for the clinicians were a common issue. Additionally, at the time of the 
study, mental health services (locally and nationally) were undergoing significant 
organisational uncertainty and change, with increasing pressures on staff. This is likely to 
have affected both recruitment and the findings.    
 
In addition and more generally, the recruitment design itself has limitations and 
introduces bias into this study. It is possible that those practitioners with a particular 
interest in this study were more amenable to assisting in the recruitment of service users 
to the study, thereby influencing the overall sample of the service user participant group. 
                                                             
87
 National Institute for Health Research 
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This may have subsequently impacted recruitment to phase two. As mentioned above, it 
was in fact only possible to record four separate meetings (out of an intended 10), and all 
four took place with the same psychiatrist. The question then arises as to why did only one 
psychiatrist participate in this phase of the study (out of a possible total of seven)?  
Recruitment of psychiatrists to this phase was only successful indirectly, via service users 
who partook in interviews (phase one) inviting their practitioner to the recorded meeting 
phase. On the surface at least, I would have expected that different psychiatrists (or indeed 
other practitioners in general) would have, in all probability, been invited to this phase of 
the data collection. However, this doesn’t take into account the support that this 
psychiatrist may have given in the initial recruitment of service users to phase one 
interviews. It may, of course, also be the case that this psychiatrist was in some way more 
approachable than others, thereby offering us a distortedly positive picture of these 
interactions at the micro level.  
 
A final consideration is the limitation of the design only taking place at one point in time. 
In particular, findings could have been enhanced greatly by introducing a longitudinal 
component to the design – exploring how decision making occurs in the context of 
developing/not developing relationships and a person’s individual recovery journey.   
 
10.4. Suggested future research 
Future research in this area may look to focus on other treatment settings and localities, 
enhancing the ability to generalise findings and explore different contexts for SDM in the 
UK mental health system, and beyond. Recent progress in the NHS research IT database 
systems would also assist in overcoming some of the recruitment challenges experienced 
in this research. In particular the ongoing development of the care register interactive 
search database (D-CRIS) would enable direct access to potential participants, therefore 
potentially bypassing the challenges of a reliance on gatekeepers in the recruitment 
process (CPFT, 2013).    
 
The findings have highlighted the usefulness of participatory research.  Hence there is 
scope for further research in this area to adopt participatory methodologies to explore 
action and change components, encouraging reflection and change locally. In PAR based 
research projects, understanding between different stakeholder groups is increased 
thereby encouraging change and positive risk taking.  Initiatives in the UK include: in 
Devon the recovery oriented prescribing group (e.g. see Baker et al, 2013), and in 
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Northumbria, the PAR study exploring recovery oriented care coordination (Brandon et al, 
2013). The national organisational program, ImROC88 is also of note, promoting a wider 
cultural change in the mental health system.  However  there is scope for the research 
components of ImROC to be expanded further, exploring it impact upon SDM outcomes 
such as the value of experiential knowledge for clinicians, and the empowerment and 
confidence of service users in decision making interactions. 
 
As mentioned above, SDM is found in this study to be a long term process occurring as part 
of ongoing developing relationships.  It would therefore be very important for future 
research to incorporate a longitudinal design, to explore how SDM occurs as part of 
recovery journeys. Choice and control are fundamental concepts for recovery, and 
therefore further research which examines shared decision making, in the wider context 
of recovery would be valuable.  In particular, therapeutic relationships and their impact on 
how people with serious mental health problems are able to take back control and exert 
agency is an important avenue for future research. More research is needed which is 
focused on exploring the links between these factors. By increasing understanding of the 
mechanisms through which choice is best utilised in the achievement of recovery 
outcomes, there are significant opportunities to benefit mental health services. The central 
issue of roles and accountability with mental health teams also needs to be included in 
these investigations. For example, there may be increased role for other members of the 
mental health team, including peer support workers to offer the support and advocacy 
during more difficult times.  In addition, the wider changes and the increased 
responsibility for the GP in day to day contact service users experience, alongside growing 
financial pressures, present questions as to how the these changes will actually translate 
to people's experience? (Coulter and Collins, 2012; Patterson, 2012). This is an avenue for 
further research to explore. 
 
Research could also explore the impact of coaching on mental health outcomes more 
generally, and more specifically on SDM outcomes.  This would be an exciting avenue with 
many implications for practice. A particular focus on whether specific roles or groups 
performing coaching duties, impact on these outcomes, would be an interesting question 
to explore. For example, whether STR workers (Support Time and Recovery) and peer 
support workers offer a qualitatively different or enhanced experience, as compared to 
other members of the multi-disciplinary team.  
                                                             
88
 See chapter one for further details 
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10.6 Summary 
 
This chapter concludes the thesis with a presentation of the key implications emergent 
from the thesis, providing suggestions for future research. Contributions to both theory 
and methodology are highlighted, and limitations of the study acknowledged.  
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Appendix I.  Example minutes taken from an advisory group 
meeting 
 
4th Meeting 
Minutes 
Date: 25th January 2011 
 
Attendees 
(DH) 
(EK) 
(GS) 
(JS) 
(MM) 
(SR) 
(FI) 
 
 Project update and feedback 
o NHS ethics application update (EK). Full approval given by ethics 
committee. Only minor amendments to supporting documents were 
necessary following committee hearing. 
o RandD approval outstanding 
o Co researcher governance checks. Co researchers may also need research 
passports within the NHS trust. Action EK investigating other possibilities 
for this. 
o Need to introduce project to practitioners within ITT by meeting with 
psychiatrists and CPN team leaders in addition to attending team meeting 
to introduce project. Action: FI and DH will approach colleagues in the 
pathway to assist with access. 
 
 Interview Schedule 
Critical incident questions explored and role plays conducted within group to explore the 
content of this section of the interview and suggestions for improvement.  
Feedback from interviewers included: 
258 
 
 
 
o Difficultly to always follow the questions: didn’t want to keep looking 
down at sheet. 
o The bullet points in the schedule (topic areas to explore) were not easy to 
understand 
o Hard to focus on the positive and negative examples separately. 3rd 
question ‘a time that sticks in the mind’ easier to work with. 
o With practitioner questions, maybe need to be more specific. For example, 
instead of ‘what did you want to achieve at the meeting’ you could ask, 
name 3 things wanted to achieve at the meeting 
o It may also be useful to explore in more detail, who the meeting was with 
that is being talked about 
o Maybe difficult to pull out one meeting or situation as a decision: to review. 
Feedback from interviewees included: 
o Felt good to answer questions and talk on this topic. Nice experience. 
o Interviewer made me feel relaxed and comfortable and I really enjoyed the 
interview because of that. 
o Difficulties with remembering specific meetings and details. Couldn’t 
remember specific meeting easily but instead more general memories 
about meetings. 
o In practitioner interview, would have preferred to start with a positive 
example and not a negative question. 
o Questions were too open ended. Needed to be more specific. 
o In practitioner meetings, generally didn’t think of one example but a few 
different examples that helped to illustrate the point. 
Additional thoughts and suggestions from group: 
o To help with talking about specific event instead of thinking in general, 
need to dramatise the questions emphasising the positive and negative. Eg 
Can you think of a meeting which was a ‘complete disaster’ or ‘really 
productive’. Or maybe use terms such as one of the best or one of the 
worst. 
o During the training it will be important to ensure that all researchers feel 
comfortable in asking the questions if they are worded in a more dramatic 
way.  
o Going back and reviewing the research questions will help answer the 
question as to how specific to one event or how general to keep the 
questioning 
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o In the practitioner schedule it may be useful to replace the term 
‘consultation’  with ‘a meeting with a service user’ 
o The time period to use when thinking about a certain memory or event 
should be longer – 12 months. 
o The time period should be referred to throughout most of the questions, to 
keep reminding people to try to think about the last year only and should 
also be referred to at the beginning of the interview. 
o Support for co researchers. Being able to have a chat following each 
interview. Need to build in an informal debriefing for researchers within 
the research group following each interview. To be planned in advance 
when organising interview timings. 
 
Actions 
EK to review above reflections and amend interview schedule and plans accordingly.  
EK to send amended schedules to team for further review via email. 
 
AOB: None 
 
o Proposed next meeting date: Tues 29th March 2011 4-6pm, ARU. 
Please confirm attendance asap. 
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Appendix II. Selected entries from the research diary 
 
General reflections, group dynamics and data collection preparation including co 
researcher training  
May 2011  
Training and co researchers: two training sessions have been undertaken. Far more time 
is needed than I originally thought and we are still not near being ready to go (that 
includes me – I feel more preparation is necessary). SE SURG provided a good introduction 
and this session helped building confidence within the group, in research skills. 
The co researcher group is strong and there is a good mix with different skills apparent. 
After the first training session, I was worried there was too much variation in style in 
conducting the interviews, and some group members have a strong preference to go off 
script. What should I do about this? My initial reaction was to create more structure in the 
interview schedules, and encourage the use of the script, learning questions before the 
interview.  I facilitated the second training session, and used this approach. I was 
impressed with the interviewing skills of the group. Again individual style varied and not 
everyone felt the need follow the script. This may be just due to it being a supportive and 
training environment and not the ‘real’ thing.  
June 2011. 
Busy period - I had another (3rd) training session on Friday with co researchers in addition 
to a steering group meeting. It is a very confident group now. It was a rather a tricky start 
to the session, dominated by a lot of commenting on the script, whereas the main purpose 
was to role play and feel comfortable with conducting the interview. Less time left for this, 
so in the end we had 20 minutes each then swapped. 
In the future, I need to make sure I am organized with the group. This has slipped slightly 
recently and was noticeable in this session.  Also, I need to find out who M’s case worker is. 
I don’t know why I didn’t previously pick up that M has received services from this team? 
89 S is receiving services from the South team, so I will need to ensure all her interviews  
are within the north team.  I have raised the issue of confidentiality with both M and S, and 
ensuring that interviews are conducted in the alternative team should eliminate any 
potential issues of knowing the participant / people being discussed, in the interviews. 
 
Recruitment challenges 
April 2011 
Although active and productive, April was also a month where insecurities, doubts and 
larger concerns have raised their head. I was excited and nervous about actually going to 
meet the practitioners in the CMHT – these are the people who will be instrumental to this 
project’s success. A couple of weeks later and my worries have increased. I have had no 
responses following the initial presentations and have had to cancel my ‘recruitment 
evening for SUs’ because flyers were not handed out, as requested. Barriers seem to be 
present in starting the data collection process. Following my conversations with the team 
leaders, I get the impression that getting numbers to anywhere near where I want them is 
                                                             
89
 I have followed this up: M actually receives services from another team, so this is no longer needs 
consideration in the interview planning 
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not going to be an easy task.  My main worry is the TLs.  They do not seem to want to 
promote this project for me, and there is a sense of lack of ownership, such that it is very 
much up to me to try to engage each person individually, without senior backing.  I do not 
think this is a brick wall but I suppose I would have liked this phase to have been slightly 
more productive. What to do next? Persevere and aim for a snowball effect. I need to build 
interest and confidence with each practitioner in the team.  
 
September 2011 
Recruitment has progressed over the summer months, but at a slow pace and only with 
practitioners. I am not making any progress with service user recruitment. In September, I 
again contacted the team leaders to promote service user recruitment. I have had to 
compile more leaflets, and now have decided to leave these in reception. I have also asked 
a TL to do a postal send out. Again TL appears very supportive, but following this I still do 
not know if the information is in the hands of service users or whether the TL has done 
what she promised. 
 
Conducting interviews 
 
September 2011 
Refection following the first SU pilot interview. This was a useful exercise. S led and I 
shadowed. Difficult customer: he practically did not answer one question. I felt he was 
quite aloof and was over thinking some of the questions. He also had an agenda for being 
there, to share and reflect on his experience and views and was using this opportunity for 
this purpose. Any reference to decision making was medicalised, e.g. decisions based on 
serum levels. Interesting in one sense in that little reflection of acknowledgement of 
involvement in decisions, and happy to follow recommendations made by the doctor.  S 
did a good job of sticking to script and maintaining rapport. But given the difficulty of the 
interview, my approach would have been different. I would have gone off script and just 
tried to pull out relevant information by probing on relevant nit bits. I gave this feedback, 
to have confidence, to build on what the participant says and to draw more out. But it was 
difficult for me to give this advice as this will result in less structure and consistency, 
especially across the full co researcher group. I think I have to manage this on a one to one 
basis: for some co researchers, more structure, stick to script, for others less. I have also 
realized that some questions need to be reworded. So this was a useful exercise. 
On related point, my interview with a CPN yesterday was an interesting one with some 
strong views and recommendations expressed. She was very passionate about her work 
and how to make things better and would often use the questions as an opportunity to talk 
more widely about mental health services and her views about what improvements are 
necessary.  SDM model came across strongly as her ideal, although once again very much 
sitting in a larger therapeutic relationship. She also did talk about women and the female 
aspects a number of times and there seemed to be a gendered discussion with some of 
what she was saying – I did also feel there was a motherly aspect to what she found 
important. The examples were interesting in that firstly success involved coming off 
psychiatric meds and going on instead to very low dose depot. Example of failure focussed 
on not being able to get someone off high dose meds (because psychiatrist wouldn’t agree 
with her). First observation : both examples demonstrated her negative attitude towards 
psychiatric medication. Possibly more interestingly, both examples were centred around 
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her role, as a CPN and being in control / not in control. She did not touch on SU 
empowerment/ownership in any obvious way – it was instead about her knowing what 
was best and seeing that through (or not in the failure example) for the best of her clients 
– so actually both examples had a strong maternal element. 
 
My reflections following this interview was that it was more emotionally charged than I 
had been prepared for. The passion in her responses was apparent, and there were a 
couple of occasions when I thought she was hiding back a tear. This affected how I found 
the interview, at times, I found it emotionally challenging. I did feel like a fuller debrief was 
necessary following this interview (for me, but also importantly, for her). I reflected that 
until this point I have been mostly concerned with the ethical concerns for service user 
interview experience and potential distress. However, I am beginning to think that instead 
practitioners are actually finding this process more distressing in a number of ways. 
Whereas possibly service users are used to talking about what has happened to them and 
appreciate talking about their views, practitioners perhaps have less opportunity to 
reflect, take a step back and think about what is particularly important etc. I think the 
practitioners are perhaps finding these interviews difficult. I have not been consistent 
with the debriefing aspect of the interview and think I need to be far more mindful of this 
going forward. However, this is not only because I had not realized the potential ethical 
impact for practitioners, but also because of deeper issues around roles and 
responsibilities. I am the naive and external researcher interviewing trained mental health 
professionals. In a way I find it embarrassing and patronizing to ask: are you ok? to people 
who are used to doing this everyday in their own jobs.  I also think practitioners prefer the 
distance and to remain in the ‘professional’ role. Having said this, I do think I at least need 
to acknowledge more openly the ethical – distress elements explicitly post interview. 
 
November 2011 
First interview with M and service user participant.  I led, M shadowed. Another 
interesting interview. Some  strong themes are emerging from these interviews. I was 
worried that people may get dragged of track and present their life story, and although 
this happens it doesn’t dominate and remains focussed on topic. Happy with M’s 
performance. He was nervous and again lacked confidence, but when encouraged, the 
question he asked made a large contribution to the interview and really helped bring the 
interview back to the area. I think he has good interviewing skills. Only potential problem 
is tiredness – he has said he found it very tiring and I do think the interviews are rather on 
the long side: need to be mindful of this. 
 
 
Initial reflections from interviews and coding process 
September 2011 
CPNs 
Some differences between interviews are now becoming apparent (5 interviews with 
CPNs only). 
Models of ideal working (in terms of involvement in decision making) – some themes from 
some interviews around empowering clients to take lead in decisions, giving them the 
skills to be able to make informed choice and learning skills to know how to go about 
helping themselves. So med mgmt in this sense fits in with larger therapeutic role and a 
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focus on self management. This is also in tune with pathway strategy where after 18 
months you are on your own. There is also acknowledgement of clients being the decision 
maker with clinicians ‘backing off’ if someone is set on something. However, in the same 
breath, practitioners always give opinion and keep suggesting what they think will work. 
But if this is different to client, that is not necessarily an issue, seen as a learning 
experiment and a trial and error process. Honest open and trusting relationships key. 
Some examples of success include descriptions about when the client leads the way, even 
if different from practitioner. Some examples of failure centre on when the conversation 
was not real. Ie. fears SU not open or telling truth, - this seems to be the hardest situations 
for practitioners to handle. One example talks about how they just back off, don’t bother 
pushing it if that is the case.  However in other interviews a far more 
maternalistic/paternalistic approach comes across – directive, expert, supportive, thinking 
about the longer term. Need to look at these interviews a bit more see where the links 
across are. 
Note to self – it would be useful to share some of the transcripts with Shula, Nicola and 
Carol. I would like to get their impressions of some of these interviews (one of each 
stakeholder group) to assist initial analysis. Is this appropriate or not?   Is it perhaps 
better for me to lead this at this stage?  
 
 
January 2012 
Initial notes following an interview with a psychiatrist 
Key notes whilst transcribing Cons Psych 1. 
P.5. regular appointment 'fundamentally unhelpful' (i.e. in response to views surrounding 
reduction in continuity of care in psychiatrist role) 
 
'How they are doing' job of other professionals’ 
 
P. 6 "yeah, well on the whole, except for a few rather rare circumstance, uh, I think they 
are kind of absolutely involved because they are the ones who have to take it" 
 
P. 7. Side effects - better to discuss upfront rather than for the service user to find out 
afterwards and then talk about it 
 
P.7. Sensitive information - telling people about sexual side effects  
 
P.8 Presenting choices. Admits choice often limited and use of 'but ‘to rule out certain 
choices in conversation 
 
Options sometimes presented as a plan b - i.e. if this doesn’t work, next step options 'go 
away and we can meet next time' [but how does this fit with not holding routine 
appointments'] 
 
Barriers 
P.10 people lying as affecting involvement  
Fear of being taken to hospital if admits not taking meds [lack of honesty related to fear of 
coercion] 
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Being involved as a tool for encouraging compliance? 
 
How giving information is part of "involvement" 
 
P. 11 Thinking about long term solutions 
 
P.13 Meeting of success - "him having his plan, me having my plan" I explained why his 
less likely to work. Outcome, left him to decide "he can kind of do what he wants really" 
[persuasion]     "took into account not just the tablets but also his kind of wider life" 
 
P.15. Negative example 
Not understanding the person and feeling not connected - i.e. "but particular to me" - not 
same to other practitioners. Having two conversations 
 
Not meeting "never quite meet the conversations" 
 
P.16.  lack of shared understanding  
 
role of carer - another pair of ears.  
- but also can make relationship more fraught, 
-coercive relationship. 
-wider social environment. carer also affected. 
 
Notes from interview with CPN 
‘You become like a well-trained sniffer dog. You see things, you notice’.  
Go between. 
Other evidence and supporting people full you in on their experience. 
P.4  Legal consequences for not listening, not explaining. 
 
Role of meds 
"travesty of human justice really"  
P5: Its important to find out, so you can use those as a leverage to be able to support and 
listen and advise and yet encourage concordance.  
 
-barriers to concordance - system factors 
- Want people to tell you when not taking prescribed medication, but at same time still 
encourage compliance as you have a responsibility (risk versus empowerment), 
 
P.6 Different info within and outside services 
P7 Share but personalised 
Reinforced revisit 
 
P7. reference to ongoing experiment. 'kept going until we found somebody who was 
willing to listen’ 
 
P8 First para - important factor influencing involvement class, background 
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Role of carer,  
P8 - role of meds 
P11 - Success. "Walking the journey together" Pulling and pushing 
‘But actual what’s integral to it is first of all, winning somebodies confidence and trust’. 
 
Reflecting on this transcript 
 
In terms of initial reflections on content and important themes 
 
*Role of meds and the morality of psychiatric medication strongly presented throughout. 
Also the desire for greater accountability 
 
* Involvement as walking the journey together, as trust and caring for the person and the 
therapeutic relationship.  
 
*The role of the CPN - The importance of having an opinion and being brave enough to 
enter conflict with other practitioners about decisions. Being a voice / advocate for the 
service user. 
 
* Some aspects of enhancing control to the service user were talked around as important 
aspects of decision making, mainly in terms of providing information.  
More strongly, I felt this transcript was about the importance of caring and treating people 
with dignity and protecting people from aspects of the system and feeling. The priority for 
psychiatric medication management was about having a real understanding of the person 
and care of the person. 
 
*This doesn’t necessarily fit with SDM as an ideal. 
 
April 2012: Creating structure 
 
Creating the conceptual themes: I am now trying to separate out the conceptual and the 
structural (or functional, need to check correct language for this) coding framework. I 
found drawing a mind map especially helpful in which initial themes are presented from 
the list of nodes for ‘conceptualising involvement'.  I have grouped the list into 9 themes, 
with codes underneath and this does help. 
 
 
I am still struggling to incorporate examples of success and failure into the conceptual 
framework. I think I am stuck and unhelpfully hanging on to the idea that this section of 
the interview is somehow qualitatively different, and hence needs separating from the 
general question section of the interview.  It is helpful to remember the research 
questions: data from the interviews is only useful as directly exploring this. Therefore 
complicating the coding by keeping success and failure separate is not useful. Having 
thought abou this I am proceeding to keep the idea of positive and negative, but pooling 
content under the previously coded themes. 
 
June 2012 – Lack of insight 
266 
 
 
 
 
Lack of insight as a barrier mentioned by 2 / 13 SU interviewees. This is compared to 5 or 
6 / 7 psychiatrists and 4/8 CPNs. I need to return to the transcripts and check this. 
 
Being in crisis is described as a problem for SDM by most SU interviewees, especially in 
terms of problems of concentration, being able to focus on information at the time, and not 
feeling in 'right place' to make decision. I wonder if this difference in emphasis needs to 
form part of write up? Esp. in the context of a CMHT?  
   
June 2012. 
Barriers 
The morning has been spent building themes within the barrier node. I feel happy now the 
nodes are a useful way of exploring barriers talked about by service users. Interestingly, 
the two most frequently mentioned sub theme nodes 'About the service user'. 31 refs 
(being in crisis vs lack of insight  - see memo above) and ' power and control' 22 refs.  I 
think an important aspect of the write up and discussion will be centred on how to bring 
together these two components.   
 
Choice 
I need to re examine ‘choice’. For the service user data, there doesn’t appear to be enough 
nodes, to pull this as an overarching theme.  
 
July 2012. 
I have started to write the findings in time for my next supervision in a couple of weeks or 
so. 
I think it is useful to think of this as a way of assisting the analysis. It is through writing 
that some clarity may emerge. The first difficulty in embarking on this process, however is 
how to structure the chapter?  
 
After some thinking and reading other findings chapter, I emerged with the idea of 
presenting the findings of the interviews in layers, similar to the diagram suggested for the 
social science and medicine article. I can split the key themes, as coded in n vivo according 
to the 3 layers, system and structural, relationship and conversation. This will be 
presented for each stakeholder group and then a separate analysis section on exploring 
important differences and similarities. 
 
I like it, feel it makes a lot of sense for what we are exploring and helps make apparent the 
complexity. By not using such a framework I run the risk of creating a very messy picture 
with a long lists of findings for each stakeholder group without a framework to guide 
them. 
 
August 2012 
 
Version 1 of the findings chapters adopts a three layer approach: the conversation, the 
relationship, the system, incorp. diagram. This represents the overarching data themes in 
a better way than mere subtitles for examples, barriers, facilitators etc. The three layers 
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can explore the data driven themes for each layer.  
 
But I also want to return to the transcripts and focus on these question responses from the 
interview: 
 
What is the role of the psychiatrist? 
 
In an ideal world, how would you prefer for decisions to be made about your medication? 
 
Are there problems with involving people in the decisions about their medication? 
In particular, this may be useful for exploring the differences between stakeholder groups. 
I will code these questions in the structural coding folder and examine again. 
 
Excerpt following collaborative analysis meeting (also see appendix VII) 
 
October 2012 
The collaborative analysis meetings have started and are proving very insightful and 
enjoyable sessions. From my perspective it is really good to hear other people’s 
perceptions and interpretations of the transcripts and it has resulted in me going back to 
the initial coding and reemphasising certain aspects  (e.g. continuity of care, practitioner 
as going above and beyond). The team dynamics of the meeting are interesting too. The 
session (SU3 transcript) was a good example of this.  I did notice that certain participants 
in the group were more likely to assert their interpretations quickly and contribute to the 
meeting than others, but I found that by formally asking each person individually, this 
helped ensure that everyone did contribute. People in the group appear very comfortable 
and we all consider ourselves friends and colleagues now, as oppose to performing a 
certain role. At times it was necessary to seek clarification about the point in relation to 
the transcript, as some themes were poignant to group members own experiences and 
there is a tendency to move into a more general discussion. The other aspect to consider 
was the dynamic between the practitioner member of the group and service user 
members – at times I felt group members continually were seeking affirmation from the 
practitioner member and that the practitioner member would sometimes act in their CPN 
role as oppose to a co researcher for this project. I have spoken to xx about this, and he 
does reflect that often he has to rush straight to the meetings from work so it is hard to 
switch mind set quickly. But in general and most of the time, all members appear very 
comfortable with being researchers, passionate about the research and topic, as oppose to 
merely representing their profession / identity as service user/carer.  
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Appendix III. Interview schedules 
Service user interview schedule (co researcher script) 
                                    
1. Opening the interview 
 
Introduce yourself 
Your first name and little background (where you receive services/ your spouse receives services 
(if carer)).  
 
Hello, my name is xxx. I am a current / former service user / carer and I/my spouse receive services 
from xxx. I am here today to ask you some questions for a research study. 
 
A reminder about the study 
‘The study is about how mental health professionals and service users discuss and make decisions 
about psychiatric medication. We want to find out about people’s views and experiences of being 
involved in decisions about medication they have or don’t have. We think there is more than one way 
of coming to a decision so we are not looking for the right or best way for making decisions. We know 
that different ways will suit different people. We would like to hear about your experiences and your 
opinions about things like how you and the mental health professionals talk about medication and 
making decisions about this.’ 
Check consent 
Did you receive the information sheet? Have you signed the consent form to participate in the 
research? 
If not, STOP, give a copy of the information sheet, ask again if they have seen this before, check have 
you seen this before? check notes, call Emma if appropriate. DO NOT PROCEED WITHOUT 
CONFIRMING THEY HAVE GIVEN WRITTEN CONSENT. 
  
Confidentiality and Format 
Please talk about what you feel comfortable with (has control over what information is disclosed). We 
can stop at any time if that is what is preferable or take a break. Everything that is disclosed in the 
report will be made anonymous so you cannot be identified. This study has nothing to do with any 
services you receive and is independent. 
Friend or supporter present? 
 
 
Because we only have a limited time, I may need to ask you at some point to stop talking so we can 
proceed with further questions. Please do not be offended if I ask you to do this, I am just very keen to 
make sure I can get as much information from you as possible in the time we have. 
 
Permission to record 
This is a digital recorder which I would like to use to record our meeting. Is this OK? 
If unsure, explain, this is only being used so that we can make sure we capture everything you 
say, otherwise I might forget to include something which may be important in the analysis of 
the data later. When it is analysed it will be made anonymous and you will not be identified in 
the report. 
If still unsure, ask why this is causing a problem? If not easily resolved at this 
point, explain you will need to stop the interview and reschedule at a later date or 
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cancel it as you do not have the resources to do the interview without the digital 
recorder. Apologise and close interview 
 
Agree time to finish. 
This should take around one hour. Is this time OK with you? 
 
 
1. Background information  
NOTE: SHORT CLOSED QUESTIONS 
 
If I can just take some basic details first: 
 
Age: 
Male / female: 
Are you currently in receipt of psychiatric medication? Yes / No 
In general, approximately how long have been in receipt of medication (years or months – total time 
and on / off if appropriate):  
NOTES: names of meds if known: 
 
2. Making decisions about medication 
NOTE: BRIEF UNDERSTANDING OF HOW PSYCHIATRIC MEDICATION DECISIONS ARE MADE 
and WHO MEDICATION IS DISCUSSED WITH 
 
Firstly, I would like to understand more about the people you talk to and how decisions are made 
about your psychiatric medication (N/B this may include decisions around not taking medication, 
also). 
 
Can you tell me then, how are decisions made about your psychiatric medication?  
 
Who do you talk with when decisions are made about your medication?  
 
PROBE: Who is in the room: Psychiatrists, CPN etc?  
 
How often is a decision made about your psychiatric medication? 
 
PROBE, how often are things like for example changing the dose, the type of medication or 
even when deciding to stay the same 
 
How often do you talk with the above people about your psychiatric medication, but no decisions are 
made,(with each person above)?  
 
What role do you play in making decisions about your psychiatric medication?   
 
What role do you think the psychiatrist plays in making decisions about your psychiatric medication?  
 
What role do you think the nurse plays in making decisions about psychiatric medication? 
 
Who usually makes the decision about your psychiatric medication? 
 
Do you have an advance directive in place? 
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(That is have you specified what you would like to happen if you have a crisis and what treatment 
you would like or not like in these situations?) 
 
 
Are there other people involved in the process of making these decisions about psychiatric medication? 
(For example, carers, social workers, pharmacy services) 
 
Are some meetings more difficult than others for you to be involved in decision making about your 
psychiatric medication?  
 
PROBE: Does your being involved in the decision making about your psychiatric medication 
depend on anything? 
 
 
Have you learnt anything which helps you in meetings where psychiatric medication is discussed? 
What?     and how does this help? 
 
Is there anything you would find useful to you when your psychiatric medication decisions are being 
made? 
 
3. Participation in Consultation - General 
USE PROMPT SHEET IF NECESSARY 
 
I would like to explore now your general views of how people are involved in making decisions about 
their psychiatric medication. 
 
Preferences for decision making 
 
In an ideal world, how would you prefer for decisions to be made about your medication? 
 
PROBE: How involved would you like to be in decisions about psychiatric medication? See 
PROMPT sheet 
 
Does this preference for how you would like decisions to be made depend on anything? 
 
PROBE: Are there times or certain things which would change how involved you would like 
to be in decisions about psychiatric medication? 
 
Do you think your preference for how decisions should be made is typical for other service users too? 
 
If yes is there anything about your view which is different to others in your opinion? 
 
If no, why not? 
 
In general, what are the problems (if any) with involving people in decisions about their medication? 
 
4. Defining moments and some examples. 
NOTES: DETAIL IMPORTANT> FOCUS ON RECENT MEETING OR EVENT.  IF STARTS SPEAKING 
MORE GENERALLY, PULL BACK TO THE PARTICULAR EVENT. ANSWER 2 out of 3, ONLY. 
 
For each question, try to think about: 
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 Range of options 
 Identify decisions 
 Identify points of involvement 
 What factors make it memorable 
 
OPTION 1: Example of success (positive example).  
 
I would now like you to take a minute to think of a specific time in the last 6 months (a meeting for 
example) which sticks in your mind when you felt good following a decision was made about your 
psychiatric medication? 
 
PAUSE. WAIT FOR ANSWER. IF Struggling move to OTHER 2 QUESTIONS BELOW 
 
 
PROMPTS: 
OK, can you tell me about this time/meeting:  
Who was the meeting with? How long have you known them? Do you have a good 
relationship? 
 When was it? 
So what was the meeting about? Who brought up the conversation about the psychiatric 
medication> What did you say? What did they say? And how did that make you feel? OK, so 
then what happened?  
So were different options talked about? What decision was made? 
So what was it about this meeting which you think made you feel good? Why? 
What did you expect before the meeting? Were these met during the meeting?  
Did something happen in the meeting you didn’t expect? 
 
If you were to have this time again (meeting) would you do anything differently? 
 
 
OPTION 2: Negative example.  
 
I would now like you to take a minute to think of a time in the last 6 months (a meeting for example) 
which sticks in your mind when you felt not good following a decision was made about your 
psychiatric medication? 
PAUSE. WAIT FOR ANSWER. IF Struggling move to ALTERNATIVE BELOW 
 
PROMPTS: 
OK, can you tell me about this time/meeting:  
Who was the meeting with? How long have you known them? Do you have a good 
relationship? 
 When was it? 
So what was the meeting about? Who brought up the conversation about the psychiatric 
medication> What did you say? What did they say? And how did that make you feel? OK, so 
then what happened?  
So were different options talked about? What decision was made? 
So what was it about this meeting which you think made you feel good? Why? 
What did you expect before the meeting? Were these met during the meeting?  
Did something happen in the meeting you didn’t expect? 
 
If you were to have this time again (meeting) would you do anything differently? 
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OPTION 3: Defining moment. Brief exploration. 
 
Is there one meeting or time that you particularly remember, (either positive or negative), which sticks 
in your mind and involved making decisions about your medication. 
PAUSE. WAIT FOR ANSWER.  
NOTE: Use prompts (same as above questions) if appropriate 
 
If you were to have this time again (meeting) would you do anything differently? 
6. Closing 
1. Thank you very much for your time and your comments. 
 
2. Do you have anything else you want to say/ask? 
 
3. This has been very interesting/useful/helpful.. 
 
5. Remind about confidentiality. 
 
5. Arrange next time to meet- or state when I will contact them again.   
 
We will also be looking to invite people who participated in these interviews to a discussion group 
later in the research process, would this be OK if we contact you about this in the future (few months 
time)?  
 
6. Debrief: reaffirm purpose of research, check reactions and wellbeing. Give out information 
sheet with useful contacts if person has questions about their medication and/ or refer back to 
care team. 
  
7. Transcript to be looked at for accuracy?  
Would you like to receive a copy of the transcript of this interview so you can check it is accurate or 
are you happy not to receive this? 
 
Practitioner – Interview Schedule and Topic Guide 
 
Date 
Time 
Male / female. 
Interviewer comments: 
 
Length of time in position and experience. 
 
 
Opening 
 Introductions 
o Name, role and institution and little background (2 sentences) 
o This research is completely independent to mental health service provision 
 Reminder of what study is about  
 Confidentiality  
 Free to talk about what feels comfortable with (has control over the information disclosed).  
 We can stop at any time if that is what is preferable or take a break. 
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 Friend or supporter present? 
 Permission to record? 
 Agree time to finish. 
Possible starter: 
Can you tell me a bit about you and your background in ... 
(length of time in profession/ speciality ; ?training; age) 
 
Background questions 
 Overall approach to consultations and any differences to other practitioners 
 Changes in approach to consultations over time 
 The value of medication in mental health treatment programs and recent changes  
 
Participation in Consultation – General 
Can we talk a bit about your views about how people are involved in making decisions about their 
medication, in general. 
 
•     Role in decision making process. Factors that affect this. 
 Preferred level of involvement with patients in decision making 
 Examples of strategies used to involve patients in decisions 
 Level of information provided to patients and factors affecting this 
 Selection of treatment options 
 Factors affecting ability to involve patients in decisions 
 Views on role of the carer in the decision making process 
 Views towards patient participation 
 Benefits participation offers 
 Barriers to participation 
 Suggestions for assistance in decision making process (training, support, etc) 
 
 
Decisions in Consultations. Exploring defining moments and examples. 
It would help me to get an idea of the process you go through in a consultation which involved 
making decisions about medication. Could you tell me about a typical consultation (if there is such a 
thing)  
 Range of options 
 Identify decisions 
 Identify points of involvement 
 What factors make it memorable 
 
PROMPT: or think of an example of a service user you saw recently and talk me through the 
consultation 
•  Range of options 
•  Identify decisions 
•  Identify points of involvement 
 
Example of success (positive example).  
Can you give me an example of a recent (last 3 months) consultation which you felt resulted in 
successful decision being made about medication? 
 Context. Existing relationship with client, decisions made, process of meeting and exploration 
of what decision was made? 
 Reasons for success 
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 Step by step process 
 Role in the decision 
 Factors which helped achieve success 
 Barriers and how overcome 
 Expectations and fulfilment 
 
Negative example.  
Can you talk through a consultation which you felt was not successful in terms of making decisions 
about medication? 
 Context. Existing relationship with client, decisions made, process of meeting and exploration 
of what decision was made? 
 Reasons for disappointing outcome 
 Step by step process 
 Roles in the decision 
 Factors affecting disappointing outcome 
 Barriers and how to overcome 
 
Closing 
1. Thank you very much for your time and your comments. 
2. Do you have anything else you want to say/ask? 
3. This has been very interesting/useful/helpful.. 
4. Statement of confidentiality. 
5. Arrange next time to meet- or state when I will contact them again. 
6. Check transcript for accuracy? 
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Appendix IV. Removed OPTION scale analysis (phase two) 
OPTION Scale : Initial analysis of phase two data. 
This analysis has been removed from the thesis.  
The OPTION (Observing Patient Involvement) scale (Elwyn et al, 2003) was originally 
chosen for the analysis as it explores the extent to which practitioners engage patients in 
decisions about medication and undertake competencies seen to be required for shared 
decision making. This instrument demonstrates acceptable reliability (Cronbach alpha - 
0.79).  This scale was designed from a set of competencies seen to be requirements for 
SDM and has received much attention in the broader health care SDM literature. I thought 
the use of this tool might assist with the exploration of the extent of SDM in psychiatric 
medication management practice, for phase two data.  Initial analysis undertaken on the 
recorded meetings is presented below. 
 
 
 
Using this measure some skills are employed by the psychiatrist in three out of four 
meetings, including: exploring the patients expectations or ideas about how the problems 
ITEM strongly agree agree neutral disagree strongly disagree
(1) The clinician identifies a problem(s) needing a decision making
process
(2) The clinician states that there is more than one way to deal with an
identified problem (“equipoise”)
(3) The clinician lists “options” including the choice of “no action” if
feasible
(4) The clinician explains the pros and cons of options to the patient
(taking “no action” is an option)
(5) The clinician checks the patient’s preferred information format
(words/numbers/visual display)
(6) The clinician explores the patient’s expectations (or ideas) about
how the problem(s) are to be managed
(7) The clinician explores the patient’s concerns (fears) about how
problem(s) are to be managed
(8) The clinician checks that the patient has understood the information
(9) The clinician provides opportunities for the patient to ask questions 
(10) The clinician asks for the patient’s preferred level of involvement
in decision making
(11) An opportunity for deferring a decision is provided 
(12) Arrangements are made to review the decision (or the deferment)
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X X X
X
KEY- SERVICE USER NAME (pseudonym): 
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are to be managed, giving opportunities to ask questions, and allowing an opportunity for 
the decision to be deferred.  Arrangements to review the decision are also made for Rose, 
Lara and Linda. However for Lara, there is no presentation of options and no pros and 
cons of options are presented.  On the face of it then, it would appear that Lara was being 
less involved than other participants (- Carl, who is discussed later). This does not fit with 
the conversation analysis undertaken, where Lara displayed strikingly more assertive 
dynamic than the other service users. If we explore this further an obvious explanation 
emerges. In Lara's meeting, there is little in the way of a direct 'problem' as described by 
Elwyn et al in their descriptions of the SDM process (Elwyn, 2003; Charles et al, 1997). In 
fact, much of the conversation with Dr Kos and Lara centres around Lara's recent 
improvement in mood, with Dr Kos often making comments that there is much 
improvement. As such according to this narrow definition of SDM, a problem, as described 
in item one, does not exist, thereby making many of the subsequent items irrelevant. 
However a decision around medication was made at this meeting, where Lara increased 
her dose of  Lamotragine, even though a particular 'problem' was not directly referred too. 
Instead, and in fact, this meeting involved the discussion of other physical symptoms, 
including memory loss , concentration problems and skin conditions, which may have 
been a side effect of the medication. However this was not seen as a 'problem' by the 
psychiatrist and no decision making around these problems were entered into by either 
participant. 
 
Carl's meeting could also not be directly coded further than item one, using this scale. In 
Carl's example, again, no problem was identified and whilst a review of the medication 
was undertaken, no change was made at this meeting. So according to this measure, this 
meeting does not emerge as requiring SDM. 
 
One observation from this analysis is the apparent lack of fit of such a measure to 
exploring SDM for medication management practice in mental health. The importance of 
exploring the context of the meeting, and the expectations of both participants, not just the 
behaviours of the practitioner, is apparent through this analysis, and the ticked boxes 
above do not really enhance our appreciation of collaborative medication management. As 
such this analysis has been removed from the main thesis. 
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Appendix V. N vivo data driven coding framework 
CPN parent nodes 
 
 
Psychiatrist parent nodes 
 
 
Service user parent nodes 
 
 
 
 
 
Name References
Choice 4
Barriers 18
Facilitators 25
Power 11
involvement spectrum 34
Relationship 31
The conversation 33
Name References
Barriers to involvment 46
Choice 44
Decision making process 36
Desire to involve SUs 1
Facilitators 37
Involvement spectrum 8
Meeting of experts 15
Miscellaneous 2
Power 11
Process over time 11
relationships 18
SU empowerment 11
Name References
Barriers 104
Choice 5
Facilitators 45
Involvement spectrum 48
Other sources of information 16
Power 21
Process over time 20
relationships 22
The conversation 49
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CPN first stage coding 
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Psychiatrist first stage coding 
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Service user first stage coding 
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Appendix VII. Example transcript and coding following a 
collaborative analysis session 
 
N vivo coding framework from collaborative analysis transcript (service user 3) 
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Appendix VIII. Jeffersonian transcription convention used for 
phase two recorded meetings 
 
Abbreviated Jeffersonian transcription conventions. 
Adapted from Atkinson and Heritage (1999), pp.160-166.  
 
[[  Simultaneous utterances 
[ Overlapping utterances 
= Contiguous utterances 
(0.0) Intervals between utterances 
(.) A short interval between utterance 
::  Extension of sound or syllable 
^ rising in intonation 
___ emphasis 
CAPS Capital letters are used to indicate at utterance that is spoken much louder than the 
surrounding talk 
(( ))  gesture or expression 
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Appendix IX. Example transcript (phase two) 
UNEDITED TRANSCRIPT: ROSIE 
This is a review meeting, lasting 22 minutes between Dr Kos and Rosie. No other people 
were present in the meeting.  
------------------------------------- 
2 mins: General discussion: new house and housemates, possibility of funding a course and current 
situation with benefits. Concerns about money. 
2 mins: Rosie raises concerns about hearing voices She says she just wants them to go away now. 
Asked how often, every day? What do they say? Extremes either good things like patronising 
complements or it can be the opposite negative Does mood have an effect? Yeah 
2 mins: Rosie mentions that she wants to do more exercise but that the gym is too expensive. The 
conversation then returns to hearing voices.  R then asks when the voices happen, how I should deal 
with it, should I ignore it, should I answer back?  Psychiatrist says, Is it around when at home and no 
one around? R: when at work was better was more focused, P:  so activity is good, so a course and 
learning something new is a good idea and part time jobs and routine very helpful distracting yourself 
or ignore……  
---------------------------------- 
6.20  
1. P:  Did you find actually that uh when you uh were on the amosulpride th::at you had le::ss voices 
than you having ye::s[ 
2. R:  (mumbling)   [h u:m 
3. P:    [yeah da yeah (.) but:t they probably had side effects are ::n ther[ 
4. R:          [  ye::s even on the lo::west d 
5. P:              [even even on the (.) fifty milligrams you had the side effects = 
6. R:  ye[ah 
7. P:       [yeah HOW do you find uh the aripriprozole do you have any problems at all and the side  
8.  effects with the [ 
9. R:  [ UUM I get quite sle:::py [ 
10. P:     [ uh hum 
11. R: um in the mornings its very difficult to g::et u::p[. 
12. P:       [ uh hum 
13. R:  E:ven if I go to bed at t::en I could still (.)[wake up] at te:n or twelve e:ven (.) u:::m (2) nnn  
14.      [uh hum]     
15. R:  apart from that  its OKay.= 
16. P: Its OK. So (.) Umm so there was also concern about we::ight gain when you went on the  
17. amosulpride DO you find that you uh might have lost some weight since you are on the aripriprozole 
      R:  Yeah= 
18. P: yes:s 9.) so it defina << ley but the voi::ces are slightly [bit worse] 
19. R:                   [uh hum] 
20. P: Do you think it is because of the medication of becasue you had a job at that ti::me and we::re 21. 
more busy busier [ 
22. R  [ UUHH actually I have to admi::t that I have been dri::nking alcoho::ll aswell s:::oo 
23. u:::mm that’s pro::oba::bly the thing to consider = 
24. P: How m[uch 
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25. R:  Its s::ooo difficult lik::e all the social [pressures] 
26 P: [ uh hum] 
Time: 7.40 
------------------------- 
2 mins: Discussion about living in a shared house and peer pressure of drinking in new accommodation. 
-------------------------         
    
Time: 9.40 
27 P: (1) A::nd do you think that uh um your house::mate might understand that you cant drink 
28. alcohol or it would be difficult difficult to re::fuse= 
29. R:  We::ll I don’t know thats the difficulty [because] he knows that I’m on table:;ts so I was open   
30. P:      [uh hum]  
31. R: about that after a couple of weeks of saying no (.). He only knows that Im on anti 
 32. depressants uh becasue uh theyre in my cupboard and I just thought he they might[ 
33. P:          [Ye::S 
34. R:  a chance that he would see them (.) uuuhmm bu::t he’s quick to label so (.) there’s a lot of (.)  
35. uum he also somebody to say have a drink 
Time: 10.08 
 
36.  Discussion about peer pressure to drink by housemate and fear about housemates finding out  
37.  which medication on apart from anti depressant (stigma) 
 
38. P:  But at the moment  you don’t fee::l that uh they are excluding you or or they seem to be or = 
39. R:  I don:::t kno:::w I find it so::o difficult to get past my own moo::d [ 
40. P:         [ yes yes 
41. R:  and the voices as well  
42. P:    [hum um 
43. R:  which leads me to my next que::stion (.) would it be::e possible to try a different medication  
44.  at sometime  
45. P: Yes I think it might be a good idea to see whether you have any (.) uh (.) I mean  we switched 
46.  to aripripozole simply becasue of the side effects you had on on a amosulpride and uum (.) and it  
47.  might be worth to to try something different because even the combination of the two when you  
48.  were taking a very low dose of amosulpride then it seemed to work (2) because of the side  
49.  effects 
50. R:= because of the [side effects] 
51. P:   [side effects exactly (.) so u::m (.) in terms of other medication I mean are  
52.  you happy on venlafaxine in terms of the mood do you think thats that working 
53. R: Yes= 
54. P: YES yes  we we will not change that so really the question is whether we should change the  
55.  aripriprozole uh the afilofy to something different (.) in terms of uh (.) a group of medication  
56.  which are the same group of medication you you youve taken amosulpride and it has side effects  
57.  and the other ones are olanzapine uh quitayapine respiridone have you had any experience with  
58.  any any of these = 
59. R:  Unfortat:::ely [ 
60 P:    ALL OF them= 
61. R:   Most of them no:::ot  [olanzapine] but all the rest Ive tried respiridone I find quite str[ange] 
62. P:    [ uh hum]           [huum] 
63. R:  quitayapine I got (.) I felt quite [fra:::ile] with it and um (2) what was the other one?= 
64. P:     [hummm] 
65. P: Uh (1.) uh olanzapine I think olansapine what you mentioned  
66. R:  Olanzapine I haven’t tried 
67. P: Yes yes[ 
305 
 
 
 
68. R:  [Ive heard that makes you eat lo:::Ads so  
69. P: Yess I mean this this can this can be a side [effect] yes 
70. R:        [humm]  OKay mayb::e a low dose would be 
71.  Okay= 
72. P: Yes yes yes And in terms of the uh the problem you had with the amosulpride I think it’s less  
73.  likely with olan::zapine (.) so youre prolactin level was quite high even on the small  dose of 
74.  amosulpride I hope thats much less likely on olanzapine BUT I think what we should do we  
75.  should have a prolactin level tested now just to have a baseline level and probabl::y ab::out a  
76.  couple of weeks later just to see whether you have any problems on olanzapine and well keep an 
77.      eye on your uh on uh your eating and on your weight as well. SO IF you if you would join the gym  
78.  no::w that would be a very good idea because then then uh (.) then you might be able to to kind  
79.  of control the the weight gain, the weight gain unforttunatley can be side effects with the  
80.  olanzapi::ne= 
81. R  Would the la::dy in the social inclusi::on (.) help me with that? 
82. P:  Yes  I think I think what we should do just uh (.) because um Charlie is no longer Charlie is on 
83.       sick leave and you don’t really need THAT kind of support that you have been receiving from her 
Time 15.10. 
----------------- 
2 mins: Discussion about who else in the team Rosie is currently seeing. Discussion about housing 
contract. Discussion about alcohol, social drinking and its effects on mood 
------------------ 
Time: 17.50 
84 .P:  So uh HOW would you like to proceed Would you like me to uh uh to prescribe medication  
85. t oday or would you like to have some reading first uh or think about it and then um and  
86.  then you can (.) see your GP and I can send the recommendation to your GP about how  
87.  to change it to 
88. R: UUMM I would like it if you prescr:::ibed it [today] if thats Okay  
89.P:           [uh hum] 
90. P: Yes so in terms of  in terms of sides effects what we discussed that if you compare to  
91.  especially aripriprizole you mi::ght feel that youre appetite increased so its uuhh (.) and and  
92.  weight gain might be an issue and generally also what we recommend that you have uh um a 
93.  blood sugar level tested once a year (.) before you start taking the medication MAY I ask you uh  
94. (.)  to have an appointment with your GP for a prolactin level tested JUSt in case to make sure  
95.  that we are uh you have a normal level now if we if for ANY reason have an increased uh uh uh 
96.  rating then its not because of the (.) ol::anzapine 
97. R: Yep yeah 
98. P: OKAY AlRIGHT, so I will I will send the fax to the GP and I will prescribe the medication and I 
99.   WILL let you know how I would like you to take so you are taking uh thirty milligrams of 
100.  aripriprosole is that right? 
101. R:  Uh hum = 
102. P: (.) Do you take it uh in the evening or do uh  
103. R:  in the evening[  
104. P:  [ in the evening so I WOULD like to ask you that once you  start once you have the 
105.  prescription or you can start the olanzapine you had a blood so if you had a blood test  
106. tomorrow you can start taking the olanzapine you DONT have to necessarily have to wait for 
107.  the results (.) just I think it would be a good idea that you have a blood test first 
108. R:  Okay 
109. P:  So reduce the aripripisole to twenty milligrams and take olanzapine 2.5 this would be uh day 
110.   one (.) and day two (.) and the::n (.) on day three (.) please drop the aropriprosol (1) to 10  
111.  milligram only and increase the olanzapi:;ne [to]  five milligram and then this would be day 4 (.) 
 112.  and day five (.)  
113. R:         [yep] 
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114. P: You stop the aripriprosole (1) 
115. R: Okay 
116. P: But you take the olanzapine seven point five milligrams  
117. R:  Okay 
118. P:  And uh and I will talk to the team and also offer you an appointment in a couple of week s 
119.   time to review how things are going I WOULD like you to ask to stay on the seven point five 
 120.  milligra:::ms  this especially if  you found the quitapine uh a little bit making you drowsy I think 
121.   you don’t have to increase the dose any further  
122. R: Okay 
123. P: If you FEEL that on the seven point five you are drowsy but you absultely fine on five then 
124.    just stay on five milligram [SO] so what I will do in order for you to  have five milligrams and two  
125. R:   [Okay]  
126. P: point five I will provide you with a prescription of two point five and five::S milligrams  
127. R: Uhhum 
128. P: so which will you the flexibility that in case if you can’t tolerate the seven point five you can 
129.   still reduce back to five milligrams 
130. R:  OKaY 
131. P:  oKAY okay. 
Time: 21.06  
 
Appendix X  
Terms of reference 
The terms service user and patient are used interchangeably throughout the text. This 
reflects the different literature which is referred to in the text and the different context 
and connotations the terms service user and patient encapsulate. Many other related 
words, such as ‘consumer, client and user’ are also apparent in the literature referred. 
These terms have not been used to allow for greater consistency and ease of reading 
throughout.  
‘Practitioner’.  Again, in order to maintain consistency I adopt the wording 
‘practitioner’. This may reflect other terminology used in the literature including, 
clinician, mental health staff etc. 
 
